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FOREWORD 
This volume is a n  account of a brief but intense experience with transplan- 
tation of kidneys into uremic patients. Despite the involvement of many individ- 
uals and the representation of many interests in a project of this sort. the mo- 
t i1.e~ ha\.e been simple and fen-. namely. to help the patients alld-to the extent 
possible - accuinulate da ta  that \\-ould allolv e\  aluation of' current conccpts and 
methods with an eye to the future.  Although the procedure is a n  experimental 
one. there has  been little experimentation in thc usual sense. but simply a n  in- 
tense effort to  care for the patients in the 1)est possil~le manner  Sollo\\-ed by 
careful obserx.ation, abo\ e all, careful recotxling of' data.  and. fillally. frequent 
summation and analysis of results. Certain dil idends ha\ e accrued from this 
approach, and there are also disad\.antages. The tnethods of' m;inagement have 
varied little. making it possible to accjuire a hoinoqeneous bod! of data  from 
which some conclusions have been reached \vith a degree of certainty that  was  
not pre\.iousl!- possible in evaluating renal transplantation as it exists in 1964. 
The main and far-reaching conclusion is that orqan transplantation has  
some cliriical application ~ v h i c h  is not yet perfect but is mox-ing in that  direction. 
It seems of qreat ii-nportance that  foul- of the first six patients ill this Denver 
series are still xrell. Doctor Sta~,zl  and the nunlerous other people \ ~ h o  ha\-e con- 
tributed to  the project and to this \-olume h a \  e n-orlieti Iiaid to cal,r>- out such 
transplantation research in addition to their usual clinic~rl and teachinl: duties. 
They deserl-e our thanks. 
\T'ILLIA&I R. \TADDELL, M.D. 
Professor and Chairman 
Departmeilt of Surgery 
Uni\-ersit! of Colorado 
School of hledicine 

PREFACE 
The past 20 years have been a time of unprecedented progress in  the field of 
tissue transplantation, as attested bv thousands of published experimental stud- 
ies which treat of'the events, n~echan isms ,  and prevention of rejection as  well a s  
innumerable other facets of' the problem. Throughout this period, there were 
sporadic attempts to apply renal honlotransplantation to the treatment of hu-  
inan disease. During the past f 'e~v years, such eff'orts ha\-e become more insist- 
ent  despite the fact that  the pooled results of' cases fro111 throughout the world 
present a dismal picture of' repeated failures and only an  occasional success. 
The ethical and moral issues in \  ol1.t.d in a clinical undertaking of'tllis type have 
beell sub,jected to critical scrutiny. especially by those in\-ol\-ed in the actual  
care of the patieilts, and by others as ~vell.  
The place, if an!-. of renal hetero- or homotransl>Iantation in the treatment 
of terniillal renal disc,ase is not yet clear. To say that the problem of homograft 
rejection has 1,een s:xtisl'ac.toril\- solved is f'oll!-. The converse \-ien- that this 
means of therap! has  110 real 1-alue ivould, hon-e\-er, appear to be an  equally 
lilnitecl attitude. A11 operation 1111icll can in the iildi\idual case pro\.ide five 
years of re l~i t i~ .e ly  healthful existence, as has  been the case in lIurra!-'s first 
successful transplant bet\\.ee~l a nonidentical donor and recipient, cannot be 
said to be ~vi t l io~i t  si':llific;int tvorth ;it least ill the isolated c,ase. 
The collections that ha\-e heen made of total experience n.it11 h u m a n  renal 
homotransplantation cannot be acc.epted as accuratel!- reflecting the outlook of 
a patient to be treated in this \!-a? toda!. Such compilations often do not delin- 
eate the deficiencies of those t11er:ipeutic nletllods e~nplo!-ed in the earl!- era  as  
compared to the modern one. In order to characterize the lirnitations and the 
spheres of usefulness of renal l ~ o i ~ l o t r a n s p l a l ~ t a t i o ~ ~ .  it is desirable to analyze 
the results f ~ o n l  series in 1vhic.11 hoinogeneous care has  heel1 pro\ided. Objec- 
ti\-e scrutin>- of such series can s e n e  as a better index for e\~aluation o f t h e  pro- 
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cedure than occasional cases treated in different ways, by different personnel, 
and with s-arying case selection and follow-up. 
Thus. the primary objective of this book is not to recapitulate all previous 
experience with human renal transplantation. Rather, the purpose is to present 
a simple and practical analysis of those cases treated by this means at  the Uni- 
versity of Colorado hledical Center. in order to help define the indications, tech- 
nical requirements. limitations, causes of failure. and results at one institution. 
The laboratory effort supporting the clinical program will not be treated in 
detail. It is sufficient to say. however, that no program of human renal homo- 
transplantation can hope to succeed without a strong collateral investigative 
effort involving animal research. 
Although primary attention will be focused upon cases treated in this 
series, it kvould be inappropriate not to state that most details of both the tech- 
nical and nonsurgical care have had their origin in other centers.The pioneer 
contributions of Murray, blerrill, Hume. Calne, Kiiss, Goodwin. \1700druff, Ham- 
burger, and numerous others have provided the base from which our efforts 
have begun. Furthermore. the personal encouragement. advice, and unifying 
exchange of information from most of these men have made it possible for us 
to pursue this work at a time when the effort might otherwise have been dis- 
continued. 
It is to be hoped that the publication of this work with the large number of 
cases involved will not be misconstrued as evidence that renal homotransplan- 
tation has now outstripped its infancy, or that the procedure is ready for general 
use. The employment of renal homografts is still a fundamentally experimental 
practice, which is attended by a distressingly high incidence of early failure 
even under the most nearly ideal circumstances. hloreover, the fate of homo- 
grafts in terms of function for years or decades is not known, and can be learned 
only after the passage of time. There will inevitably be an increasing experience 
with human renal transplantation, but a stampede of uncontrolled activity at  
this time will serve no useful purpose. and may discredit the operation before 
its merits are fully determined. 
A special note is ~varranted concerning the type of environment in which 
renal transplantation can be carried out with benefit to the patient and to the 
scientific community. In its present developmental state, homotransplantation 
requires an institutional effort. since es-en the studies which are necessary to 
document the course of a single patient are beyond the knon-ledge. skill, and 
time of any indi\-idual or small group of physicians. 
Thus, the program at the Universit!. of Colorado AIedical Center has had 
strong representation from almost el-ery major preclinical and clinical depart- 
ment. In addition to those who ha1.e written chapters for the text, important sup- 
port and independent effort has-e been contributed by Doctors Robert S. Brittain, 
Gilbert Hermann. Olil-er G. Stonington. I.C.S. Knight, hIartin P. Hutt. David W. 
Talmage. IIatthew H. Block. David A.  Ogden. Philip L. Dern. James L. Tong, 
Kurt N .  1-011 Kaulla. Ruheri .I. Perez-Tanla!-o. Carlos E.  Garciga. Dal-id S. Le 
Vine. John H. Githens. Conrad 11. Riley. Joseph H. French. Dal-id T. Rowlands, 
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Jr.,  Catherine \V. Anthony, Elizabeth H. Alacintyre. David E. S tarre tt. Frederick 
H. Herring. James K.  LVear-er. Eugene Heller, and Arnold H. Greenhouse, 
as well as illan>- pediatric. medical, and surgical interns and residents. 
In addition. such a program could not be sustained n-itliout unrs-avering in- 
ternal support from the adnii~listration of tllc in1-olr-ed hospitals. There are 
many I exing problems which concern tlie financing of hospital care. relocation 
of bed cluotas. and establishment of special in\  estiqatil-e facilities. to mention 
just a fer!-. -1 deluge of unn-anted l a y  publicit!- has pro\-ed to be una\-oidable, and 
those officials n-110 are entrusted n-ith presenirlg the dignity and integrity of 
institutions both here and elsewhere ha\-e 11een confronted with many painful 
and unf'alniliar dilemmas. Doctors Robert ,J .  Glaser and John ,J. Conger, the past 
and prcsent Ilcans of the Unis.ersit!- of Colorado lIedical School, provided such 
support fro111 the l~eginning: as did Doctors Paul 11. Ireland and Joseph A. Hall, 
the Hospital Director and Chief of' Staff'. respectir-ely, of' (lie Denr-er \'eterans 
Administration Hospital. 
Finall!-. the de\.elopl-nent and grorvth of a 1i1e:iningf'ul transplantation en- 
dea\-or is llot possible without that unique dual p e r s o n a l i t y  the able adniinis- 
trator who is also a rvorking and inr.entir-e scientist. Doctor \\'illialn K.  \I.addell, 
Chairman of the Department of Surgery of the Uni\-ersity of Colorado 3Iedical 
Center, has filled this role as fe\v men could har-c. His  influence has  been felt 
from tlie initial planning stages to the present time in all aspects of transplan- 
tation research as well as in the peri'orn~arice of day-to-d‘iy patient care. In  addi- 
tion to helpinl: formulate medical policy. he has  sub,jt.cted himself' to personal 
sacrifice in ordci. to raise f'uncls f'or continuation of' the rvork and to insure that  
the ine\.itable release of information f'or public consumption would be done with 
propriety and accuracy. The faults of' this book 1 inust bear alone. Its merits, if 
an!-. result f'roln a collaboration r~- i th  iin rvhich is based upon 110th 111~1tual sci- 
entific interests and a Ivarin personal friendship. 
Denz~er .  Colorado THOMAS E. STARZL 
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Chapter One 
INTRODUCTION 
Although the possibility of organ homotransplantation has  intrigued 
surgeons since antiquity, nlajor strides toward this end have been achieved 
only in the past few years. Iniiially. progress avas limited by lack of un-  
derstanding of the processes in\.ol\-ed in homograft rejection. Prior to the be- 
ginning of the Second Li'orld LT'ar. many physicians believed that  homograft 
rejection avas the consequence of a primary technical failure. In 1944 and  
1945, hledaavar published the classic studies which not only defined the events 
that transpired after the placement of' skin homograf'ts. but pro\,ided a rational 
explanation for the rejection process. He demonstrated that  hoinografts 
behaved initially in much the same manner  as autografts, but that they were 
eventuall!- sloughed after a \ aryinr: period of' time. The histologic altel -a t '  lons 
in the transp1:lilts coiisisted of n~ononuclear cell infiltrates. a a-ariety of vas- 
cular lesions, and eventual distortion or destructioii of' the normal architecture. 
IMMUNOLOGIC REACTION OF HOST 
RIedan-ar's studies pro\-ided strong evidence that  these phenomena were 
due to a n  immunologic reaction of the host to the foreign tissue (Fig. 1). The 
key obser\.atio~i in support of this concept was that  once a homograft had been 
placed. second graft from the same donor avas destroyed in an accelerated 
fashion (second set reaction 1 ,  suqqesting the acquisition of host immunity. The 
immunity conferred by contact I\-ith the first graft Ivas of 1011% duration. and  
applied to all tissues s ~ ~ l ~ s e q u e n t l y  transplanted from the same donor. The sen- 
sitization \\-as specific, i n a s n l ~ ~ c h  as homoqraf'ts from other donors 11-ere not 
rejected in an  accelerated nlanner. -1 feeble quantitati\-e effect lvas noted by 
AIedan-ar. ~ v i t h  Inore rapid 1.ejec.tion of larger than of smaller grafts. 
These important o11ser1-ations 11-ere soon extended by Dempster and  by 
Simonsen to 11-11ole orqan honloiirafts of the kidne!-. in i\-liich the nlode of re- 
\'ascularization is quite different. Free skin %rafts sur\-il-e \\-ithout isll~nediate 
restitution of blood supply. re\-ascularization occurring from the graft bed over 
1 
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Immune $y$ t em a$ " Eon-~el~' '  with 
Qvent7dal rzqECtlon. 
Figure I .  Response to autografts (left) and homografts (right). Tissues transferred between iden- 
tical twins behave as autografts and are notrejected. 
a period of days. With kidneys, a blood supply is promptly restored by means of 
surgically performed vascular anastomoses. Despite this difference the fate of 
rena l  homografts  was  comparable  i n  most respects to t ha t  previously 
described for skin. 
The delay between exposure to a foreign graft and rejection has prompted 
comparisons between homograft immunity and the delayed tuberculin type 
sensitivity. Howe\.er, the precise details of homograft immunity are not 
known. The nature and location of the antigen and of the resultant antibodies 
are matters on which there are conflicting opinions. There is abundant evidence 
that the reticuloendothelial system plays an important role in rejection (Fig. 1). 
After the placement of skin grafts. the regional lyn~ph nodes become enlarged 
and packed with large lynphoid, reticulum. and plasma cells, while a similar 
reaction is seen in the subjacent graft bed. A11 x-ascularized homografts are 
ultimately invaded by lymphocytes and plasma cells during rejection. If70rk 
by \f7eaver. Algire, and Prehn has focused attention upon the small lymphocyte 
as the ultimate cellular agent of destruction (Fig. 2). 
Although it has been customary to think of homograft rejection primarily 
in terms of a host cellular response. recent el-idence has pointed to the pos- 
sibility that humoral factors may also be of great practical importance. 
Najarian and Feldman's inl-estigations. ~vhich demonstrated the in\-ocation of 
a presumed host hulnoral rejection factor b>- specifically sensitized tissues 
isolated in millipore chambers, is particularly pertinent in this respect. Clini- 
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Figure  2. Diffusion chamber experiment of Xlgire. The enclosed homograft which is protected 
from physical c o n t : ~  t ~ v i t h  Iy-mphoc,>-tes can ,,ur\ i \  e f o ~ .  protrac teti periods. 
callv, A I u r r a ~  a n d  his  .issociates ,111~1 H'iniburqer ha\ e also d r a w n  at tent ion 
to the piob,il~illt\  th,it \ ~ ~ d d ( ' ~ i  h o t l i ~ q l , ~ t t  f , t ~ l u ~ e s  could be clue to humoral  
factors onl \ .  ]lot onl\ 11ec ,lustx of t l ~ e  I c l l ~ ~ d i t ~  of d c > s t l ~ ~ ~  ti011 of sollie grafts,  bu t  
hecausc hi\toloiic c.1 icic,nci of tc~l!ul,ii ~ n h l t l , c t ~ o l ~  11,is oftell i ~ o t  11eei1 piesent  
under  t h t ~ s c  c licurnst,lnc i s \  I ~n , r l l \  c \ ~dr ,nce  to I)e dr.scr11)r.rl \ ~ i t h l n  0111 own  
experic,rit c 11~is rlqqc st(  ci th.it io~iic d~ Io tc>i lo~~\  c ' f f c ' c  1 i  upon  thc. l io l~ ioqi~rf ted  
kidlie\ must  11c~ t x l ~ l ~ c  <ll)lc I ) \  11)r.c 11 ,1111i1 i i i  otll( 1 t h , ~ r i  < ( l l t ~ l < r t  111\ <1i1011 1 hese  
\ .~r ious of ~nfc.lc~ntr,il (,\ i t l r . i icc3 I I , I \  c I ( ~ c 1  to co~lslclet ,cIjle spec u l , ~ t i o ~ i  t ha t  
.in lml)ort,lnt. i f  not \i t , i l .  el(ln~cl~it of the lc3jectlon plocess m,i\ be .In im- 
rl~unoloylc .11l\ m c d ~ ~ i t c ~ d  p ~ o c  (>ii 11 I11c 1 1  I I I \  oI\ (,i t l i r  I)lood \ t,isels. leadinc: to a 
\ ascul,ll c ,~ t a s t rophe  \\ hich el ther  occurs i n d e p e n d e n t l ~  or  concomitantl> wi th  
cellu1,ii in \  ,ision 
Methods of Altering Host's Reaction 
Because of the el-idence indictilig a n  immunologic etiology for  homograft  
rejection, it \ T  a s  na tura l  tliat i i t te~ition slioulcl 11e focused upon m e a n s  of al- 
tering the i~ i i l~ iunologic  c ;ipacit?- of' the prospecti\-e host.  
Totril Botlli I r ~ . c i t l i c i t i o i / .  IIost c~onditioninq ~1- i th  total body irradiation w a s  
e s t e n s i ~  el!- e l  alu,ltc,tl fol. this 1)urpose in 111c~ e,il.l! 10.50's. Successes in csperi- 
~ n e n t a l  ;iiiim;rl.; i~-el.c> ].;ire I ) cc , ,~ l~ ie  i ~ ~ ~ ~ , r d i ; ~ t i o ~ ~  o  i i , j t , ed  the treated an ima l  
tha t  sul.1 ir-ill ill , r  ~iol.tli,~l e n \  i r o ~ ~ ~ i i c ~ ~ i t  i r i  i11iposiiI)le. T11e ~ n r t l ~ o c l  of total 
l ~ o c l >  i i , ~ . ~ ~ d i a t i o ~ i  ~ \ ; r i  2 j \ ~ ! i  ( l i ~ ~ i ( ~ ; r l  1ri~11 I ) ? ~ I U Y I , ~ ~ \ -  c r ~ i c i  liis ~l<ioci:ites a t  the 
Peter I:ent E ~ ~ i y l i ~ i n i  Hoil,jt,rl i l l  the. 11iid 1050 ' i  . l!tliouzli o ~ i l ?  olir iuc,cesi  w a s  
at tained.  this 11 .I\ .\ ijzn,il f , \  f:~it iinci. :he i.i.ci11ic.lit of tliis l ic~~nogr~i f ' t  fl.olii his  
~ ~ o l i i d e ~ i t i c a l  t i ~ i n  I~t~otl icr  i. i t i l l  .ili\ t. ,inti i. the hrst ex, i~nl) le  of .I c l i~onica l ly  
s u c c e s ~ f u l  h ~ ~ m , i ~ i  h o n i o t ~ ~ ~ r ~ i ~ j ~ l ~ ~ ~ i t ~ t t i o ~ i  I t ' t i ~ c > i . l i  .r t io t io~  ,ind recipirnt who 
11-ere ~ c l i e t i c  ,1l1? dlfi t ~ , r ~ i t .  Tlic 11io.t c o ~ i i i ~ i o ~ ~  c ,ruse of f ililure \ I - , I ~  hone 
InarroIi- d c ~ p ~ ' e ~ i i o i ~ .  ,iz1.;11111li1c\ toii.. . i ~ i t i  o \  el.iT 11i~l111ji1: i l ifei t i o ~ l .  S ~ l 1 , ~ e c ~ u e n t  
efforts I ) ?  E L I I , O ~ ~ . ~ I I ~  1111 c~ . t i~ : i tor~ .  ~ i o t ~ t l ~ l \  K ~ I \ .  Lil ic i  l I c ~ . ~ ~ ~ l ) ~ ~ ~ : ~ ~ i ~ ,  i ~ ~ r e  iome-  
\vhat Inore ~ ~ i i c t . s i f ~ l .  h c - \ e l ~ r h c l e ~ s .  the piohpect oi dcliieiiiig collsistent 
success ~vi t l i  thi, approac.11 li'ii ultini;itel! appeared to be ~~ i r tua l l !  hopeless. 
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Drug Inzmu~zosupp~ession.  A new chapter in immunosuppressive therapy 
was opened in 1959 by the work of Schwartz and Dameshek, who demonstrated 
an  obtundation of immunologic response in animals which were exposed to 
foreign protein antigens while receiving 6-mercaptopurine. One year later, 
Schwartz and Dameshek, Calne, and Zukoski independently demonstrated 
that this drug prolonged homograft survival. Still later, Calne and Murray 
demonstrated an  improved effect with a chemical compound closely related to 
6-mercaptopurine, termed azathioprine, especially if it were combined with 
weaker antirejection agents such as actinomycin C and azaserine. These drugs, 
alone or in combination, were superior to irradiation in that their effects were 
more incisively directed. It was possible with these agents to inhibit homograft 
rejection without the production of agranulocytosis. Thus, for the first time, 
rejection could be prevented or delayed without rendering the host totally 
nonreactive against other environmental antigens. 
CURRENT STATUS OF 
RENAL HOMOTRANSPLANTATION 
Despite these encouraging findings, it was not yet possible to obtain con- 
sistent success with homotransplantation procedures, either in experimental 
animals or in man. Like the elusive jigsaw puzzle, in which many of the pieces 
had been fitted into their appropriate slots, the picture was not yet complete. 
The pioneer efforts of Murray, Kiiss, Hamburger, and Hume had all demon- 
strated that a renal homotransplant was capable of protracted function in- 
the occasional case. If this could be achieved sporadically, it seemed reason- 
able to expect that the proper manipulation of a number of small details might 
provide a consistently successful solution. Despite this expectation, almost all 
renal homotransplants had failed when, in the spring of 1963, Goodwin and 
Martin compiled the known renal transplants from various centers throughout 
the world. Less than 10 per cent of those cases treated to that time had survived 
for as long as three months. 
The courageous and often tragicall) unsuccessful attempts of the early 
pioneers provided a vast. although frequently uncatalogued. background of 
valuable information upon which future progress might be built. Quite apart 
from the information obtained concerning the prevention of homograft rejec- 
tion, important strides were taken of a purely technical nature. The surgical 
technique described by Kuss in 1951 was popularized as a result of its use by 
Murray and Harrison for the transplantation of kidneys betn-een pairs of iden- 
tical twins (isografts) in 1954. Subsequent repeated successful experiences 
with identical twins have contributed much to the definition of effects of is- 
chemia upon subsequent renal function, the response of the host patient to 
sudden alleviation of his complex metabolic disorder. and the unique problems 
of pre- and postoperative care presented by these chronicall)- and terminally ill 
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patients. As will be suggested, it is possible that  extrapolation of these lessons 
to the field of true homotransplantation has  been too free. 
Despite the great ad\-ances made by the aforementioned pioneer workers, 
as lvell as man>- other investigators, renal homotransplantation is not yet 
regarded as a standard surgical operation. because it has  failed to conform to 
certain criteria. These requirements are:  first. that  the operation be performed 
\vith all acceptabl>- l o ~ v  mortality: second, that the patient he restored to a rea- 
sonable state of health for a significant period of time: and finally. that  the 
financikil burden of care should be ~vi thin  the reach of the patient, the hospital, 
and the cornmunit!-. If' these practical objectil-es could be achiel-ed, it would be 
possible to extend the use of kidney transplantation to a more general utility in  
\vhich such care could be offered in a n  increasing number  of hospitals. 
Experience at the Uni\-ersity of Colorado 3Iedical Center within the past 
year has  led to a g~.on.ing hope that these objecti\-es may be \.r-ithiri reach,  a t  
least n i th in  a highl! st~lectecl group ofrecipients. The purpose of this book is to 
documt.nt expc1.iellc.c \\it11 ;dl the patients treated a t  the University of Col- 
orado AIedical ( - ' c , ~ l t r . ~ .  f'1.0111 .1Iarch 27. 1962, to AIarch 30. 1964. During this in- 
ter1.21. 75 renal transplants Lvere perf>rmed, 73 involving the transfer of kid- 
neys from donors othel  that1 identical txvins. In the course of this experience, a 
\.ast alnoullt of' i~if 'o~,~liat ion has been obtained relating to the procurement and 
presen tition of' the graf'ted tissue during its transfer, details of' the iniplanta- 
tion of the orqan, the relationship of ABO blood group incompatibility betxveen 
donor and  r e c i ~ ~ i e n t  to success or failure, the influence of consanguinity on 
re,jection, the 1.elatio11 of early f'uiiction to the ultimate outcome, the identifica- 
tion and  t h e  r , e \e r sa l  of t h e  re ject ion process ,  t h e  de \ . e lopment  of h o s t  
tolerance to the homograft, the ability of the sur\,i\ ,ing patients to resume 
nornial acti\-ity while receiving i~nrnunosuppressi\.e therapy. the procurement 
of cacla\ eric organs. the influence of age and associated disease ~ipoil  prog- 
nosis. ant i  the potential future \ alue of heterografts. 
The chapters \\-hich folio\\ contain an account of the procedures employed 
a t  th is  c e n t e r  in  the  t l ,ea tment  of pa t i en t s  recei i - ing r e n a l  homo-  a n d  
heterotranspl~ints. Although some of the details ma>- seein trifling. they are 
presented in f'ull for tivo reasons. First, the problem of patient care is so 
co~-nplex that the olnission of a single precautionary facet has  on occasion led 
to an  inexorable chain of ud1-erse e\-ents and death.  Second, the steps n-hich 
are ilnportant. and those x\-hich are inconsequential. ha\-e not yet been clearly 
delineated. For e\-aluation of the methods used, it has.  theref'ore. been neces- 
sary to describe each detail, in the hope that eventual simplification of overall 
procedure mill he possible. 
Throuqhout  the  text .  t h e  courses  of i n d i \ i d u a l  p a t i e n t s  ha1.e been  
frequentl>- used to graphicall!- illustrate certain features. I11 addition. tables 
ha \  e been included xvhicli summarize the influence of 1 arious factors upon 
results. Such t,xbles. \\-llich lvere brought up to date 011 J u n e  1. 1964. ha\-e been 
dra~r-11 clliefl! from those earlier cases in n-hich longer folloxv-up makes 
analysis more nleaningful. A11 extended sumnlar>- of all patients operated 
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upon prior to March 31, 1964, is included in the appendix, brought up to date to 
June 1. 1964. In this tabular summary (Chap. 28), the patients are listed in 
four groups depending on the source of the donated organs. The categories are: 
1, living donors (LD): 2, cadaveric donors (CD): 3. simian (baboon) donors (SD); 
4, identical twin donors (ITD). Each illustratioii in the book is coded so that by 
cross-referencing to the appendix, the current status of an individual patient 
can be readily determined. Thus. further details of the patient identified as LD 
2 in Chapter 2 (Fig. 3) can be quickly obtained by consulting the same number 
in the appendix. 
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Chapter Two 
PROCUREMENT AND ORGANIZATION 
OF DATA 
T h e  ca re  of pat ients  receiving r ena l  homotransplants  crosses all specialty 
barriers,  involving a s  i t  does the  services of t he  internist,  hematologist,  urol- 
ogist, pediatrician, iinmunologist,  neurologist, psychiatrist,  a n d  surgeon. T h e  
interdigitation of effort i s  so complex a n d  the  quanti ty of d a t a  so voluminous 
tha t  a c o m p r e h e n s i ~  e grasp  of' the  course of even  a single pat ient  m a y  become 
difficult or 1-irturllly impossible. 
In caring for the earl>- pat ients  in  this series. dependence w a s  placed upon 
collection of da t a  ~ v i t h i n  s tandard hospital char t s .  This  practice pro\ ed to be 
inefficient. A -\~n:~croscopic \.it.\\, of' the  ent ire  course of any  indi\-idual pat ient  
rvas frequently inlpossible n-ithout a daily exhaust i \ -e  re\-ier\ of' the  char t .  I n  
addition. \.:rl~l:~ble da t a  were lost because of fai lure of' secretar ial  recording of 
laborator?- e s a n l i n ~ ~ t i o n s  knon-11 to ha \ -?  been ordered, but  f rom ~ v h i c h  the  
results were misplaced. Coinl~lete  retrospect i \e  documentat ion of such  vital 
mat te rs  a s  pharnlacoloqic therap! 11 a s  sometimes unl,eliable. I\-hen represen- 
tatives of different s ~ ~ e c i a l t !  yroups recolnmended therapy f'or a patient.  the  
significance of' the  sugp,estiolls freyuentlj- Ivas not understood b y  other  
members  of' the t eam.  Because of fai lure in the central izr~t ion of' da t a  collec- 
tion. a b r e a k d o ~ r n  r las  obse1.1-ed in ~ n ~ ~ n a g e n l e n t  of' he cases in I\-hic.11 dif- 
fusion of responsibi1it~- d e l ~ r i ~  ed the patient of the pri1-ileqe of 11a1-inq a single 
physician who had  sole final responsibilir! for all details of care .  
. I t  this institution. the el-elution of ,I mas ter  f lo~r-  sheet  h a s  solved m a n y  if 
not most of these problems Table 1 . The  f lo~r  sheets  a re  21 11~- 3 8  inches i n  
size, d i~nens ions  I\-hich allon- a t t ach l~ len t  to a ti all of the hospital room. E a c h  
iten1 of informration is recorded b!- the nurses on dut!- or b>- the ph!~sicians in-  
\ - o l ~ e d  in the case .  The  sureeon in cha ree  of' the case is responsible for the  
daily upkeep and accurac!- of each  detail of the record. .A cluick check c a n  a n d  
mus t  be performed on all the d a t a  for ecicll cia!-. The  progresi in  the preceding 
7 
Patient - 
Date Splen - 
Table 1 .  Master Flow Sheet 
Date Rt. Neph - 
Date Lt. Neph - 
Pt. Blood Type - 
Pt. Age - 
Donor - 
D. Blood Type - 
D. Age - 
Table 1 .  Master Flow Sheet (Continued) 
Organ Preservation - 
Ischemia Time 
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Figure  3. Comparison of' hospital and outpatient records (on stool) n i t h  simplified flow sheet held 
by the recipient of a renal homograft. The patient ( L D  2 )  was operated upon in January, 1963, and 
the photograph was taken 11 months later. 
days or during the entire hospitalization can be readily reviewed within a few 
minutes. The simplification of record keeping can be appreciated by a com- 
parison of the flow sheets with the hospital record of a patient operated upon 
in January, 1963 (Fig. 3) .  All relevant information is contained on two flow 
sheets, weighing 5 ounces. The official hospital records stand 12 inches high 
and weigh 7l/4 pounds. 
Aside from the convenience of the flow sheets in formulating daily 
therapy, they have contributed to easy and frequent analysis of the results for 
purposes of scientific communication. The use of the same format and the 
procurement of comparable information in all cases permits simultaneous 
study of some or all of the cases with a minimum of effort. Trends are easily 
observed, and recurrent patterns can be readily identified and quantitated 
which might otherwise be lost in a maze of detail. 
An additional use of the flow sheets has assumed importance because of 
the peculiarly developmental nature of renal homotransplantation and the 
need for constant interinstitutional exchange of experience. Accurate and un- 
biased information is frequently requested by visitors engaged in or contem- 
plating entry into this field. The system described permits prompt communica- 
tion to interested parties of a completely up-to-date account in a compact and 
usable form. 
Chapter Three 
SELECTION OF CANDIDATES 
FOR HOMOTRANSPLANTATION 
Proper selection of candidates for renal  homotransplantation is  of para- 
mount importance if good results are  to be obtained. The pressures which are 
applied in behalf of some of the prospecti\-e patients may be intense. despite 
the chances of' a successful outcome being small because of a \.ariety of' com- 
plicatiny cil.c.ulnstances in a particular case. Referring physicians may be 
cauqht in the same  e i~~o t iona l i sm as that  afflicting the f~ilnily and l ~ e  unable to 
accvpt ~ v i t h  equaninlity a decision against this f 'orn~ of' thera l~y.  In  order to re- 
sist c o e r c i o ~ ~ .  it rna! 1)e con\-enieiit to escape behilld :l f'acade of' committee ac- 
tion. hIost of' tlic, 1neml)ers of' s~rc.h n selectio~i yroup ~ v i l l  11e able to act  objec- 
ti\ ely l~ecause  of' freedom from previous personal con~mitrnents to the patient or 
the f'ainily. 
Clinical Status of Patient 
From a medical point of view, the requirements for candidacy are  rela- 
ti\-el>- siinple. The patient should ha\-e irrel-ersible renal disease from which 
life expect;ancy is limited to a fen- ~ v e e k s  or months. He inust not ha\-e a major 
e l en~en t  of infection at the time of transplantatiol?. X normal lo~ver  urinary 
tract i11~1st be present. Other serious disease processes must  be ruled out. 
Vascular. cardiac. or neuroloqic. cllanqes l\-hich are secondar> to the renal  
failure should be ,judqed to be re\ e~.s i l~le .  Fillall\-. it is necessar! to have 
el  iclence that the prospec ti\ e recipient can 11-ithstand the i111medi;ite t r auma 
of :I major surgical procedure after the niasinlal i ~ n l ~ r o l ~ e l n e n t  of p1,eoperative 
reiuscitation. ' \ l t h o u ~ h  these ~.equirelnenti  ~ lppear  to 11e s t r i i ieht for~\-xd.  they 
ha\-e not been met in all our patienti .  \-iolatioiii h a l e  ,illnost inelitably 
resulted in transplantation failure. 
1 1  
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Table 2. Influence of Age on Survival':' 
Age in Years No. Nonre la  ted Donors Alive Dead 
*AI l patients were operated on before December 10, 1963. Survival i s  
to June 1, 1964. 
Some of the most difficult decisions of patient selection concern the role of 
age as a disqualifying factor. In the first 45 patients receiving homografts 
from living donors, the results were better in that group who were less than 35 
(Table 2), although these results were heavily influenced by the use of a large 
percentage of genetically nonrelated donors for the older recipients. Neverthe- 
less, the need for individualizing each case is demonstrated by the number 
of socially useful middle-aged or even elderly citizens who have returned to 
responsible vocational activities after transplantation. In general, it has ap- 
peared that a reasonable prognosis can be offered to older patients only if 
operation can be performed at a somewhat earlier phase of their disease than 
is necessary for the young. If cardiac, vascular, or neurologjc complications are 
severe, or if the older patient has been bedridden for a prolonged period, the 
chances of success are slim. 
Disease 
The diseases necessitating transplantation in all the patients at  the 
University of Colorado are listed in Table 3.  Chronic glomerulonephritis was 
the commonest renal disorder, accounting for 59 cases. End-stage pyelone- 
phritis and polycystic disease were next in frequency. A few unusual indica- 
tions were present in the rest of the cases (Table 3 ) .  
Those potential recipients who have an established infection in the upper 
renal tract fall into a special category in which transplantation should be of- 
fered only after extirpation of the diseased organs. Infected polycystic kidneys 
and active pyelonephritis. for example, require preliminary bilateral nephrec- 
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Table 3. Etiology of LTremia i n  First 73 Cases of Transplantat ion a t  the  
L1ni1-ersity of Colorado hIedical Center  
-- 
"Chronic glornerulonephritis 5 9 
***Polycystic kidney 3 
Congeni ta I renal hypoplasia 1 
Inadvertent rernova I of on1 y kidney 1 
- -  - 
*Several patients had coexisting pyelonephritis. One had superimposed 
gouty nephritis. 
**One pat ient oi.igina l l y  had congenita I urethro l valves. Another had 
congenital absence of one kidney and ureteropelvic obstruction of the 
remaining olgan, vjhich was previously treated w i th  nephrostorny. 
***One patient had mult iple absce~ses in  the cysts and coexistent 
pyelonephritis. 
tomies in  a first s tage ,  se\ ,eral  weeks before immunosuppressive t rea tment  is 
begun.  Only when  all wounds a re  healed a n d  the  sterility of the  lower ur inary  
tract h a s  been delnonstrated is it possible to safely proceed a t  a second s tage  
lr i th placement of the homograft  (Fig.  4). Fai lure to obtain primary heal ing a t  
the first operation allilost certainly cloonls the  pat ient ,  whether  or  not t rans-  
plant;ition is ~~erf 'ornlr~ci .  In one of our  cases ,  first-stagy nephrectomy xvas car-  
ried out in patient  tho had had a t~eph~,os toniy  tube for  10 ?-ears in his  only 
k idne\ .  X massi \-c   round infection delayed transplantat ion f'or t\ro ~ i ion ths ,  
during ~ t h i c  h time h e  was  ~ n a i n t a i n e d  ivith dial!-sts I Fig. 5). Complete heal ing 
of the fi;lnli I ~ - O L I I I ~  could n e \  el, l ~ e  o l~ ta ined ,  dvspite rvhich tra~lsplal l tat ion w a s  
carried out .  . - \ l t l lo~~qh the kidne>- f'unctioned 1.easonably I\-ell. dea th  occurred 
one mon th  latei. f'roln p n e u n ~ o n i a ,  sepsis in the originall?- infected n-ound,  a n d  
general  paralysis resulting fro111 pol!-neuritis. 
T h e  acceptance of patients ~ l - i t h  infected kiclne?-s for t ~ r o - s t a g e  therapy im- 
poses a permanent  ~ n o r a l  obligation upon the ph!-sicia~ls in charge  of the case,  
inasnluch  a s  creation of' a n  anephric s ta te  is an  integral part  of' the overall 
plan.  I t  mus t  be made  clear  to the f 'a~nil>-  that  it is possible tha t  t~ ,ansplanta t ion  
\$-ill ne\-er  be f'easible in the e\.entualit!- of a bacterial n-ouncl complication. I t  
mus t  also be accepted b!- the in\-011-ed medical rena l  uni t  that  such  a pat ient  
ma'- beco~nt .  a candidate f'or chronic hemodial!sis f'or the rest of his life, or  
until  the recjuirenlents for a seconcl-stage operation c a n  be fulfilled. If these 
condit io~ls  a re  unacceptable to the fanlily 01. to the physicians ~ ~ - 1 l o  ma!- h a v e  to 
assunle the responsihilit>- for chronic dial!-sis. surgic.;il care  of the case should 
not be undertaken. 
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TIME IN DAYS 
PRE OP DAYS 
Figure 4. Course of a 15-year-old girl (LD '22) who received staged surgical care because of a 
urinary tract infection. She had polycystic kidney disease with coliform and fungal abscesses within 
multiple cysts of each kidney. Bilateral nephrectomy and splenectomy were carried out a t  a first 
stage, resulting in prompt relief of the pre-existing hyperpyrexia. Three weeks later, a maternal 
homograft was placed. (By permission of A r c h .  S u r g .  89:87. 1964.) 
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F i g u r e  3 .  Course of a 33-year-old patient , L D  11) ivho h a d  removal of h is  remaining kidney i n  
ivhich a nephrostom)- tube  h a d  been present tor 10 years.  The  flank \toulld developed a mass ive  
i n f e c t i o ~ ~  requirino, lonr- term dial!-sis therapy \Vound Ilralinq did not occur  Transl2lantation was  
done ill spite of th i i .  ,ind thi. 11,itient r \  r n t ~ ~ ~ i l l !  d ~ e d  of sep5is. S o r e  tha t    if ti.^. tl.<in5l1l,i1ltation, a 
ma i s i i  e tiiul.c\~\ oicur.~.eci hut 11 a i  lollo\\ed i \ l t I i i~ i  ~i(-, Iioul.5 I,\ ,inur1<i The  ~ ~ o s t - r r . a n s ~ ~ l , i ~ ~ t  r ena l  
shutdoi rn  \ \ h i i h  lasted lo r  115 o 15 e eh i  15 '1s r e \  erslble, L i~ ld  at  the  tillle of de,lth t h e ~  \\-cis i ~ n p r o v i n g  
kidney function.  
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Donor Availability 
Finally, consideration of the availability of a donor may influence the 
overall e\-aluation of prognosis. Although this subject will be considered in de- 
tail in Chapter 5, it is appropriate to state that a prospective donation from a 
genetically favorable source such as a parent or sibling may significantly in- 
fluence the decision for or against transplantation. Because the difficulties 
encountered in control of rejection are predictably fewer in this circumstance, 
it may be reasonable to rule favorably for a patient who might otherwise be 
considered too ill. 
Lower Urinary Tract lnvolvement 
In attempting to meet the criteria delineated at the beginning of this 
chapter, a special note should be made of the problem of ruling out mechanical 
defects of the lower urinary tract. It is important to obtain as much informa- 
tion as possible concerning the integrity of the bladder and urethra, without 
compromising the possibility of a transplantation. This can almost always 
be done without instrumentation by means of a careful history and physical 
examination, and by procuring records from other hospitals or from other 
physicians. A clear diagnosis nearly always results from perusal of old records 
and x-rays, without the necessity for imposing further potentially dangerous 
diagnostic procedures. Cystoscopy or retrograde pyelography has not been 
necessary in a single case in our series, and even preoperative introduction of 
a urinary catheter has been performed only on unusual occasions. 
History 
Detailed analysis of past records is also valuable in determining the in- 
exorability of the patient's deterioration. If a pattern of consistently decreasing 
renal function can be demonstrated by retrospective study of serial biochem- 
ical studies, a decision for transplantation may be reached at an earlier time 
than would otherwise be possible. 
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Chapter Four 
PREPARATION OF RECIPIENT 
FOR TRANSPLANTATION 
The recipient's preparation for renal transplantation often starts in  the  
outpatient clinic, occasionally when a n  elevated B U N  is discovered for the 
first time. As a first step, it is important to establish that  the etiology of the 
azotemia is primary renal disease rather than a nlecharlical defect of the lower 
urinary tract. or a systemic disorder such as lupus erythen~atosus,  amyloidosis, 
or multiple m)eloma. Urine cultures are obtained. and if an  infection of the 
urina1,y tract is found, appropriate antibiotic therapy is instituted. If there are 
abnorn~ali t ies of' the bladder or urethra,  these should he corrected surgically if 
transplantation is e\.er to be considered. A trial of' consex\ at i \  e management is 
almost allvays attempted in order to ascertain the need for more aggressive 
measures. Regulation of fluid and salt intake, control of' hypertension, and 
cardiac care are components of the regimen. An! sources of bleeding ~ v h i c h  
might increase the in\-ariabl>- present anenlia should be defined and treated. 
At the beginning. it is important to discuss xvitll the family the ultimate 
prognosis of tlie case. slid it may be prudent to ~nent ion the potential role of 
renal transplantation in the future managemtnt .  \\'it11 solnt  families, discus- 
sion of transplantation at this time ma>- ]make easier the ultimate decision 
concerning this form of' treatment. e l  en in those instances in 11 hich a single 
dialysis may inlpro\-e the patient's condition so n1~1ch that proper conserx-ative 
~nanagement  ins>- ciela>- the need f'or other measures f'or man!- nlonths. 
In 111ost cases. hen-ex-er, tlie patient is referred f'or transplantation in a 
state of ad\-anced uremia. Here. the dial>-sis unit is an  absolutel>- essential part 
of the transplantation procram. since a major operati\ e procedure cannot be 
considered until resuscitative measures are carried out. In addition to a n  
ele\-ated B U S ,  such patients frequentl! ha\-e fluid retention. heart failure, 
11)-perkalemia. liyponatremia. or acidosis. -111 these complications are readily 
corrected by dial>-sis. Often the first treatment with the artificial kidne) must  
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Figure 6. Chest x-rays before (A) and 2 months after ( B )  renal homotransplantation. The patient 
(LD 15), who was of A- blood type, received a kidney from an older brother of O+ blood type. Note 
resolution of cardiomegaly and pulmonary edema. 
be done as an emergency procedure to treat pulmonary edema, hyperkalemia 
with cardiac arrhythmia, convulsions, or coma. Emergency pericardiocentesis 
or thoracentesis may be necessary. 
Congestive heart failure is present in at least half the cases. A typical 
chest film shows an enlarged heart and pronounced pulmonary congestion 
(Fig. 6A). This is compared with an x-ray of the same patient taken two 
months later after a successful renal transplant with complete regression of 
these abnormalities (Fig. 6B). This patient had had several previous admis- 
sions to the hospital for treatment of pulmonary edema and congestive heart 
failure. 
In contrast to the usual case in which water-logging is a primary problem, 
a few patients will be severely dehydrated either because of continued nausea 
and vomiting, or because of severe oral lesions which prevent food and fluid 
intake. 
PROCEDURES IN DIALYSIS 
All patients considered to be potential candidates for renal transplantation 
are treated by hemodialysis. The use of peritoneal dialysis can delay surgery, 
as  occurred in several patients referred for transplantation from other 
hospitals. Septic complications at the abdominal sites of dialysis delayed 
transplantation in some cases and precluded it altogether in others. 
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Figure  7. Chrorlic Scribner-type Teflon 
shunts used for chronic dialysis. Note that 
tubing is brought through the skin at a dis- 
tance from the sites of their intravascular 
insertion. 
Hemodialysis w a s  performed wi th  the  conventional Kolff disposable twin- 
coil artificial kidney.' T h e  Renal  Service now does approximately 300 dialyses 
a year. T h e  exact  technique used a t  this institution is described i n  greater  
detail in references cited a t  the  end of the chapter .  
As soon a s  a decision is m a d e  for  t ransplantat ion.  a n  es t imate  is m a d e  of 
the total nunlber  of dialyses ~ v h i c h  tvill be necessar>- prior to opel,ation. If only 
one or t ~ v o  are  anticipated. ca the ters  a re  placed in  the  artery 311d \ ein before 
each  dialysis ~xnd remo\  ed a t  the conclusion. If a more protracted period of 
managemen t  is prognosticated, a n  ind~vel l ing  Scribner- t>pe arterio\-enous 
Teflon s h u ~ l t t  is inserted. a s  shon-n in  Figure 7. allon-in% continuous blood flow 
through the connecting plastic tube in the inter\.als betxveen treatments .  At 
Equ~pmerlt  obr,xined tllrou-h Tra \  enol Lal~or~itor.it>. I n c . .  i Iorton G1.o~-c. I11 
iThese C C I ~  be lnade  from iolr imeri ia l l~ L ~ T  allLiblt Tefloil tublrlg. or purchased ready-made 
from the L-.S. Catheter and Instrument Co.. Glens Falls. S . Y . .  or fro111 the S\I-edish Freezer Co., 
Portland. 01,egon 
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the time of dialysis. the connecting loop is removed, and the arterial and 
venous cannulas are connected to the coil system. While there is an increased 
risk of infection inherent in the use of such a prosthesis, this is usually more 
than offset by the ad\ antages of the ease of dialysis, the reduced trauma to the 
patient. and the increased frequency with which treatment can be con- 
veniently provided. The majority of complications occur in the last two hours 
of a six-hour dialysis, so that the use of a shunt which permits shorter and 
more frequent runs is ad1 antageous. When an  arteriovenous shunt is used pre- 
operat i~ ely. the prosthesis is often kept in place until the time of transplanta- 
tion. As soon as homograft function is demonstrated, the shunt is removed in 
order to avoid the possibility that it will serve as a source of bacteremia in 
the postoperative period. Remo\ a1 is usually accomplished in such cases 
during closure of the transplant wound. 
Several techniques of dialysis are particularly pertinent in preparation for 
transplantation. \t7ith a twin-coil unit, fluid can be removed both by increasing 
the osmolality of the bath (by increasing glucose concentration) and by 
constricting the outflow of the coil unit to raise the filtration pressure to a 
maximum of 240 mm Hg (monitored by an aneroid manometer). Using this 
high-pressure dialysis system. as much as 4 to 7 kgm has been removed during 
a single six-hour run. The patient is dialyzed on a weight scale so that an ac- 
curate record can be kept of the fluid changes. Regional heparinization is 
usually employed. introducing heparin into the extracorporeal circuit as the 
blood leaves the patient and neutralizing it with protamine as the blood is 
returned. In many uremic patients who have a hemorrhagic diathesis at  the 
time dialysis is begun, it is possible to restore the blood coagulation time to . 
normal during a six-hour dialysis. In these cases, anticoagulants may not be 
required, at least at the beginning. Von Kaulla has suggested that a circulating 
thrombin inhibitor is being removed in such instances. 
After regional heparinization is started, Lee-White coagulation times are 
measured from both the coil system and the patient every 30 minutes. The 
only other routine laboratory test during dialysis is the hematocrit. A fall in 
hematocrit value usually indicates the need for transfusion at the end of a 
treatment, and this is commonly done with packed red cells. The blood can be 
removed from the extracorporeal circuit and used for immediate postdialysis 
transfusion after separation of the cells. 
In  some patients, the flow rate through the coil is kept low (less than 200 
cc per minute) to minimize changes in osmolality and to prevent rises in in- 
tracranial pressure, ILIeasurements may be made of intraocular tension (using 
a S c h i ~ t z  tonometer) and interpreted as an index of changes in intracranial 
pressure. 
Hemodialysis is employed with one or more of the following objectives: to 
correct serum electrolyte abnormalities: to remo\ e body fluid: to remove urea 
and other retention products: and to lower serum potassium in patients with 
hyperkalemia. The bath solutions are selected to achie1-e the specific altera- 
tion desired. 
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The frequency of dialyses 1-aries in difYerent preoperatix-e patients, 
ranging fronl once every three or four days to once el-er!. 13 or 20 da\-s. The 
primary ob,jecti~-e is to get the patient into a n  acceptable condition for inajor 
surger>-. S o  attempt is lnade to establish a completel>- normal llletabolic state. 
The nuinber of dial!-ses required in preparation for transplantation can be 
reduced b!- consen ziti\-e management.  15-ater intake is restricted. Daily fluids 
are limited to the pre\ious day's output plus an aclditiollal allowance for in- 
sensible \vater loss. \vhich nlay vary from 400 to 1.000 cc per day. The insen- 
sible loss nlust be determined for each patient, based on weight changes and  
apparent fluid retention as estilnated clinicall!-. On such a regimen, patients 
complain of thirst and ~lsual ly  ha\-e a marked reduction in sali\ ary flon-. Gum 
chen-in2 is encoul,aged as a ~~rophylact ic  measure to prel-ent acute parotitis 
and to assist in nlouth care. The oral lesions commonl! obser\ed in uremic 
patients are treated bl- a periodontist. Oral and phar!.ngeal cultures are ob- 
tained on all patients ~ v i t h  ulcerati\-e mouth or p h ~ ~ r y n g e a l  lesions. 
The presci.ibed diet is usually limited to 20 to 30 gm of protein dad>-, the 
a i ~ ~ o u n t  depending on the patient's ability to excrete urinary urea nitrogen as  
descriljcd in the follo\ving section. In badl>- debilitated patients. protein al- 
Ion-ance may be increased e\-en though this may necessitate extra dialyses. 
Drug adn~inistrat ion is kept to a minimum, since inany agents are unusually 
toxic in uremic p:ltients. 
Electrolyte Control 
Although hyperka lemia  i s  a ser ious  problem i n  only abou t  ha l f  t h e  
patients, it has  been a frequent indication for emergency dialysis. There are 
three colnnlonly accepted procedures for controlling a progressive rise in  
serum K without resorting to dialysis: the use of cation exchange resins either 
orally or by rectum: administration of s o d i ~ ~ i u  l~icarbonate.  particularly lvhen 
the Con combining power is markedly reduced: and administration of hyper- 
tonic solutions of glucose \vith insulin. The cation exchange resins have 
pro\-ed the inost useful in our hands.  \\'hen the serurn sodium is Ion-. sodium 
c!.cle resins are gi\ en.  \\.he11 tlie sodium is abo\ e normal, ammonia cycle res- 
ins are used. \i-hen the serum sodium approximates normal. a half'-and-half 
~ n i s t u r e  is emplo>-ecl. ,A dose of' 13 gm is adnlinistered one to four times a day, 
the frequent!- dependill? 011 the sel.erit\- of' the hypcrkale~nia.  \\'hen the 
patient cannot take the resins 1 , ~  mouth. retention enemas are used. Each 
gram of' sodium c!-cle resin contains approximately T 1nEc1 of sodiuln. .After 
passage through the intestine. each gram of resin 11-ill contain approxilnatelv 6 
mEq of catioll dil-ided as 3 mEc1 of' sodium. 2 inEcl of potassiunl. and 1 mEq of 
lnixed calcium and maqnesiunl ions. The sodium retained in the bod>- fluids 
after the exchanqe serl-es to correct the associated acidosis. \I7hen resins are 
administered. the serum sodium and CO, conlbinin.: pol\-er as [\-ell as the po- 
tassium should be checked frequent1~-. since proloneed therap>- ma>- produce 
h~perna t re in ia  and alkalosis. 
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F i g u r e  8. Combined preoperative use of' dial>-sis and ion exchange resins (LD 1). Thymectomy, 
splenectomy, and bilateral nephrectomy ITS & Bilat. Neph.) mere performed 13 days before trans- 
plantation. Note the alkalosis and hypernatremia caused b?- sodium cycle resins during the anephric 
interval. The homograf't I\-as gi\ en b\ the patient's wife. 
Figure 8 is illustrative of the hypernatremia that can occur with use of 
sodium cycle resins. In this case, the resins were effective in reducing the 
serum potassium concentration, but there was an associated rise in serum 
sodium and an increase in Con combining power with conversion of an  acidotic 
state to one of alkalosis. Hypernatremia could have been prevented by decreas- 
ing the dosage of resins as the serum sodium rose and the CO2 combining 
power increased. Figure 8 also illustrates the frequently obser1-ed inverse 
relationship between serum potassium values and C02 combining power. In 
some patients n-ho ha\-e reduced serum calcium concentrations. tetany and 
muscular twitching may be the first clinical indication of alkalosis caused by 
resin o\-erdosage. 
Figure 8 also illustrates that in an anephric patient, total body fluids can 
be controlled and a steady decrease in weight achiel-ed b!- fluid removal at  
dialysis, and b!- appropriate restriction of intake. It also shows that the interval 
between dialyses can be long n-ithout detriment, despite the absence of renal 
function. This mas- be due to depressed tissue catabolism, since the rise in 
BUT\: and serum phosphate concentration is sometimes surprisingly gradual. 
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Fecal  impaction and  ileus a re  frequent  complications durinq the use  of 
resins. and  these problenls ma!- persist for in,il:>- da!-s a f te r  the t ransplanta-  
tion. A lllild l a x a t i ~  e administered .i\ith the resins \\-ill often pre1-ent these side 
effects. Since the resins a\ idl!- take u p  n-ater ,  the assulnption is lliade in  cal- 
culat ing fluid in take  tha t  half the fluid adininistered ir i th the  resin is not 
a\-ailable f'or dilution of the bod? fluids. 
Prior to t ransplantat ion.  the blood concentrations of' sodium and  potassium 
c a n  be effecti\.ely controlled b>- linliting the socliuni. potassium. and  protein in-  
take. 111 those pat ients  \ \ h o  are  excreting urine. m e a s ~ ~ r e m e n t s  a re  m a d e  of t he  
23-houi, urillar?- sodium anel l~otass iuni .  and  the allowed in take  is planned ac-  
cordingly. T h e  urinary urea  niti,ogen is also deternlineci. and  the results a r e  
used a s  a basis f'or restricting proteii: iiltaht,. Thus .  a p a t i e ~ l t  excreting 6 gm of 
u r e a  nitrogen per da! coultl be allor\-ed a requlal. hospital diet,  while the  
patient excreting 3 gin pel. da! i i  usually restricted to :t protein in take  of' 20 to 
30 gin.  E l - e n  \\.it11 s e \  c1.c p ro t e in  r e s t r i c t i o n .  11;ilanc.e s t u d i e s  on  t h r e e  
pre0peratii.e patielits tlid not dc3lnolistr;ite ~i signific:int negati\ .e nitrogen bal- 
ance.  If the patient h a s  lost li~l'g(i amounts  of' iveight. ~i high protein diet m a y  
be required in order to i111pro\ c the paticnt 's condition f'or surgery a s  discussed 
before, a n d  the frequency of dialysis increased accordingly. 
Control of Pre-existing Conditions 
In the managemen t  of' cardiac f'ailure. digitalis i s  avoided whenever  pos- 
sible, especiall! \..hen the pat ient  will require f requent  dialyses. T h e  fal l  i n  
serur-n potassium anel the 1.apid shifts in  extracellular electrolytes occurring 
during dialysis ma!- ~iccc,ntuate digitalis intoxication and  produce cardiac ar- 
rhythnlias. It  is irnpol.tant that  the  EKG be inonitoreel throughout  dialysis so tha t  
;\ny serious arrh!.tlinlia 111~i!- Ile corrected by read , jus t~nent  of' the ca lc ium,  po- 
tassium. or inugnesiulll concent r~i t ions  in  the 11~1th. Pre\-ention of' fluid over- 
load is the most inlpoi,tant f';ic,tor in m a n ~ i g i n y  cardiac f'ailure in  the uremic 
patient.  111 addition to \I eiglit c l i a ~ ~ q c ~ s .  a n  increast. it1 fluid load is best judged 
]I!- e l  aluation of the neck ein diste~ltioil  a11d the presence of' pulmonar> con- 
gtJs tion. 
Hypertension is treated \\ , i th the usual  :tlltih!pertensi\ e agents .  It  is not 
~ l sua l l>  f 'easil~le to reduce tlie 1~)looci pressure to nornl:tl le\-els.  The  general  
]~oiic!- is to o l~ ta in  systolic Ijlood pressures I j e l o ~ ~  180 111111 Hg.  The  closes of' a n -  
tihype] t e n s i ~  e agents  nlust 11e iv,~tciled c arei  ull! . since less medication is 
of'ten required in  indi\ i d u ~ i l s  I \  it11 '1 reduced ~ l l . i l l ~ i ~ , >  \ olutne. Sodium restric- 
tion is the most important  iileLill, of coiltl .ollin~ h! pertension. ra ther  t han  phar-  
macologic agents .  On a salt-restricted diet. the serum sodium is I~rought  clown 
to a preselected le\-el. usuall>- 1'30 1nEq liter. The  iodi~ll l i  excretion is thereafter  
determilied in the p'itient's urille. c ~ ~ ~ d  precise iodium i~epl;ic.el-iient is prescribed. 
Reserpine shoulcl be used ipal,ill:l>-. '1s it tentis to nl'the the pat ient  lethargic. 
Ganglionic blockers ha\-e pro\-ed useful.  but  apresoline is usually tried first. 
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Bed rest may be used in refractory cases, although this is generally an  undesir- 
able practice in preoperative patients. 
A special note should be made of the preoperative management of anemia, 
which is almost aln-a>-s present in these patients. Except for the packed red 
cell transfusions employed after hemodialysis. transfusions are avoided during 
the phase of resuscitation unless the hematocrit value drops below 20 per cent. 
Additional packed cell transfusions may be given just prior to surgery to in- 
crease the hematocrit value, although most patients go to the operating room 
in an anemic state. In those patients who have received multiple hemodial- 
yses, it is frequently difficult to obtain cross-matched blood for purposes of 
pump priming. presumably because of multiple previous exposures to ho- 
mologous blood. 
Precautions w i th  Dialysis 
Although the minimum use of preoperative dialysis just described has its 
disadvantages, there are reasons for this policy. The financial and professional 
demands made by more frequent dialyses in any one patient would preclude its 
use for others who require this service just as urgently. In addition, the fol- 
lowing complications and dangers may be associated with dialysis. The use of 
2 units of blood to prime the coil system entails a risk of transfusion reaction. 
The patient is often fatigued or nauseated for some hours after completion of 
therapy. A febrile reaction lasting 24 to 36 hours is common, and sometimes is 
due to bacteremia. Hypotension, which is usually a result of too rapid a re- - 
moval of fluid, may occur, although this can be alleviated by administering 
fluids or albumin. Conversely, sharp increases in blood pressure may occur 
during dialysis, and sach episodes are often difficult to treat with pharmaco- 
logic agents. Severe headache sometimes occurs in the later portion of a dial- 
ysis. This may be related to increases in intracranial pressure secondary to 
rapid solute shifts. In several patients with this complication, measurements 
were made of intraocular pressure, and definite increases were observed. Fi- 
nally, dialysis in patients receiving preoperative azathioprine carries an  in- 
creased risk of septicemia, as will be discussed in Chapter 21. 
An example of the use of dialysis during preoperati~e care is shown in 
Figure 9. A 15-year-old boy was referred with the diagnoses of glomeruloneph- 
ritis and renal failure. He had been maintained at home on conservative 
management for six inonths with occasional hospitalization for dialysis. De- 
terioration avas progressive, however, and on his last admission he had acute 
uremia  with a B U N  of 260 m g m  per cent .  He required three dialyses 
preoperatively. Serum potassium was controlled (Fig. 9). After the third 
dialysis, the B U S  dropped to 30 mgm per cent. and although the urine volume 
was negligible. the B U N  rose s l o ~ v l ~  to a value of only 100 mgm per cent just 
before operation, making a final dialysis unnecessary. The patient had a good 
result following transplantation with an early initial diuresis and a rapid drop 
in the B U N  to normal range. 
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TIME IN DAYS 
P R E  O P  DAYS & P O S T - O P  DAYS 
Ficlzcrc 9. Typical preoperat i~e resuscitation ( L D  13). Note coilicident correction of hyperkalemia 
and acidosis 11-it11 each dial>sis.  Bilateral ~lephrectomy and \l~lenectonly I!-ere pert'ol.med at the time 
of' trarlsplantatioll. The boy's  noth her proxided the Ilo~nograft. 
Final Preoperative Dialysis 
Once the date for homotransplantation has  been set, a decision must then 
be reached concerning the final preoperative dialysis. Usually the final r u n  is 
carried out t ~ v o  or three days prior to transplantation, thus permitting the 
patient to recol-er completel>- from any immediate ill effects. The B U N  and 
serum electrol5-te concentrations are checked on the morning of surgery to 
lllalie s u r e  t h a t  110 a b n o r m a l  p a t t e r n s  h a \ - e  developed \I-hich would be  
dangerous during surgery. On a fen- occasions. it has  been necessary to correct 
an elel-ated serum potassiuln b!- a short dialysis the night before or 011 the 
morning of operation. The presence of azotenlia alone does not present any in- 
herent hazards during anesthesia. Because of the polic>- of scheduling the last 
dialysis sel-era1 days before holnotransplantation. allnost all the patients go to 
the operating room ivith sigllificant azotemia. the blood urea nitrogen being in 
excess of 100 ingm per cent in the majority of cases. In only one case has  a n  
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operative complication occurred xvhich might be attributed to this nonaggres- 
sive preoperati~e regimen. X 30-!ear-old man de~eloped a cardiac arrest 
during the transplantation procedure. which TI as the consequence of an un- 
recognized pericardial tamponade. Although the patient su rv i~ed  the proce- 
dure. death f o l l o ~ ~ e d  10 days later from infection in the nound required for 
open cardiac massage. 
In some cases, it may be necessary to stage the surgical care of the re- 
cipient as described in Chapter 3. The surgically anephric patient must then be 
maintained by dialysis for 10 to 20 days or until the first-stage operative wounds 
are completely healed. The most common indication for staging is the presence 
of an established infection in the kidneys which requires their preliminary 
removal. Another indication for bilateral nephrectomy may be hypertension 
which cannot be controlled by medical treatment. The first-stage operation 
reduces the patient to a stage of renoprival hvpertension. which is less severe 
and which can be readily controlled by medication. Another indication for 
staged surgery is the presence of an active peptic ulcer, which in two cases 
necessitated emergency gastrectomy and vagotomy prior to transplanta- 
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Fzgure 10 Preoperat~r e management  of a patlent LD 231 111 17 hom a bleedlng duodenal ulcer 
complicated the preoperative azotemia. Gastrectom!-. \-asotomy. bilateral nephrectomy, and sple- 
nectom>- were carried out ar a preliminar!. operation 13 da!s before rransplanration. S o t e  con- 
comitant correction of hyperkalemia and acidosis \\-ith sodium c!-cle resins. Dial>-sis, performed 
too quickly after the first stage operation. apparentl>- was responsible for the formation of a wound 
hematoma. The homograft Iras donated by the patient's younger brother. 
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tion. Collconlitant bilateral nephrectom! rind sl~lenec,tomy TI-ere carr ied out ,  
and  the pat ients  receil-ed renal  homografts  13 to 28 da!-s later .  
The  hospital course of' one of these patients is i l lustr~l ted i n  Figure 10. 
Three  dial!-ses were reciui1.t.d to prepare the patient f'ol, the  preliminary 
procedure. Sodium c!-cle resins \ \ e r e  used .is ,l supl~lenlentary  ineails of 
controlling h\-perkalemia. There 11-as ,i rise in COi coinbining power during 
resin thel.;ipy, a t  11-hich t ime tlie p ~ i t i e ~ l t ' s  dail! ~ri l l~11.y \.oluine ranged f rom 
200 to GOO cc.  
On the third day af te r  the first-stage operation, dialysis Lvas repeated (Fig. 
10  1 .  Pre\-iousl?- n-ell-healinq ivouiids de i  eloped esteiisi\ .e helnatoinas.  which 
were probahl!. the  result of' inad\ .er tent  s!.stemic hepa r in i~a t io r l  dur ing  
dialysis. As a r rsu l t  of this and 21 f'rn- othcl. s i n i i l : ~ ~  c s ~ ~ c r i c . n c r s .  procrastination 
for a s  long a s  possible nf'tei, 111ajor surger! 11ef'ol.e perf 'or l~l i i i~,  heliiodial!-sis is 
now priic,ticed. To do this.  it is necess;ii,!- to c~iref 'ully plan tlle last  preoperative 
dialysis so tha t  the pat ient  Lvill not require a postoperative t rea tment  for  a t  
lc,:ist foul. to fi\.e days. 
TREATMENT OF INFECTION 
Care of' any  inf'ectious complication is a n  impor tant  problem dur ing  the 
pi.eoperatiie period. The  pat ient  is increasingly a t  risk dur ing  this t ime 
because of' the use  of preoperati\ ,e azathioprine ( see  Chapters  14 and  21). All 
wounds are  cul tured.  ;ind ilitcnsi\.e local care  is gi\.en to the cu t -do~vn  sites 
used for  di:ilysis. Cultures :ire obt:iint.d t'roni tlie t h i ~ a t .  skin,  urine,  and  blood. 
111 a11 cases.  cul tures a re  ol)tni~irtl  J'rot~i tile c re\ ices of' the uinhilicus. Because 
of' the subnorm~i l  teml,eratul,ps \1llic,I1 a re  characteris t ic  of ureinic pat ients ,  
f c \ e r  may be allsent ciespitc, a n  estnl)li\hed i~if'ectioii. :I l,ise in  ivhitc cell count ,  
rn hich is ordin;lril>- :a good index of' iiif'ectio~i l l  ui,elnic patients.  ma>- also be 
depressed i n a s n ~ u c h  a s  p~eti.eiiti-nerit \\it11 :i/,itlliopi~ine is u s ~ ~ a l l y  useci ( s ee  
Chapter  14). 
The  patient who  h a s  been relidered anephric 11) a first-stage operation con- 
stitutes a special prol~leln f'oi prophylaxis of infection. In this case.  an antibi- 
otic solution selected on the I ~ a s i s  of' sensiti\-it! stuciies is inserted into the  
bladder er! tiyo da\-s xl-ith a fij~c. ca the ter .  The patient is asked to retain the  
fluid for a s  1011% ::is possi l~le.  Llsuall>-. h e  \\il l  Ilc ,1111~ to holci the solution until  
just bef'ore the t i~ l l e  of the next  instillation \ \  lleli lie is asked to 1 oid. In this 
TI a!-, the bladder is n e \  e r  free of '  loc.al antibiotic. Tliis use of c'itheterization i s  
thc onl!- one pernlitted piior to t r , r l ls j~l~i i l tat io~i .  .tnd then onl! for the fen- sec- 
o ~ l d s  necessar!- to 1~l:ite the f i ~ l i d  illto the I11,idder. 411 ~\- ; i rd personnel a re  in- 
s t ~ u c t e d  not to ins t rument  tlit. 1011-er ul inar>- tract 1 0 1  all! other  reason i n  
patients being prepared f o r  reli,il tl,ansplantcition. I f '  the pcitient is iinuric on  
ai'ril-al, the ultrasonic col1lpo~lnd scan  i i  used to deterlliine if the bladder con- 
tains urille. there],!- a\-oidillg tile l i e~c i  f'or diaynostic ccltlleterization. 
T h e  t rea tment  of progressi1-e uremia  af ter  t ransplantat ion is s imilar  to 
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that just described. Of the first 48 patients, 10 required a total of 23 dialyses 
following operation. \Then possible. dial) sis is avoided when the white count is 
low because of the increased hazards of infection. In patients who h a ~ e  al- 
ready r ece i~ed  homografts, shorter and more frequent dialyses are usually 
used. In several patients, dialysis has been a critical factor in maintenance of 
the patient until the transplanted kidney passed the rejection crisis and 
resumed function (see Chapter 16). 
PSYCHOLOGICAL FACTORS 
It is extremely important to prepare the patient and the patient's family 
psychologically for renal transplantation. As much understanding as possible 
must be provided of the many problems which will be encountered from the 
time of admission to the time of eventual discharge. Furthermore, the patient 
must plan to remain under close medical scrutiny for an  indefinite time after 
operation, and agree to be seen regularly for studies in a follow-up clinic. In 
many instances, the patient has already accepted the immediate eventuality of 
death and must now reconsider a new life. The decisions involved may bring 
out hidden emotions and antagonisms within the family. When members of 
the family discuss the source of kidney donation, further emotional problems 
become evident, and situations of familial ostracism can be created unless 
care is exercised to avoid donor coercion. Overconcern and overprotection are 
often manifested by one or more members of the family which may disturb the. 
patient and interfere with his hospital care. In most instances, these problems 
are the responsibility of the internist in charge of the case and of an  assigned 
social worker. Occasionally, it is necessary to obtain psychiatric help. In some 
cases, the family's minister has been of great help. Association of the patient 
and his family with other patients undergoing this procedure is inevitable, and 
in most instances seems to be helpful in solving some of the difficulties men- 
tioned. 
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Chapter Five 
SELECTION AND EVALUATION 
OF LIVING DONORS 
In evaluating donors, priority is given to those volunteers having genetic 
relationships to the patient. A mass of experimental evidence can be cited in 
support of the position that homografts are tolerated better and for a longer 
period of time if the donor and recipient subjects are closely related. In hu- 
mans, a similar tendency has been noted. For example, donations of mothers 
to offspring have been highly successful in our experience (Table 4). Dona- 
tions from siblings fared less well (Table 4). Although it is possible to prevent 
rejection of homografts obtained from genetically nonrelated donors, the 
means necessary are more extreme. leading to a heightened incidence of drug 
toxicity reactions and frequent deaths from infection or bone marrow depres- 
sion. In the last group, only four of the 13 recipients treated before December 
10, 1963, were alive on June 1. 1964 (Table 4). 
In  discussing kidney donation with those who wish to volunteer,  a 
perfectly objective account  is given. not only as  regards the risks to 
themselves. but concerning the prognosis of the recipient patient. The sacri- 
fice of the donor ma) be so great that he must not commit himself to participa- 
tion without realizing that there is a significant chance of early failure. 
Furthermore, he must understand that the results in the late stages of ho- 
motransplantation are not known with any degree of certainty. Undoubtedly, 
the eagerness with which family members or friends offer themselles is re- 
lated to the results being obtained in any particular clinic. ITith a mounting 
hopeful experience, the incidence of unsolicited offers increases accordingly. 
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Determination of Blood Groups 
After availabilit?- of donors for any given patient has  been assessed, 
samples are drawn for the determination of major blood groups. Although con- 
formity of the donor and recipient major blood types is not a1x.r-ays necessary, it 
is more desirable than not to work with pairs n-ho ha\-e illajor group com- 
patibilities. IT'hen blood type dissilnilarities exist betxveen the donor and re- 
cipient patients, they must meet the requirements outlined in Chapter 6. Any 
other similarities are taken into consideration if' the donor is genetically re- 
lated. Physical resemblance, for example, would be considered a fax.orable 
sign. 
Table 4. Effect of Consanguinity in First 45 Patients in Whom Living 
Volunteer Donors \Yere Used (LD Series) 
N o .  A l i v e  Dead 
**Mother t o  son 8 5 3 
Mo the r  t o  daughter 5 5 0 
Father to  daughter 2 1 1 
*::Brother to  brother 10 6 4 
Brother to  sister 1 0 1 
**Sister t o  brother 6 4 2 
Unre la ted 
**Same sex 
Female t o  male  
M a l e  to  female 
*Al l  operations were done between November 24, 1962, and December 10, 
1963. Fo l low-up i s  to  June 1, 1964. 
* * In  each 9:-oup, one add i t iona l  homograft was donated and removed e i ther  
immedia te ly  01- ea r l y  i n  the postoperative course. The fai lures were due 
to  ei ther breaches o f  ABO inconpa t i b i  l i t y  (two cases) or the imposi t ion 
o f  excessive ischemia ftv:o casesl. Second homografts wet-e placed, and 
i n  the above tabulat ion,  on ly  the f i na l  donot-s are corysidered. 
* * * Inc ludes two  sets of f1.a-erna tv.i.ls. O r e  patien: i s  al i . /e a f te r  more 
than a yeor .  T4e ot i ier  d ied  sf a i u n g ~ s  bra in  abscess and sastroin- 
test inal  hemorrhage aC:ei- 2C8 da j s .  
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Medical Evaluation 
Once an expression of willingness from one or more potential donors has 
been given. a general medical evaluation is conducted to ascertain the consti- 
tutional suitability of the volunteer. Under special circumstances, as with 
maternal donors, kidneys have been taken from volunteers as old as 57 years. 
In general. howel er. selection is confined to those less than 45 years of age. A 
careful history is taken to detect past cardiovascular, pulmonary. or chronic in- 
fectious diseases. Complete physical examination is performed. In addition to 
the studies of renal function described below, an  electrocardiogram and a 
chest x-ray are obtained. 
Unsuspected pathologic findings of importance are sometimes uncovered. 
One 39-year-old woman was found to have a serous cystadenoma of the ovary 
which was so large that it had been interpreted by her as obesity (Fig. 11). 
Another patient was found to have a coin lesion of the right lower lobe (Fig. 
12). This was remoLed by pulmonary wedge resection and found to be a his- 
toplasmoma. The latter patient subsequently underwent donor nephrectomy. 
The rest of the studies are designed for the mutual protection of the donor 
patient and the prospective recipient. The information sought concerns the 
quality of renal function of both donor kidneys and the clarification of any an- 
atomic abnormalities in either organ. Particular care is taken to be sure that 
the kidney which is to be left in the volunteer is normal. At the same time, the 
technical difficulties presented by the organ to be removed are analyzed. 
Determination of Renal Function 
General determinations of renal function are first obtained with analysis 
of blood urea nitrogen (BUN) and creatinine (Ccr). If these are normal, mul- 
tiple urine cultures are procured, using a noncatheter method of specimen 
collection. An intravenous pyelogram is obtained. If this and the other tests are 
normal, retrograde aortography is done with transfemoral insertion of the 
catheter under fluoroscopic control (Figs. 13, 14). 
Some clinics do not believe that aortography is warranted, because of the 
slight but definite risk to the donor patient. Those holding this point of view 
believe that the operative penalties imposed by the necessity for reconstituting 
a multiple arterial supply to the donor organ are not sufficiently great to jus- 
tify this diagnostic procedure. Nevertheless. in our hands. the longer time 
necessary to construct more than one arterial anastomosis has been a serious 
deterrent to success, as will be discussed in an ensuing chapter. For us, the 
aortogram has been the most useful single determinant in deciding which kid- 
ney is to be excised. Xortograms ha\-e been obtained in all but four of the living 
volunteers. In many cases, this examination has directly influenced the selec- 
tion of the kidney to be used, most frequently because there is a single vessel 
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Figure 1 I .  Large serous cystadenoma of the 
ovary discovered in a prospecti1 e donor. The 
abdominal x-ray was obtained prior to an 
Intravenous pyelogram. The mass tvas of 
~ u c h  large sire that it had been interpreted 
by the patient as obesit!. The patient xvas 
treated ~v i th  hysterecto~n>- and bilateral 
ialpirlgo-oophorectoln?. and \ra5 rlot further 
considered for donation of' ti hornoeraft R> 
per~nissioil of 4rc,lz. Szc rcj. 8 8 :  71 1 .  I O G l .  I 
Fzqzlre 12. A 22-year-old volunteer con- 
\-ict donor who \$-as found to have a coin 
lesion in the right lolver lobe. \%'edge resec- 
t1011 Jvas performed for  hat prox-ed hi\- 
tologicall!- to be a histoplasn~oma. Donor 
nephrectom)- Fvaa subsequentl) performed 
(for LD 23).  
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Figure 13.  A common vascular pattern noted with aortography. In this case, there are two renal 
arteries to the right kidney and a single vessel to the left. The left kidney was used for a homograft 
(for LD 30). (By permission of Arch. Surg. 88:711, 1964.) 
on one side and a double arterial supply on the other, an  arrangement which 
has been found in 30 per cent of the cases (Fig. 13). 
Aside from allowing selection of the kidney which can be transplanted 
with the greatest facility, aortography has on occasion offered protection to the 
donor patient as well. In two cases, long renal arteries were detected which 
appeared to have significant segmental occlusive disease. Both donors were 
women with moderately ptotic right kidneys (Fig. 14). Excision of the more com- 
monly used donor left kidney would have left them with a predictably high 
future morbidity. If any equivocal abnormality is detected in either of the 
donor kidneys, the less perfect organ is used for the transplant. The first con- 
sideration of safety is always given to the donor. 
On two occasions, violations of these general rules were perpetrated. In 
one case a mother scheduled to provide a kidney for her 15-year-old daughter 
(LD 17) was known to have had a past episode of pyelonephritis. At the time of 
removal of her right kidney, it was noticed that there were multiple pitted 
areas in the cortex typical of chronic pyelonephritis. On the day following oper- 
ation, a positive urine culture of E. coli was returned from a previously submit- 
ted specimen. Surprisingly, the pyelonephritis in the transplanted kidney was 
brought under rapid control with antibiotic therapy. Effective treatment of the 
mother's urinary tract infection was also carried out. The case is more com- 
pletely discussed in Chapter 21. 
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i r e  4 .  A ~j;n.ti,ill> o c c l ~ i d i r r ~  \ . I S (  LII,II. lisiion \ \ , i s  rrotc,tl In the n i~ l j l r~op to t~c  r.r-ht kidney i n  a 
42-year-old \voni:ill. \llro \ \ C I S  u~icic.~. (oni~tic,r,itioil . I \  C I  tior~or. 1 0 1  11t.r d,~uqIi: i .~. .  L' \c ,  of' the  more 
comino~l l )  emplox-eti let t hitilie! \ \ o ~ ~ l t l  l1,1\ (. l i .1  t 11t.1. i t 11  , I  dr\c.,~\c.cl I . ~ V I I , L I  \ ~ ~ s c  111~11. sulj111>- in  her 
~.ernaininq organ.  C l t i m , l t e l ~ .  the ri:lit hitiric.\ \ \ . I \  uic,tl 101 .  , I  honli~:r,tlt. t r ,~ns t .c t inq  the  r ena l  
iirter). as far d i s t n l l ~  :IS possiljlt~. An ccsci.llc.nt re5~1lt  \\.I. o l~ t~c l r~c t l  LII i,i I .  U! pe~.riiissioli o i ' d r ch .  
511! '< ] .  88:71 I ,  l(164, 
In  another case, a 53-year-old Lvar i e t e r a ~ l  ~ v h o  had sustained a shrapnel 
ivound near  his left kidney insisted upon donation of his right kidney for his 
,51-year-old brother ILD 12). N o  other donors ~vert. a\-ailable. After protracted 
tliscussions, the operatjon ivas perf'ormed in AIay. 1962. Both brothers have 
returned to ~vork  and both are ivell. althouqh the recipient had a mild delayed 
rejection 10 months after  operation i~ .hich n-as easily cor~trolled. 
RECENT CLINICAL EXPERIENCE 
During the el-olution of the experience a t  the University of Colorado, a 
slight hut definite challpe in philosoph>- has  el-olved in relation to donor selec- 
tion. Froill the beginning. the primary issue has  been ensurance of the donor's 
safety. If this could be achiex-ed. kidneys n-ere used despite predictable tech- 
nical difficulties of' transplantation in1 olx-in2 the use of kidneys xvith nlultiple 
srllall ar:eries. LIore recent1~-, there has been a firmer insistence upon not only 
leavin?. but also remoxinq a11 ideal orean. If  a kidneJ- cannot be found which 
has a single renal artery of adequate lenqth and diameter, donor nephrectomy 
is not thou2ht to be justified. The donor patient must endure an  operation of 
major proportions. I t  is as unfair  to  him ai to the recipient to subject h im to a 
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nephrectoiny. kno~ving that the chances of success are materially and pre- 
dictably reduced. Only in the case of identical twins is the use of kidneys with 
multiple renal arteries thought to be a justifiable practice. 
The experience in the Colorado series in the selection of donor kidneys is 
quite different from that which inight have been predicted on the basis of a 
previous anatomic analysis by Ross and his associates, which concerned the 
random usability of kidneys for homografting procedures. For various reasons, 
these authors concluded that the left kidney would be anatomically satisfac- 
tory in only 33 per cent of the cases and that the right kidney would be suitable 
for transplantation in only 3 per cent of the cases. In practical experience, it 
has been found that all kidneys, no matter what their side of origin. can be in- 
serted without difficulty. In the first 42 cases of the Colorado series, 25 left kid- 
neys from l i ~  ing donors were placed into the right iliac fossa, and 18 right kid- 
neys into the left iliac fossa. In three other cases, donated right kidneys were 
transplanted to the right side of the recipient. 
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Chapter Six 
PATTERNS O F  PERMISSIBLE D O N O R -  
RECIPIENT TISSUE TRANSFER IN 
R E L A T I O N  T O  A B O  B L O O D  G R O U P S  
I t  h a s  often been  stated tha t  rena l  honlografts should be  employed only 
\\.hen the ma jo r  blood groups of the donor and  recipient patient a re  identical.  
Although blood group antigens are  not generally thouqht  to be ill\-olved i n  the  
iinmunologic process of rejection. it h a s  been f'earecl tha t  hemagglut inat ion 
~ ~ o u l d  occur ~ v i t h i n  the  grafts .  Adherence to this \videl\- accepted 1-iexv h a s  
restricted the donor pool. and  is known to ha \ -c  resulted in the  denial of therapy 
to otherwise acceptable candidates f'or homotransplantat ion.  
It  is of historic interest tha t  the first attcnlpt at  h u m a n  renal  homotrans-  
plantation by \'orol1o!- in\ol\-ecl the t r~ ins f ' e~ ,  of a f:- Aidne! to a patient  of 
0- blood type. Initial ur inary exeretioil \\-as ol)ser\-ecl. but dea th  followed 
in 48 llours a f te r  reaction to a postoperat i \e  blood transfusion.  Since tha t  
time, there h a s  beell a halldful of' reports.  s u n i ~ n ~ ~ r i r e c l  Hunle.  concern-  
ill:. similar violations of the dictum tha t  doiior-recipient blood q1.oup ~ n a t c h i n g  
ib essential.  The  of these pioneering ex l~e r i ence i  is difficult to 
el-aluate for TI\-o reasons.  First.  Iiian>- of the case5 Tiere d o ~ i e  before 1955 
\1-he11 effecti1.e alltire,jection thel.,ipy ~ i - a i  not ,I\ ai1,ible. 1Iol.e inlport,intly, 
the quality of the I;idne> 5 used \\-as poor in ,11111ost all c.iies. SIoit of the homo- 
grafts TI-ere obtailled fro111 cadax-ers. ~ i s u ' ~ l l \  ~ \ . i t h  \ er\- prolonged periods 
of ischeinia. alld frecjuently n-ithout an!- protecti\.e de1-ice such  a s  coolirlg or  
Perfusion. 
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Table 5. Blood Groups of Donors and Recipients in the First 45 Patients 
Treated with Living Donor Kidneys':' 
No.  A l i v e  Dead 
6-1 -64 
**0 Recipient with: 
Related 0 donor 
Unrelated 0 donor 
Related A donor 
A Recipient with: 
Related A donor 
Unrelated A donor 
Related 0 donor 
Unrelated 0 donor 
Related B donor 
B Recipient with: 
Related B donor 
Unrelated 0 donor 
AB Recipient with: 
Unrelated AB donor 
Unrelated A donor 
*In the four patients receiving two homografts (LD 19, 23, 29, 35), only the 
second or def in i t ive donor i s  tabulated. A l l  patients were operated upon 
before December 10, 1963. 
** In  two of these 0 recipients (LD 19 and 23), A and B homografts were 
placed. The transplants were destroyed immediately after revoscular- 
izat ion by an apparent hemagglutinative process, and removed; second 
homografts from 0 donors were placed 10 and 14 days later (see text). 
In one o f  the cadaveric cases (CD I ) ,  an  A to 0 transfer was made. The 
result i s  described in  this chapter and i n  Chapter Eight. 
More recently,  reports f rom Hume  and  from our own clinic have  
documented the successful use of renal homografts provided by donors of dif- 
ferent major blood groups from those of the recipient patients. In our experi- 
ence, good function was obtained with various combinations of mismatches, 
and it was initially thought that indiscriminate crossing of blood groups was 
possible. This conclusion was supported by the fact that initially satisfactory 
renal function was obtained with virtually every combination (Table 5). As 
more experience accumulated, it became apparent that the transfer of mis- 
matched tissue was safe only under specific circumstances, and that an in- 
creased incidence of early failure would be encountered if these conditions 
were not met. 
In defining the circumstances in which blood group barriers may be safely 
crossed. principal credence will be given to that practical experience acquired 
at the U n i ~  ersity of Colorado Medical Center, rather than to that described in 
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the literature. The case material studied at this center has  the ad\-antage of 
homogeneity. I n  all but one of the first 12 cases in IT-hicl~ -1BO blood type incom- 
patibilities existed, the homograft n-as donated I,!- a li\-ing \-olunteer. The is- 
chemic periods were reasonably short in all but the cadan-eric kidney. ensuring 
a generally good quality of tissue. A11 organs xvere perf'used \J-ith cold lactated 
Ringer's solution in order to remo\-e residual blood before re\-ascularization 
I see Chapter 10). The immunosuppressi~-e therapy n-as similar in each case. 
There were no mechanical failures to alter the statistics. 
CASES WITH MISMATCHED KIDNEYS 
In  12 cases, kidneys were obtained from donors with different ABO blood 
groups from those of the recipients. The donor-recipient transfers were 0 to A 
in five patients, 0 to B in one patient. A to 0 in three patients (including one 
cadaveric kidney). B to O in one patient. B to A in one patient. and A to AB in  
one patient. In  three of these ABO mismatches, there was a coexistent Rh in- 
compatibility. 
With the cada\.eric kidney, in which transplantation n-as f'roln a n  A+ 
donor to a n  0+ recipient, the time from death to re\  ascularizutioll in the new 
liost was 120 minutes. Urinary excretion n-as delayed f'or eight h o u ~ s .  For the 
first 10 days a slow reduction in the BUN Lvas seen. but after this there was 
progressive uremia until death 25 days af'ter transplantation (see  Figure 23, 
page 58). Histologically, the homografted kidney n-as extensively damaged. 
There was minimal cellular infiltrate, but there n-as considerable hemorrhage 
and moderate tubular necrosis. Se\ ere generalized arteriolitis inas noted. I n  
this type of case, the influence of the blood group mismatch upon the unfa- 
\orable outcome is difficult to assess, because of the introduction of other 
factors attendant upon the use of sel-erel!- ischelnic tissue. 
In the other 11 cases, the homografts mere obtaitlcd f'l.oni li\.inq donors 
under uniformly favorable conditions. All  kidneys i n  ere d e \ - a s c ~ l i z e d  f'or less 
than 40 rr:inutes, and all \yere cooled by intra-artei,i;~l perf'usion. The greatest 
experience ~ v a s  1z.ith kidneys donated by 0 donors to X recipients. Fi\ e such 
combinations were used, as n-ell as an 0 to B donation (Table 5,. Immediate 
gratifying diuresis \vas observed in all six cases. The difficult!. in controlling 
the rejection process Lvas Comparable to that encountered in patients receiving 
matched kidneys. The rejection crises occurred one to 19  da!-s after operation, 
:ind were rex-ersed (see Chapter 13). Three late deaths due to sepsis occurred 
after  77. 79. and 206 days (see appendix). 
In another case. a n  A+ kidne!- rn-as donated by the ~ \ - i fe  of an  -1B recipient. 
ILrcellel1t renal fullctioll persisted until the death of the patient f1.0111 sepsis 
;liter 113 days, The homograft xn-as relati\-el? undisturl~ed ]I!- d series of ca- 
l.imitous colllplications, including ~nult iple 11-ou11d infections. intestinal ob- 
struction. and a lnassi\-e pullllonary embolus treated b! pulmonar!- enll~olec- 
tomy and subsequent plicatioll of the inferior ella ca\-a abol e the trallsplanta- 
tion site (Fig,  15). Histologic sections of the homo~raf ' t  obtained at autopsy 
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BUN mgm ./o 
LAPAROTOMY 
A* 
\ 
V C PLICATION ACTI-C 
Figure  15 .  Course of patient (LD 4) with XB+ blood type n-ho received an .A- kidney from his 
wife. A definite rejection crisis did not occur. possibly because of' the prophylactic use of prednisone 
(see Chapter 18). D - Dial!-sis: TS & BLN - Thyn~ectomy, splenectomy. and bilateral nephrectomy; 
Acti C-Actinomycin C, each arrow equaling 200 pg actinomycin C administered intrarenously. 
Patient ultimately died of unrecognized intra-abdominal abscess. (By permission of Surg.  Gynec. 
Obstet. 117:385. 1963.) 
showed good preservation of architecture with only a few foci of round cell infil- 
tration. 
An additional patient with A+ blood type received a kidney from his sister 
who belonged to B+ blood group. This was the second renal homotransplanta- 
tion performed at this center. The immediate and late result was excellent, al- 
though the pat ient  had  a very severe rejection crisis 25 days a f te r  the 
operation (Fig. 16). 
In numerous patients, the Rh factors were different in the donors and re- 
cipients. the transfers being both from Rh- to Rh- and in the reverse direction 
(see appendix). Good early renal function was obtained in all. 
Complications Encountered wi th  
Mismatched Kidneys 
Three additional patients are considered separately inasmuch as their 
courses appear to have been adversely affected by problems of blood group in- 
compatibility. In these cases. h or B kidneys were transplanted to hosts of 0 
blood type. 
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Ccr 
cc / rnin 
BUN 
mgrn 
50,000- 
IMURAN 3 0 ~  
mgm/ kgm 
PREDNISONE 
r ngm/da~  150. 
250-  
- J A N -  -- - FEE- - '--Am 4 c M A Y i  
Ficjtcre 16 .  Pat ient  of ,A+ blood t > p e  \\lie rccci \ed  .I hitilie\ fro111 h ~ s  iistc.1. \ \I io 1 1 ~ 1 s  of B- I7lood 
t?pe.  The  patient is  the  same one as ihor\-n i n  Figure :i Lr)  L I 1 ri,]ec t i o~ i  ~ . i i i s  \\.hiill beyan  on the 
t \ \  c>nt).-fif'th postoperative da? \ \  :is re \  er\fltl \ \  lth st , i~id,i~,d Ilic,,rirll,ci T ~ . , I ~ \ ~ J ~ , I I I ~ , I ~ ~ ~ I I  11 '15 per-  
f r~ tmed  on , January  30. 1963. .111d the  patlc.111 li,li h,1ti 1 1 0 1 t l i ~ i 1  I C . I I ~ I ~  i~111i t io11 1 01( ,  111~111 O I I C  year  
1;1tt>r. Despite this. this t?-pe of '  dorior-rccipit,nt ~ i i l s ~ l i ~ i t (  h \\o111c1 110 I o ~ l i i ~ . ~  [ I ( ,  ( ~ l~ ip lo \ i ' d  U D i a l -  
v-;.: Th -Thymec to~n>- :  Acti C-E,ich , i ~ ~ o \ \  e~cluciii LOO o, i l i l ln~~ , I <  tll1onl\i111 C .  I \ Left nephrec- 
t(4111\ and spl rnectom? 1vn.e performeti ,it the tltnc of t l ~ ~ r ~ i i p l ~ c ~ i r ~ i t i o ~ i  K~iillt ~ ~ c . l ~ l i ~ c c  tonl! h a i  never  
b t.11 perf'on1,ed. I R>- permission of ,/.-I 11 1 187:7:14. l'10-1 
The most dramatic complications occurred with two patients who were 
0- blood type. One receil-ed his homograft from an  A- donor and the other 
from a B- donor. In  both cases. the hornografts became cyanotic within a few 
nlinutes after revascularization. The circulatioil could not be inlpror-ed despite 
illtra-arterial injections of procaine. prednisolone. heparin. and papa\-erine. 
Illcision into the parenchyma resulted in l-enous helnorrhaee Ilut  little or no 
al'terial bleeding. hI0l.e deepl>- ~ ~ - i t h i n  the inedulli~. s lue~ , i sh  arterial bleeding 
fi .is presellt, Both kidneys remailled soft I\-ithout l ~ e ~ t o r ~ i t i o n  of the f i~ lnness  
a!-ld turgor llormall>- seen, tn-o honlograf ts 11-ere relno\ ed TI-ithin three 
h:lLlrs of the tilne of their insertion. .After transec'tion of tile ~pC'cime11~. areas 
42 / PATTERNS O F  PERMISSIBLE D O N O R - R E C I P I E N T  TISSUE TRANSFER 
Figure 17. Renal homograft from pa- 
tient with A+ donor and transplanted to 
O+ recipient (LD 19). The organ was re- 
moved three hours after revasculariza- 
tion. Note dark color and hemorrhagic 
zone at  corticomedullary junction. (By 
permission of Surg. Gynec. Obstet. 118: 
819, 1964.) 
of hemorrhagic discoloration were observed at the corticomedullary junction 
(Fig. 17). 
Arteriograms of the surgical specimens showed filling of the major ar- 
terial ramifications, with absent (Fig. 18A) or poor (Fig. 18B) vascularization 
of the cortex. Histologic sections of the two kidneys were interpreted as normal 
except for areas of congestion and aggregation of red cells, especially in the 
glomeruli and small arterioles (Fig. 19). No thrombi were present. In one 
patient, sharp rises in the titer of the specific hemagglutinins were observed 
within a few days after operation (see Chapter 22). Second homografts from 
blood-type compatible donors were placed 14 and 10 days later. 
The course of a third patient of O+ blood type is thought to have been ad- 
versely affected as the result of nonconformity of the blood groups. The re- 
cipient, a six-year-old child, received a kidney from his A- mother. Diuresis 
began almost immediately, but was succeeded by oliguria within 30 hours. The 
process of renal destruction was halted and controlled with the therapeutic 
regimen described in Chapters 14 and 16. but only with the greatest difficulty. 
Reversal of the secondary acute renal failure which started after one and a 
half days required more time than any other case treated by us (see Figure 60, 
Chapter 14). In addition, ultimate renal function was impaired in several ways 
despite the fact that the BUN had returned to normal. The patient's creatinine 
clearance remained lo~v.  proteinuria persisted, and he had low grade hyperten- 
sion. Five and one-half months postoperatix ely. he developed convulsions and 
coma, presumabl) as the result of a cerebrovascular accident. He died 202 
days after operation. Permission for autopsy was denied. 
F i  l : r ' ?  18. Homografts remoT-ed a f e x ~  hour i  d t c r  re \  a ~ ~ u l ~ t r - l i ~ t r l o n  i:ci:ll 1 i . c  1;)ltnts 11-ere O+ 
bl( , d  type LD 19 and  LD 2 3 .  the dollor. \ \ e r e  1- [illti I:-. l i . \ l ) i . i r i \ c l \  I!li ,iitcrio:rain in 
'A 1s f rom the s a m e  speci~llell  as s11ox1 n in F I - L I I ~  1 -. , ifid [hi ti\ i . r c i l i i l l :  2 ~ i :  tilt c ~ ~ r a c o n l e d u l l a r y  
Ju! . tion corresponds to the he lno l~ l l ag i i  are,r see11 ill the 2roi. *peclmen 1 l l i  iol.tlc a1 d e t - a s c u l a -  
Za .on in  ( B l  is not so extreme. , B Y  perlnisiloil of Slo ' t ,  C!!!ii.i O ; , \ t t  t 1 1  S 514.  1961 
Figure  19.  Histologic appearance  of the  txvo unsuccessful  homografts seen in Figure 18. (A) a n d  
(B) a r e  i n  t he  s a m e  order. S o t e  aggregation of red cells. particularl!- i n  glonleruli a n d  i n  sma l l  
arteries.  A-H a n d  E (X 32). 'B>- permission of Szivg. Gynec .  Ohste t .  118:819. 1964.) B -H and E 
(X 80). 
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CONCLUSIONS CONCERNING BLOOD 
GROUP INCOMPATIBILITY 
A brief consideration of the immunologic factors in\-olved in  the use of 
mismatched tissues is pertinent. especially as they relate to the presence of 
preformed host antibodies. If the recipient belongs to 0 blood group, circu- 
lating anti-A and anti-B henlagglutinins are predictably present. If the re- 
cipient is of A or B type. anti-B and anti-A hemagglutinins, respectively, are 
present, although these are likely to be of lower titer. Patients of XB group will 
not have preformed heirlagglutinins of either t!-pe. .A critical issue in predict- 
ing the recipient's iininediate reaction thus in\  ol\ es el-aluation of the prob- 
able status of the hemagglutinating hulnoral antibodies in the host. 
T17ith the donor tissue, the con\ erse is true. The antibody content of the re- 
tained blood in the homograft is of little import:ince. since the kidney can  be 
flushed !as described in Chapter 10) before it is exposed to its nexv circulation. 
Although this simple technique rids the kidney of most of' its unbound an-  
tibodies. it does not alter the blood group-specific antigenicity of the tissue, 
since Hogman and Szullnan ha\ .e demonstrated that  renal parenchymal cells 
possess the same blood types as er?-throcytes. Consequently. i t  ~vould be an-  
ticipated that an  0 kidney would not react ~ v i t h  host hen~agglutinins since it 
does not ha\-e A or B antigens. A and l3 1,:idneys could react lvith host anti-A 
and anti-K antibodies if these \vere present. An AB kidney could react with 
both types of host hemagglutinins. 
Co~nparison of these theoretical colisiderations with the practical experi- 
ence already described has  led to rules go~.erning the use of mis~natched com- 
binations. These rules are based primarily on the a\.oidance of situations in 
which preformed host l le~nagglutinins are present r~ l i i ch  could rclact acutely 
against the homograft being pro\.ided. I t  has  been concluded that the donor to 
recipient incompatibilities which are relati\-el?- saf'e are O to iioll-0, Rh- to 
Table 6. Direction of Acceptable 3Iisinatched Tissue Transfer:': 
0 to n o n - 0  Safe 
Rh- to Rh+ Safe 
Rh+ to Rh- Relatively safe 
A to non-A Dangerous 
B to non-B Dangerous 
AB to non-AB Dangerous 
*O i s  universal donor. 
AB i s  universal recipient.  
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Rh-. and Rh- to Rh- except in the unusual and predictable circumstances in 
which recipient presensitization has occurred (Table 6). The combinations 
which invo l~  e a heightened risk are: A to non-A, B to non-B, and AB to non-AB 
(Table 6). Thus, the pattern of acceptable tissue transfer within the ABO 
system is comparable to that already defined for blood transfusions in that 0 
patients are probably universal donors and AB patients are universal re- 
cipients. 
OTHER BLOOD GROUP 
CONSIDERATIONS 
In  the preceding portions of this chapter ,  those combinations were 
described of donor-recipient blood group incompatibilities which were and 
which were not relatively safe. Within the larger categories of patients having 
identical donor-recipient blood types, there was a subtler difference in late 
results which is of unknown significance but which warrants description. In 
the first 45 cases of the living donor series, there were 17 homotransplants of 
A kidneys to A recipients (Table 5). Nine of the patients died at a relatively 
early time in the postoperati~~e period, a failure rate which was exorbitantly 
high with the use of both related and unrelated donors (Table 5). In contrast, 
there were only five deaths in the comparable series of 17 patients with 0 
blood type (Table 5). In both groups, excellent early homograft function was 
obtained, but the subsequent rejection episodes in A-type matches tended to be 
more severe and protracted, suggesting that a specific sensitization to the red' 
cell antigens in the homograft may have occurred and contributed to the dif- 
ficulty of maintaining homograft viability. Slight differences in the A sub- 
stance of the donor and recipient which are commonly present despite the 
absence of agglutination with direct cross-matching could presumably lead to 
the delayed production of hemagglutinins and other circulating antibodies. 
Further observations will be necessary before it can be determined if the dif- 
ficulties in transplanting A kidneys to A recipients are real or are coincidental. 
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Chapter Seven 
THE IMPORTANCE OF HOMOGRAFT 
QUALITY 
One of the most significant factors in obtaining ultimate success is the at- 
tainment of good immediate homograft function. When this is achieved, there 
is a massive postoperative diuresis with consequent early improvement in the 
patient's general condition. Later, diagnosis of the rejection crisis is greatly 
facilitated if a change in the pattern of renal excretion can be demonstrated 
against a background of initial good function (see Chapter 15). 
FACTORS INFLUENCING INITIAL 
HOMOGRAFT FUNCTION 
Incidence of Anuria 
Because of the great importance of obtaining prompt and adequate ho- 
motransplant function, it is desirable to know the prerequisites for achieving 
this state and to know with accuracy the incidence to be expected of im- 
mediate anuria. Immediate oliguria or anuria after human renal transplanta- 
tion has been noted bv a number of authorities. Although Egdahl and Hume 
believed initial anuria to be a rarity in dogs, Dempster's collected data in- 
dicated that a substantial number of human renal homografts never excreted 
urine in adequate quantities. and he suggested that the factors responsible for 
some of these sudden failures could be immunologic as well as technical. 
Data analyzed from the first 42 cases studied at the University of Colo- 
rado, in~olv ing  the use of 46 homografts from living donors, demonstrate 
that immediate postoperati\-e anuria is an uncommon occurrence, and define 
as well the circumstances which appear to have been responsible for those 
instant organ failures encountered in this series. In three instances, the inflic- 
tion of excess i~e  ischemia upon the transplanted tissue accounted for the 
absent or sluggish early function. In these three cases, the intervals necessary 
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for transplantation were 61, 71, and 83 i n i ~ ~ u t e s .  The only other cause for irnme- 
diate postoperative excretory failure n-as the presence of highl>- unfavorable 
donor and recipient blood group incoinpatibilities in two cases. as described in 
Chapter 6. 
Ischemia 
The degree to which excessive ischemic injury of homografts impairs 
early function has  not been known with certainty. It has  been assumed by 
many authors that  the margin of safety is a large one. Those holding this point 
of' \-iew allude to the almost uniform success of renal transplantation between 
identical tivins, despite great differences in the t rauma inflicted upon the 
donated kidney in  terms of ischemia and in terms of organ temperature a t  the 
t i ~ n e  of' its de\.ascularization. 
A different point of \.iew can be easily supported. based upon the conten- 
tion that the ~ n a r g i n  of saf'etl- in identical ttvins (isografts) is incomparably 
greater than ~ v i t h  true homografts. Even though s e ~ - e r e  but re\-ersible is- 
cllc>~nic njury occurs, stead>- impro\.ernent may be expected, since a secondary 
parenchl-ma1 insult does not occur when isografts are used. In contrast, the 
rr,co\.ery of homograf't function is almost ine\.itably interrupted by a rejection 
phase. The ability of the graft to remain \-iable is almost surely related to some 
extent to the quality of the tissue at the time of the rejection crisis. 
In addition. it is equally possible that the ilnlnediate function of the ho- 
nlograft is also more dependent than genetically identical tissue upon min- 
imization of ischemia. particularly in \ ietv of' the classic studies of Deinpster 
which shotved a nlore se\-ere acute edematous reaction in renal homografts 
than in comparable autografts. It has  beet1 our gro\ving con\-iction that im- 
pro\-elnent in the technical aspects of tissue transf'er, including homograft 
cooling and heparinization, is a n  important element in the at tainment of the 
prompt f'unction ~vithout rt-hich the possibilit!. of long-term success is greatly 
diminished. 
An effort has  been made to define the liinit of i schen~ia  tvithin ~ v h i c h  it 
has been safe to n-ork in our own experience. The follon-ing anal?-sis concerns 
the function obtained from 44 honloqrafts pro\-ided in the first 42 patients for 
it-horn li\-in% donors \!-ere used, excluding the txvo additional homoqrafts n-hich 
had to be remo\.ed immediately af'ter re\-ascularization because of acute 
hemaqglutination reactions Chap. 6). 
i 0 j i 1 t 1 IT7ith 23 of' the homograf'ts. time from 
occlusion of the donor renal arter?- to restoration of the blood floxv in the recipi- 
ent ranged from 17 to 30 minutes. xf-ith a mean of '23.kO.7 S E I  min~i tes  I Table 
- 
1 J .  Homograft function was generall?. prompt in these cases, and a massive diu- 
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Table 7.  Effect of Duration of Ischemia on Function in 44 Homografts 
Less than 30 m inu tes 
No.  Mean S D S E 
1. Time ur ine onset 24 33.7 36.9 7.6 
(m in) 
2. Diuresis per hour 24 511 .O 275.0 56 
for f irst 12 hours (ml) 
3. Preop BUN (mgm%) 24 71.2 23.7 4.8 
4. Lowest BUN w i th in  22 24.5 14.3 3.0 
two days (mgm%) 
5. Highest Ccr (ml/min) 22 97.9 36.2 7.7 
w i th in  two days 
31 to 43 minutes 
1 .  Time ur ine onset 
(min) 
2. Diuresis per hour 
for f irst 12 hours (ml) 
3. Preop BUN (mgm%) 
4. Lowest BUN w i th in  
two days (mgm%) 
5. Highest Ccr (ml/min) 
w i th in  two days 
61, 71, and 84 minutes (three cases)-see text 
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resis ensued of 51 1256 (SE) m l  per  hour  for the  first 1 2  hours.  \Vithin 4 8  hours,  
the Inearl B U N  fell fro111 71.214.8 (SE)  nlgiil per  cent  to 24.5~3.0 (SE)  ing lnpe r  
cent .  Creat inine c learance  rose to 9 7 . 9 ~ 7 . 7  ( S E )  1111 per minute .  The  ineal l  in- 
ter1-al b e t ~ v e e n  re\-ascularization and  the beginning of urine excretion w a s  
33 .7  7.6 ! S E )  minutes .  
I sc l le~nic  periods of 31  to 4 3  inirlutes \\-ere inflicted upon 17 hoinografts 
\\.it11 a tnean of' :38.1 r 0.8 ( S E )  minutes  Earl>- ur ine  excretion 11 as also ob- 
tailled ~vi t l i  this group after  a n  interval 0 f  30 .7  7 8 . 3  1 S E ,  minutes .  \\.ithin 48 
h0~11.s. I-;L-N's fell f rom 97.9  - 11.9 1 S E )  nigm per cent  to 38.4 6 . 7  ( S E )  i n g m  
per cent .  The  tnean cre;itiiiine clearance ivas .33.4 z 3.G I S E )  m l  per minute.  
Three additional homograf'ts required 61. 71, and  8 4  minutes  of' i schemia  
for  tra~nsfer.  'Tiines f'ronn re\.ascularization to notation of first ur ine excretion 
\ \e re  30  and fi0O n i i~ lu t e s  ill the  first two pat ients  a n d  in  the last  ca se  the  homo- 
gl,;ift Lvas ailuric until  i ts renlo\ al.  \\.ithin 48 hours,  the R U N  \.r-eiit f rom 63.5 
to 60  nigm per ccnt .  8 4  to 8 7  m g m  per cent .  and  100 to 1 1  8 mgnn per  cent ,  re- 
specti\-el?-. Creatiiline clearances Ivere 22. 15.6. and  0 1111 per  minute .  T h e  
course of the  second of these cases  is sho i \n  ill Figure Cil, Chapter  14. 
It is ob\ ious  f'rom these results tha t  ischetiiic periods approaching or ex- 
ceeding one hour  a re  unsatisfactory. Anal)sis lvas also conducted of tlie sig- 
nificanc,e of differences in those l~oiiioqraf'ts ischemic for less t h a n  30  rnirlutes 
cotnpai,ed to  those isclieinic for :31 to 33 minutes.  On the a\ erage ,  it \\.ill be noted 
('Table 7 )  tha t  the  fuiictioll of kid~le!,s \\,it11 lesser degrees of' i schemia  w a s  
superior in all aspects  cscept  Sol the titiie of' onsct of' ur ine flolr- 1vhic.h w a s  
equal ill both groups. St,itisticall>. the iilost ensil!. den~ons t r ab le  effect of is- 
che~ i i i a  ivas ol~ser\.ed in the measurements  of creat inine c lea i ,a t~ce  in \ \ l ~ i c h  
tlie difference in the  two groups lvas highl!. significant i p  0.001).  Even xvithin 
the group \vith ischelnic periods of' 30  minutes  or less ,  r ank  order analysis 
demonstrated a positil-e correlation bet\veen ischemic period and  the  magni -  
tude of '  early postoperati\-e creat inine clearance (K=0.393), the  confidence 
Ie\ el beillg 3 per cent .  
These findinqs emphas i r e  the need to de\  elop facilit! i n  perf 'ormance of 
1-asculat, anastomoses before enlharking 011 clinic.al homotr~insplanta t ion .  T h e  
d ~ i t a  support the \-ien- tha t  good function c,an be consistentl?- obtained if t he  
period of' i schemia  can  11e kept to less t han  40  ininutes.  but  the! also suqgest  
tllcit el-en n-ithin this inter\-al the results \\i l l  be roughl!. related to the t ime 
expended in re \  ascularization. Unlike inan>- other  operati1.e procedu1,es. ~ v h i c h  
ckln be learned in  the clinical operating room. the abilitl- to perforni rena l  ho- 
nlotransplantation with controlled speed t nu st first be mastered b>- extensive 
Practice ill the laboratory if good results a re  to be expected. 
H l / / j o t / z e r ) i z i ( ~ .  Eef'ore such  figures a re  accepted as quides for the perrnis- 
sible periods of ischemia.  it mus t  be e~nph~is izec l  that  one forin or another  of 
honlograft liypotherinia h a s  been consistently applied i n  the series f rom which  
H \  U o c t ~ ~ r  i l l e n  Sexton. 
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these values were derived (see Chapter 10). The degree to which cooling has 
lengthened the period of acceptable ischemia in this type of case is not known. 
However, it seems inevitable that the degree of trauma which is compatible 
with good early function would be considerably less if transplantation were 
performed with normothermic kidneys. In planning a transplant procedure, 
the need for organ cooling must therefore be related to an objective and honest 
evaluation of the projected rapidity with which revascularization can be per- 
formed. 
A o r t o g r a p h i c  Eztr lz iat ion.  Inasmuch as the speed with which transplanta- 
tion can be carried out appears to have an important influence on the prog- 
nosis, aortographic evaluation of the donor assumes a special significance. 
The use of donor organs which have two or more arteries inevitably leads to 
prolongation of the time necessary for completion of the vascular anasto- 
moses. Re-establishment of circulation to these smaller vessels has, in our ex- 
perience, doubled or tripled the durat ion of the ischemic interval .  I t  i s  
noteworthy that the organs most severely injured, in which reconstitution of 
blood flow was not obtained until 61, 71, and 85 minutes, all had a double ar- 
terial blood supply. It has become our policy not to consider donors with mul- 
tiple renal vessels, no matter how favorable the genetic relationship of the 
donor to the recipient, with the sole exception of identical twins. 
Other Elements 
Aside from efforts to minimize the ischemia during transfer of the graft, 
other measures are taken to protect the donated tissue. Heparinization, either 
by local infusion or by total body administration to the donor, may be of value 
in preventing intraparenchymal clotting. In experimental studies on dogs, 
Mims h a s  demonstrated tha t  homograft  ar ter ia l  f lushing occurs more 
promptly with the use of this drug. Care is exercised in mobilization and dis- 
section of the kidney in the donor patient to avoid inadvertent occlusion of the 
vessels. Hypotensive episodes in the donor patient are studiously avoided, not 
only to protect the kidney which is being removed, but to insure maximum 
security as well for the organ which is to be left. 
In the final analysis of the reasons for success or failure in renal ho- 
motransplantation, there is often an irresistible urge to ascribe failures to poor 
control over the biologic processes of rejection. It is necessary to explicitly 
state at this time that there may be an important interrelationship between 
purely technical performance and the ease with which these processes can be 
controlled. The clarity with which complications can be tabulated as technical 
or nontechnical is not so well defined as with some other kinds of surgery. 
Without question. many homotransplantation failures have resulted from re- 
jection. in which a complex chain of events was initiated and rendered un- 
manageable by the use of less than optimal homografts. Acceptance of these 
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failures as esselltially nontechnical must be rigidly resisted by surgeons if 
01-era11 results are to be impro\-ed. 
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Chapter Eight 
THE ROLE OF CADAVERIC DONORS 
IN HOMOTRANSPLANTATION 
b y  Thomas L. AZarchioro, M.D. 
It  is possible that in the future cadavers will be used with increasing 
frequency as a source of renal homografts. The concept of obtaining needed 
organs without the necessity of placing living donors in jeopardy is so attractive 
as to be irresistible in the long view. In order to effectively utilize cadaveric' 
sources, considerable developmental work will be necessary in both the social 
and scientific spheres. An increased understanding and willingness by the 
public and by physicians to cooperate in the procurement of permission to re- 
move postmortem tissue promptly will be necessary. In addition, more effective 
ways of processing and preserving autopsy specimens \$,ill have to be devised. 
Much of the early work with human renal transplantation was performed 
with cadaveric kidneys. Although occasiolial temporary successes were ob- 
tained, these were rare. The use of cadaveric kidneys. which almost in\-ariably 
were seriously damaged, made interpretation of the results 1-irtually iinpos- 
sible for the reasons stated in the preceding chapter. It was necessary to at- 
tempt to separate those e\-ents which Tvere a direct consequence of the is- 
chemic injury to the tissue from those n-hich resulted from rejection. An un- 
clear picture emerged concerning many \.ital details. Such important concepts 
as the combinations of blood t>-pe inis~natches betn-een donor and recipient 
patients n-hich could be accepted. the incidence of immediate post-transplan- 
tation anuria. the degree of ischenlic injury which could be tolerated with 
consistent recol-cry, the time of onset of rejection, the re\-ersibility of rejection, 
and the function n-hich could be anticipated from the chronically functioning 
homograft n-ere all obscure. 
One of the most important consequences of the use of lil-ing donors has 
been clarificatioli of most of these pre\-iousl>- unans~vered questions. An in- 
54 
THE ROLE OF CADAVERIC DONORS IN HOMOTRANSPLANTATION / 55 
creasingly lucid unders tanding  of the  problems n-hich a re  to be expected h a s  
resulted, and  a n u m b e r  of a t  least partially satisfactory solutions ha1-e e1-olved. 
It  is to be hoped tha t  this information c a n  be ultimately t ransferred to the  inore 
difficult pro11li.111~ in\-ol\ ed in the use  of cirda1-eric orqans  i n  \\-hich postopera- 
ti1 e thcrLip\ tiluit ~ i su~ l l l !  lje 111~11 ided in the absence of eood l ~ o ~ l ~ o g r a f t  func-  
tion. I n  this lvci!. cl~npiricirl regime115 c , i~ i  e \  e~itu:tll> 11e outlined xv11ic.h a re  not  
see dependent  upon function of the  rena l  homograft  for  formulat ion of day-to- 
d~i! therap!-. 
TECHNIQUES USED TO OVERCOME 
ISCHEMIC DAMAGE 
Thc  I I ~ I ~ ~ C I I I , ~ ~  deterrelit  to the successful  employment of cadaveric  homo- 
graf ' ts is the  ischcxniiic. injury imposed dur ing  the  agonal  and postmortem 
pc~l,iod. '\ ~ l u ~ l l l ) c t  of' techniques have  been described to protect the  prospective 
t ~ ~ : r n s ~ ~ l : ~ n t  l'rolll ;itlosi:i. 
H~/~~ot l~c , r . t t / ic i .  Tllis techiiic~ue lias been   no st comnlonly used.  The ele- 
g,Ince 11-ith 11.11icli Ilo~lloqrnl't cooling lias been carried out  h a s  ranged f rom 
s11n11le c 11111itig of tlie c o~ 11se 111 .l I ef r l q e ~  ,ited room. thi ouqh ~ m m e d i ~ i t e  r - 
rno\,il of the I\lcine\ .iild pl,icemc>nt 111to ,in Ice 11'1th ot ice \ \ a t e r ,  to in- 
tl,:i-artei.i:il inf'usion of' cold fiuids of' \ ~i r ious  compositions, to remo\.al  of the  
hidney :itid IIurnlI perf'usion ~ v i t h  blood kvhich i s  oxygenated with a nlechanical  
01, : iutoqc~t~ous lunq.  
Hl / )~ot l /~~r . t l l i ( l  ( / I / ( / t'('r.f'li,(iorl. 1Iore l'ecently. Ive ha \ -e  described a simple 
?'hcz tnethod e ~ ~ i p l o \ s  a11 t~xtl~:ic~ot.l)ol.~~:~l : pp:i!.:it~i\ usiny a glucose or elec- 
ti,ol) te p~.itiicd s \ s t en l  into ~ ~ l l i c l i  is itic~otyot~:ited :I Iieat escllanqcl.  1 Fig. 20). As  
soot1 as death  is certihed, c : i ~ l ~ i r ~ l , ~ i  :ii,e i~ ise~, tec i  into the aorta  a ~ l d  inferior 
\'r2t1:i c;i\ ;I tlli.ouq11 tlle easily :IC c.t,ssil)lc t't'ti~ot,:rl :lt,ter! anci \ ein.  In this Lvay, 
tc~t,il l~oti! perfusiotl and h!l~otlie~~t~ii;x c.,l~l i t~s t i tu ted  \t.itllill i n i i l l ~ t e ~  af te r  
dt.ath. I 1k11.i esti11c of '  the, Lici~ie! 01, I,idtlrx\ s c.:iti tllc.11 11e c ,irriVtl out  in  a rela- 
ti\  el! Ic>iic~l.el! l l l c l l l l l c ~ l .  ith the L ~ I O I I  ir~dcc, t h , ~ t  .~l.tifici,il c i rcu la t io~i  is being 
niCiint;ii~lect. I t1 o~,tic,t o o l ~ t ~ i i ~ i  ic~lc.c.ti\c, ~ ) r ~ t ~ i t ~ s i o n  of thy iiif'e~,iot Iliili of' t he  
c,icI,~\ el.. the loll-c.1. thoracic or upper abdoirlinal aor ta  is cross-clamped a s  soon 
a\ this is feasiljle Fig. 20). 
Se\  er,ll o l ~ i e r \  ,~ t ions  11-ere made  in the course of this it11 estieation. T h e  
u i e  of , r s c~~ l , i l  l , les\uiei  to q ~ i l d t  ~ ~ e r f u \ l o ~ l  lCite\ 15 11 ol thles\  P lessures  ob- 
tained fro111 the : ~ ~ , t e ~ i , i l  tree of' the l~erf'uiecl cacI:i\-er a re  usuall\- nea r  zero, 
preiuln,il~l!- :is the, 1,esrllt of losi of ,xscul;ir toile. To illcrease the blood pres- 
sure.  e \  i.11 to 20 to 40 111111 11:. y ~ i c h  exorl~i tal i t  fl01\- rdtes a re  required tha t  
orz;rn ruptLll,e oftell  re.~lits f yo111 01 erperf uiio11. ?'he saf'ezt flo\\- ra tes  for ca -  
dcr\ t r  p~ ' r f~15 i1~11  .lppe,~rec] to Ile :(~) to G O  1111 kc.111 per nliliute. RCrpid cooling to 
1 5  coulti ~ ~ \ u : ~ l l y  1,t. ol)t,iined \ \  itliin 3 ( ~ i  l n i n ~ ~ t e i  .l ter the- iti i t i tution of i u c h  
l(j\r- floit- perf (ision k-ic. 3 . It ;ilia ;ippe,i~.etl th,rt prololigeci cooliilir a t  low 
tenlperatures nligllt be harnliul ~o the prospec til-e honlogrdft.  The trans-  
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Figure 20. Technique of extracorporeal cadaver perfusion. Catheters are inserted via the femoral 
vessels into the aorta and yena cava as soon as possible after death. The extracorporeal circuit is 
primed with heparinized glucose or electrolyte solution to which procaine is added. The cadaver is 
anticoagulated with the first surge of the pump. Temperature control is provided by the heat ex- 
changer. 
planted organ often appeared to have been frostbitten, if the cadaveric per- 
fusion was carried out below 10" C for protracted periods. Finally, the need 
for provision of procaine in the perfusate to prevent renal afferent arteriolar 
constriction at the low temperatures was evident. The necessity for this 
pharmacologic adjuvant in hypothermic perfusion had been p r e ~  iously demon- 
strated by Couch, Cassie. and nIurray, and by Kiser and Hitchcock and their 
associates under different experimental conditions. 
Using extracorporeal cada~e r i c  perfusion in dogs, it is possible to con- 
sistently obtain functional kidneys from 10 to 16 hours after death of a previ- 
ously healthy animal. Nevertheless. there are limitations to the method. An- 
imals perfused for longer than six hours show temporarily depressed renal func- 
tion. Excretion of urine is sometimes dela>ed for as long as 24 hours after 
transplantation Acute azotemia is commonly obser\ ed xvhich requires several 
days for reversal (Fig. 22). 
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DEFICIENCIES IN  USE OF 
CADAVERIC HOMOGRAFTS 
Despite the demonstration that useful cadaveric homografts can be ob- 
tained with extracorporeal cadaveric perfusion, our clinical experience with 
three cases has been disappointing. The first cadaveric homograft used at this 
center was obtained from a patient who was thought to have a brain tumor, 
but who was subsequently shown at autopsy to have died of acute bacterial 
endocarditis. His blood pressure was 60 mm Hg or less for four hours prior to 
death. Cadal eric perfusion was instituted within five minutes after death, but 
the maximum flow rates that could be obtained were 15 to 20 ml kgm per 
minute. Extracorporeal perfusion was continued for an hour while the kidney 
was removed, and revascularization in the recipient bed was accomplished 
106 minutes after death. The homograft apparently functioned temporarily, al- 
though at reduced efficiency. The BUN fell from 176 to 119 mgm per cent, but 
then rose again after 10 days (Fig. 23). Death of the host occurred 24 days 
after transplantation from a combination of sepsis and progression of uremia. 
PT J.S. 
31 YO. 8 
TIME IN DAYS 
D9E 30 )r"E I D 2 S -  Z =  3LV5 
2,000- 
1,500- 
URINE VOLUME 
cc / day 1,000- 
500- 
0 
10 
Ccr 
cc/min 5 - 
0 
Figure  23.  Course of a 21-year-old male ~ v h o  receix-ed a cadax-eric kidney CD 1). The donor blood 
type was AT and the recipient 0-. The recipient's oxr-n kidne!-s n-ere not remox-ed. HOT?-ever, some 
80+55:4 kgm 
. , 
0 ", 
homograft function is evident from the increased urine \ olu~lles and the earl! fall in BUN.  Improve- 
ment ceased after 10 days, and the patient died of a combination of sepsis and renal failure after 
23 days. 
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Histologic sectiorls of the t ransplanted kidney s h o ~ v e d  sel-ere interstitial 
llelnorrllaqe '1nc1 the. pl,csclice of proteinaceous tnaterial in the tubules. There  
\\.as 111inilllal ~ l l o ~ i o n u c l e ~ i r  infiltration Fic .  24 1 .  The  cada t  eric donor jvas of A 
lllood t!pe. ,\lid the rec,ipic,nt \\-as 0. I11 su l~sequet l t  experience \\-it11 the  use  of 
donors ] la\  in2 cliffere~lt I)looci t! pes froin thost, of' the i,ec,ipients. it h a s  been  
fouild t l l < l t  t l i i i  c o m l ~ i i l ~ i t i o l ~  f' Ijlooti ~1.ou11s is a danqerous one r Chap.  6). I n  
retrospr>c,t. t l i i i  f';\c,tor mci\ hiit c, ~ ~ i , i t e ~ , i ; ~ l l !  co l i t~~ibuted  to the  1)oor outcotne. 
111 t l i c ,  ,I ( otld c i ~ i e .  poitlnortc'nl l i ~ - l ~ o t l i i . t ~ ~ i ~ i c  perfusion f':~iled ~ v i t h i n  a f e w  
rillliutes \lf'tet. its i ~ i c  eptiotl. I'lle do t~or  \I  110 died of' s~11jarac.linoid hemorrhage  
I\  .is se \  ercl! deli! dt.:ttt.ci tcbl.t~~it~a[l!. . atlci ~~i~ol>;l l j lv  had  ;I lo\\ 11looci \-olume. Ad- 
c'cj~~;lte \ ~ 1 1 0 ~ 1 s  1.c~t11l.11 c.o11lc1 not 1)o oljt;iinc~tl. I'lle hidlie! \\-us re \  ascularized i n  
the, rclc.ipic.~lt I)cld 124 ~ l ~ i l r u t r ~ s  < ~ f ' t t > l ,  deittli. Renal f'unc,tiorl did not return.  
1-\\ el\ c. d<i! s Iiitr.1. tile y ~ , , t l  t \ \  ;is ~~c,tilo\ c,d. . t l ' te~. it li~rtl iu l~ tu t ,ed  follox\ iilg rela- 
ti\  t ~ i i ~ l o ~ ~  ~ I , ~ I L I I ~ I : ~  inc c ~ t , t , r , c l  \I l i c ~ 1 1  tliv piitient t ' t , l l  O L I ~  01' l)etl. Histologic sec- 
tions s l i o \ ~ c d  t . \ i t l c a ~ i c , c ,  of' c.ellul,ii~ ~,c>,jc'c,tioll Fiq. 23. The  p ~ ~ t i e n t  died one  
n i o n t l ~  l;~tet, .  
.-I thircl patient.  a 42-)ear-old woman ,  l,ecei\,ed both kidneys f rom a 42- 
>,c,:ll.-old donor \vho died t'our hours ilf'tcr suff'ering :tn acu te  ~nyoca rd ia l  in- 
f',it,c.tiol~. tlie it~tr,l.\:il I)c~t\\c~cli lc :~ t l~  a11t1 thr, i l~st i tut ion of 'es t~ .acorporea l  per- 
f i15io11 I)r.itly 20 r i ~ i l ~ t ~ t c s .  I'hr, ti11it.s f'l,olli dc;tth to re\ asc.~~l:ll.iz;ltion of' t he  
liolnoyt~:if'ts \\el,(- 1 : : i  ~ i n d  "5 rn in~l tes .  Eoth i n d i \ i d u ~ ~ l s  \vere -1 1,looci type. 
7'11~. liidtic,!\ did r~o t  l ' ~ l t ~ c t i o n .  Tlle p ~ i t i c ~ ~ i t  ciietl f 'oul  da!s later  shortly a f te r  a 
postol~c~i,,lti\ c ,  cli,~l\ 51s. I)ut no c l i i c , ~ . c , t c >  c,:iuse of' dea th  lvas found at autopsy. 
l ~ l i e ~  l c ) ~ i ~ o ~ r ; i I  t i  1):ic  I ~ ~ I I I ~ I I I ~ I I  c t > l l ~ ~ l ; i ~ ,  i ~ i f i l t ~ , : i t c ~ .  
T h e  c i i s c , o ~ ~ t , i i q i ~ l c  c ~ \ l ) r ~ t ~ i c , ~ l c  r .  in t h e ~ s c  t111,t.e p a t i e n t s .  ;is wel l  a s  i n  
nunlcJl.ous otllc,t. ~ , c ~ l ) o ~ , t t ~ d  c,;iit,s. Iias sc.1~ t,d ; I  d c ~ t e ~ , ~ ~ e t l t  to el~ll~lo!,nlent of 
c,id;i\ el,ic h i c l t ~ c ~ ~ s .  ;i11c1 ~ I O \  ic1c.s ; I  t,iisis l ' o ~  tile I~elief t l l ~ i t  m u c h  of' the  d a m a g e  
ti] the l~onlograf ' t  may occur before dea th  except unde r  the  most  exceptional 
c i t~cums t~ inces .  
7'11e yood results that  c a n  be ol~taineci 11-ith c.ada\-eric kidne!s i n  ex- 
pc r i l~~e t l t a l  ; i t~inlals ha \ - e  no present counterpa1.t in h u m a n  use.  .4lthough the  
efhcienc,! of' t h r  rstrac,orl~ol.eiil postlliortem pct.fusion \ \as  elearl!- demon- 
strated i l l  do:\ I)! tlie fact t l ~ i i t  u~l i forn i  resumption of' renal  fuilction could 
be espec teci f o ~ ,  111,i11! hours .ti'tet, cie;\th. tiles? results ha1e  not 1,een repro- 
duced in clinic ,11 expelieiice. \ \  j t l l  ~ ~ s i .  of hurn,in c iida1 eric tissues. tlie degree 
of '  injur! hi15 :il~l~e;ireti o ljt '  11iucl: are~ttel , .  11ot onl>- in o ~ ~ r  llancls 111it in most  
other  cli11ic.s uiitly \ , trio~is f'orlns of j~ostniortt-111 pi,eset,\ a t i o n  This  f ac t  
sL1"" ,,esti t11,it propet d o ~ l o t  st3lt.c tion is '15 il~ipol,t:int .I f,ic.tor a s  the method 
~ i i e d  f 'ol  pre.ert cltioii .  T<i t i t~ i . !  5 obtCtirit.cl irolll  ~ ~ ~ i t i e n t s  t\-llo h a \  e h a d  a 
protracted terinin,il course .ire ~tncloul~tedl! ,il.i,ll~l>- ~ i ~ i ~ ~ ~ ~ ~ c e c l  ljefore d a th ,  
resul t inc in ~ ~ n p l , e d i c  t,il~le 1,iti.r 1 ~ i n c  tioil. C ~ ~ i t t ~ i ~ i , ~  ~ 1.i. neeclecl for the e \  a lua-  
tion of debireti or2,ilis it1 p l i t i e n t ~  ti-110 ,rrt. t l i o ~ ~ ~ h t  to ll,i\ i' ,r hopeless prog- 
nosis. in cc~rtlei to .llIot\ yre,itt.1, .c.lei ri\ it! oi tlii. + i t ~ ~ , i t i o ~ ~ i  ill t\-hicll i~u topsp  
tissue be d ~ ~ e p t d b l e .  
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Figure 24. Same patient as in Figure 23. A- Appearance of homografted cadaveric kidney 24 days 
after transplantation, compared to B -Cadaveric contralateral kidney immediately after cessation 
of perfusion. H and E (X 25). (By permission of Surgery 54:900, 1963.) 
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Figure 25. A-Homografted cadaveric right kidney removed 12 days after transplantation (CD 2). 
Note evidence of rejection. B -Contralateral donor kidney obtained at conclusion of perfusion. H 
and E (X 25). (By permission of Surgery 54:900, 1963.) 
62 / THE ROLE OF CADAVERIC DONORS IN HOMOTRANSPLANTATION 
A special note should be made of the importance of refined hemodialysis 
techniques in the care of patients receiving cadaveric homografts. Kolff and 
his associates have shown that return of renal function can occur in those 
transplants which initially pass through a phase of acute tubular necrosis if 
aggressive supportive care is provided, an observation previously made by 
Hume. The degree to which improvements in dialysis will permit success with 
cadaveric donors remains to be determined. but this type of in\-estigati\-e effort 
is certain to influence future developments in clinical transplantation. 
The ultimate in exploitation of cadaveric organs will occur when finely 
machined and controlled extracorporeal perfusion equipment is developed 
which will allow the long-term maintenance of kidneys by perfusion directly 
into the renal artery after removal from the body. Until now, perfusion circuits 
have not permitted this kind of use, inasmuch as maintenance of the organs in 
an  optimum state has been feasible for only a few hours. After a short time, 
parenchymal damage, edema, and functional deterioration have resulted. With 
more effective perfusion techniques. it may become possible to evaluate the 
function of the isolated organs and eliminate from further consideration those 
which do not have a reasonable excretory capacity. 
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Chapter Nine 
ANESTHESIA FOR PATIENTS 
INVOLVED IN RENAL 
HOMOTRANSPLANTATION 
by Robert U7. Virtue, M.D. 
Choice of anesthet ic  procedures i s  based  on  the  considerations involved in 
a n \  such  declslon. n,lmel\.  the  s:ifet\ of the  pat ient ,  the  needs of the  surgeon,  
and the comfort of the  patlent.  III t ha t  order T h e  s a f e t ~  of the  pat lent  requires 
fleui1,le methods of manaqemen t  I ~ e c a u s e  three t \ p e s  of people come  to surgery 
in 1~~11,il homotlansp!,lrlt,itioti 1 he  needs of the  suigeon are  for  a qulet pat ient  
arid .irlecju,ate 1nuscu1,ll rt.l,i\ation The  conditions des11,ihle for the  pa t ien t  
at( ,  .inLi1qt>51,r. ied,ation. ,rnd .I 1,ic h of 1efie.i effrc ts I hest. 111elequlsltes canno t  
li( Inet ~11 th  the s,inlr, lilethods 111 ,ill c ,lses 4 f r.11 p,iticnts 'Ire coopei,\tive 
Litid s ~ ~ f h c l e n t l \  ollt~iltecl i o  the\  untir~ist,rnti the necesi i t \  to1 11c111g quiet 
, I I I ~  c,r11 d o  i o  \ olunt,rlil\ Eec~oll , r l  ,rnt sthes1,i in,r\ I)e ciesll;ll~lc~ In such  c ~ ~ s e s .  
4 i t  11 11~1ti~11ts  I I < I \  c> 1)c C , I ~  (lisot tc>ntccl 1 ) l i t  c 0011e1 <i t11  t . c i ~ ~ c l  I t,qiotj<ll ~ i11~5t l les ia  
nl , i \  I)c. .idt clu,~t t  f ( 1 1  tht sc, .is 11 ell L ~ l c  oopc 1 ~ t l \  e i ~ ~ l ~ l c c  ts tnust I,e rendered 
C j L I l c  t c O t l ~ C ~ c ~ ~ l ? l l t l \  < f , I l t  1 <11 < I I l t  stllc,ilci I \  ~ ls l l<l l l \  c l l l ~ l I O \ t  cl f 0 1  t11e111 
Healthy Volunteer Donors 
The  first of the three types of pat ients  is the  kidney donor. All donors are 
heal thy.  Three f 'actors ma!- aff'ect the choice of procedure. T h e  first is t ha t  t he  
operations are  of considerable durat ion.  so a "one-shot" spinal  anesthet ic  does 
not ordinari1~- afford :i sufficient operatin: period. The  second factor  in\-olves 
the frecluent recluest b! the iui,geon for a\ ailal)ilit!- of eltctl ,ocauterv. thereby 
p re \ en t ine  the use  of c ~ ~ c l o p r o p ~ i n e .  \\-llich 11-ou1d o t h e r ~ ~ i s e  b  a most useful  
acent .  Tlle t l~ i rd  factor  is that  m;ln> dollor5 e;lrl>- in the series had  general  
h>-potl~erlni;r,  a l though tliii merliod l i ' r i  ~ i i i c e  bee11 di icontinued.  
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H y p o t h e m z i a .  Surface cooling has been safe in our hands in more than 
1,000 nonrenal cases when tn-o specific precautions were taken. The first of 
these is to establish good muscle relaxation before immersing the patient in 
the cooling mixture. Before immersion. we have usually produced second 
plane of third-stage anesthesia and then administered in addition about 9 
mgm of d-tubocurarine (to an adult). The second precaution is that of pro- 
ducing a two-step change from room temperature to ice water. \Then the 
patient has been relaxed he is first placed in a bath containing water at 15 to 
20" C. The head and arms are held out of water. Sufficient time is allowed 
(about three minutes) to ascertain that the patient shows no signs of light 
anesthesia or lack of relaxation. If any spontaneous respiration, motions of 
limbs or fingers. "goose flesh," coughing. stiffness. or eyeball activity appears, 
either more anesthetic agent or more relaxant or both are administered. When 
the anesthesiologist is assured that the patient is stable and well relaxed. ice is 
added to the water bath, and the patient is permitted to cool to an esophageal 
temperature of about 33", from which lelel  a drift usually occurs to 30 to 32" 
C. He is remoLed from the ice water and dried, and preparation for surgery 
begun. A preplaced warming blanket on the operating table is useful for 
rewarming as incisions are being closed, allowing earlier resumption of spon- 
taneous respirations which will generally not return until the temperature 
rises to or above 32.5" C. \Parming can commence as soon as the kidney is 
removed. Agents used for this anesthetic procedure may be whatever the 
anesthesiologist desires, for the subjects will all be in good condition. 
In more recent cases, total body hypothermia has not been used for living 
donors (Chap. 10). The method is still employed, however, for procurement of 
baboon heterografts and the precautions mentioned should also be observed 
for the care of these animals (see Chapter 23). 
Patients Whose Poor Renal function Will 
Not Be Improved b y  Operation 
The second type of patient is the ill person who is having surgery for a 
nontransplant procedure such as preliminary splenectomy, nephrectomy, 
drainage of an abscess, or an  emergency procedure for control of gastric hem- 
orrhage. \\'hen "splenectomy and bilateral nephrectomy" were first placed 
on our surgical schedule without simultaneous transplantation, the operating 
room personnel expressed amazement. It was grat i f~ing,  however. to follow 
the course of our patient following remol a1 of his diseased kidneys. He had 
been hypertensive with progressi~ e blindness, and had severe congestil e heart 
failure before transplantation Two n eeks later. his blood pressure had dropped 
to normal levels. Heart failure n-as no longer a problem, and his \-ision was 
improving. The role of renal dialysis in the anephric interval is discussed in 
Chapter 4. 
On several subsequent occasions, nephrectomy and splenectomy have also 
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beell dolle a t  a preliminary s tage  prior to the  t ransplantat ion.  \Then i t  appeared 
that  a spirlal anesthet ic  alone might  be of sufficient durat ion.  this n.as em-  
plo!-ed. 111 some ins tances  supplementat ion ~ v a s  required. On other  occasions 
contiliuous epidural anes thes ia  ~1-it11 or ~v i thou t  a general  agent  afforded satis- 
factor!- operatirly conditions. 
Since all the recipient pat ients  a re  sex-erel\- ill. a thorough preoperatil-e eval- 
uiition of' cerebral.  c:~rdiac. :illcl pulmonar>- s ta tus  is essential.  \Yhen conges- 
ti\ c heart  f'ailure is or h a s  been se \  ere,  ex t reme caution niust be taken  to a.i,oid 
dc,l)t,ession of' hear t  action more than  is absolutel\  essential.  Under these cir- 
c . ~ ; t ~ ~ s t a n c c ~ s ,  spinal ai iesthesi ;~ can  be u t i l i ~ e d  :is a bloodless p l ~ l e h o t o m ~ .  This  
11niclue pro\ ides excellent relaxation f'or the surgeoli. bu t  its durat ion is inad-  
c.cjil,ite f o r  prolonqed o11el~:itions. On a f'e\\ occ,:isions it h a s  been used and  
tl l i .11 s~1p11lelnentc.d \\-it11 ge~iei.:il :itirsthesia t o ~ v a i d  tlie elltl of' the  surgical  
ol)c't,;ttion. Coiitiri~lous spinal anes thes ia  ~ v o u l d  also be a good choice, al though 
\vc, h,l\ c, not used it .  
C ' l r o i c  (' o f  .4(lt,)lt. \\.hen qe1ler:il anesthesia is recluired for  pat ients  in  in- 
c i l~ ient  l~~rl~~ion;ir!- edema ,  the use  of' positi\ e pressure xvith oxygen h a s  specific 
x.alue. co~n l~ i t i cd  ~ v i t h  tninin1:il anesthet ic  agent  :itid preferably in combinat ion 
~ v i t h  sl~jlial or. epidural anesthesia.  H a l o t h a i ~ e  h a s  l~ec t i  ;i iiseful anesthet ic  
;igc.tlt i l l  this s ~ t t i l ~ q .  csl~eciitll!. \\.it11 selerel! h!~~el ' t t . l lsi\t~ pat ients ,  s ince 
this c i q c s ~ ~ t  tends to lo\~-er, thc  1)lood pressure to easily c.otitt.ollcd levels. 
t'oor i,c>nal f'unction h a s  1)eell presellt it1 all thc  tl~:itisplant candidates a n d  
it1 l'c\\ of' the post-ti~:i~isl~l:ll~t sul?jccts rvho recluirecl i.eoperation for  :i \.ariety 
of t~c>;isolis. Kelaxi l :~  agclits h a \  c. I ~ e e n  used cautiousl! in such  cases ,  s ince 
i .c~tl ; i l  yxcrc~tion is the pi,inc,il~:tl I I ) ~ . ~ ~ I I S  of' elitnination of' sonle of' these com- 
po~ltids. \\ 'lien it is t h o ~ i g h t  tha t  ret~i i l  t 'sct,ctio~l i v i l l  11e 110 better a f te r  t h a n  
1)c'f'ot.e ol~ct.:itioti. -:,el:ixatiot~ is l ~ e s t  obtained r\.itli Lit1 iiili:~littioil agent  r a the r  
th,ltl ~vit l i  an  agent  tha t  tllc kidtie!. tnust eliminate. 
O the i  reasons c a n  be c,ited f'or c a ~ ~ t i o n  in  the use  of rnuscle re laxants  for  
p:rtients TI it11 renal  disease.  L I I I C ~  especiall! those ~ v h o  h a \  e been recently dial- 
!reti. l ~ r l ~ t i n e n t  exal1111le l\ .as o l ~ s e r \ e d  a f ' e \ ~  \ e a r s  aqo in  a pat ient  who  
dc \  eloped se \  ere 111uscle spastns ;inel 11aillf'~ll C I . ; ~ I I ~ ~ I S  in his legs ivhile being 
di,rl!-;led. 7'0 t,el;is the 1c.q -:muscles. 1 0  nicm of' succin!-lcholine Tvas given in- 
tr,i\ enousl!.. This  stoppt.d not onl! his respir~i t ions but c~lso his he,irt. H e  Tvas 
rt.suscitatec1. and  a sainplp of blood ~ v a s  clrct\\ 11 f'or :iji,tl! sis. The  p l a s ~ ~ ~ : ~  c,holin- 
rs terase coiltent hiid c1inli1liiht.d to rero. For tllii rc>ason. .ill>- pat ient  ~ v h o  
has  recentl>- been d i a l v ~ e d  is one in \I 11o111 the use  of xuc,c.ii~! Icl~oline is a\-oided. 
-1 fel \  p,ltients 11;ix-t. come to the o p e r ; ~ t i t ~ ~  1.oo111 1-ith st.1 e re  gastric hemor-  
r h , i ~ c  either before or after tl,iiniplantatio11. Tlle choice of' : ~ y e n t  here h a s  been  
c>-clol~rol~,ine. since induc tioli nnusr be dolle r ~ i l ~ i d l > .  F u t ~ t l i e ~ ~ ~ i i o r e .  c>-clopropane 
does not ciepress r e n , ~ l  funct ion.  atici it does ~ i o t  cciu.e h!potension. -1s ~ t i t h  
nonrelial patients ~vi t l l  s imilar  hetnorrhages.  depth of anextlleiia should be 
kept licllt. I t  is nlalidator>- to pro \ ide  1:xrge x-enous i , ~ n ~ i u l a i  for administra-  
tion of fluids and blood. 
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Patients Whose Poor Renal Function Will 
Be Improved by Operation 
The third type of patient is the one who receives a transplant. These 
subjects have almost invariably been kept alive for varying periods by means 
of the artificial kidney, and many have already had preliminary operations as 
discussed earlier. Despite preparation with dialysis, the patient is neither 
normal nor stable in respect to internal fluid or electrolyte environment. Most 
patients are water-logged. As soon as the homograft is placed into circulation, 
Table 8. Anesthesia Used for First 55 Patients 
Treated with Homotransplantation 
- - . . - 
Transplant operations (usually also splenectomy and bi lateral nephrectomy): 
Spinal alone 1 
Continuous epidural alone 1 
Halothane alone 2 1 
Fluroxene alone 2 
Cyclopropane alone 2 
Spinal supplemented w i t h  halothane 11 
Spinal supplemented w i th  fluroxene 4 
Spinal supplemented w i th  cyclopropane 1 
Continuous epidural supplemented w i th  halothane 7 
Continuous epidural supplemented w i th  fluroxene 4 
Continuous epidural supplemented w i th  meperidine 
and nitrous oxide 
Surgery for recipient patients other than the actual homografts: 
Spinal a lone 
Continuous epidural alone 
Halothane alone 
Fluroxene alone 
Cyclopropane alone 
Nitrous oxide alone 
Spinal supplemented w i th  holothane 
Continuous epidural supplemented w i th  halothane 
Continuous epidural supplemented w i th  f luroxene 
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urine is forlneci in copio~ls  iinlounts. .As 11iuc11 :is 16 liters h a s  been excreted 
11 it]iin 1.2 Ilouri f'ollox~ in: ti,c~ni;plantation. \ \hen l~ r i sk  ciiureiis it t irts 011 t he  
~lpyr;ltilly t c ~ l ~ l c > .  t l i c>  t ~ t , i t i ~ ~ r >  fl~licl 105s is p:lrticill> i ~ c . ~ ~ l ~ i c ~ ~ c i  ~1sttal1> 75 11c.r cent)  
l\-ith 1;ict;~ted F:iiiyc'l,'i solutioli. ;I qc,neral 111;iti ~1-hicli  i i  i,itn.ic.d illto the  post- 
c)ljr,rclti\t '  ~~cl , io t i  :is d i s c , ~ ~ s s e d  ill C'11~1pter 12 L't~itie e\c.retioll nia>- !)e so great  
t l i ~ ~ t  t \ \ o  lL~l.:e l~~orr ,  \ e ~ l o ~ ~ ~  c,ithetrvs ~ i i ; t > -  I l r .  ~,t.qi~it,?ti tot, c~fficient leplace-  
~ ) ~ c . ~ i t .  I . ( ] \ ,  , i l l ( ]  ~ ~ t ~ ] ) l ~ i c e ~ ~ i t ~ t i t  of 11Iooci I \  11ot i i i t ~ < i l l x  < i  c i i f f l c ~ ~ l l t  prol)lelji, I f ' rena l  
t ~ ~ ~ i t l ~ l ) I ~ l t i t ; i t i o t ~  t l i t l  sole> p i ~ ~ c c ~ ( i t ~ i ~ t ~ .  l , ; t t i \ i~~i io t l  i i tiot orcii~iaril\ needed. 
..\tl , I \  c.1.,l:i3 01  1 .OOO c c  11lood is ~,c,cj~iired fo l  iitiltilt;itleotls I~il:itc.ral nephrec-  
t 11i1\. ~ ~ ) I ( ~ I I ( ~ I  t o t ~ i > .  :itid t ~ ~ ~ i ~ i i l ~ l ; i i ~ t ~ i t i o i ~ .  .A\  11-itli  t l i c l  scco~lcl t>11? of' pat ient ,  
t 1 ~ < t t i >  of' tIl(: ~ , t x c , i i ) i c , t i t i  ]];I\ !: ! i> l )c~~~t(~t i s io t i .  Tllis t ~ i ; ~ \  l ) c ~  s;iti\f':tc,tot,il>- rc,q~tlated 
11 i t 1 1  li,ilotli:i~ir~. I f '  tlio p:rtic>tit'i I~lood ~) t ' t . s i~ i t ' c~  c'ncls to 1)e lo \ \ .  h;t\ c used 
f l i ~ t ~ o \ ( ~ t i c ~  ot  \c3\  V I , ; L I  oc,c < i \ io~i ,  to 1)1,o\ id(, sCit(> < i t ~ < i I y ( , i i ; l  \I-itliot~t ~11,011 01' l~ lood 
pl'c.ss~~t'e. 
In  thc  first cases.  12.5 qm 01 tiianllitol \ \ ; I \  itif'itsc>d into the patient jus t  
h(,f'ot,c, c,i~.c.ulation 11 a s  1)equti tht.011y11 the‘ I I ~ \ \  kiciti('\.s. I f '  diurc,sis colnmenced,  
t o t i t  - 8  I 01' ~ i ~ t ~ t i i t o l  I t i  i ~ t l ' t t l  i l l i t i c ~ t i i l l .  I'hc prr,sent 
p1,<1c tic,(>. I):I\<\CI oli c o t i t i t i i~ i~ iy  c ~ ~ ~ ~ c ~ t ~ i c ~ t  (>. i t 1  \ 0 1  \ c,\ ~ ~ ( l t i i i ~ i i s t ~ ~ ~ ~ t i o ~ ~  cot' c ) t i l ~  t he  
f ~ r i t  12..? yt l i  01 111:11ltiif 01.  , \ l t l i o ~ ~  211 t l i t ' ~ ~ ,  is tio c ~ l i ~ i i c ~ ~ i l  ( > \  i c ( , t j ( , [ >  t1i;it this is es- 
sc>nti;il. \tutlic>s i t 1  cloys i ~ t y c c ~ i t  t l ~ ; i t  i ~ i in~c~d i ; l t c~  t,c,n:~l I)lood f io \~ .  is therchy in- 
ct~!~;lsc~(l. 
I.ittl(. 11;~s 11et.n s:iid c.oncei.nin: the ac~ttt:rl i ~ ~ i e s t h e t i c  ;i<c3nts employed. 
Ol)c'i.;ititiy ~ ) t ~ o c ~ i ~ d u ~ x ~ c  (,;it1 bc, don(, ~ v i t h  i ;~fc. t \  i f  thi, d l , t ~ c i  ;tnd p~~oc,c~dures  a re  
cIioi(,ti O ~ I  t l ~ ~  11;lsii of t11(> c~o~iclitioti ; i t l ( I  t ~ ( ~ c ~ t t i ~ ~ ( ~ ~ ~ i o t i t \  01' tlic. i~icii\iciual 
p ~ ~ t i c ~ t ~ t .  t , i L i i q  itito ; ~ c ~ c ~ o ~ i t i t  tlio i111,yic < I /  pt,o( ( > ~ I I I I Y  1 0  l ) t ,  1x~l.I ol~t~ic~cl,  I t  \\ ould 
lx> :i ti~ist~iAc> to o ~ ~ t l i t i ( '  ; i  proc ~ ( I t t t ~ o  ~ ' O I  ; I I I \ O I I ( >  to f 'o i lo \~ .  fl;itlic>t,. SLIC,II  clecis- 
ions art2 ~ i i i ~ t i c .  ,if t c ' r  c , 1 1 ~ 1 ~ 1 t l l  itud! 0 1 ' t l i c .  itidi\ i c l i r , i l  i i t ~ ~ ~ ~ t i o ~ i .  . \  ~ I I I I I ~ I I ; I T . ~  of' the  
1 < ~ t , i o t ~ s  ~ ) ~ ~ o c ~ t ~ ~ I ~ i t ~ ~ ~ s  1i;1\ c, ~ ~ t i l i / ( , ( l  Jot, t ,o(.ipi(>t~t l ) ; i t i c ~ ~ t t \  i \  \llo\111 iii T a l ~ l e  8. 
Otlic~l~ ; t i t , i t l i (~ i~olo : i i t \  1 i l ; i1  1)1~of'c~1~ to l t i ( >  otItc,t~ t < ~ c ~ l ~ t i i c / ~ ~ c ~ s  to], tl~c,ii, 1j:itic3nts, 
t l~c. tlecisiot~s 1'01 the ~llethocis tiset! 1 1 t ~ 1 t t ~  11<rsi ( 1 ril)oti t l ~ r , i t ,  ! I \ \  11 p a i t  experience 
and immedia te  judgment .  
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Chapter Ten 
DONOR NEPHRECTOMY 
b y  Thomas L. Marchioro, M.D. 
The donor operation must satisfy two requirements. It must be safe for the 
patient who is sacrificing the kidney. In addition, it must gusrantee delivery of 
a minimally traumatized organ, inasmuch as a most important factor in the 
ultimate outcome of a transplant procedure is the quality of the tissue that is 
transferred. The procedures used appear to have satisfied these objectives. 
A general comment is in order concerning the surgical exposure employed 
as it relates to the full needs of donor nephrectomy. In contrast to many extirpa- 
tive renal operations, complete vision is needed for each step. Sharp dissec- 
tion is required in many areas that are ordinarily mobilized by blunt means. 
Because of the long vessel segments required. and the consequent necessity 
for freeing them to their origins, perfect exposure is mandatory near the aorta 
and inferior vena ca1a. Finally, the ureteric blood supply from the renal 
pedicle can be preserL ed with certainty only under ideal operating conditions 
(Fig. 26). The generous incision that is used allows exposure for such meticu- 
lous dissection. thereby pro1 iding protection not only for the patient but for the 
specimen as well. 
HOMOGRAFT COOLING AND 
HEPARlNlZATlON 
All kidneys are delivered in a cooled, heparinized state. This has been 
achieved in one of two ways. If the donor and recipient were of the same ABO 
blood type, as in 32 of the early cases, total body hypothermia (30 to 32" C) was 
used for the donor patients. Fi\ e minutes before removal of the kidney, 2 mgml 
kgm of heparin was given intra1 enous l~ .  As soon as the specimen was removed, 
protamine sulfate, 2 mgm kgm, m-as given in 100 cc of 5 per cent dextrose in 
water over a 10-minute period. Although both heparinization and hypothermia 
might be expected to increase problems with hemorrhage. careful hemostasis 
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Figure 26. Blood supply of pelvis and ureter occasionally encountered in autopsy studies, in which 
multiple fine vessels are distributed from the renal pedicle. The fatty-areola area enclosed by the 
aorta, renal artery and vein and ureter is removed en bloc in order to avoid injury to the ureteric 
vessels. (By permission of Arch. Surg. 86:600, 1963.) 
throughout the entire procedure prevented this difficulty. Among all the do- 
nors at  the University of Colorado, none has received transfusions. 
Nevertheless, the practice of donor cooling and heparinization has been dis- 
continued, as will be noted, in favor of a cold perfusion technique. 
Total body hypotherrnia and systemic heparinization have never been used 
in the presence of an ABO blood group incompatibility between donor and re- 
cipient patients. Instead, the donor nephrectomy was performed at normal 
body temperature. As soon as the kidney was removed, a plastic tubing or a 
blunt needle of appropriate size was inserted into the renal artery, and the 
kidney was perfused with lactated Ringer's solution or with 10 per cent low 
molecular weight dextran in normal saline" (precooled to 15" C) each liter of 
which contained 50 mgm (5,000 units) of heparin and 1 gm of procaine 
chloride (Fig. 27). 
In performing the renal arterial perfusion, certain precautions are neces- 
sary. All antiseptic must be washed from the tubing, and air should be flushed 
out before insertion of the tip into the renal artery. It is important to avoid 
traumatizing the intima of the renal artery with the nozzle, since this might 
later necessitate sacrifice of vessel length. After the perfusion is started, the 
'Supplied as Rheomacrodex by pharmacia Laboratories, Inc., New York, New York. 
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Ttachniquc 08: per - 1+0 cm. H20 
fusior: ;< :3~-~y  q4\;ii:: 
C D ] ~  R~::Q LL 7-+- b -.>.3&2. 
Figure  27.  Method of cold perfusion of renal 
homograft. Various other solutions (see text) 
have been evaluated. (By permission of Sur- 
gery 55:195, 1964.) 
hydrostatic pressure can be controlled either by the elevation or lowering of 
the stand from which the solution is administered or by a pressure bulb at- 
tached to the air inlet of the perfusate fluid container. The pressure employed 
is approximately 70 mm Hg (90 to 100 Cm HzO). In the usual case, approxi- 
mately 200 cc of fluid is required before the kidney has been thoroughly washed 
of blood and before the effluent from the renal vein returns clear. 
A special note should be made concerning the use of procaine in the per- 
fusing fluid. Experimentally, the use of cold electrolyte solutions that do not 
contain this substance or some other vasodilator results in unsatisfactory per- 
fusion. Flo~v ceases within a few minutes, apparently owing to afferent arteri- 
olar vasospasm. The addition of procaine avoids this vasospasm and uninter- 
rupted flow can be obtained for as long as desired. 
A controversial point concerns the choice of fluid to be used with this 
method. Kiser and Hitchcock and their associates believe that 10 per cent low 
molecular weight dextran in normal saline is superior to pure electrolyte so- 
lutions, but Knight could not demonstrate such an advantage. In our experi- 
ence, both have been satisfactory. 
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I n  ou r  institution the  technique of cold perfusion ~ v a s  used  a t  first only for  
those donors ~ v h o s e  major  blood groups n-ere different froin those of the re- 
cipients. and  for  the specific purpose of prex-enting intral-ascular  hemagglut in-  
ation at  the t ime of the  subsequent  re\-ascularization. LTse of cold perfusion 
lvas liinited to such  cases  for se\-era1 reasons.  First.  a n  additional three to 
l ( , - n ~ i n u t e  period of i s c h e ~ n i a  is imposed b!- the use of' this technicjue. s ince 
this is the tinle necessar!. for adequate  perfusion. Second. there is a risk of in- 
fiic,ting d a n ~ a q e  upon the renal  artery a t  tlic time of insertioii of' the  perfusion 
tip. lil~all!-, the efl'ect upon u l t imate  rena l  f'unction of instilling cold electrolyte 
iolutions is not precisely knolvn. al though no harmful  sec~uclae  ha \ -e  been seen  
i l l  our esperie11c.e. ..if'ter the  perf'usion technique pro~.ecl to 11e a11 entirel>- s a fe  
mi,thod, it beci i l i~e the preferable lnethod for all cases.  since the  sliqht but  defi- 
~ l i t c  additional risks of donor heparinization ailcl total bod! hhpotherinia Lvere 
thereby avoided. 
RIGHT NEPHRECTOMY 
liight nephrectomy is usually performed if t ransplantat ion is planned to 
the' lef't iliac fossa of' the  recipient.  A modified lateral  position is employed (Fig. 
28 8\ I .  using a kidney rest. which is raised in order to extend the  presenting 
f la~ih .  The  patient is slightly rotated posteriorl! to pro\-ide exposure of' the  
1o11c.1, lateral abdoinen (Fig .  28K). The  underlyinr: left ley is kept relati\-ely 
s traiqht ,  aiid the o\.erlying right lower extrennity is flexed a t  the knee. It  is im- 
portant to protect the f i t~u la r  head with padding in  order to pre\-ent peroneal  
palsy. The  patient is ~ n a i n t a i n e d  i r l  position J\-ith strips of' tape passed across 
the, pel\-ic girdle and  fastened on either side of the operat ing rooin table. If 
desired, exposure tnay be e n h a ~ i c e d  by extendilly the 11e:icl or foot of ' the  table. 
The  posterior part of the incision is macie directly o \  e r  the elex.enth rib 
F i z .  28.A1, and  the irlcisioil is extended across the lateral and  aiiterior ab- 
tio111en to a point mid\\-a?- l ~ e t ~ v e e n  the unlbilic~us ;rnd pullis (F ig .  28B). T h e  
nlt~ciial end  c~f the incision is frequently cu r \  ed inferiorly. parallel to the lateral  
11o1der of '  the rec tus  shea th .  for 2 or 3 inches Fiy. 28B !. .Aftel. illcisiny the  skin 
irncl iul jcutaneous tissue. one encounters  the first 111usc1e layer. consisting of 
r l ~ r ,  I a t i s s i l nus  clorsi poster iorl!  a n d  t h e  e x t e r n ~ r l  o l ~ l i q u e  m u s c l e  a n d  
crpo~~c'urosis  anteriorl?- (F-ig. 28C1.  After these inusc l t~ i  :ire tii\iclc~d. the  
~)ei,iosteunl of the elel  ~11 th  rill c an  be i iua l i red .  'The perioitc.u111 i i  iricised and  
1 1 1 ~  elel en th  rib i i  resected subperioste,~ll>- Fig. 28C' . The  plcrne of incision of 
tile periosteal bed is the11 folloir-vd iinteriol,l?-. dix-idin2 the internal  o l~ l ique  a n d  
tr>ins\-ersus abdonlinis muscles Fig. 28C . Finall>-. the i n n e l  la>-er. x ~ h i c h  
coniists anteriorl! of the trans\-ersalis fascia.  is d i ~ i d e d  through the ent ire  
Ielizt11 of' the iilcisioll . f i g .  29L) . \\-it11 the last s tep.  the re t roper i to i ie~~l  space  is 
entered. 
Special care  m u s t  be exercised in the posterior end  of the xvound a t  the  
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Figure 28. Operative exposure for donor right nephrectomy. X and B-Position and extent of 
incision. C-Eleventh rib has been excised. (By  permission of Arch. S u r g .  88:711, 1964.) 
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Figztre  29, Donor right nephrectomy (cont.). Exposure after incision of the periosteal bed and 
transversalis fascia. D-.4natomy as encountered before manipulation. S o t e  pleura 'posterior) and 
Peritoneulll arlterior . E-Jlobiliration of the kidne>- and its inr-estments posteliorl>-. B>- permis- 
<ion of i r c h  s l i rc1 .  68:;11. 196-1. 
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junction of the thorax and abdomen. In this area, pleura is almost always seen 
protruding beneath the stump of the excised rib (Fig. 29D, E). Just below this, 
diaphragmatic fibers are frequently encountered (Fig. 29E). Both the pleura 
and the diaphragm are gently swept superiorly, obtaining adequate mobiliza- 
tion with the placement of a chest retractor so that they are not torn. The 
wound is then opened widely. The kidney and its investing layers are pushed 
anteriorly off the quadratus lumborum and the psoas muscles (Fig. 29E). 
The paranephric fat  is now in the central part of the wound, bracketed by 
the pleura laterally and the peritoneum medially (Fig. 29D, E). The fat layer is 
entered and pushed off the underlying Gerota's fascia by gentle blunt dissec- 
tion. The numerous small vessels running in this tissue should be carefully 
electrocoagulated or ligated prior to division. 
Once the superficial surface of Gerota's fascia has been exposed, this 
structure is incised superoinferiorly (Fig. 30F). The underlying perirenal fat  
must be detached from the true renal capsule to which it is attached by 
numerous areolar bands containing vessels. These vessels must be ligated or 
electrocoagulated (Fig. 30F), not only to insure hemostasis in the donor patient 
but to provide a dry homograft for subsequent use in the recipient. Dissection 
is continued until the entire presenting surface of the kidney has been cleaned 
(Fig. 30F). 
In proceeding with mobilization of the kidney, it is advisable to free the 
upper pole as a first step. Having done this, it is possible to extract the kidney 
more completely into the wound, making the remaining dissection easier. In 
carrying out this step. caution is exercised not to divide an anomalous superior 
polar branch of the renal artery. This danger is largely averted if preoperative 
aortograms have been obtained with which such anomalies can be detected in 
advance. 
Next, the renal convexity is freed in a similar manner (Fig. 30G). When the 
inferior pole is reached, dissection and mobilization are discontinued tempo- 
rarily. 
The kidney is placed back into its normal anatomic position and attention 
is turned to the identification and dissection of the proximal renal vein (Fig. 
30G). The renal vein is the most anterior structure in the renal pedicle. On the 
right side. its junction with the inferior vena cava is seen almost immediately 
and cleared of all areolar tissue for approximately 1 cm distall). Within this 
segment of the right renal vein, there are usually no entering tributaries which 
need to be ligated and divided. 
After mobilizatioll of the major portion of the kidney is completed. the rest 
of the operation allows elentual removal but aLoids as far as possible the 
central hilar structures. First. the grool e betneen the renal vein and the more 
superiorly located adrenal gland is separated. ligating and d i~ id ing  in con- 
tinuit) the bridges of tissue between these structures (Fig. 30G). Following 
this, the groove between the inferior vena ca\ a and the ureteropel~ic junction 
is separated with a similar technique (Fig. 30G). 
F i g z c r e  30. Donor right nephrectom>- cont . )  F-Incision of C;erot,i's f c ~ i i i : i  and  ~ ~ c - i i r c n ~ i l  f a t .  Note 
careful herllostasis of capsular  \-essels. G-Kidne>- extracted froni i r i  bed KloiL exti.ion h a s  been 
*tarted 11-ith separation of t he  kidlie? medial]? and laterall! and iimm rht- , i d r r ~ i ~ i l  r I , i~?d.  I<-ithout 
tiist~~rl,in: the cent ra l  l ~ i l a r  i t rucr t i re i .  T l ~ e  a i i te r io i l~  I o i , t t * - t i  ~ r n ~ t l  ini.11- I L I I ~ L ~ I O I I  151rll the ~ e n a  
cayc+ i, \ i sual l red  cleared.  H-Tl ie  I;~tinr.\ di .~)I . t~ed .inrt:il i l l  , i ~ l ~ i  11lc p i ' \ i i - i .~ i  : .~n , i l  artery 
ciiisec tcd t ree  If  111~ Lirerer 1s cur.  I[  1. a11011 ed drLiln ri tr- l> ~ailil; . L I ! ~ - ~ - ~ , L I L I - . L  I i n. ., ,i!. \,!3) p e r ~ l u s -  
sion of drclz. S z ~ r g .  88:711. 1964.) 
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Finally, the kidney is lifted from its bed and rotated anteriorly (Fig. 30H). 
The renal artery is identified as far proximally as possible, usually at  the point 
at which it passes beneath the inferior vena cal  a (Fig. 30H). The artery is skel- 
etonized to or toward its origin from the aorta. Occasionally the field of dissec- 
tion beneath the inferior vena cava may be obscured by one or more large 
lumbar veins. These should be ligated and divided after it is ascertained that 
they do not drain part of the eventual homograft specimen. After completion of 
this dissection, any filamentous bits of tissue connecting the contiguous renal 
artery and vein are divided and ligated. 
The right kidney is now completely free except for its vascular and ure- 
teral connections. If the recipient operating room is nearly read) for receipt of 
the kidney, the ureter is divided as far inferiorly as possible with a single distal 
ligature of 2-0 silk. The site of transection is at or beyond the common iliac 
vessels in order to proLide adequate length for implantation. L17hen the 
proximal end of the divided ureter is lifted into the wound, a few filmy areolar 
connections which bind it to the posterior ~zrall are encountered. These are 
divided between ligatures. Upon signal from the recipient operating room that 
all is ready, the final steps preparatory to removal of the kidney are carried out. 
The necessary equipment for hypothermic perfusion is checked (see preceding 
section on "Homograft Cooling and Heparinization"). In the actual removal, 
right-angled Pott's clamps are used to grasp the artery and vein individually 
(Fig. 32E). For transection of the artery, a single clean cut is made. leaving a 
cuff of 2 or 3 m m  for closure of the stump (Fig. 32F). Di~is ion  of the vein is 
best accomplished by making a small incision in the inferior border of the 
vessel, distal to the vascular clamp. By compressing the vein between the 
index finger and the thumb. the incision can be kept bloodless and the anterior 
and posterior walls of the 1-ein incised separately. This procedure permits more 
accurate incision of the vein and preLents intimal stripping which has oc- 
curred on occasion when the vein was transected by one cut of the scissors. 
The kidney is then carried directly into the recipient operating room and per- 
fused with cold solution. 
The vessel stumps are closed with continuous 5-0 vascular silk which is 
reinforced with a second layer (Fig. 32F). The wound is extensively irrigated, 
and all loose fat and other debris is remo\ ed. Occasionally a pneumothorax is 
encountered due to a rent in the pleura at the upper angle of the wound. Such 
pleural defects are closed n i th  interrupted figure-of-eight sutures after 
evacuation of the pleural air \vith a No. 20 French catheter. Only two patients 
have required the subsequent insertion of a chest tube during the postopera- 
tive period. 
The wound is closed in layers, using interrupted silk technique throughout. 
Drainage is not used. 
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Figure 31. Incision and exposure for donor left nephrectomy. 
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LEFT N E P H R E C T O M Y  
Left nephrectomy is usually performed if transplantation is planned to the 
recipient right iliac fossa. The position is a mirror image of that used for right 
nephrectomy. The general technique and all of the steps of exposure are com- 
parable (Fig. 31A. B). There are, however, important differences in the dissec- 
tion in and around the hiluln which should be thoroughly appreciated. 
After mobilization of its convexity and poles, the kidney is placed back into 
its normal anatomic position. As on the right side. the renal 1-ein is the most 
anterior structure (Fig. 32C). Its junction with the inferior vena ca1-a cannot 
easily be seen since this is deeply located within the wound to the right of the 
aorta (Fig. 32C). In contrast to the right renal vein which receives no 
tributaries in the area cleaned off for transection, the left renal vein regularly 
admits the testicular or o\-arian 1-ein and the adrenal \-eins in this location 
(Fig. 32C). The adrenal vein enters superiorly, and the 01-arian or testicular 
veins enter inf'eriorly. These \.essels are ligated in continuity and di\.ided. Oc- 
casionally, the testicular or 01-arian 1-ein is absent and may be replaced by 
ureteral veins in the same location (Fig. 33D). The ob\,ious hazard of venous 
ligation in the latter circumstance makes it imperati1.e that all inf'eriorly 
oriented veins be accurately identified before they are sacrificed. 
As on the right side. left nephrectomy is designed to allow block removal of 
the hilar structures with a nliniinuin of dissection except at the sites of 
transection. After the renal vein is prepared the kidney is rotated anteriorly, 
. 
and the renal artery is located at or near its origin from the aorta. In contrast 
to the situation on the right side, this is easily accomplished because the aorta 
is not obscured by the inferior vena cava (Fig. 32D). As soon as a suitable 
length of artery is obtained, the grooves separating the aorta from the uretero- 
pelvic junction and the left renal vein from the left adrenal gland are separated 
(Fig. 32C, D), and the bits of tissue are tied in continuity. \f'hen one opens the 
space between the adrenal gland and the renal artery, a small adrenal branch is 
frequently encountered which must be ligated. This must be done with care 
since a small branch to the superior pole of the kidney also may take its origin 
from this segment of the renal artery. Inadvertent ligation of such a vessel has 
resulted in a small superior polar infarct in one case (Fig. 47. Chapter 11). 
The subsequent manipulations prior to and after rerno1-a1 of the left kidney 
are exactly the same as those emplol-ed on the right (Fig. 32E. F). In closing 
the stumps of the transected renal vessels. it n-ill once again be noted that in 
contrast to the anatomic arrangement of the other side, the aorta is most acces- 
sibly located, and the inferior vena cava is deeply recessed in the depths of 
the wound. 
Ficjzcre 32.  Donor left  nephrectom?- cont.  C - Dissection of left renal  l e i n  S o t e  inaccessibdity 
of i ts  junction wi th  t he  v e n a  ca l -a .  a n d  the  testicular ior ovarian; and  adrenal  tr ibutaries wh ich  
r u s t  be l igated.  D-Exposure  and  dissection of left r e ~ l a l  artel.?-. r o t e  tha t  all dissection is  a t  t h e  
'leatest possible distalice frorn tile cell tr ,~l  Ililar i t iuc tures .  E -Po t t s  cl,imps on s tumps  of vessels 
ciirer specirlleil is re11101 ed.  F-  D o ~ ~ b l e - s u t u r e  closure of cuff5 B! pernl i i s io~l  of . i r t  iz. S z i r g .  88: 
-11, 1964.) 
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VARIATIONS I N  ANATOMY OF THE 
RENAL VEINS 
In approximately 15 per cent of cases, large lumbar veins are found en- 
tering the posterior surface of the renal vein proximal to the site of proposed 
transection (Fig. 33A). These vessels are ordinarily of no consequence, al- 
though they must be ligated before removal of the specimen. Their surgical 
significance is that blind dissection of the back wall of the renal vein could 
lead to serious hemorrhage if their presence was not suspected. 
As has been preLiously described, donor patients are not accepted for 
surgery without complete preoperatil e evaluation of the arterial blood supply 
to the proposed homograft. If previously unsuspected anomalous arteries are 
encountered. it is mandatory to attempt \ascular reconstruction. since oc- 
clusion of even tiny branches leads to renal parenchymal infarcts. \t7ith the 
renal veins, the situation is quite different. There is no practical means of de- 
termining the pattern of renal venous drainage prior to operation. In addition, 
it has been demonstrated by Smith and his associates that large auxiliary 
renal veins can be ligated, with the expectation that return can occur through 
widely anastomosing collateral channels. 
Multiple renal veins were encountered in five cases. In four of these, there 
were two ~ e s s e l s ,  a large upper and a small lower one (Fig. 33B). In a third 
case, two medium-sized vessels occupied the upper part of the hilum, and a 
large third Lessel was found inferiorly (Fig. 33C). In these cases the smaller - 
vessels were ligated. lealing only one renal \ein for anastomosis in the re- 
cipient patient. Homograft function was prompt. and no sequelae were ob- 
served that were attributable to the sacrifice of a portion of the venous 
drainage. 
A final potentially dangerous venous anomaly \vas observed in one case. 
During performance of left nephrectomy. two enous channels were observed 
entering the renal vein inferiorly. Because these did not look like the custom- 
ary testicular or 01 arian \ eins, a more distal dissection was carried out which 
disclosed an anomalously draining ureteric \ ein (Fig. 33D). With occlusion of 
the abnormal vessel. the distal ureter became intensely cyanotic. Failure to 
recognize this anatomic variation nould probably ha\  e resulted in \ enous in- 
farction of the distal ureter. 
POSTOPERATIVE CARE 
L~L- ine  tubes and urinary catheters are not used unless they are specifi- 
cally required. Resumption of a graded diet and ambulation are begun on the 
morning after operation. The patients are usually discharged in six or seven 
days. Repeat urine cultures and renal function tests are obtained at increasing 
intervals. It is planned to examine donors periodically for the rest of their lives. 
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Figure 33.  Venous anomalies encountered. A- Posteriorly entering luinbar \ ein. B D o u b l e  renal 
7-ein. The small x-essel is sacrificed. C -Triple renal vein. 0 n l ~ -  the largest T-essel is used for anasto- 
mosis. D-  Ano~nalous ureteric vein which must be preserved. 
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Table 9. Complications in the First 74 Volunteer Donors 
Subcutaneous wound in fect ion 2 
Deep wound infect ion 1 
Pneumothorax 2 
Atelectasis 1 
Pulmonary embolus (?) 1 
Transient peroneal nerve palsy 1 
Renal insufficiency has never been observed. With statistical analysis the 
mean differences in pre- and postoperative B U N  and serum creatinine were 
not significantly different. In the first 40 donors, postoperative creatinine 
clearance studies within the first month after operation showed an  average 
decrease of 21.6 ml per minute. but return to p re~ ious  values usually occurred 
within six months. 
COMPLICATIONS 
There have been no donor deaths. The complications in all 74 living donors 
are listed in Table 9. The only life-threatening complication was a possible pul- 
monary embolus in a 48-year-old mother who donated a kidney to her 17- 
year-old son (LD 39). Three weeks after discharge, she was re-admitted for 
right pleuritic pain, anemia, fever, and calf tenderness. An infiltrate in the 
right lower lobe was compatible with the diagnosis of pulmonary infarction. 
She was gil en a two-\seek course of heparin therapy n-ith improvement and 
with resolution of the pulmonary densit!,. 
The deep ~vound infection in another case in1 011 ed the retroperitoneal 
space, but responded immediatel? to drainage and antibiotics. The pneu- 
mothoraces were treated with closed catheter drainage of the pleural space. 
TRANSABDOMINAL NEPHRECTOMY 
Heterografts. obtained from baboons, and cadaveric human homografts 
have been remo\-ed from an anterior approach employing a total midline ab- 
dominal incisioll n-ith or ttithout a thoracic extension. The principles and 
technical details are the same as those described ~s.ith the flank incision, with 
emphasis on block excision and preservation of ureteric blood supply. 
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Chapter Eleven 
RECIPIENT OPERATIONS 
A description of the surgical techniques employed in homotransplantation 
involves more than the homografting procedure, since recipient right and left 
nephrectomy and splenectomy are also integral parts of the plan of treatment 
a t  this inst i tut ion,  and  a re  usually performed a t  the s a m e  t ime a s  ho- 
motransplantation. The additional adjuvant procedure of thymectomy, which 
was used in nine of the patients early in the series, will not be described since 
its use has been discontinued, at least until later evaluation of these earliest 
patients demonstrates a superiority in long-term survi\ al. 
From a general technical point of view the problems are not different from 
those encountered in any major surgical procedure. Nevertheless, the predicta- 
bly poor healing caused by the metabolically depleted state of the patients and 
by the necessity for immunosuppressive therapy reduces the margin of safety 
which may permit success in other operations in spite of the commission of 
small errors. Specifically, constant vigilance is necessary to aLoid breaches in 
aseptic technique. Operating fields are treated with a double skin prep, and 
such areas are healily draped. Attainment of absolute hemostasis should be 
an obsession, in order to aLoid later foci of infection caused by hematomas. 
This may be difficult, since man) of the patients have complex coagulation 
deficits. Interrupted fine silk sutures are used for the closure of all incisions. 
Cystostomy tubes or drains are never used, in order to avoid retrograde con- 
tamination of the wounds or of the lower urinary tract. 
One of the greatest potential sources of wound contamination is the 
bladder, which must be opened for the ureteral implantation, hIeticulous care 
is therefore exercised to prevent introduction of bacteria during catheteriza- 
tion. A separate 10-minute perineal prep is performed before placement of the 
Foley catheter. Fifty cubic centimeters saline, to which 1 gm neomycin and 
50,000 units bacitracin have been added, is inserted into the bladder To assure 
that the solution will be retained, the catheter is clamped until just before ure- 
teroneocystostomy is begun, at which time it is allowed to drain. 
84 
RECIPIENT OPERATIONS / 85 
Table 10. Staging of Recipient Nephrectomles. Spleiiectomy. and 
Homotransplantation in First 42 Patieilts I 1.D Series I 
-- - -- - 
- 
N o .  A l i v e  6-1 -64 Dead 
One stage (splenectomy, bi lateral 
nephrectomy, and transplantation) 31 18 13 
Staged recipient operations 1 1  5 6 
- 
" A l l  patients were tl-eated prior to November 27, 1963. 
INTERRELATIONSHIP OF OPERATIONS 
Originally. it lvas thought that  multiple operations would be required 
I~ecause of the critical condition of patients with terminal uremia. Subsequent 
c,.sperience h a s  shown t l i ~ ~ t  th is  i s  not t h e  c a s e .  Bi la tera l  nephrec tomy,  
il~lenectomy, and l~o~notransplanta t io l~ ha\-e been better tolerated a t  one stage 
tli.111 at separate stages (Table 10).  'l'hel-e appear to be sel era1 reasons for this. 
! t splenectorny is to I)e of' maximal \.slue, it should I I ~  dollc - at least on theoret- 
! (  11 grounds-before or a t  the tilne of' tr:inspl:intatit,11 (see  Chapter 13). Yet 
\i,lenectomy, if performed in ad\.ance. does nothin2 to impro\.e the patiellt's al- 
, c  <tdy serious condition. If the nephrectonlies arc done as a ~ ~ r e l i m i n a r y  
I  erati ti on, the metabolic disorder is temporarily further complicated by re- 
!!oval of' whatex-er renal function remains. necessitating ;an interim period of 
+ensifled dial\ sis the1 all\ l l l teinati \  el \ .  ~f one ot 110th ncphrec tomlei are 
; 8.rf'ormed at a later time. after transplantation. there are at least f'our disad- 
~n tages .  Function of the homograft is not easily assessed because of' the re- 
-.. dua l  f u n c t i o n  of t h e  p a t i e n t ' s  own kidneys .  T h e  delayed operat ion or 
lerations must be perfornied while the patient is receiving inlmunosuppres- 
\ e therapy to protect the recentl\ ,iccju~red homogiaft Retentloll of the kid- 
.!-s may aggral-ate a pre-existing hypertensi\,e state, to tlie detriment of the 
: ~nsp lan t .  Finally, there is at least a t11eoretic:il risk that  in the patient with 
-lornerulonephritis his oivn renal tissue ~vill contribute to the del-elopment of 
I e same disease in the homogl dft 1 " t i  clllsl~lclllt dliease" 
Despite the ad\-antages of an all-inclusi\ e iiilrle operation. there are oc- 
i,tsions when staging is still carried out for specific indicatioils. such as the 
rj:,esence of localized sepsis in the recipielit's o ~ l  11 kidneys. For ex:ilnple. if in- 
:[ c.ted polycystic or pyelonephritic k i d n e y  are kno i~-n  to be present. it is manda- 
: , ry  to remol-e these. maintain the patient on dial>-sis. and o1,tain cleanly 
riealed ivounds before proceeding at a later date n-ith l~o~llotransplantation 
.ee Figure 3.  Chapter 3 ) .  Cnder these circumstances sp1enectonl~- would also 
- performed at the time of the nephrectomies. I11 other situations in which 
!:!eliminar>- laparotom! becomes necess;u>- for sollie other reaion,  it may be 
':I\-enient to add bilateral nephrectom! and splenectomy to the operatio11 for 
: ilicll the e.cploratioll n-as prilllaril>- performed. This 11-25 done in two patients 
!lo required gastrectolll!- alld \-~xgotom!- for a bleedine duodenal ulcer. i ~ ~ h i c h  
i:,~ld el-eloped n-l~ile they xvere being el-aluated for kidney transplantation (see 
10. Chapter 4). 
86 / RECIPIENT OPERATIONS 
Coordination of Operations 
A variet>- of exposures have been used for patients receiving one-stage 
therapy, depending to some extent upon the location planned for the homo- 
graft. Most versatile and most commonly used at the present time is an upper 
midline incision through which both kidneys and the spleen are removed 
transperitoneally, in combination \vith an  oblique left or right lower abdominal 
incision through which extraperitoneal transplantation is performed (Fig. 34 C). 
If transplantation of a donor left kidney to the right iliac fossa is planned, 
both transplantation and right nephrectomy can be done extraperitoneally 
through an oblique right lower abdominal incision, and left nephrectomy and 
splenectomy can be performed transperitoneally through a separate left subcos- 
tal incision (Fig. 34A). In transplanting a donor right kidney to the left iliac 
fossa, three incisions may be used-one for extraperitoneal transplantation, 
another for transperitoneal left nephrectomy and splenectomy, and a third for 
either extra- or intraperitoneal right nephrectomy (Fig. 34B). In four children 
of three to eight years, the entire operation was performed transperitoneally 
through a total midline abdominal incision (Fig. 34D), using relatively oversized 
homografts from adult donors. 
Although the donated kidney is customarily placed on the contralateral 
side of the recipient, this is not an essential feature of the operation. As will be 
described in the section on "Special Problems of Transplantation" (p. 106), it is 
no more difficult to transplant the organ to the ipsilateral side, and this has 
been done without difficulty in both children and adults. 
In order to coordinate activities in the two operating rooms, it is necessary 
to have a ~vell-planned sequence of the various operative manipulations and a 
rough estimate of the time required to complete each step. The bilateral ne- 
phrectomies and splenectomy are done first. Completion of these preliminary 
procedures. closure of the upper abdominal wound or xvounds, and preparation 
of the transplantation site for reception of the homograft require 90 to 150 
minutes. If the operations on donor and recipient are started simultaneously, 
both patients are ready for transfer of the kidney at approximately the same 
time. If homotransplantation is the only procedure to be done. operation on thea 
donor is begun 60 to 90 minutes before operation on the recipient. 
PROCEDURES IN HOMOTRANSPLANTATION 
As previously mentioned, the donated kidney is usually placed in the con- 
trateral iliac fossa after the method described by K&s and by Murray and 
Harrison. The anteroposterior relationships of the hilar structures are thereby 
reversed, placing the pelvis anteriorly and the renal vein posteriorly in the new 
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Fiq~cte  34. Combinations of incisions used for bilateral nephrectomp. splenectomy. and  renal 
transplantation. The various procedures c a n  he done in  stages or preferably a t  a single operation. 
A t  present. the incisions sho1r.n in  C are  most often used. 
-1-Transplantation to the  right iliac f'ossa. Riaht nephrectorny ma>- be done through the trans- 
IJ .int incision. The left kidne!- and  spleen are rernox ed r l ~ r o u e l ~  tlie left subcostal exposure.  
H-Transplantation to the left iliac fossa.  Splenecrolil! and  left nep11rectoni:- are performed 
:Il:ough the left subcost,il ~ncisiori .  and right nephrectoni!- through '1 rielit subcosr,il incision. 
->Iosr 1-ers'itile espo,m.e. Uephre t to r~~ le .  and ~ple~ie i tor i i !  ,ire p e ~ f o r n i c d  through tlie upper 
J .;tiline incisiorl. Tra l lsplanta t io~i  s to either ili'ii t o s ~ a  
D-Total abdorllirlal incislon used i11 children for one-ir'ige rrdnspenroneal operation. 
' B!- Permission of Arch. S u r y .  89:87. 1964.) 
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location. There are no important differences in technique with transplantation 
to one side as opposed to the other. and the following description, in which the 
homograft is placed on the right, applies equally to the comparable operation 
on the left. Usually, the splenectomy and nephrectomies hase already been 
completed in those patients receiving a complete one-stage operation, and the 
upper abdominal incision or incisions have been closed. 
Preparation of Homograft Bed 
An oblique incision is made from the lateral border of the rectus abdorninis 
muscle into the flank. 1 to 1.5 cm above and parallel to the inguinal ligament 
(Fig. 35A). Subcuticular bleeding usually occurs, and is best controlled with 
electrocautery. After Camper's fascia is incised, the external oblique muscle 
and fascia are split to the lateral extent of the wound and 1 cm onto the rectus 
sheath medially (Fig. 35B). The subjacent internal oblique and transversalis 
muscles are fused, and are best incised as a unit, rather than separately (Fig. 
35B). The medial fascia1 continuation of these muscles which forms part of 
the anterior rectus sheath is also partially cut, and the lateral edge of the rectus 
abdominis muscle exposed (Fig. 36C). The transversalis fascia is opened, care 
being taken not to cut the underlying peritoneum. This fully exposes the inferior 
epigastric artery and vein for ligation and division near the medial end of the 
incision (Fig. 36C). Just lateral to these vessels, the spermatic cord (in males) 
or the round ligament (in females) is skeletonized, ligated in continuity, and 
divided (Fig. 36D). 
The retroperitoneal space is exposed by rostra1 blunt dissection of the 
peritoneum off the iliac vessels and the iliac fascia (Fig. 37E). If the operation 
is on the right side, mobilization can be carried up to the inferior pole of the 
kidney, and that organ immediately removed from below (described on page 107 
in a subsequent section on right nephrectomy). 
Attention is next directed to cleaning OR the fatty areolar and lymphatic tis- 
sues overlying the external iliac vein, just medial to the external iliac artery 
(Fig. 37E). It is particularly important to ligate and divide in continuity all 
tissue in this region in order to prevent lymph leaks and the postoperative 
formation of Iymphoceles. The dissection is carried superiorly from the in- 
guinal ligament until the hypogastric artery is encountered running across the 
vein into the pelvis (Fig. 37F). Throughout this length, the external iliac vein 
is completely freed so that it can be con~.eniently controlled during the sub- 
sequent \-enous anastomosis. It is usual1~- necessary to ligate one or two small 
posterior tributaries. 
An effort is made at this time to detect any 1-enous 1-alves n-hich might be 
present in this segment. These ha!-e been found in almost half the cases, and 
can be readily identified bl- the oblique white impression made on the surface 
of the vein by the 1-all-e attachments and by the slight bulges more inferiorly 
which conform to the cusps. Val\-es have been found at all levels of the 
Tes t  conti7zz~es 012 page 92. 
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Figure  35. Exposure for renal transplantation to the right iliac fossa. 
A - Line of incision. 
B -Incision of muscle layers. 
B? Permission of Arch .  S u r g .  89:87. 1964.) 
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Figure 36. Exposure of retroperitoneal space. 
C-Ligation and division of inferior epigastric arten. and vein. 
D- Quadruple ligation and dix ision of the spermatic cord or round ligament. (By permission of 
Arch. S u r g .  89:87. 1964.) 
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F i o u ~ e  37. Exposure of the iliac vessels. 
F:-Dissection of the external iliac 1-ein. Note that all tissue in this area is doubly ligated before 
d l \  ision in order to prex-ent the subsequerlt development of lymphatic leak. 
F--The external iliac \eirl is freed to the point at ~ \ l ~ i t l ~  ~  is crossed by the hypogastric artery. 
Ci-The h!-pogastric arterl; is derluded disrall>- to its nlajor division. 
B! Permission of .-lrc/z. 520.8. 89:8;. 1964. 
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Figure 38. Location of venous valves which were encountered in almost half the cases. Sites of 
venous anastomoses are indicated by solid circles. When possible, anastomosis is placed to avoid 
instrumentation of valves. 
external iliac vein, and their presence may influence the location of the renal 
venous implantation (Fig. 38). A decision is made concerning the site of the 
subsequent 1.enous anastomosis: if a valve is present in the general area 
selected. the suture line is planned for placement above or below this point, if 
possible. If this is not possible, the L alve leaflets are excised when the vein is 
opened. 
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Kext, the hypogastric artery is freed and mobilized. starting at its origin 
(Fig;, 37G). The angle formed by the junction of the hypogastric and external 
ili,ic x te r i es  is cleaned with special care to allow mobility of this area. but no 
otliel  orti ti on of either the external or con~inon iliac arteries is freed. The 
h!;~oqastric artery is dissected distally to its bifurcation into ~ n a j o r  anterior 
a ~ i d  posterior branches (Fig .  39A). Frecluently one or tn-o snlall branches are 
el:ioantered, ligated, and di\.ided proximal to this di\-ision. .At  the site of even- 
t ~ i . 1 1  trailsection and anastoinosis. the \ essel is denuded of' ad\  entitia to facil- 
i t L i r t ,  later suturing. In all cases the ilunlber of' renal arteries to the homograft 
11~15 l ~ t ~ e n  determined by donor aortoqraphic studies. alld in allnost all cases the 
Lit i~lc . !  selected has  a single blood supply. I11 the exceptional situation in which 
t i \ ( )  or inore renal arterial anastomoses are necessary, the dissection is con- 
titrueti more deeply, freeing the terminal branches for :inastornosis to the mul- 
t i t ) l t ~  homograft vessels. After preparation of the llypogastric artery, it is not 
t~,,ttisected or further disturbed until the renal arterial an:tstomosis is to be 
~~vl . i 'or~ned.  In this \Yay, blood f l o ~ v  through the \ essel continues until the last 
poisible moment- a detail of technique which may be of importance in prevent- 
i t iq  intimal trauma. drying. or undetected clot formation ~vi thin  the lumen. 
After these steps ha\.e been completed. an  assistant coordinates the final 
stvps in the operating rooms. This is important. not only to allow perfect timing 
o f  el-ents. but to p r o ~ i d e  last-nlinute information for the recipient's surgical 
tc5:tln concerning any anatonlic peculiarities in the kidney \vhich is shortly to 
l i i ,  deli\.ered. In every case. the most in~portant  inforination to be transmitted 
at this time is the size of the renal ein, since the aperture for its anastomosis 
into the external iliac vein is fashioned before the kidney is deli\-ered. 
After it has  been ascertained that the kidney will 11e available within a few 
illinutes. as much as possible of' the external iliac \-ein is isolated between 
lioncrushing sponge rubber c l a m l ~ s  (Fig. 39A. B). These instruments are partic- 
ul~irly well suited to this function. not only because their size and shape allow 
2111 easy fit into the ~vound.  but because the sponge c o ~  ering ensures minimal 
trauma to the \.essel." The anterolateral surface of the \.ein rvall is then grasped 
ilith a fine pickup, and by cutting beneath this an  ellipse is removed from the 
a11 (Fig. 39B). If a venous \-all-e is present, the leaflets are excised at their 
Littachments. The defect in the 1-essel is di1-ided into quadrants b!- the place- 
1l;i'nt of arterial sutures of 5-0 silk. including one at each end (Fig .  39C). EX- 
1)osure is maintained. and all activit>- is suspended until the hornograft is 
deli\-ered from the donor room. 
The clatnps described b\ Bronn are mailufactuled b\ Edn ard Keck and Co Brookhn, New 
lork  
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Figure 39. Venous anastomosis. 
A - General operative field. 
B -Excision of an ellipse of the anterolateral wall of the external iliac vein. 
C -Placement of guide sutures connecting the renal and external iliac veins. 
(By permission of Arch.  S z i r g .  89:87. 1964.) 
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Ureteroneocystostomy 
The person n-ho delivers the kidney is asked to place it in the position i t  
ivould have occupied in the donor patient in  the supine position. The land- 
ln,~rLs are checked, and the kidney is placed on the drapes adjacent to the 
11 o~ lnd ,  in its normal anatomic position. Thus,  the \.ein. n-hich is ailastornosed 
f i p t .  is anterior and easily exposed (Fig. 39C). The sutures previously placed 
il l  the ends of the oval defect in the external iliac 1-ein are then attached, pass- 
iiiz f'rom the luinen to the outside in the superior and inferior corners of the 
lynal \.ein. The lateral suture in the iliac 1-enous defect is silnilarly placed in  
the appropriate position (Fig. 39C 1. The kidney is then guided doivn the guy 
s t~turcs  until the intima of the tlvo \ eins is coapted. The sutures are tied (Fig. 
401)). The homograft is then rolled laterally and the fourth of the quadrantic 
2~1ide sutures is passed through the renal I-ein (Fig.  40E). The lnedial and  
I : ~ t ~ r a l  stay sutures are of extreme ilnportance in pre\ enting accidental grasp- 
i l l y  of the opposite wall while the \.enous anastornosis is forined. since the 
1 <,in can be flattened and spread by gentle traction (Fig. 4OE. F). The \.enous 
~111;istoinosis is then fashioned. with the use of' one end suture f'or sewing. 
('orltinuous over-and-OT-er su t~ i r ing  is used, taking care to e \  ert the lips, and  
p .~is ing around the entire 360 degrees. It is usually somewhat easier to suture 
tlic anterior ro\v first and then reflect the kidney medially to obtain access to 
the posterior surface (Fig. 40F). 
After the venous anastomosis is completed, the kidney is placed in wha t  
:il)pe;trs to be the most comfortable position in the iliac fossa (Fig. 41A). A 
liqature of 2-0 silk is passed around the distal hypogastric artery (Fig. 41A). 
T'liis is tied, a noncrushing vascular clanlp is placed across the origin of the 
II! pogastric artery, and the 1.essel is transectecl. Because of the curl-e which 
11l~1st be negotiated by the arterial trunk, the hypogastric artery is incised with 
'i 35 degree be\-el (Fig. 41X). Anchoring sutures of 6-0 arterial silk are placed 
at the tip and base of the be\-eled cut end and attached to the coinparable posi- 
tions on the renal artery (Fig. 41B). It is preferable to use silk \vith a needle 
niounted on each end. since this al lo~vs placement of the sutures from within 
t i l t >  lumen of each 1-essel. Disparities in size of the hr-pogastric and renal  ar- 
t~ lies frequently make it necessary to dilate one or the other 1-essel with a 
ilnooth hemostat (Fig. 41C). 
After the stay sutures are tied. the arterial anastonlosis is fornled with 
continuous over-and-ox-er ex-erting techniques, using the same suture f'or the 
entire 360 degrees. The anterior ron- is conlpleted first and the 1-essel then 
:'(,rated (Fig ,  31D. E ). The kidney is then re1 ascularized. Certain details of tech- 
lliclue are scrupulousl!- obserx-ed at this time. Both arterial and \-enous 
:lamps are remo\-ed at exactly t l ~ e  same time. The clalnps are released ab- 
lllptl>- rather than ill a graduated fashion. The suture lines are scrutinized for 
leaks between or a t  the sutures. alld these are systematicall>- repaired. Under 
no  circumstallces is the blood suppl!- to the liidne!- el-ex interrupted again. It is 
.111va>-s possible to repair the small suture line leaks \I-ithout re-occluding the 
circulation. 
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Figure 40. Venous anastomosis (cont.) 
D-Fixation of the venous anastomosis by tying the guide sutures. 
E-Performance of circumferential anastomosis using continuous silk suture which is carried 
around the entire 360 degrees. 
F - Completion of anastomosis. 
(By permission of Arch .  Surg .  89:87, 1964.) 
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F i y z ~ r e  41. Arterial anastomosis. 
4-The hypogastric artery has been ligated distally and is cut. Note bevel of incision line which 
"lakes a smoother curl e of the reconstructed vessels. 
B -Fixation sutures conriecting t ~ v o  1 essels. 
C -Dilatation of the srnaller of the txio X-essels. the renal in this instance. 
-)-C0111pletion of the ailterior ro\\  lid beginning rotation of the anastomotic line. 
-Continuous suture of the posterior suture line. 
B! Perrnissiorl of Arch. S u r g .  8 9 : 8 i ,  1964.) 
Figure 42. Various positions assumed by the homografted kidney. The placement selected is the 
one which appears at the time of operation to be the most comfortably accommodated. (By permis- 
sion of Arch. Surg. 89:87, 1964.) 
Before the ureteroneocystostomy is undertaken, experimentation is again 
conducted to determine the most comfortable position for the homograft. The 
most useful rule is that the kidney will usually seek the position which is most 
suitable. The integrity of the vessels and their anastomoses should be checked, 
after which the decision regarding position can be made. The ultimate location 
of the kidney has varied considerably (Fig. 42). In some patients the hollow of 
the ileum is adequate to accommodate the organ, but in others. particularly 
recipients of small stature. all or part of the homograft is extrapelvic. 
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Once the homograft is positioned, the ureter is anastomosed to the bladder 
by a lnodification of the method of Paquin and i\Iarshall (Figs.  43. 44). I n  the 
prr\-ious description of the operati\-e exposure. no mention was ~nacle of mobil- 
icCltiol1 of the bladder. hIobilization is also avoided 1101~. Ilthough ureteral im- 
l l~ ,~t~tLl t io i i  is thereby made more difficult, the retropubic space is not entered, 
5 , ,  .i, to prel ent  the formation of a retropubic dead space n-hich \~.ould need to 
:il,:~ined. A rather small incision is niade in the dome of the bladder near the 
pc~l.ltoneal reflection (Fig. 43A). By appropriate manipulation of' thin-bladed 
ri !lLic,tors. a n  adequate 1-iew can be obtained of' the interior of the bladder. 
A site is selected 2 or 3 mnl abo\-e the ipsilateral ureteral orifice for the loca- 
tion of the new ureteral opening. A small nlucosal incision is made a t  this 
l~oint, and a similar counterincision is placed 1 to 2 c m  higher on the lateral 
1\ ;111 (Fig. 43B). The txvo defects are joined by blunt submucosal dissection 
: I ' iq .  -13C). A right-angled c l a n ~ p  is thrust through the upper niucosal incision 
; i l l t i  out through the lateral bladder wall (Fig. 43D) The tip of' the ureter is 
gi,<ksped and brought into the bladder (Fig. 43D) and guided through the previ- 
ou5ly formed tunnel (Fig. 43E). The upper of the txvo mucosal incisions is 
clo5ed ~ v i t h  a coiitinuous 6-0 plain catgut suture (Fig. 44F). The proper ure- 
t( , i , i11 length is determined and the ureter fixed in its definitive position by 
pl;lc.e~nent of one or txro sutures a t  the point at which it enters the bladder 
1.-ig. ME-). 
Attention is then directed to formation of a ureteral nipple and a rnucosa- 
to-mucosa allastoinosis of'the tip. The excess ureter is drawn up  with a clamp, 
;~lld the ureter is partially transected a t  the site of the eventual nipple (Fig. 44 
(; . The cut is made on the deep relatively inaccessible portion of the ureter, 
iintl the residual distal connection is used for retraction (Fig. 44G). The prin- 
c i!jC~l ureteric blood 1-essels are identified and ligated with 6-0 plain catgut a 
f c . l i  millimeters from the cut  end (Fig. 44G). The partially transected ureter is 
split 3 or 4 mnl in its long axis, forming txvo posteriorly placed fish-mouth flaps 
I Fiq. 44G). Three 6-0 plain catgut sutures are placed. catching first the bladder 
t?iiicosa. then the ureteral adventitia 3 or 4 nlrn proximal to the cut end, and 
filially grasping the edges of the ureteral rnucosa (Fig. 44H. I). When these 
t!lt'ee sutures are tied. a partial nipple is immediately formed n-ith good lnucosal 
i(, ,tptation of the part of the anastonlosis ~ v h i c h  is most difficult to see (Fig.  445). 
J-lle rest of the nipple is formed after the trailsection of the ureter has  been 
~ ( ~ ! u p l e t e d .  In doillg this, a flap of tissue is preserx-ed I Fic. 44.J. I() so that  the 
LllJper part of the nipple is eccentric n-ith more tissue than the lon-er aspect 
1%.  44Lj. This flap of tissue is sutured into position with se \  era1 fine 6-0 plain 
(-:[gut sutures (Fig. 44L). 
The cystotomy is closed in three la\-ers. The mucosa is sutured n-ith con- 
!i!luous 4-0 chrolllic catgut (Fig.  4411. N ' .  S l i ~ h t  e~-ers ion is deliberately ob- 
t m e d  to prel-ent intral-esical bleeding from the raw mucosal surface. Con- 
!';luaus 4-0 chrolnic catgut is also used for the second la>~er .  grasping the 
'it~lrusor llluscle in firm bites :Fig. 4 4 0 ) .  The superficial tissues are approxi- 
m t e d  with interrupted fine silk (Fig. 44P). 
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Figure 43. Ureteroneocystostomy. 
A-Bladder cystotomy performed. 
B - Beginning of creation of the submucosal tunnel by performance of two mucosal incisions. 
Note proximity of loxver incision to trigone. 
C -Completion of tunnel with blunt hemostat dissection. 
D-The ureter is pulled through the bladder wall at an angle so that an additional tunnel effect 
is created. 
E-Extraction of the intral-esical ureter through the preformed submucosal tunnel. 
(By permission of Arch. Surg. 89:87. 1964.) 
~ - ~ ~ i s i ~ ~  ?J ki33&;yl0sed 
F i < / l t  re 44. Ureteroneocystostom~- ! cont.). 
F-The upper mucosal incision has been closed and the ureteral length decided upon. Note that 
the x-ascular bundle of the ureter has been litrated. 
( , -The ureter has been hemitransected and a fish-mouth is beirle created. Note that the latter 
( L i t  1s made at  the lllost recessed and iriatcessible portion of' the ureter. 
f f - -4  3-0 or 6-0 catgut suture is placed frorn the bladder murosa to the urethral adx-entitia and to 
1' :Iles of' the fish-1nout11 incision. 
1 -  Placement of similar corner suture5 catihlnq the tipi of the f i sh-n lo~~rh  flaps. 
1 - rile three anchoring sutures hal-e beell ried. and a flap of u r e ~ e r d  irluioia is fashioned for the 
" !  .late formation of a hood. 
i' - Corltlnuation of flap illcision. 
. . 
- The eccentric flap is completed and sutured in place. 
. . 
-P - Bladder closure. Sore that [he inner t x ~  o la>-ers are of continuous catgut, insuring a water- 
"-!-' closure. The evterrlal la!-er is of interrupted black silk. 
Oi' Pernlishion of . l r c i~ .  S u r g .  89:87, 1964.; 101 
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Many of the details of the bladder and the ureteral manipulation seem to 
be inconsequential. Yet they are designed to achieve two specific objectives: 
first, the construction of a wound which can be closed without drainage and, 
second, the establishment of a situation in which the urethral catheter can be 
safely removed within 12 to 24 hours after operation. The precautions exercised 
to provide complete and reliable closure of all mucosal rents, to protect the 
blood supply of the ureter, to provide the flap valve action of a long submucosal 
tunnel, and to assure watertight closure of the cystotomy are all insurance 
factors which circumvent the need for prolonged postoperative decompression 
of the bladder. 
Before closure, a final check is made for hemostasis. The wound is ir- 
rigated with 1,000 to 2,000 cc of saline solution. All residual fluid is with- 
drawn, after which an antibiotic solution of 0.5 gm neomycin and 50,000 units 
bacitracin, suspended in 50 cc normal saline, is instilled into the wound. 
Closure is carried out in layers with interrupted 3-0 or 4-0 silk sutures, each 
layer being irrigated with antibiotic or saline solution. 
Figure  45. Special problems in arterial reconstruction. Occlusion of the hypogastric artery, neces- 
sitating end-to-side anastomosis to the external (A) or common iliac (B) artery. 
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SPECIAL PROBLEMS OF TRANSPLANTATION 
IN ADULTS 
Deviations from the operative plan just described have been necessary, 
fl.r'ciuently as a consequence of abnormalities o f t h e  1-essels of the donated kid- 
l l ~ . \ .  or of the recipient patient. In  five cases the hypogastric artery Lvas par- 
t i , . ' ! ;  or completely occluded with atheroinata. The arterial anastonlosis was  
p l , !  end-to-side to the common or external iliac artery (Fig. 45A,B). When 
t i i  . 1, necessar>-, the at tachment of the renal artery lies most satisfactorily if it 
ii 1 :o 2 cln superior to that  of the renal vein. A quartering technique similar to 
t l l  :I ,ilready described for the renal \-ein is employed. 
111 four instances. it was necessary to restore the arterial blood supply 
t l , !  > ~ l g h  two renal vessels. Although this can easily be done by using more 
(11.: 1 1  1)ranches of the hypogastric artery to connect to the renal arteries, the 
p i ,  lenl of' obtaining smooth and unkinked cur\.es may be trying. Solutions to 
i(,;. t ,  of' the mechanical problems are depicted in Figure 46. 
It has been stressed throughout this chapter that  the donor kidney is usu- 
all! transplanted to the contralateral side of the recipient. This has  been a 
t i  ,~tlitional technique. justified by the theoretical ad\.antage that  the pel\.is and 
u~r , t e r  are thereby placed anteriorly, in I\-hich aspect they are less likely to be 
coinpressed by the iliac ~ressels or iliopsoas muscle. 
In practice, i t  h a s  been demonstrated that  placing the kidney contralat- 
el .~lly is not necessary. In three cases. donor kidneys have been transferred to 
the? ipsilateral iliac fossa or paravertebral gutter with satisfactory results 
( I - I ~ .  48). 
Other interesting departures from standard techniques are possible with 
ti!( llse of cadal-eric organs. Hume has  dealt ~ v i t h  multiple arteries by suturing 
a (iiic of aorta containing the origins of the 1-essels into the side of the external 
il!,ti. artery. Goodwin has  described block excision of' both kidne>-s 11-ith revas- 
(:.ii,~irization by insertion of a seg111ent of attached aorta and \.ella c~i\-:i nto the 
1 ' ~ :  ipient's vascular system, a technique n-hich has  been applied with modifi- 
c'ltions to heterotransplantation (see Chapter 23) .  
In two cases, snlall infarcts resulted froln the operati\.e procedure fol- 
l(,,.:-ing occlusion of arteries too snlall to be reconstructed. In  one case,  a small  
P'.! ir artery originated in the line of' transection of the renal arter>-. In  forming 
tie. anastomosis, this arterl- was closed b>- the suture line (Fig .  47A). 111 the 
c'?i.rr case, ligation of the same \-essel occurred accidentally during operation 
:he donor (Fig. 47B). The area of i n ~ o l v e m e n t  of renal parenchyma was 
c'sl:lost identical in both cases. There n-ere no detectable iinlnediate or late 
5 ~ q  uelae. 
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Figure 46. Special problems in arterial reconstruction. 
A-Usual arrangement of artery. Kote be!-el of cut hypogastric artery which promotes proper 
curvature of anastomotic site, 
B-Telescoped anastomosis, necessary when major disparity exists between the size of the two 
vessels. 
C-Connection of double renal arteries to the anterior and posterior trunks of the hypogastric 
artery. Note the sharp rotation of the posterior trunk I\-hich is necessary. 
D-Similar problem in rr-hich the posterior trunk is rolled in the opposite direction. 
E-Double renal arteries connected to the side and to the terminal branch of the hypogastric 
artery. 
Common disc a. 
Figure 47. Superior polar infarcts encountered in two cases, due to inadvertent occlusion of small 
bl.,inches of the renal artery. 
: l P o l a r  branch included in suture line (LD 8). 
K -Polar branch tied during donor operation (LD 19). 
Figure 48. Technique used for transplantation of adult homografts to infants or small children 
ILD 2.0. 34. 41. 61). Entire operation is performed transabdominally (see incision in Figure 34D). 
(B\ Permission of S u r g .  G y n e c .  Obs t e t .  119:106. 1964.) 
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SPECIAL PROBLEMS OF TRANSPLANTA- 
TION IN INFANTS AND SMALL CHILDREN 
Use of the extraperitoneal operation is inconvenient or impossible in  a 
child if an  adult kidney is used. because the large homograft may not fit into 
the relatively diminutive iliac fossa. In addition, the pelvic vessels may be so 
small compared to those of the homograft that the unfavorable disparity can 
create additional hazards. 
These problems have been considered in four children whose mothers 
provided the renal homografts. The patients were eight, six. five, and three 
years old, and weighed 22.5, 20, 15, and 15 kgm, respectively. A previously un- 
described method was employed for transplantation. 
A midline abdominal incision is used, extending from the xiphoid to the 
pubis (Fig. 34D). Splenectomy and left nephrectomj- are performed. An inci- 
sion is then made in the posterior peritoneum to the right of the ascending 
colon. The ascending colon is reflected to the left as in the preparatory stages 
of colectomy (Fig. 48), and the right kidney is removed. 
The terminal inferior vena cava is freed circumferentially for a distance of 
3 or 4 cm. Posteriorly, two or three tributary lumbar veins require ligation and 
division. The junction of the aorta with the right common iliac artery is sim- 
ilarly denuded. The bifurcation of the aorta occurs at a slightly higher level 
than that of the inferior vena cava, consequently, the right common iliac ar- 
tery crosses the lower end of the vena cava en route to its location lateral to the 
right common iliac vein. Just above this point, an  anatomic window is present 
in which lies the mobilized portion of the vena cava (Fig. 48). 
The technique is essentially the same with use of either the left or right 
donor kidney. After the homograft is brought, a segment of the distal inferior 
vena cava is isolated between noncrushing clamps, and an end-to-side renal 
venous-inferior vena caval anastomosis is formed with 5-0 silk. The end of the 
renal artery is attached with 6-0 silk to the side of the common iliac artery just 
below or at the origin of the latter vessel from the aorta (Fig. 48). It is not neces- 
sary to completely occlude the terminal aorta at any time. since a proximal 
vascular clamp can be placed in such a \vay that flow to the left comlnon iliac 
artery is not interrupted. Distal control is obtained by cross-clamping the com- 
mon iliac artery just abo\-e its di1-ision. In three cases, the renal artery was 
brought in front of the terminal vena cava. In the other case, it n-as more con- 
venient to bring the renal artery behind. During and immediately after resto- 
ration of homograft circulation. particular attention n-as paid to the recipient's 
hemodynamic response. No elddence of high-output cardiac 01-erload was en- 
countered in the cases in which the method was used. 
The adult organ almost completely fills a child's right paravertebral gutter, 
extending from the undersurface of the liver to the pelvis. Since rel-asculariza- 
tion of the homograft is provided from a level which is lower than normal. but 
which is higher than that in the customary retroperitoneal operation. the 
anatomic position of the new kidney is mechanically perfect. The ascending 
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colon is dropped back onto the anterior surface of the transplant, and no other 
fixation for the new kidney is provided. 
7'he ureter is brought inferiorly. crossing the colnnloll iliac artery inidway 
aloli: its course, and is tunneled retroperitoneally to the base of the bladder. It 
is 1 , ;  iurht through the \-esical 11-all just superior to the normal entrance of the 
urc t+.r  and implanted, as described on page 95. 
if'ter operation. the patient is confined to bed for 38 hours. during which 
t i l : i  he is allowed to lie only on his back or right side. ilmbulation is then 
c ~ : ,  ,:lenced. 
Good renal function lvas obtained in the four cases outlined. and no ad- 
\ ei,-,c consequences of any sort h a \  e been encountered \I hich could be at- 
t~ i i , .  . red to the operative procedure per se. 
i 11 t~z-o f the Sour cases, donor right kidneys 11 ere transferred to the right 
I),:!  , \  twebral gutter of the recipient. \Yith this arrangement. structures of the 
I , ( , ,  : pedicle occupy a nornlal anteroposterior relationship in the transplant 
i in contrast to the more traditional retrnperitoiieal technique. Ho\.r-e\-er, i t  
[I.;-. just as easy in the other cases to transplant the donor left kidney to the 
s a , : . cL  location in the recipient's right side, since the technical details were es- 
sc , !ally unchanged. 
ilthough the operation has  thus fa r  been employed only in the children 
dc . i,ibed, the space it pro\-ides for the homograft is such that  arl adult organ 
cc. '4 probably be fitted into a recipient of e\-en smaller size. Because of the 
st, I1 total bod? din~ensions,  the length of' ureter that  is necessary to reach the 
1 1 1  : ' ler is no more than usual,  e \  en though the kidney is placed at a lliqher an-  
at5 , ,iic position. There is little likelihood that  relati\.e stenosis of the three 
re ton loses will result from grorvth of the recipient patient, since the lumina 
cli :ted are as large as will el-er be required. 
RELIPIENT RIGHT NEPHRECTOMY THROUGH 
.NSPLANT WOUND 
Kight nephrectomy through the transplant wound is sometimes performed 
n the transplantation is to the right iliac fossa, but it is feasible only when 
t l l  ~ecipient ' s  kidney is small. The right nephrectomy is ordinarily performed 
1 )  Ire the h o r n o r a f t  is installed. Xfter the basic exposure for the transplanta- 
(11 has beell prol-ided, the posterior peritoneunl is mobilized superiorly until 
t l  . right kidlle!- can be palpated. .ifter placeillellt of deep retractors, two 
:re5 are placed ill the illferior tip of Gerota's fascia, and an  illcision is made 
11 , llis structure (Fig. 49A.B). A finger can then be inserted through the perirenal 
f ,  
.ind the inferior tip of the kidne>- exposed Fig. 49E r .  -4 lar re  figure-of- 
" - : ~ t  0 silk suture is then placed through the renal parench\- I I I~  Fig. 49C). 
I t  - possible. lvith gentle traction. to pull more of the orgall into the operative 
f i t  1. 15-ith blullt dissection. ill :vhicll the perirenal structures are mo\.ed aside, 
"luie and more of the kidnev is mobilized until the hilar structures can  be 
.saxnl3nx~s x81yy jo uoyl~8y~ - a
xnlns $y2ya-jo-a.1n2y a8.1~1 e y1y.11 .i~.~opaju~ palsex~xa sy .iaupyy ayL- 3 
'uoylsassyp .1a2uy $unIq yly.rt pazqyqour iaupyy ay~ pue pas~sul sy eyas~j s.elo.1a3-8 
s!A sy SaLIpq lysp ayl jo a~od Jouajuy ayl '[ylun pauado ST aseds ~eauo$uado.~~a.~ ay~-v 
.punoM ~u81dsuag ay3 yBnoxy3 burol3axydau ~y8y~ '6~ a~n6?d 
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\-isualized and ligated. Because of the difficult exposure. it is important that 
the hilar structures be ligated in continuity, inasmuch as it would be extremely 
difficult to find and control the renal vessels if a ligature were to slip (Fig. 49D). 
 hi, performance of nephrectomy with this awkward exposure is sometimes 
trying, but it usually can be completed within 15 to 30 minutes. 
RIGHT NEPHRECTOMY THROUGH A RIGHT 
SUBCOSTAL INCISION 
Right nephrectomy through a right subcostal incision is occasionally per- 
follned when the transplantation is to the left iliac fossa. A short right sub- 
costal incision is made, starting at the lateral border of the rectus sheath. The 
external oblique muscle is cut, and the two subjacent muscle layers are split. 
Tllcs retroperitoneal space is entered, and mobilized. The lateral portion of 
Gt ~o ta ' s  fascia is identified, and incised between two stay sutures. The kidney 
is \belled out of its bed with blunt dissection, and the hilar structures are in- 
dl1 idually ligated. The wound is closed without drainage. 
Alternatively, the right nephrectomy can be performed transperitoneally 
tll~ough a subcostal or midline incision. The technique is similar to that 
dt ~cribed in the following section. 
SPLENECTOMY AND LEFT 
NEPHRECTOMY 
The abdomen is entered, the splenorenal ligament is incised, and the 
splenocolic and splenophrenic attachments are freed. The raw surfaces are im- 
rliediately examined for hemorrhage, and the resultant fine capillary bleeders 
electrocoagulated. All splenic hilar tissues are ligated and divided in continuity. 
111 obtaining adequate exposure for this purpose, the most important initial 
step is ligation and division of the upper one or two short gastric vessels. Special 
ktttention is paid to prevention of pancreatic injury. The best way to insure this 
i \  to separate the splenic pedicle into the two layers from which it avas embryol- 
(:<ically derived. The anterior layer, containing the short gastric and the gastro- 
cpiploic vessels, is defined with a finger placed into the lesser omental sac. 
.Alter ligation and division of this layer in small bites. the posterior layer, con- 
[,lining the splenic vessels, is similarl?. treated. 
After completion of the splenecton~y. the stomach and the splenic flexure 
and its mesocolon are retracted i Fig. 50). and left nephrectomy is performed. A 
*mall incision is made in the posterior peritoneum o\-erlying the kidney. The 
!kidney is then extracted through this rent. and the hilar structures are identi- 
fied, doubly ligated. and divided (Fig. 50B). 
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Figure 50. Transabdominal left nephrectomy. Splenectomy has  been completed. A-Kidney mobi- 
lized; B -Completion of nephrectomy. 
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Chapter Twelve 
POSTOPERATIVE CARE AND 
SURGICAL COMPLICATIONS 
The unique aspects of postoperative therapy are concerned with preven- 
tion of homograft rejection; the measures which are necessary for this purpose 
a r e  deta i led  i n  C h a p t e r s  14 a n d  16. O t h e r  more  g e n e r a l  f a c e t s  of 
post-transplantation care are also vitally important. 
Virtually all patients considered for homotransplantation are in the ter- 
minal phase of their disease. Despite resuscitation. it is often not possible to 
transform them into good operative risks. Many are profoundly anemic, and 
restoration of a n  acceptable heinatocrit level by transfusion may be impossible 
I~ecause of the danger of causing acute heart failure. Muscle wasting is  in- 
\ ariably present. Allnost t~vo-thirds of the patients have nervous system 
disorders, including neuropathies, conla, convulsions. and psychoses. Many 
come to su rgery  wi th  gas t ro in tes t ina l  disorders s u c h  a s  hypomotil i ty 
syndromes. frank ileus or diarrhea, or with a recent histor? of gastrointestinal 
I~leeding. 
iYit11 successful transplantation. man?- of these e1-ents are re1.erst.d with 
such abruptness that  the consequent homeostatic alterations ma>- he a poten- 
tial threat to life. A massi\-e diuresis almost inr-ariabl>- begins on the operating 
table (Fig. 31). In  the first 32 patients who recei1-ed kidneys froin li\-ing do- 
nors, the mean interval between re\-ascularization and the detection of the 
flyst flow of urine n-as 3 2 ~ 7 . 8  t SE) minutes. ranging from fi1-e to 600 nlinutes. 
I n  these 32 patients, the hourly urine output a~-e raged  444 = 39 SE 1111 for the 
flyst 12 hours I Table 11 J,  being as high as 2.000 1111 per hour in one patient who 
died fro111 an  acute electrol?-te i~nba lance  12 hours after operation. 
During the diuretic phase. good manaqement of fluid balance is of the 
utmost importance, and in planning therap?.. accurate E;no\.r-ledqe of' the uri- 
nary composition is mandatory (Table 11 \ .  The urirlar!- sodium and chloride 
content is rllost predictable. The Inean concentrations in these 4.2 patients 
11-ere 9 7 ~ 3 . 3  (SE)  1l1Eq liter and i ' E 3 . 0  SE mEci liter. n-hile specific qravity 
'vas 1.01 1=0.0003 SE 1 .  Urine urea concentration 11-as 2 9 k 1 9 . 4  I SE ! mgm 
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Figure 51. Postoperative management 
of a 15-year-old girl (LD 17) who received 
a renal homograft from her mother. 
During the first 48 hours after operation, 
the child lost more than 30 pounds of 
weight. During the acute diuretic phase. 
intake was provided to replace approxi- 
mately two-thirds of the fluid loss. The 
diuresis immediately after surgerJ- was as 
much as  1.000 cc per hour. Bilateral 
nephrectom?. and splenectomy were car- 
ried out a t  the same time as transplanta- 
tion. 
, , , ,  
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Table 11 .  Mean Urine Volumes and Composition Observed during Acute 
Postoperative Diuresis in  44 Homografts Obtained from Living 
Donors for Treatment of 42 Recipients" 
No.  Mean SD S E 
Diuresis (ml/hr) 
N a  (mEq/l i ter)  
CI (mEq/l i ter) 
K (m Eq/l i ter) 
Creat (mgm%) 
Urea (mgm%) 
Protein (gm/24hr) 
Specif ic gravi ty 
* In  a l l  but three cases, the diseased kidneys of  the rec ip ient  pat ient were 
removed before or a t  the time of  transplantation. A l l  determinations 
were not ava i lab le  for each patient; hence the difference in  numbers. 
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per cent and creatinine was 57.9i6.8 (SE) mgm per cent. Significant protein- 
uria was common initially with 24-hour excretion of 4.19 z 0.48 (SE) gm during 
the first day. but this finding usually disappeared within 48 hours. Potassium 
lvas 16.4 I 1.3 (SE) mEq liter (Table 11). 
When the general range of electrolyte loss is known, it is possible to use a 
simple empirical regimen of intravenous replacement. The patients are usu- 
ally given 5 per cent glucose in 0.45 per cent saline in an amount equal to two- 
thirds to three-fourths of' the urinary output of each preceding hour or the 
same fractional replacement is carried out with lactated Ringer's solution. 
I-nder ordinary circumstances, potassium is not replaced, but if the diuresis is 
~~lass ive ,  10 to 20 mEq liter potassium chloride is added to the fluid. Despite 
the usual predictability of these electrolyte values, it is necessary in all cases 
to perform "spot checks" of both serum and urinary electrolytes, at least every 
four or eight hours, to be certain that the expected composition is present. 
The tragic consequence of mismanagement during the diuretic phase is 
illustrated by the death of a 16-year-old girl (LD 261, who succumbed 12 hours 
,tfter operation as the result of hyponatremia and hyperkalemia. Diuresis had 
.~veraged 1.310 ml per hour, and was as high as 2,000 ml per hour. During this 
critical period, sodium losses were not fully replaced. She was accidentally 
civen excessive quant i t ies  of potassium chloride. Because of the large 
? olurnes, relatively small deviations from the proper composition of the in- 
iravenous infusions greatly magnified the errors. Cardiac arrest was the cause 
of death. 
The urine volumes described usually begin to diminish after eight to 24 
hours (Fig. 51), but remain so high for the ensuing day or so that it is advisable 
to continue intravenous therapy, even though the patient resumes alimenta- 
tion. The nasogastric tube is ordinarily removed on the morning following 
surgery, and a liquid diet instituted. On the following day a bland diet can be 
qiven. After two or three days, fluid intake becomes greater than the urinary 
output (Fig. 51). 
Weight loss during the first few days after operation has ranged from 5 to 
35 pounds. The change in mental responsiveness is frequently astonishing; a 
itate of hopelessness and mental apathy changes to one of euphoria. Ambula- 
tion is encouraged, beginning on the second postoperative day. A high calorie 
diet is ordered, and no fluid or salt restriction is imposed until the onset of a 
rejection crisis as described in Chapters 15 and 16. If pre-existing hyperten- 
iion persists during the phase of reco\-ery. as occurs in approximately one- 
third of the cases, it is managed n-ith antihypertensix-e drugs. 
During the entire hospitalization, the patient is kept in as sterile an envi- 
ronment as can be attained with reasonable precautions. One to four post- 
operati\-e patients are quartered in a room. Nurses and physicians don masks, 
':owns. and glox-es before entering for the administration of treatment or for 
examination. The care n-ith \vhich these procedures are follon-ed is compara- 
ble to that employed in the standard treatment of burns. It is probable, as 
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will be discussed in Chapter 21. that the chief accomplishment of these 
precautions is protection of the patient from the indigenous strains of bacteria 
which are commonly present in most hospitals. 
After three or four days, or as soon as the patient is physically able, he is 
encouraged to lea\ e the sickroom and spend the greater part of the day pur- 
suing whatever act i~i t ies  he prefers outside the hospital. A member of the 
family pro\ ides the necessary care during such absences. By this tlme. no dress- 
ings or other manipulations of the wounds are required. inasmuch as drains 
are not inserted at the time of surgery. This outpatient activity is continued, in 
most cases, e \ e n  during treatment of the almost inevitable rejection crisis. 
With the ad\ent  of rejection, adjustments are made in the drug and dietary 
regimens as described in Chapters 14, 15. and 16. Antibiotic therapy during 
both early and late phases of convalescence is treated in detail in Chapter 21. 
SURGICAL COMPLICATIONS 
The events described pertain to the majority of patients. The appearance 
of any deviation from this sequence of recovery is a serious omen. The greatest 
risks are relatively specific consequences of the use of immunosuppressive 
agents, as described in subsequent chapters; most deaths resulted from drug 
toxicity and generalized sepsis which were induced during efforts to reverse 
unusually vigorous rejection crises. Those deaths which were the direct result 
of drug toxicity are discussed separately in Chapter 19. 
In addition, certain complications have been observed frequently which, 
while not unique to renal homotransplantation, appeared to occur far more 
often after this than after other major surgical procedures. The operation itself 
and the therapy necessary to achiel-e chronic function of the homograft im- 
pose an increased danger in several pathophysiologic areas. as will be dis- 
cussed on the basis of analysis of the first 42 cases in which homografts were 
obtained from living donors. 
The cyclic course which follows renal homotransplantation is fully 
described in Chapters 15 and 16. Briefly, a technically successful operation is 
followed by a temporary period of good renal function. At a \.ar)-ing inter\-a1 post- 
operati\-ely, ranging fro111 one to 42 days. I-irtually all patients pass through a 
crisis, during which homograft rejection is threatened. The acute illness which 
occurs at this time avith fever and n-ith evidence of acute functional deteriora- 
tion of the homograft can usually be reversed with the addition of actinomycin 
C and massive doses of steroids to the azathioprine therapy (see Chapter 14). 
Many of the complications ~vhich ha\-e had their inception at this critical time 
are probably due, at least partially, to the presence in the retroperitoneal space 
of foreign tissue which is under immunologic attack, as well as to the phar- 
macologic agents which must be used in high doses at this time. 
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F i g z i r c ~  52. Course of patient (LD 10) who  h a d  multiple postoperative complications.  His  blood 
type was  0-. The  homoqraft  \\-a\ donated by a c,onvict of' 0+ I~lood type. I l a s s i \ e  qastroilltestinal 
I iemonhages  o c c ~ ~ r r e d  on the twent>-e ighth  ;111d I'orty-ninth pos to l~e r ,~ t i \ e  d ;~?-s .  On the  first of 
these occasions. eiqht transfusions M.CW recluircd in a 12 - l~our  period. Tlic patient ' \  course w a s  
t iirther complicated n ni!ocardial i ~ i f ~ i r c t i o n  a t this timi', r l i e  rapid c l ~ ~ i n q c s  in  str~roicl therapy 
\ \ e r e  due  to the  tornplexities of' tliallaqemetit tiurinq the I~leedilii! el1i5odcs I'liree n io~ i th s  af ter  
operation. aseptic ~ i ec ros i s  of' the  first l u rnb~ i r  \ -er tebr~i  1% as di,iqnosed and  latn.  tl,e;rted 11-ith curet-  
tcLge and  spinal fu s io~ i .  Tlie patient died 295 daks a l t e r  operation of uncontrolled la te  rejection. 
l c t i  C I n t r a ~  enous  actinomycin C. 
Gastrointestinal Hemorrhage 
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A high incidence of gastrointestinal bleeding occurred in  the early post- 
operative period in close temporal relation to the rejection crisis. During maxi- 
mum steroid therapy. 33 of' the first 42 patients treated with homografts from 
lir-ing donors de\eloped guaiac-positir-e stools. In ser-en cases the hemor- 
rhage n-as of sufficient magnitude to require transfusion (Table 12). The most 
1nassil.e bleeding occurred in a 36-year-old nlan who required 8 units of blood 
in one 12-hour period (Fig .  52).  Unf'ortunatel>-, he  sustained a coronary oc- 
clusion during this time. but recovered. He died of an  uncontrolled late rejec- 
:ion 295 da>-s after operation see Chapter 20). .4nother patient LD 9) died six 
~ n o n t h s  and 23 days after  transplantation see Fiqure 70. Chapter 1 5 ) :  10 days 
before death. he  under\!-ent suture ligation of a bleeding duodenal ulcer, 
combined n-ith p?-1oroplast)- and \-agotomy. . i t  autopsy. multiple fungal brain 
abscesses n-ere also found. 
I I '  - ![ ! ,  
7: L jJ- 
! 4 
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Table 12. Noninfectious Complications in First 42 Patients Treated with 
Homografts from Living Donors (LD Series) 
Urinary fistula 2 
Hydronephrosis 2 
Testicu lar necrosis 1 
Bladder hemorrhage 4 
Renal hemorrhage (on heparin treatment) 2 
Paralytic ileus 6 
Intestinal obstruction 2 
Operat ive cardiac arrest . 1 
Thrombophlebitis 
w i t h  pulmonary emboli 
without pulmonary emboli 
9 
6 (5 proved) 
3 
Diabetes me1 l itus 13 
Pancreatitis 5 
Hepatitis 2 
Gastrointestinal hemorrhage 7 
Coronary occlusion 1 
Aseptic bone necrosis 1 
Neurologic compl ications 
Neuropathy, myopathy, or both 
Coma 
Convulsions 
Stroke 
Bra in  abscess 
Psychosis 
Arthralgia 
*The complicat ion was present before operation i n  a l l  18 patients. 
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Other Complications of Steroid Therapy 
Other complications were directly or indirectly attributable to the tempo- 
rary high-dosage steroid therapy. All pat ients  t reated with prednisone 
developed some evidence of steroid-induced diabetes mellitus. The tendency to 
liyperglycemia or glycosuria was progressive, usually requiring several weeks 
to develop. In the nlost severe examples, pol!-dipsia. polyuria. weight loss, 
~lcidosis, and ketosis Tvere present. In the majority of cases. therapy with in- 
sulin was not necessary. and the alterations in carbohydrate metabolism were 
rluickly reversed as the doses of prednisone were subsequently reduced. In 13 
of the first 42 cases. however, the diabetes Lvas se\-ere and required active 
lnanagement (Table 12). As nluch as 120 units daily of NPH insulin was ad- 
ministered. although the usual maintenance doses were 30 to 50 units per day. 
In all but two patients the need for insulin was eliminated when the dose of 
prednisone was reduced to less than 30 mgnl per day. In these two exceptional 
patients, who were possible latent diabetics, there has been a continuing need 
f'or insulin despite reduction of prednisone to less than 10 n ~ g m  per day. 
Another colnplication which may be related to steroid therapy is pancreat- 
itis. Biochemical evidence for this diagnosis was present in five patients, and 
In three, confirmation was obtained at autopsy. In one case pancreatitis, which 
has been noted both in animals and in man after prolonged steroid administra- 
tion, was the only postmortem finding that might have accounted for death 
'Fig. 53). The patients. \vho died 83 days after operation, had passed through 
two rejection episodes and had good renal function until she died (Fig. 53). 
As would be expected, physical appearance has been affected by the 
prednisone therapy. \'irtually all patients de\-eloped moon facies and abnormal 
Sat distribution, which Lvere temporally related to the period of such therapy. 
One patient developed aseptic bone necrosis of the first lumbar vertebra, ap- 
parently as a result of steroid-induced osteoporosis, as has been described by 
Boksenbaum and Mendelson (Fig. 54), and two others developed spontaneous 
femoral fractures (see Chapter 20). 
Thromboembolic Complications 
Nine of the first 42 patients had clinical evidence of thrombophlebitis 
during con\-alescence. and in five of these the presence of one or more pul- 
monary emboli n-as pro\-ed either at the time of pulmonary einbolectomy or at  
autopsy (Figs. 5 3 .  56). Pulnlonary e~nbolization \vas not the direct cause of 
death in an!- of these f i ~ ~ e  patients. The diagnosis Tvas made clinically in only 
two instances. In txvo of the nine patients, heparin therapy xvas begun, but had 
to be discontinued because of serious hematuria (Table 12). 
The high irlciderlce of thrombotic complications is of great interest, and 
may ha\-e been caused bl- a combination of factors. Virtuall>- all the recipients 
\vere in the terminal phase of uremia n-hen homotransplantation xvas first 
Text co ,~ t i , zues  oir puye 121. 
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Figure 53 .  Course of a 44-year-old woman (LD 161 who died of acute and chronic pancreatitis, 83 
days after hornotransplantation. Prednisoile schedule \\-as unusually protracted because of two 
rejection episodes. The pancreatitis lvas thought to have been steroid induced. (By permission of , 
Arch. Szc rg .  89:87. 1964.) 
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Figure 54. Lateral x-ray showing fracture of L1-L2 lumbar vertebrae (LD 10). Case is the same 
as in Figure 52. Spinal fusion was performed. (By permission of JAMA 189:397, 1964.) 
\ , Isolated 
F i g u r e  55. Distribution of pulmonary emboli 
in  case (LD 4) treated as  shown with cardiopul- 
monary bypass and pulmonary embolectomy. The 
principal clots were in  the right pulmonary artery. 
Forty-eight hours later a vena caval plication was 
performed in the indicated location. The patient 
died of sepsis two and a half months after the 
embolectomy. A t  autopsy, the distal vena cava, 
ileofemoral systems, and transplanted renal ~ e i n  
were completely filled with clot. Despite this, renal 
function remained good (see Figure 15, Chapter 6), 
adequate capsular venous collaterals having evi- 
dently developed. (By permission of S u r g e r y  55: 
503, 1964.) 
4- S o ~ ~ l * c e  / :  
0 f 
elnboli 
F i g u r e  56.  Pulmonaly elnboli remo~-ed uring pulmonar!- einbolecroln!- LD 1 .  B!- permission of 
S u r g e r y  53:505, 1964.) 
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considered. Their degree of muscle wasting, debility, and inactir-ity was usu- 
ally extreme. During the early postoperative period. accentuation of weight 
loss was frequently seen, some patients losing as much as 50 or 60 pounds. 
Such patients n-ould be expected to have a heightened incidence of throm- 
bophlebitis after any surgical operation. 
\J7ith renal transplantation, specific dangers are added. There is the 
necessity for direct manipulation and anastolnosis of the external iliac vein. 
f'ostoperatively, there are major changes in body fluid conlposition during the 
diuretic phase. with a sudden relative dehydration. Finally, the adjuvant 
procedure, splenectomy. is knom-n to cause thrornbocytosis, and may accen- 
tuate a clotting tendency. 
Vascular Anastomoses 
In the care of the first 42 patients treated with living donors, 46 homo- 
grafts were employed. There were 97 vascular anastomoses, five homografts 
requiring reconstruction of a double arterial renal blood supply. No known 
anastomotic failures occurred. Although closure of an arterial anastomosis 
would certainly become clinically evident, there is no assurance that a venous 
occlusion would be detectable without examination of the specimen, as il- 
lustrated by the course of the patient described who had a pulmonary em- 
bolectomy (Figs. 55 and 56). 
This 35-year-old man, who had a massive pulmonary embolus five weeks 
after homotransplantation, rvas treated by cardiopulmonary bypass and pulmo- 
nary embolectomy. Two days later a Spencer \-ena caval plication was per- 
formed. The patient recovered from these operations, and had good renal func- 
tion until his death froin sepsis inore than two months later. At autopsy, it was 
found that the entire ileocaval system was completely thrombosed. including 
that segment into which the renal 1-ein was anastornosed. Furthermore, the 
renal \-ein itself' rvas occluded out to its smaller branches. There were exten- 
sive venous collaterals in the surrounding tissues which had allowed adequate 
drainage and continuation of good function (see Figure 15. Chapter 6). 
Ureteral  Anastomoses 
Ureteral implantation was also relatively free of early technical complica- 
tions (Table 12). In one case, a ureteral fistula at the ureteroneocystostorny site 
developed six days after operation. Reiinplantation rvas carried out im- 
mediately with an apparently satisfactory early result. Ker-ertheless, the 
patient (LD 7) ultimately died of a perinephric abscess surrounding the ho- 
mograft, as will be more completely described in Chapter 20. 
In a second case. a sinall area of necrosis de\-eloped on the anterior sur- 
face of the pel\-is of a renal homograft which had functioned satisfactorily for 
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Figure 57. A- our-minute intravenous pyelogram (LD 2) 24 days after renal transplantation to 
the right iliac fossa. Prompt and concentrated dye excretion is observed. Within 24 hours after this 
roentgenogram was taken, the patient experienced a severe rejection crisis and became essentially 
anuric. Recovery was ultimately complete. Note area of ureteral tunnel. B-Three-minute intra- 
venous pyelogram (LD 1) nine and a half weeks after transplantation and four weeks after complete 
recovery from a rejection crisis. Note prompt and concentrated dye excretion in the kidney which is 
located in the right iliac fossa. - 
almost three weeks after operation. The patient (LD 35) had entered a rejec- 
tion'crisis a few days previously. At re-operation the interior of the uretero- 
pelvic junction had patchy necrosis, and the extrarenal collecting system was . 
filled with debris and tissue which appeared to have blocked the distal ureter. 
It was not possible to be certain whether this complication represented throm- 
bosis of the blood supply to the ureter and pelvis, was secondary to a technical 
error resulting in obstruction of the ureter, or was the consequence of the 
tissue injury incurred during the rejection crisis. The homograft was removed 
and a second transplantation carried out 19 days later. The patient died of 
sepsis 10 days after the second homotransplantation. 
Intravenous pyelograms were obtained in all cases either before rejection 
or after its reversal. In the entire experience at the University of Colorado, 
hydronephrosis was encountered in four patients to be considered separately 
in Chapters 19 and 20. In some cases, the area of the submucosal tunnel could 
be seen (Fig. 57A). In others, drainage was so rapid that delineation of the fine 
details of pelvic or ureteral configuration was not possible (Fig. 57B). 
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Genitourinary Hemorrhage 
Serious hemorrhage was encountered from the lower urinary tract in  four 
of the first 42 patients (Table 12). In  each instance the hemorrhage began a 
few hours after operation follo\ving an  early period of relativell- clear urinary 
excretion. Once initiated. the tempo of the bleediilg increased progressively; 
transfusions n-ere required in tkvo cases. The urethral catheter was removed, 
and the hemorrhage ceased \\-ithin minutes. In some subsequent cases. it was 
;ioted a t  the time of cystotorrly that in the area of the triqonc. a beef'! area of 
hemorrhagic cystitis de\.eloped near the point of contact \$-it11 the Fole)- catheter. 
Fhis finding, and the observation that  renlo\al  of the catheter resulted in  
c:essation of bleeding. indicate that such a focus of h e m o r r h a ~ i c  chstitis was  
responsible for the disquieting complication. 
As mentioned. genitourinary hemorrhage --as induced in tlvo additional 
patients during treatment with heparin, but it subsided at once lvith discon- 
tinuation of anticoagulant therapy (Table 12). 
lleus 
I n  36 of the first 42 patients treated with homografts from living donors, i t  
was possible to remove the gastric tube and resume alimentation within 24 
llours after operation. In the other six. gastric suction lvas required for two to 
eight days (Table 12). During this time, therapy with azathioprine was provided 
in an  intravenous solution (see  Chapter 13). and steroid therapy. if required, was  
qiven with in t ran~uscular  prednisolone. Two patients had surgery Sol intestinal 
obstruction 29 and 32 days after transpl~xntation. both requiring adhesiolysis. 
One (LD 34) had a n  uneventful recox-ery. The other iLD 4 )  died se\-era1 months 
later of a left para\-ertebral gutter abscess ivhich probabl) formed following 
laparotomy. 
Neurologic Complications 
The most frequent complication involved the central or peripheral nervous 
system. and usually began in the preoperative period (Table 12). Advanced 
neuropathy or inyopathy. both of 1vhic1-1 Lvere much more common in older 
patients. indicated a poor prognosis. If such chailges were se\-ere enough to 
prevent effectix-e alnbulation during the postoperatix-e period, prolonged 
survi\.al was not attained in a sinqle case. Such bedridden patients frequently 
developed decubitus ulcers, could not eat  well, and n-ere unusually susceptible 
to drug toxicity. 
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The relatis e irreversibility of urenlic neuropathy is of interest. Two patients 
with advanced foot drop ha1 e nos\ been followed for 12 and 18 months. but have 
shown almost no impros ement. Correction of the original metabolic abnor- 
mality therefore cannot restore to normalcy the patient who is crippled with 
uremic neuropathy. 
Acute neuropsychiatric disorders such as con\ulsions, behasioral disor- 
ders, or coma occurred in both the pre- and postoperatis e periods, but these did 
not have a grave prognostic significance except when the underlying cause 
was brain abscess (three cases) or a massis e stroke (one case) (Table 12). In 
two patients with postoperatis-e convulsions. the seizures occurred during the 
acute post-transplant diuresis, and were probably due to rapid shifts in body 
water composition. 
Infectious Complications 
Failure to control infectious complications has been the leading factor in 
mortality: this special problem is analyzed in detail in Chapters 19 and 21. It is 
encouraging to note here tha t  a n  uncontrollable infection in  ei ther  the  
splenectomy-nephrectomy or transplant wound occurred in only one of the first 
42 cases and that superficial infections could be efTectis ely treated (Table 13). 
Table 13. Clinical Wound Infections in 42 Patients (LD Series) 
No.  Control led Uncontrolled 
Transplant wound 
Superficial 
Deep 
Thymectomy wound 
Superficial 
Deep 
Splenectomy-nephrectomy 
Superficial 
Deep 
Other wounds (deep) 
Cardiac arrest, thoracotomy 
wound 
Previous f lank nephrectomy 
Intestinal obstruction 
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Miscellaneous Complications 
One patient had a cardiac arrest during transplantation, and died 10 days 
later (see Figure 61. Chapter 14). .lnother del-eloped testicular necrosis post- 
operatively necessitating orchiectom~- (see Figure 67. Chapter 15). There were 
two nonfatal cases of hepatitis. Five patients del-eloped arthralgia postopera- 
tively which seemed to be related to the use of antil~ypertensi\.e drugs. 
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Chapter Thirteen 
ROLE OF EXCISION OF 
LYMPHOID MASSES IN 
ATTENUATING THE REJECTION 
PROCESS 
Excision of two lymphoid masses, the thymus and the spleen, has been 
carried out at the University of Colorado. At first, both thymectomy and splen- 
ectomy were performed, but the former procedure was discontinued after it had 
been done in nine cases because of the excessive number of surgical complica- 
tions encountered and because there was no early evidence that the operation 
was of significant value in mitigating the rejection process. Four patients who 
had their thymuses removed are still alive, with normal renal function, after 
14 to 20 months (LD 1. 2: 3. and 6), and comparison of the long-term fate of 
this small group with those later patients who did not receive thymectomy may 
eventually be of value in defining subtle effects of the procedure which are not 
obvious with short- term follolv-up. In  the subsequent  cases ,  the use of 
splenectomy alone has been continued, to some extent because it has appeared 
to be a safe and easily executed procedure. 
Justification of the excision of these or other lymphoid masses depends to 
a large extent upon projecting the results of research in lolver animal forms to 
the homotransplantation problem in man. Frequently, the findings avhich 
might be interpreted as fal-oring the use of the adjul-ant operations are inferen- 
tial. Lest the follo~ving remarks appear to indicate 01-erenthusiasm, it should 
be stated at once that the 1-alue of thymectomy or splenectolny in promoting 
homograft acceptance is entirely unprol-en. In our studies, and in those done 
in other laboratories, attempts to delllollstrate increased homograft sur\-il-a1 in 
dogs that received one or both of the ancillary operations have been unsuccess- 
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ful. The follo~ving discussion should. therefore, be construed as a n  argument 
for clinical experiment, not as a recommendation for the use of either thy- 
mectomy or splenectomy. or both. 
The most immediate and oh\-ious consecluence of hot11 operations - espe- 
cially splenectomy-is reduction of the total mass of lymphoid tissue. There is 
abundant el-idence that lymphoid tissue plays an  important role in rejection, 
as described in Chapter 1. Ne\ ertheless, the degree -if' any - to n-hich reduction 
of the total 1)-mphoid mass influences the rejection process is unhnown. If the 
effect is related to the amount of imniunologically acti\.e tissue removed, 
splenectomy inight be expected to be of some I alue. The thymus, in contrast, 
has undergone atrophy in all but young patients. All surgical specimens in our 
nine patients prepared with thynlectomy weighed less than 20 grams. Histo- 
logically, the glands consisted chiefly of fibrous tissue infiltrated ~ z i t h  fa t ;  
morphologically, it is almost inconceivable that  such a n  inconsequential 
remnant could contribute \.igorously to rejection. at least in a direct way. 
Since remo\.al of lymphoid tissue may ternper the force of the host's im- 
mediate inln~unologic attack, it could also be reasoned that  removal of the 
thymus, the spleen. or both could alter the organization of the host response. 
For example, the role of' the thymus in promoting in~munologic reactivity in  
the newborn state appears to be unquestioned, as a result of' bliller's in\,estiga- 
tions. In  rodents, thyrnectomy performed shortly after birth results in im- 
munologic crippling and subsequent inability to reject homografts in a normal 
manner.  Removal of the thymus a t  this stage of de\-elopn~ent results in  
generalized lymphoid hypoplasia, due either to the absence of a thymic or- 
ganizer substance which promotes lymphoid del-elopinent, or to the absence of 
thymocytes ~ v h i c h  migrate to distant areas of the lymphoid system and popu- 
late them. In adult life. thymectomy has  no demonstrable effect on antibody 
response or homograft s u r \ i \ a l .  Hoxveler. it has  beell shown in adult mice 
that thyinectolny combined xt-ith total body irradiation can result in homograft 
tolerance of a high degree. This finding, reported by bIiller, suggests that  the 
thymus gland may resume its preceptor function in adult life under cir- 
cumstances in which there is temporary suppression of the lymphopoietic 
system. 
It has  already been stated that the ~norphologic features of thymic tissue 
make it difficult to belie\-e that  this organ could resume a n  iinportant role in  
determining the immunoloqic defenses of adults: nevertheless, judgment 
m u s t  be reser \ -ed concern ing  t h e  n-orth of thymec tomy i n  h u m a n  ho- 
motransplantation. The chronic courses of' the four patients n-ho had this ad- 
,ju\-ant operation ha\-e been without any e\-idence of delayed rejection, in  
contrast to those of later recipients n-ho receil-ed kidneys from equally fa-  
vorable familial donors. 
The spleen may also play a significant role in the de\.eloprnent of total 
body response. It has  been known for decades that the antibod\- response to 
many antigens is obtunded after splenectomy. IYissler and his colleagues have 
recentl>- reported histologic el-idence that  the spleen is the most acti1-e organ 
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Figure 58. Theoretical considerations in the use of adjul ant thymectomy and splenectomy for 
the conditioning of recipient patients. The concept of organizer function of the th>-mus in establish- 
ing fetal and neonatal immunologic reac t i~ i ty  is based largely on the work of lliller, and may have 
no relevance in  the adult human.  The role of the spleen in controlling response to antigenic stimuli 
in  adult life is suggested by the work of'\Vissler and his colleagues. The contribution of these ancil- 
lary procedures to homoqraft survival is highly speculative at present. ( B y  permission of Surgery 
36:296, 1964.) 
of the adult lymphoid system in responding to intravenous antigens. On the 
basis of findings in rats immunized to various antigens, Wissler has suggested 
that migrant cells from the sensitized spleen can populate other lymphoid 
tissue and establish specific clones in their new location. The moderator role of 
the spleen in determining antibody response in the adult rat could thus be en- 
visioned as roughly comparable to that described at an earlier stage for the 
thymus (Fig. 58). 
With splenectomy, a restraining influence upon the peripheral white blood 
count is removed. In the normal subject. relati1 el! long-lasting thrombocytosis 
and leukocytosis result from this operation. In the patient n-ho is receiving im- 
munosuppressi\ e therap! following transplantation, the same effect is noted 
as will be described in Chapter 14. As a consequence. l t  might be expected that 
larger doses of azathioprine could be administered nithout causing leuko- 
penia, at least early in the postoperative course. \Vhether or not splenectomy 
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allows larger drug doses to be used is not known. and will be determined only 
with controlled studies. 
Recently, a sonie~vhat different justification for splenecto~ny at the time of 
transplantation has been defined as the result of reports from Hunle and Ham- 
burger and their colleagues. Both authors  reported la te  sequelae of 
hypersplenisln necessitating delayed splenectorny, sometimes under unfa- 
\-orable circumstances. in several otherwise successful1~- treated cases. This 
eventuality is a\-oided if the spleen is removed initially. 
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Chapter Fourteen 
ANTI-REJECTION THERAPY 
While the effectiveness of splenectomy or thymectomy in mitigating the 
vigor or persistence of the rejection process has not been proved, as was noted 
in the preceding chapter, that of certain pharmacologic agents has been 
clearly demonstrated. These drugs are crucial in preventing destruction of the 
foreign tissue. That this could be achieved by means which did not destroy the 
host seemed an impossibility prior to the experimental reports of Schwartz and 
Dameshek and of Calne and Murray on the immunosuppressive qualities of 
some of the thiopurine compounds. notably 6-mercaptopurine and azathioprine. 
The most important single drug in the management of rejection is azathi- 
oprine (Burroughs \$7ellcome 57-322, "Imuran"). This compound is an imidazole 
derivative of 6-mercaptopurine. It was developed by Doctor George H. Hitchings 
and his colleagues at Burroughs \Vellcome and Company. Inc., Tuckahoe, New 
York, and found by them to inhibit hemagglutinin formation in mice challenged 
with heterologous red blood cells. The efficacy of azathioprine in modifying or 
preventing homograft rejection in experimental animals was later demon- 
strated by Calne and Xlurray. The precise mode of action of this drug is not 
known. although the main effect is thought to be by interference with nucleic 
acid synthesis. 
In our institution. azathioprine was used until December 10. 1963. in a 
way fundamentally different from that of the other pharmacologic agents to 
be described subsequently, in that it n-as administered continuously rather 
than in response to specific acute indications of rejection (Fig. 39). It was used 
before. during, and after rejection and n-as, therefore, prophl-lactic during the 
first and last of these periods. Xzathioprine was the basic agent in immunosup- 
pressi\-e therapy to which other drugs Tvere temporari1~- added. Use of it has 
not been discontinued in any of the sur1-i\-ing patients, e1-en those followed 
postoperati\-ely for more than a year. 
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F i g u r e  59. Typical use  of i n ~ l n u n o s u p p r e i s ~ \  e nqerits in fil.\t -15 l~,ctic.i~ts i.e:itrti \vitli llonlografts 
obtained f rom living donors. The  .izathioprine \\-as s t ,~ r t cd  \ c \  vral dn ls  11cfo1.c o11vr;ition  usually 10) 
.ind continued throuyliout the  entlrc cou1 . i~ .  \I,ciii\ i. d o i e i  of p r rdn i ion r  .~dtivd dur ing the  
rejection crisis. The  steroids Irere t hen  11 ithdr:i\\ 11 .I\ c~LI~c! ,~ !  ,I\ 11oisil)le thcre.if ter. .Ac.tinomycin 
C was  emplo!ed olily durini: thc  1,c,jcctloli cl . i i i i .  L-ltin~;itrl!, i f '  ~ )o i \ i l i lc .  the p,l t ic~it  !\-as returned 
to therap!- \\-it11 ;I \in:le ,igetit. .iz,ithiol~rit~i> ' I ' l~ i i  lS-!eafiold l~o! LD 1:: 1 i . i~c t .~ \  ed ;1 t r , iniplant o n  
J u l y  3. 1963. H!- J;lnuar\  1 .  l9Cil. preciliisone h,id I?i>rn discoi~ti i iued.  ind liis m,iinte~i, ince therapy 
\ \ a s  solel>- xrith , i / ~ ~ t l l ~ o p r i t i e  R \urnptioll oi n i , i i~ i t c i i a~ i i c  stelold tlii.r.il~\ I,iter I,ecCime necessary.  
250- PATIENT M S  P 
15YO O" WEIGHT 43+56 kgm 
BUN Ccr 
mgm % cc/min 
0 
For reasons m-hich will be discussed in Chapters 18 and 19, this one-sided 
approach to drug therapy n-as subsequentl!- modified. .All patients treated 
since December 10. 1963. hal-e also receil-ed prophylactic prednisone which 
was started before operation and continued into the postoperatil-e period. 
Nevertheless. the following discussion is based primarily upon information ob- 
tained during the earlier period, n-hen the practice ~ 1 - a ~  to add one drug a t  a 
time. since conclusions about pharmacologic action car1 be interpreted more 
clearl!- when the agents are added sequentiall!-. 
Pretreatment IT-ith azathioprine has  been emplo>-ed in rnost patients both 
before and after December 10. 1963. beginning eight to 10 days before 
operation. in a dose of 1.5 to 4 m g m  ligm per day (Figs. 59. 60). On the last day 
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F i g u r e  60. Course of a six- yea^,-old boy :LD 201 of'0- I~lood type I\ 110 recei\ ed a kidney f'roin his A- 
mother. Bilateral nephrecto~-rly. splenectomy, and transplantation \\-ere done at a one-stage opera- 
tion. Note early rejection crisis !\-hich started 30 hour5 .lf'ter operation. The total count of' nucleated 
cells in the peripheral blood is seen. as \r.ell as the true ~vhite  I~lood count T\ hich is indicated by the 
lower stippled area. Each arrolr- indicates 200 g'lrnrna i n t r n ~  enous ,ictinomycin C .  The shower of 
normoblasts persisted for three months and \\-:is associated ~r-ith fel er. Bl- permission of Surgery 
56:296, 1964.) 
or two preoperatively, the dose is temporarily increased to 5 to 8 mgmlkgm. 
During this interval, resuscitative measures, including dialysis, are continued 
as described in Chapter 4. Although this use of the drug adds the additional 
hazard of bacterial complications during the preoperative period. only two 
patients have developed potentially lethal infections. In both cases, staphylococ- 
cal septicemia resulted from infected dialysis cut-down sites. 1Yith discon- 
tinuance of azathioprine therapy. and institution of appropriate antibiotic 
therapy, the infections were controlled and ho~notransplantation was done in 
the first case 10 days later. and in the second. 14 days later. 
The rationale for the practice of pretreatment ~vi th  azathioprine is based 
on the 60 dog experiments summarized in Table 14,  in 11-hich homotransplanta- 
tion and bilateral nephrectomy were performed. Untreated animals lis-ed for 
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Table 14. Influence of Pretreatment with Azathioprine upon Post-transplant 
Longevity in  Dogs 
N o .  Mean Survival Days SD S E 
Controls 2 1 10.8 2.75 .06 
Acute azathioprine 2 1 36 13.7 3.0 
Azathioprine pretreatment 18 69.1 68.1 16.1 
Comparison of groups 2 a d  3 (p < 0.001). 
10.8 20.06 (SE) days. Animals which received treatment with azathioprine, 
started on the day of operation, lived 36 i 3 . 0  (SE) days. Animals which re- 
ceived preoperative treatment with azathioprine for seven to 30 days, as  well 
as postoperative therapy, lived for 69 ~ 1 6 . 1  (SE) days. The difference between 
the two groups was highly significant (p <0.001). 
Importance of White Cell Count 
From the beginning of azathioprine therapy, close scrutiny is accorded the 
hematologic picture. \Vhite counts are obtained on each subsequent day during 
hospitalization. This laboratory measurement makes a uniquely important 
contribution to the determination of the dose schedule. Although the white 
counts give no indication of the effectix-eness of azathioprine in preventing or 
treating rejection, they pro\-ide an  index of the toxicity of the drug and a direct 
clear warning when o\.erdosage has occurred. From the beginning, the de- 
sirable dose is fixed at  ~vhatever  level is possible without causing leukopenia. 
The white counts thus deterinine the doses beyond which further increases 
are dangerous. These limits hax-e been purposefull>- exceeded in the past only 
in a few patients whose rejection was unusually x-iolent or prolonged, as  de- 
scribed in Chapter 16. and it is our present policy never to induce leukopenia 
deliberately. 
Because of the importance of the xvhite blood count in determination of 
azathioprine dosage. some note should be made of the delay between adminis- 
tration of toxic doses of the drug and the response of the forrned elements of the 
blood. This is difficult to determine with accuracy, but it has commonly 
seemed that a depressed xvhite count could be ascribed to the therapy provided 
five to sex-en da>-s prex-iously. as exemplified by one case in which excessive 
doses of azathioprine, first gix-en on the da>- of operation and continued for 
several more days, resulted in leukopenia in six days and fatal  agranulocytosis 
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Figure  61. Azathioprine toxicity in patient (LD 3) who received excessively large doses at  the time 
of transplantation and shortly thereafter. Note the leukopenia which was already developing within 
five days after the first large dose of the drug. The patient ~ v h o  had a cardiac arrest a t  the time of 
transplantation died of fulminating sepsis in the chest xround through lvhich cardiac massage was 
performed. Terminally, there xvere ahnost no platelets or white cells in the peripheral blood. 
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in  10 days (Fig. 61). Conversely, it has  been noted that  established leukopenia, or 
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even agranulocytopenia, fortunately has  not persisted for more than a few 
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days in those patients who did not die of acute sepsis, provided the drug dose 
was immediately reduced. 
In prescribing azathioprine, it is also important to know that variations in 
responsiveness of the white count to the therapy are regularly observed 
throughout the course of an  individual patient. Preoperatively. relative11 small 
doses (1 to 3 mgm kgm per day) may cause a rapidly de~-eloping leukopenia, 
particularly in those patients n-ho already have the relatively low white counts 
which  a re  commonl>- obserl-ed i n  u r emia  (F ig .  62 ) .  Immedia te ly  a f t e r  
operation, this se11sitivit~- to the drug is replaced by a resistant state. In many 
patients n-ho are operated upon despite low 12-hite blood counts. an immediate 
leukocytosis is observed (Figs. 62. 63). In almost all patients, the substantial 
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Figure 62.  Death of patient frorn cornbination of rejection crisis and druu toxicity I LD 23). Note 
the abrupt develop~nent of agranu1oc)tosis on the la5t cla! of lif'e. Platelets , ~ t  his time were less 
than 20,000. The combination of uremia during rejectio~l,  plus druq toxicity. rvas the most common 
circumstance leading to death. Note also the leukopenia induccld prcol)er,ltl\ vly rrith small doses 
of azathioprine and the marked leukoc) tosis r \  hich follon-ed suryrr> d t . s l~~te  a preopcrnti~ e white 
l~lood count of onl) 1.200. Bilateral nephrecto~n! a ~ l d  splenectoni\- \ \ -we carried out ;it the satne time 
as transp1:intation. Each arro\v is equal to 200 pg actinomycin C intravenously. (By permission of 
S l c r c j e r ~  56:296. 1964.) 
leukocytosis seen in the immediate postoperative period permits a n  increase i n  
azathioprine dosage for several days. The phenomenon of a sudden rise in  
white count is undoubtedly contributed to both by the nonspecific t rauma of 
surgery and by remox-a1 of the specific inhibitory influence of the spleen. 
A second phase of nonresponsix-eness of the ~ v h i t e  count is inconstantly 
obserl-ed during the rejection episode (Fie;. 591, especially in those cases in  
xvhich secondary deterioration of' renal function is not \-el.!- sex-ere. If prex-iously 
satisfactor>- doses are continued in such cases. n-hite counts ma>- rise to 40,000 
to 30,000. During this critical period. as much as 10 or IS mgm kg111 per day of 
azathioprine may be required temporarily to return the T\-hite coulit to a normal 
or slightly elex-ated lex-el (Fig.  59). After the rejection threat has passed in such 
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F i g ~ t r e  63. Demonstration of effect of actinomycin C upon the white blood and the platelet count 
in  a patient (LD 17) who had previously been on a long course of continuous azathioprine. Note the 
striking leukopenia and thromboc?-topenia which appeared three days after institution of a course 
of intravenous actinon1)cin C .  After discontinuing actinomycin C,  there was prompt recovery, and 
it was possible to resume therapy with azathioprine. The transplantation, bilateral nephrectomy, 
and splenectomy were performed on Jul?- 19. 1963, and the patient has  been well with normal renal 
function. (By permission of Sl i rgery  36:296. 1964.) 
cases, a safe and stable maintenance dose can quickly be established at 2.5 to 
5 mgm kgm per day. Only after the maintenance dose is established can the 
patient be permanently discharged from the hospital. 
Paradoxically, other patients, particularly those who have an extremely 
severe rejection crisis with marked impairment or even cessation of renal func- 
tion, have the opposite change in sensitivity to azathioprine. It is in such cases 
that drug toxicity is the greatest threat, as will be discussed in Chapter 19, 
since continuation of moderate doses of azathioprine may unpredictably cause 
profound leukopenia (Fig. 62). The altered susceptibility to bone marrow depres- 
sion has seemed to be directly related to the degree of secondary renal failure. 
Thus. patients with mild rejection can be treated 1-igorously, since they usually 
exhibit leukocytosis as described in the foregoing paragraphs. Patients with 
severe rejection episodes cannot be treated aggressil-el?, since even small 
doses of azathioprine (2 to 4 mgm kgm per day) may be excessi1-e, leading to 
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sudden agranulocytosis (Fig. 62). The relation of the degree of renal failure 
during rejection to azathioprine therapy is of interest, since this drug is not 
thought to have a major renal pathway of detoxification. 
In following daily white counts, it is important to know differential values. 
In some patients, particularly in the pediatric age groups, the peripheral smear 
sometimes has four or five times as many normoblasts as white cells (Fig. 60). 
Failure to differentiate these nucleated red cell forms from white cells could 
lead to misinterpretation of the white count values. with potentially tragic 
consequences. The shower of normoblasts, when observed, is usually of tran- 
sient duration, but OF occasion it has persisted as long as three months (Fig. 
60). Doses of azathioprine are guided by the corrected white counts during this 
time. 
The continuity of azathioprine therapy is of great importance. Ideally, the 
dose should not be omitted for even a single day. For this reason, intravenous 
administration has been temporarily used in some patients who were inca- 
pable of alimentation, the day's dose being infused slowly over a 12 to 14-hour 
period. It has been our impression that the potency is somewhat increased 
with the intravenous route. A powder form of the drug is added to isotonic 
saline which has  been alkalinized by the addition of 1 gm molecular 
equivalent of sodium hydroxide. Two milligrams of azathioprine are added per 
ml of saline. The resulting yellow-tinged solution is sterilized by passage 
through a Seitz filter and either used or discarded within 24 hours. Some 
typical constituents of the infusate are as follows: 
400 mgm azathioprine 
1.4 ml normal NaOH 
200 ml isotonic saline 
300 mgm azathioprine 
1.1 ml normal NaOH 
150 ml isotonic saline 
200 mgm azathioprine 
0.7 ml normal NaOH 
100 ml isotonic saline 
No matter what the route of administration, an  order for azathioprine is 
written each day at 6 PM. The entire day's dose is immediately ingested by 
those patients who are able to eat. Divided doses are avoided, to prevent confu- 
sion. During hospitalization, this timing allon-s analysis and collection of all 
the morning hematologic and biochemical data, before that day's therapy is 
determined. 
Despite the value of azathioprine, it cannot in most cases prevent rejection 
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of the homograft when used as the sole immunosuppressive agent. In only two 
patients has uninterrupted recovery occurred without the necessity for adding 
the other drugs to be described. In the first of these exceptional cases, the 
kidney was donated by a fraternal twin in whom all of the major and 21 of the 
23 minor blood subgroups were identical with those of the recipient. In the 
other case, the kidney was provided by a nontavin brother who also had a high 
degree of blood group identity. 
PREDNISONE 
The unique value of prednisone when used as an  adjunct to cytotoxic 
drugs was first appreciated clinically by Goodwin and his associates. They 
described a case in which severe rejection occurred, despite therapy with 
nitrogen mustard and cyclophosphamide, after renal homotransplantation 
from a mother to her daughter. Administration of large doses of prednisone 
resulted in startling alleviation of symptoms. A similar experience was 
reported by Merrill and his associates in treating late rejection in a kidney 
donated by one fraternal twin to his brother. They employed supplementary 
total body irradiation, plus intermittent steroid therapy. An attack of rejection 
was aborted, but the roles of irradiation and steroid therapy were difficult to 
differentiate. The consistent reproducibility of this beneficial effect has sub- 
sequentlv been demonstrated in our investigations and those of others, both in 
dogs (Fig. 64) and in man. 
In almost all the cases treated by us before December 10, 1963, prednisone 
was added to the basic azathioprine therapy for treatment of an established 
rejection reaction and slowly withdrawn when the symptoms had been al- 
leviated. The value of prednisone and the principles governing its use were 
most clearly defined in these earlier cases (see Chapter 16). The benefit of 
steroid therapy, not only in restoring rapidly failing renal function. but in 
reversing the systemic complaints found at this time, is frequently evident 
within a few hours after it has been started. The more recent use of steroids as a 
prophylactic measure is considered separately in Chapter 18. 
The massi\-e quantities of prednisone 1150 to 400 rngm per day) admin- 
istered for the treatment of a rejection crisis are usually required for only a 
few days, after which the dosage is sloxs-ly reduced (see Figure 39). In suc- 
cessfully treated cases. the control and re~-ersal  of rejection is usually rela- 
tively complete 1s-ithin one month (see Chapter 16). By this time, the dose of 
prednisone has usually been reduced to 30 to 60 mgm per day, at which time 
the patient can be discharged from the hospital. During the ensuing months, 
administration of prednisone is further reduced and, if possible, stopped al- 
together. \Then steroids are used prophylactically, a similar n-ithdrawal 
program is follon-ed (see Chapter 18). 
Necessar>- as they are for success, these large doses of prednisone are not 
without conti~luous danger. Seven of the first 42 patients so treated developed 
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Figure 64. Effect of prednisolone on B U N  in  dog \vhich dex-eloped 1.ejectio11 despite therapy with 
.iznthioprine. Notr  rr\er.s:il of a ~ o t e m i ; ~ .  R U N  did not 1.ise ag,iin \x-llc~i prednisolone ~ s a s  discon- 
11nued. :i chain of e \  ents  fYequriitly obser\ e.d in clinical cases.  i K \  prl.misxio~l of' S l i  t.cjc,ry 55:412, 
1 063.) 
acute upper gastrointestinal bleeding (see Chapter 12). Consequently, all 
patients treated with steroids are immediately placed on a strict program of 
ulcer management,  with antacid and milk and cream administration every 
hour during both night and day. 
In a n  occasional case. oral ingestion of prednisone has  not been possible 
for various reasons. IT-hen this has  occurred. intramuscular prednisolone has  
heen used. following the same dosage schedule. 
The mechanism of the action of prednisone in the re\-ersal of rejection is 
not known with certainty. It-lien used as the sole in~munosuppressi\.e ~neasure ,  
yteroids ha\-e a \-er?- feeble potentiatinq effect on holnograft sur\-i\-a1 which can- 
!lot e\-en be demonstrated except under the most riqid1~- controlled ex- 
perimental circumstances. Deinpster. \vorking x~-ith qreyhound dogs. x~ as un- 
able to prolong the sun-il-a1 of renal homografts despite the adiministration of 
130 to '200 ingm of cortisone acetate per da?-. Hoxve\-er. his meticulous histo- 
logic and ph?-siologic studies pro\-ided a rationale for the use of steroid therapy 
for renal homotransplants n-hich are undergoing rejection. He slioxved that  the 
vascular endothelial reaction in the rejecting tissue \vas materially reduced, 
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that the plasma cell and lymphocyte infiltration was moderated, and that the 
arteriolar constriction which characterized the active rejection process was 
reduced, thereby pro\.iding a better peripheral blood supply to the kidney while 
it was under immunologic attack. 
As experience accumulates, it is possible that adrenocortical steroids other 
than prednisone will be found to be more advantageous. either because of 
greater potency or because of fewer undesirable side effects. In the search for 
better agents, general guidelines established by earlier work on the poten- 
tiation of skin homograft s u n  i\ a1 with steroid administration may be of value. 
These earlier studies indicated that cortisone and cortisol had the greatest effi- 
cacy, that ACTH had a feeble effect. and that corticosterone was without 
value. 
Actinomycin C is used for the treatment of an established rejection (see Fig- 
ures 59 and 62).  This agent is a mixture of three related antibiotics, isolated 
by Brockman from S t r e p t o m y c e s  c h r y s o m a l l u s .  Actinomycin C has  a 
cytostatic or a cytocidal action on lymphoid tissue and upon certain tumors. It 
inhibits the synthesis of nucleic acids by intact organisms and enzyme prepa- 
rations. It has been said that actinomycin C is effective in the dose range used 
(200 to 400 pg per day) without causing bone marrow depression, but this 
opinion does not appear to be justified. Two cases have been studied in which 
acute leukopenia and thrombocytopenia occurred in patients who had been re- 
ceiving relatively fixed treatment with azathioprine. In one instance the 
patient died of sepsis and a diffuse hemorrhagic diathesis. In the other 
recovery followed promptly a f te r  discont inuance of t rea tment  with ac- 
tinomycin C (Fig. 63).  The original maintenance dose of azathioprine was im- 
mediately reinstituted. Superficial ulcerations of the oral mucous membranes 
are an  additional common annoyance after the use of this drug. 
At the time of rejection, actinomycin C is given intermittently every three 
to five days in a dose range of 4 to 8 ,ug kgm per day (Fig. 59). The entire dose 
for a day can be given at one time intravenously over a five or 10-minute period, 
or it may be given as a divided dose, every 12 hours. As soon as the threat of 
rejection has passed. administration of the drug is discontinued. 
The true value of actinomycin C for the treatment and re~.ersal of a rejec- 
tion crisis is difficult to assess in the clinical setting in which it is used at this 
inst i tut ion,  i nasmuch  as  it is added to the regimen concomitantly with 
prednisone. Experimental studies reported by Calne. Xlexandre, and Murray 
have established the synergistic value of actinomycin C under more exact ex- 
perimental conditions. 
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Local irradiation by the method of Hunle has been used at the time of rejec- 
tion. The techniques and indications of this 1 aluable adjunct are described in 
Chapter 16. 
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Chapter Fifteen 
HOMOGRAFT REJECTION IN 
PATIENTS RECEIVING 
IMMUNOSUPPRESSIVE THERAPY 
I n  describing the untreated rejection process as  i t  affects both the host and  
the renal homograft, it is necessary to rely heavily on information learned in ex- 
periments on animals, principally dogs. The classic studies of Dempster and  
Simonsen ~ v h i c h  have since been confirmed by numerous in\-estigators clearly 
define the events that  follow homotransplantation in the canine species. At 
first, urinary excretion occurs, but within three to six days there is oliguria and 
anuria,  proteinuria, and progressive azotemia. Dempster was particularly lucid 
in his description of a b'toxic syndrome" frequently obserl-ed at this time which 
was characterized by f e ~ . e r  and apathy in the dogs and which was of indetermi- 
nate  etiologl-. Once initiated, the rejection process was inexorable in untreated 
animals. Spontaneous resumption of renal function has  lie\-er been observed 
under these experimental conditions. The pathologic features of the rejected 
kidneys were alluded to in Chapter 1. and are fully described in Chapter 25. 
In  m a n ,  comparable information is scant!-, being found principall! in the 
brilliant studies of Hume and his colleagues IT-hich assume a special signifi- 
cance since it is unlikely that opportunities ~vi l l  el-er again be a\-ailable to 
study the fate of untreated homografts in humans.  The cases reported by 
Hume confirmed. at least in general terms. that homograft rejection in m a n  
follo1.r-ed the same clinical course as that in dogs. \!-it11 the exception of two 
important features. The rejection process appeared not onl!- to be slo~ver in 
beginning, but Ivas less \-iolent. resulting in protracted homo%raft function in 
two cases: in one for fil-e and a half months. Hume suggested that this could 
be due either to a species difference in the \.igor of host ilninunologic ac- 
tis-ation. or to a suppression of the recipient's antibod!- mechanism secondary 
to the chronic uremia from which all his patients suffered. Subsequent 
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evidence suggests that both factors nla! ha\-e contributed to prolonqation of 
the graft s u n  i\-al. 
The importance of the foregoing studies in understanding the pathologic 
physiology of rejection can hardly be o\,erestirnated. Ne\ ertheless. it is also 
necessary to describe the rejection process which occurs in the patient who 
is recei\.ing irnmunosuppressi\-e therapy. I11 this chaptct. the course of rejec- 
tion n-ill he char;ictel.ir.ed :is it has  l ~ e e n  obser\ ed ill cliilical practice a t  the 
Uni\ ersitl- of Colorado l ledical  Center. This series lends itself' \yell to analysis, 
since ~.ir tuall> all the p:itients operated upon befol.t> r>ecember 10. 1963, were 
treated in a comparable manner.  AIost rtcei1-ecl kidne>-s f'rorn l i \ ing donors. 
Azathioprine was generall>- used in these earlier cases as the sole chemother- 
apeutic agent until el idence of' acti\-e rejection \!-as fir~nl?- established (Chap. 
14). Secondar>- drugs lvere added a t  this time i l l  order to re\.erse the process 
(Chaps. 14 and 16). It is of' interest that Kliss. hIurray. Shackman. \T'oodruff, 
Hamburger. Huine, and Good\viil ha\ e all made obseri-ations similar to those 
to be recounted, using \.arious therapeutic approaches to the problem of im- 
n~unosuppressioil. Further~nore.  the one patient in the Colorado series who 
had prirn~ir!. treatment \\it11 total 1)ody ii.~~adiation experienced the same se- 
quence of c.1-ents as those patielits treated xvith :izathiol)l.itle I Fiq. 6 3 ) .  Finally, 
the change in therap! initiated 011 l lecember 1 0 .  1963. after n-hich date steroids 
Ivere used proph>-lacticall> .!, caused quantit;iti\-c. but not clualitati\.e changes in  
rejection (sc,e Cliapter 18 ) .  Thus the following dcsc1,iption is not peculiar to any 
one nlethotl of' m:in;igemc.nt. but the 1 arious f'eatures :i1.tX cleal.ly delineated 
only \vhen tlierapeutic agt,nts arc3 added in seciuencr. The c ,o~nments  are based 
on experie~lcc. n.it11 the first 43 patients. and the influence of prophylactic 
steroids ~ ~ p o n  these el-ents is described sep:iratc.l>- in Chapter 18. 
TIME OF ONSET OF REJECTION 
In  the usual case, the homograft begins to excrete urine within 90 minutes 
after it is re\ ascularired, pro\-ided it has  not been excessi\.ely damaged by 
ischemia c see Chapter 7). :I 1-ariable period of good renal function is then ob- 
s e x e d .  LTre11ii:i is allel i ~ i t t d ,  esceys I~ociy fluid is quickly eliminated. and the 
pa t i en t  e x p e r i e ~ l c e s  a feel iny of ~ v e l l - b e i ~ l g .  Despi te  con t inuous  i m -  
munosuppressi\-e t r ea t~nen t .  thi i  phase of impro \ -e~~len t  is interrul~ted in 80 to 
90 per cent of' patients 1 , ~  an a l~rup t  secondar>- illness 11-hich is characterized 
b>- s>-stemic nlanif'estations ,111d 11>- ~nult ifaceted ex-ide~lce of' acute renal 
failure. This rejection crisis has  manifested itself' as earl>- as 18 hours after  
operation a ~ l d  as late as 42 da>-s. the a\-erage tinle of onset being approximately 
13 da>s .  -111 patients and their families sllould be arned of this el-entuality in  
ad\-ance. Failure to do so ca~ lsed  an unsuccessful suicide attempt b~7 one 
patient in our series 11-110 concl~~decl t11,it the onset of' rejection meant that  
death Tvas imminent. 
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Figure 65. Rejection crisis in  patient (LD 1) treated initially with total body irradiation (400 R). 
Note transient oliguria, depression of creatinine clearance, and elex-ation of blood urea nitrogen, 
blood pressure. and urinary protein excretion. The changes were all rex-ersible. The patient previ- 
ously had undergone bilateral nephrecton~y. splenectomy, and th>-mectomy. R-Dose total body 
irradiation: Xcti-C -;\ctinolnycin C .  each arrorr- equals 200 p g  of actinomycin C adnlinistered intra- 
venously. Imuran is synon>-mous 11-ith azathioprine. These general el-ents of rejection ha\-e occurred 
despite treatment ~r- i th  x-arious therapeutic regimens used at this and at other centers. B!- permis- 
sion of Surg.  Gynec.  Obstet .  117:383, 1963.) 
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Figure  66. One of the exceptional patients ILD 3) in the series who did not have a clearly demon- 
strable rejection crisis. The patient. a 21-year-old male. received a kidney from his fraternal twin. 
Renal function has been excellent from the tirne of operation on February 9. 1963. However, a 
striking eosinophilia Tras observed in the second and third months after operation 1%-hich probably 
was a manifestation of' ~n i ld  re,jection. The patient did not h a \ e  fe\ er. LS8rS-left nephrectomy 
and splenectorny. Riqht nephrectomy was done at the time of transplantation. 
Three of the first 45 patients in this series never passed through a demon- 
strable rejection episode, and two of these three were never given any drug 
other than azathioprine. One received his homograft from a fraternal  tn-in, the 
other from his younger brother. Although deterioration of renal function was  
not obserl-ed, there n-as other e\-idence of in~lnunologic alteration during the 
postoperative course. Both patients had substantial eosinophilia, one from the 
thirty-second to the ninetieth postoperatil-e day (Fig .  66). and the other from 
the eighteenth to the fiftl--fifth postoperatil-e day. No systemic manifestations 
were present in the first of these patients: but in the second a protracted fever 
was recorded (Fig. 67). 
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Figure  67. X patient (LD 14)  similar to that  s h o ~ v n  in Figure 66. in  whom a fully developed rejec- 
tion episode did not occur.  Protracted eosinophilia n-as obser~.ed.  hon-el-er,  lasting for more than  
one month.  In addition, the patient had a febrile crisi i  for ~ v h i c h  no explanation could be found. It  
w a s  a t  first t h o u s l ~ t  that  the f'e! e r  d ~ ~ e  to i l if ;~rit ioll  of tlie testis ~ ~ 1 1 i c h  hrld occurred on the  
side of transplantation. ,111d later that  CI deep noul id  infection ~niql i t  Ile present.  The pc1tient w a s  
first sub,jected to lef't ort liiec ton]!. and  later to I I O L I I I ~  1~-rxplora t i011 Y l t i ~ ~ ~ a t e l y .  th~1.c' {vai defer- 
\-escence ~vitl lout pro\ iiion of il~eciflc thel.,~])!. lo dl.u!: otiicl. t l i ,~n  ,iz.ithioprine {\  CIS  ? \  c r  e l i~l~loyed.  
Bilateral nephrectom!- and splenectom!- were performed a t  the t ime of transplantation. B! permis- 
sion of S u r g e r y  56:296, 1964., 
A third patient of AB+ blood type received a n  A+ kidney from his wife. He 
was treated differently from most of the other earlier patients in that  large 
doses of prednisone, in addition to azathioprine. \2-ere given from the time of 
operation (see Figure 15 in Chapter 6). Falls in his seruln colnplelnent level 
were noted after 17  and 42 days. but no clear rejection attelnpt could be identi- 
fied in the 113 days of his surl-ix-al. He died el-entual1~- of sepsis. In retrospect, 
t h e  a b s e n c e  of f e a t u r e s  of re ject ion n -as  probably d u e  to prophylact ic  
treatment with steroids (see Chapter 18). 
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CLINICAL FEATURES OF THE REJECTION CRISIS 
The rejection crisis is a co~nplex illness which cannot be diagnosed on the 
basis of any single s?-mptom. sign, or laborator? measurement.  I t  is inanifested 
by a systemic host reaction to the foreign tissue and h!- renal failure caused 
by an immuno1ogic:il assault ~111011 the nc~.r-ly accjuirecl orcan.  An! one of the 
features of thr. rejection c,risis coulcl be sinlul,ltcd b\- other etiologic factors. 
Consecluently. the diagnosis may be difficult. and it is a l~vays  inferential. Only 
the constant siftilly of' a Inass of' data TI ill allo\I- consistc,nt ancl accurate identi- 
fication of' the onset alid course of tlie re,jection c,risis. Solne I!-pe of' silnplified 
but c.omplete flolv sheet. such as  that described in Chapter 2, is essential for 
this purpose. 
Importance of the Sequence 
The single most important aid in  accurate identification of a rejection 
episode deri1.e~ from perusal of the entire course. The dramatic early improve- 
ment follo~ving transplantation has  already been described. Deterioration a t  
any tiine follon-illy this irnmec1iatel~- bcneficinl phase is suspected of' heralding 
rejection, and demonstratic~n of such a pattern in ~ v h i c h  an  acute secondary 
illness succeeds an  inter\.al of initial impro\ enlent is nlore inlportant than any 
other critei.ion in making the diagnosis. 
Diagnosis in the Incipient Phase 
There is 110 reliable  neth hod as yet for accurately diagnosing a rejection 
episode in its pi ,en~ol~ito~,?- asymptomatic phase. Goodwin and Hume believe 
that  the appearance of' I?-mplloid cells in the urine may occur early, but we 
ha\-e not obserl-ed this consistently, and others ha\-e expressed disappointment 
about the reliability of this tcst. .At one tilne or allother. it l ras  thought that  one 
or more of the features to be clescribeti I~elon- preceded the others. In qeneral, 
h0n.e~-er,  the el-ents have seelneci to o c c u ~  allnost sin1ultaneous1~-. Tl-ith the 
exception of fel-er. tvhich ma! be present for sel-era1 da!~s before any other 
finding is notecl and Tvhich ma! oc.c,ur alone in occasional cases Fig. 67). 
Systemic Manifestations 
Fever is the most prominent systemic manifestation in  patients not re- 
cei\-ing proph!~lactic prednisone. \\'hen the rejection crisis occurs early in  such 
cases. within a fen- da!-s after operation. hyperpyrexia is sudden and extreme. 
Temperatures of 10.5- F. are colnlllon Fig. 68 and relatil-el\- unrenlitting until 
secondar? druq therapy i i  s t a l ~ e d  Chaps. 14 and 16. \\-it11 the more common 
later rejection, loll--grade but pi.ogressi\~el!- increasing fel-er often precedes 
other findings b>- ser~eral  da!-s. 
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Figure 68. Classic rejection crisis in patient (LD 6) treated with drugs alone. Deterioration of 
renal function began 19 days after transplantation. All stigmata of rejection are present except 
for acute hypertension and weight gain. which were successfully prevented by medical treatment. 
Acti-C -Actinomycin C ;  LN- Left nephrectomy at time of transplantation; R N  - Right nephrec- 
tomy. Imuran is synonymous with azathioprine. (By permission of Surg .  Gynec .  Obstet .  117:385, 
1963.) 
Differentiation of the hyperpyrexia of rejection from that of sepsis is an  
important aspect of management at this time. An exhaustive search is made 
for evidence of sepsis, since the therapy for rejection is counter to that which 
would be desirable for infection. It is partly for this reason that the rejection 
episode was not treated in our earlier series until definite e\-idence of homo- 
graft damage was obtained. In patients receil-ing prophylactic prednisone, 
fever is usually complete1~- masked (see Chapter 18). 
It has ahead>- been noted that important and often unpredictable altera- 
tions occur at the time of the rejection crisis in the responsi1-eness of the white 
blood count to immunosuppressi~-e therapy (Chap. 14). The predominant cell 
type is usually the polymorphonuclear leukocyte. although relative lympho- 
cytosis and eosinophilia may occur. 
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Certain less easll\ d e h ~ l t  ti 111,tlllft s t , , t ;o i i  o f  ,\ s t (  l l l i c  i l l i l ts i .  l i icluding 
anxie t l .  apathx . ,ind p,11 ,i~rold heh,l\  I O I .  '11 e ,ilia c o ~ l l ~ l l o l ~ l \  8 , l~,e; etl 111 some  
patients a n o l e x i ~ l  de \  elopi.  illti uillesi t~ ~i l ls lent  ~t ~ i i , i \  t i c  c 101 11ito ,I peculiar 
~sas t inp ,  disease 11hlt11 outlast5 the lelectlon c l ~ s l ,  ,~nct 11 hlch 112s l ~ r o u g h t  
some pat ients  to the biinA of  dea th  Thls  n u t l l t l o ~ l , ~ l  diioidei ~ l i , i \  he clue pri- 
marl11 to the  cht.mothr,lalx elnplo\ eci to l e \  c'i ye l e  jec t1011 
H\pertenslon.  IT hic 11 is f i  ecluentl\ 111 eielit  111 ,r 1111ld fo11ii ltlllllediately 
af ter  transplantation. tencls to 1)econle n l ~ ~ c h  tnole i e \  e l e  durlnq ,l ~ v l e c t i o n  
episode (see Flgule  67). a l t h o ~ ~ g l l  contlol 1s l )osi~l j le  \I  ~ t h  t l ~ c  i;)plopii;ite ant i-  
h \pe i tens l \  e d l u g  the1.ip\ l- li: GS I 1 \ I ~ P I I C ~ J  t o  l ) i  j ) i ( ' i ~  nted iilgqr s ts  t ha t  t he  
l l vpe r t ens i \  e c r i s e s  o b s e r \  e d  a t  t h i s  t l l ne  a r e  b a s e d  u p o n  t h e  Go ldb la t t  
mechanism 
Changes in Homograft Function 
hlost in\.estig:itors ha1.e documented  several  consistent  al terat ions ob- 
served a t  the  tin~tx of' rejection ~v l i i ch  a re  dependent  upon local processes 
within or around the  graft .  These  include progressil-e azotemia ,  decline i n  
creatinint '  c,lt.a~,:rnc.c. l ) rotein~~ri : l ,  oliquria or anur ia .  tenderness over t he  
t ransplant  site,  and  thc  a1)pearaiic.e ot' urinary cas ts  c Figs. 63. 68. a ~ ~ d  69). 
I11 addition, important  alterations in u ~ . i n e  composition oc,cur :it this  t ime.  
I11 man!- pat ients ,  ur inary const i tuents  1vel.e seriall!. n l e a s ~ ~ r e d  i)eforv. (luring, 
and  af te r  a re,jection cpisocic. Si111il;ii. chamyes \vere ol)ic~rr.c:d in ~ t lmos t  all 
these cases.  Sha rp  dec1int.s in sociiuli~ coiicentration \$-ere most c,liar:\c~teristic, 
sonletilnes to a s  lon- a s  0 to 1 0  nlt.;cl liter. dcsspitc, :I continuinq illthough 
reduced urinary output r Pi?. (59). Xltc~rations in cliloride r a lues tended to be  
i n i r  P o t r s ~ i ~  I I I S  i r i l  1 1  I i i c  - e s c i l I  - c~ ,ea t in ine  
concentratiolls usu:ill!- I-ose. l'ht. efft.c,t of pl.ednisonc. up011 ~n inc ,  coml~osi t ion 
\vas paradoxical ill tha t  this drug.  1111ic.11 ot~ditiirl~il\- p ~ . o ~ i ~ o t t , s  salt t.c,tention, 
appeared to promote sodium escrrtioil  c f i g .  691. 111 o n e  patielit n.ho 11:iti th ree  
distinct re,jec,tion episocles. such  :iltet,:itiol~s n-erc noted o;i all three occasions 
Fig. 70). El-en in  thost> pat ients  har  i n %  a suddell earl! ~.e,jec.tiou \!.it11 pt,ofound 
c~liguria or anur ia .  similar hut  nlore rapicll! e1-ol\ illy cllallzei I1,1\-r. been  
documented \!-it11 the anal! i i s  of four-hour urinal.! a l lquoti .  3'11t. nlarked sa l t  
retention is undouhtedl! a n  inlpo1,tant factor  ill the tie\ elopment of the fluid 
retention and  acute  h!-pertension 11-llic h are  of'ten seen  :it tliv til-iie of reicction. 
Blood u rea  nitrogen R C S  is Inore freclucntl!- de t e r~n ined  t11~i11 :ill\- o ther  
111easuremeni. p~.jrnaril!- I ~ e c a u i e  it c.an 11e eirsil!- anti :~c,curatel!- iirl,~lyzed. 
Il)eterminations are  o l~ ta ined  ecxc,h da! before. during.  and  af te r  tlie 1,ejection 
crisis. The  de\-elcpment or ~ , e~ l - l i i i i on  o i  ,irotemi;i call therel~!- 1~ fo l lo \~-ed  gross- 
ly. i t-ith a re,jection epiiode elel-;ition of the H L S  is usu:ill>- proinpt. 
The  B L S  is a relati\  el! i i isen>iti\  e intiex of total i.pnai funct ion,  however, 
B? Doctor Da\  id .A Ogden. 
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Figure 69. Changes  in  u r ine  sodium (LD 18) commonly  seen in  pa t ients  with a rejection crisis of 
modera te  intensity.  S o t e  the  fall  in  urine sodiulm concentration at  t he  t ime of the  rejection crisis 
occurring concomitantl? \ ~ i t h  relati\-e oliguria and  a sha rp  drop in crea t in ine  c learance .  T h e  ur ine  
sodium excretion is influenced paradoxicall!- h! the  addition of prednisone.  a drug 11 hich ordinarily 
causes  sodium retelltlon. Ins tead,  the  <~ddlrion of this ' ~ y e l ~ t  to the  rec lmen .ippeared to 11,1ve in-  
creased sodium esil.etioli Other  st lqinata of r e j e i r ~ o n  ] \ere  present durinq the ~ n d i i a t e d  interx-al. 
includinr: fexer.  ll!pertelision. local l ena l  t ende l i~es , ,  proteinuria,  and  aroteni ia .  Tlie B L - S  which 
h a d  dropped f rom 130 n ~ g n l  per cent  p reope ra t i~  el! to 31 nignl pel, cent  by t h ~  f o ~ ~ r t l l  postoperative 
day rose to a secondar!- peak of 71 ~ n g l n  per cent  011 the  n in th  pos rope ra t i~  e da! and declined there- 
af ter  xr-ith resu~l lp t ion  of good functiorl. B!- permission of Slircgery 56.296. 1961. 
REJECTION IN PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY / 151 
rngrn/day 
400 2000 2 C 40 60 80 0 C  2 0  4 0  160 8 0  200 
.+ TIME IN DAYS 
F i g l ~ r e  70. Course of p;itic.nt LL) 9 ;  \vho had tllt,ee sepnt,lte ~r , j rc t io l l  episodes, l o t ?  decline of 
sodium excretiotj on  each occasion,  and r e \  e r \a l  of'p,rttc.rn \\it11 predliicone dose i t~cre : i se i .  He died 
10 days af ter  enierqrnc! opel.,lti\ r ,  tl.e~ctnleilt of .I I~let.tiin: .:1uodeiicil ul t  r r  ,It ,iutops>-. multiple 
funga l  bra in  a l~sces ses  Irere also found. I H ?  l~errnission of : l r i r i .  1 ~ 1 t .  AtIt.rl. 6 1 :  September ,  1964.) 
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making it desirable to follow other expressions such as  creatinine clearance. 
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This is particularly true in  patients in whom rejection occurs in  a late and  in- 
dolent manner.  In  this type of case, the BUN level may remain normal for 
prolonged periods despite a persistent lowgrade fel-er and a progressil e fall in  
creatinine clearance to a fraction of the normal value. Failure to recognize this 
BUN 7 5 ~  
rngrn% 
50 
-. 
25 
as a delaled and attenuated rejectlo11 crisls has  lesulted in ~xlthholdlng ap- 
0 
propriate therap)- during the sloxs- del-elopment of' se\-ere renal darnage. 
I n  those patients n-ho del-elop an  earl?- rejection crisis one to four days) 
measurement of the urine \-olume pro\ ides the onl>- information xvhich can  be 
obtained quickl>- enough to be of I-alue. Progression from the first el-idence of 
fever and systemic toxicit!- to a state of absolute anuria may require only a few 
hours !see Figure 5. Chapter 3 ,  and Figures 72  and 73. Chapter 16). This is 
perhaps the lnost ol-erridino, emergent!- in clinical transplantation and one 
lvhich can be effectil elv treated onl? lf ilnmedlate and ~ l q o r o u s  action is 
taken (Chap. 16,. 
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RECOGNITION OF A REJECTION CRISIS IN 
A NONFUNCTIONING KIDNEY 
One of the most difficult problems encountered in renal transplantation is 
the recoqnition of' .i r e ~ e c t i o ~ i  criiis in the patient 1~110 has  not had good post- 
operati\-e holnograft function. Historicall!-. this has  been a recurrent problem 
when c~idal-eric, hidne>-s h a \ e  been used, and it is p robab l~  a n  iinportant 
reason for the \ er? high failu1.e rate under these circumstances. Inasmuch as  
the diagnosis of rejrctiol: depends in large part upon accurate e \  aluation of 
renal  function. it becomes impossible to pro\-ide decisi\-e therapy. It then 
becon~es  necc.ssar!- to clepc~ncl upon s\ steillic e \  iclence of' rejec:ion. l ~ u t ,  unfor- 
tunately, e1,t.n such siqns 1:l;i~- b v  obscu1,ed in the presence of unrelenting 
uremia. The serious condition of' tlie patient 11 ill llot lje imlnediatel! improved 
by the installatio~l of' the r1,af.t. a l ~ d  i t  is ~isually telnl)o~.~u,ily ;iqg~.a\-:lted. X new 
systemic disease - ~. t~ , jec t io~l-  lias bee11 added to tlle olie :ilreatl\. pl~eselit in \vhich 
the nonspecific finclinq of' fe\.ei. may 1)e \.iituall! the oiily sign: if steroids have 
been administcreci prophl-l;~ctically ;is described in Chapter 18, e\.en this sign 
is eliminated. The diagnosis of rejection therefore must  be made on \,cry ten- 
uous grounds. 
If such blind therap? is effecti\e, tlle organ. which tmost colnlnonly has  
been damaged hy acute tubular necrosis. may reco\.er. Huine had one case in  
which tlie first urinary excretion from a cadaveric homograft was observed 
one month af'ter trallsplantation. 
DIAGNOSTIC INSTRUMENTATION 
Diagnostic procedures are often considered a t  the time of rejection, usu- 
ally for the purpose of' proving the mechanical integrity of the anastomotic 
connections. Re-exploration of' the wound, arteriography. cystoscopy, retro- 
grade ureteral catheterization. and open or closed biopsy of the kidney are all 
possibilities. 
hluch information has  been gained from such procedures, especiaily from 
serial needle biopsies. I11 spite of this. it is our policy to carry out absolutely no 
instrumentation a t  this tiine, unless there is a highl!- specific indication for it. 
If the kidney has  pre\-iousl!- been functioning well, it is assunled that  the 
transplant is n:ecl:anicall~- satisfactor>-. and that a rejection crisis is a t  hand. 
Appropriate therap! is then started Chap. 16).  
PATHOPHYSIOLOGIC MECHANISMS 
For a nunlber of >-ears. it has  been considered that  focal and diffuse 
mononuclear cell in\  asion I\-as the most typical and ubiquitous lesion in ho- 
nlograft rejection. 1Iore recently. there has  been renen-ed interest in 1-ascular 
lesions \vhicl: n-ere clearl?- described by Dempster and Sinionsen. The vas- 
culitis is char~~c te r ized  b?- the presence of edema in and bet~veen the layers of 
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the vessel n-all, depositioil of an eosinopliilic fihrinoid tnaterial in these 
locations, endothelial proliferation. and inhltratiou !\it11 p!roniiiophilic 
m o n o ~ ~ u c l e a r  cells. The lesions are not dissimilar to those found in collagen 
vascular disorders. 
Porter has  drawn attention to the more chronic proliferatir-e arterial and 
arteriolar changes n-hich occur at a later stage in h u m a n  renal homografts 
that h a r e  been tlansplanted neehs  or montlls ealliel Theie IT as  f lequent nar- 
rowing and coiliplete closule of the Iumiiia of these 1 essels, ol disiuption of 
components of the tnedial lar el Both Poi tel and Daniinln h a \  e demonstrated 
that these a le  ler erslble ch,inees. e \  cil late 111 thc  c o u ~ s e  I he relation of these 
late changes to those found , ~ t  ,111 ealliei tlme has  not I ~ e n  plo\ ed. 1)ut i t  is 
possible that the?- are different stages of the suine process I see Chapter 25). 
The relationship of the 1-ascu1:rr lesions to c,l:tssic cr,llular infiltration and 
the possibility that the tn-o types of' changes occur independently or er e n  by a 
different mechanisnl are not established, although an attractir-e hypothesis is 
that  the vasculitis is related to a n  independent humoral response of'the host, a s  
has  recently been suggested by Kamos on the basis ofobser\  atioris ~ v i t h  cardiac 
homografts \5'hat is clear 1s that in actu,rl c l l~l~c, r l  cxpeiience n ~ t h  renal ho- 
mografts, nl,in\ cases har e been obwr! ed in n llic h functional deterioration 
has  occurred with little or no evidence of classic cellular rejection (see Chapter 
25). 
With the demonstration of rilultiple sillall \essel  disease, it becomes 
feasible to suggest that  one of the first and iilost important e\  ents In rejection 
is acute ischemia. \.arying in intensity from that  of an  acute ascular calamity 
to a more indolent process. Edgerton's studies of \.ascular chaiiqes in skin 
grafts support this reasoning, as do numerous othor obserr-ations rvliich are 
discussed in  detail by Porter in Chapter 25. 
There is also sonie physiological e1-idence that  such a mechanism is a t  
least partly responsil~le for the rt.,jectio~i crisis in transplanted kidneys. As de- 
scribed earlier in this chapter. chanqes are seen in uliiiary electrolyte excretion 
when the rejection crisis is of  noder rate intensity. the lnost common findings 
being reduction or er-en cessation of sodium excretion at a time xvhen urinary 
volume is declining and increases in creati~line concentration are seen. The con- 
comitant der-elopn~ent of' hypertensioil suqgests the presence of'1,enal ischemia, 
since the aforementioned water tind electrol\-te alterations are comparable 
to those lvhich are obserr-ed in the experimental Goldblatt preparation and 
which form the basis of the clinical Horvard test and Statney test for renal  
ischemia. 
In  r-iolent early rejection in n-hich anuria occu1.s rapidly. siiililar changes 
in sodium excretion har-e also been measured recentl>-. If rei-ersal is not 
quickly achier-ed. the consequences are like those seen in partial or complete 
acute tubular necrosis. Aicute ischeillia of a more sei ere nature ma?- also be 
the explanation in this type of exaggerated rejection. the difference being onlv 
that  of degree. It is noteworth!. that  restoration of function in this type of case 
can occur. but sollletiines not until anuria has  been present for man! days, a 
time sequence similar to that seen in reco\~er>- from acute tubular necrosis (see 
Figure 5 in Chapter 3 and Fiqures 7.2 and 73 in Chapter 16). 
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Chapter Sixteen 
REVERSAL OF REJECTION 
I t  was  pointed out in  the  previous chapter that  complete prevention of the  
body's attempt a t  homograft rejection is usually not possible. This fact  has  
been the cause of much pessimism concerning renal homotransplantation, 
since rejection has  historically been considered to be a n  e\.ent of finality. The 
immunologic forces subser\-ing this process are generally thought to be so 
powerful and perst.\ erinq that. ollce initiated. they lead inexorably to destruc- 
tion of the transplanted tissue. 
Recent ohser\-ations indicate that  the rejection process is by no means  
such a d e c i s i ~  e e \  ent .  The clillic,;~l f'eatures of' rejectioll can 11e 1,e\ ersed regu- 
larly and completel!-. e\.ell ~ v h e n  the degree of' acute renal c1am;lge is profound. 
The functional capacity of kidney transplants after re\.ersal of re,jection h a s  
eventually returned to essentiall!- nolm~al standards in inan>- of our cases, even 
in those patients undergoing the   no st I igorous crises. 
That rejection is not a n  all-or-nothing phenornellon n-as first suggested by 
the canine retransplantation experiments of' Balankura and his associates. 
The!- found that renal homografts n-llic11  ere undergoing :~acti~-e rejection 
resumed function and normal histoloqic appearance ii' the!- were returned to 
the original donor \I-ithin se\  era1 days. Subsecluent isolated obsel-\-ations by 
Calne, 3Iurray. AIerrill. Goodwin. Shackman. Hume. TVoodruff. Hamburger, 
and K~lss  ha\-e all suggested the possibilit! of re\  ersing the homograft rejec- 
tion. either in dogs or in nlan. In  the Cni\  ersit>- of' Colol.ac1o series. it has  been 
demoi~strated that most rejection episodes can be re\-ersecl. no matter  if these 
are 1-igorous or mild. 111 this experience, the ke>- to success has  pro\-ed to be the 
proper management and re\-ersal of the rejection crisis. rather than its preven- 
tion. This has pro\-ed to be so in borll the earlier cases in n-hit11 steroids were 
gi\-en onl!- after rejection ~ I - a s  establislled. and in the more recently treated 
patients bvho were gi\ en  prophylactic prednisone. 
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SALVAGE OF THE HOMOGRAFT 
At the tinle of rejection, immunosuppressive measures are added to those 
alreadl- in use. In patients treated initially with azathioprine alone, prednisone 
is added (Figs.  59. GO. 68-73)  as well a s  intravenous actinomycin C and local 
irradiation to the l~olnograft. If pruphylactic prednisone was  begun previously 
(see Chapter 18 1 .  the steroid dose nlay be increased, actinoln>-cin C added, and 
local irradiation eniplo> ed. as discussed later in this chapter. \Vhen practicable, 
doses of' azathioprine are iricreased, although this is not without danger (see 
Chapters 14 and 19). Rejection being subject to remission. the ~;a lue  of any 
detail of added therapy cannot be pro\.en in a given case. since recovery may 
have occurred without it.  Ne\.ertheless, the \ , d u e  of' each adju\  ant  measure h a s  
been demonstrated more or less clearly in animal experiments and in  different 
clinics. 
With these n~easures .  i t  has  been possible in nlost cases to reverse the 
features of rejection (see  Figures 5. 59. 60. 65, and 68-73), The fever responds 
most quickly to the seconclary drug therapy, hyperpyrexia usually being 
relie\-ed wi th in  a f'erv h o u r s  a f t e r  t h e  beginrl ing  of^ pr.ednisone the rapy .  
Frequentl>- there is a sho1.t-li\.ecl progression of deterioration of renal function, 
lasting for sel era1 days. I)c>f'oi.c the KLTN altd creatinine clearitnce are restored 
toward norl~lal .  I l l  otller c,;ises. the risinq H U N  becomes telnpolxril>- fixed a t  
a n  abnorrna1l~- hi gh let el, somt,timc,s despite a brisk secolldary diuresis (Fig. 
71). I n  :ippi'osin~;lrel!. 18 pel, cc,nt of'cases. a period of complete anuria is noted 
that  lasts one to 13 cia).; 1,ef'ol.e exc.l.txtion is resutned ( see  Figcu.es 5, and 
71-73). In nlost instances, however, complete cessation of function does not 
occur !see Figure 68). 
The tern] "1.ejectiosl crisis" isnplies the development and resolution of graft 
rejection \\-ithill a relati\ ely short time. This has  been true in a few patients in 
whom rejection began. reached its zenith. and reqressed a t  least partially 
within a few days. hIore colninonly. the crisis has  been protracted. The most 
extreme example was in a six-year-old child who recei1-ed a kidney from his 
mother. Kejection began approximatel>- 30 hours after operation. and a sig- 
nificant re\-ersl-11 of the process Tvas not obtained until almost tn-o months 
later. The child. ivho 11 eighed 20 kg111. Tvas in fair health throughout this entire 
period. despite the fact that  he recei\.ed betn-een 80 and 130 Ingm per day of 
prednisone and T~ery large quantities of azathioprine and actinomr-cin C (Fig. 
60). Tlle most important factor of success in a protracted episode of rejection is 
the avoidance of either o\-er or undertreatment. The consecjuences of under- 
treatment are ob\ious. If the patient is given too much azathioprine, a fa ta l  
agranuloc?-tosis or leukopenia ma>- de1-elop. 
As soon as it has been clearl!- de~nonstra ted that renal function is once 
a g a i n  i m p r o \  ing .  t h e  doses of steroid a r e  progressix-el>- reduced  to a 
maintenance dose 11-hicll is usually 30 to G O  111g111 per da!- Figs. 71-73'1, Rapid 
reductions belon- this lex-el are sonletinles possible. but one of the nlost serious 
errors in manaqenlent in our experience has  been to reduce the dose of 
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Fiqzire 71 .  Rejection crisis ILD 2).  Note temporary deterioration of renal  function. coincident 
I\-ith fever and  ~ r e i g h t  gain starting on  the t\\ent!--fifth day  after t r c ~ l ~ s p l a n t a t i o l ~ .  The patient was  
anuric for three d,l)s. c ~ ~ i d  e \  en 'if'ter resumption of' urine excretion. azotenlia persisted for several 
txeeks. sate reversal of all parameters illcludilin acute hvpertenslon. n h i c h  is comrnonlx- observed 
 it this tinie. . l i t i-C . l c t i n o m ! c i ~ l  C .  each ;trro~\ e q ~ ~ a l s  200 I*?. D-Dial!>li. Imuran 1s s!-nonl-mous 
~ v i t h  azarhioprille. Oper,itloll \x-ai 011 . I , ~ ~ L I ~ + Y >  '1 1 .  lcih3. The pCirient 11,ii had  normal renal function 
tor more than one ) e a r  ,By perniii i ion of S i i  I /  G g l i t c .  O l ~ \ t t ' t .  117.  3hJ;  1963,  
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Figure  72. Development of t>ar.l! rcjectioli crii15 .~f'tcr :if; ho~11.i L-D 13,. \ I t l i o ~ ~ y h  temporary 
anur i a  resulted. the  crisis xvas re \  ersed Di,~lv$i\ 11,i.j I>ee~i  recli~ired d u r i ~ ~ c  thi ,  1,election (,pisode i n  
18 per cent  of' the ca5es Splenec,tomv , ~ l i c l  I)il;1tc>1.,1l nc~l) i i~r~c~tornv ~ v e r e  pc.rf'or11lc.d on  the. i a m e  day 
a s  t r a n s p l a n t a t ~ o ~ i .  1)-1)inlysis. E , ~ i h  .irrow is 200 y;inilIl,i at ti~ioni!-ti11 C'. I .\-.  tl! permission of 
S z ~ r c j .  G!jtzec.. O i~s t t ' t .  118:8IC). I c ) ( i i .  
prednisone too quickly. This has resulted in early secondary rejection crises in  
three cases (Figs. 53, 70). 
During reversal of the rejection crisis, it is important to follow several indi- 
cators of renal function. After initial improvement in the seruin biochemical 
values, the decline in B U N  may stop at 30 to 40 lngm per cent, despite the fact 
that the patients ha1.e rlorinal creatinine clearance and urea excretioli (Fig. 
71). The inability to immediately restore the B u n '  to normal is probably due to 
the excessive catabolism known to be induced b>- the large doses of predni- 
sone. As the doses of steroids are further reduced. at a later date. the BUN or- 
dinarily returns to normal. Completion of reversal, defined as the time neces- 
sary to restore normal or relatively normal renal function. has required five to 
55 days. 
In addition to the treatment described. local irradiation to the homograft 
has been employed in many patients, most ha1-ing complete arluria at the time 
of the rejection episode. The technique used was adapted from that described by 
Hume and his associates. using doses of 130 R e1-er>- other day for three or four 
treatments. Instead of local irradiation being gi1-en prop11~-lactically. it was 
used only at the peak of the rejection crisis (Fig. 73). Urinary excretion was 
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F i g u r e  73. Use of' local irradi,~tio~-i to rlie l i c ~ m o e ~ ~ ~ l t  cl 1r11-i~ ~.eji>ition (1.iii5 I,D 441 .  'l'llree doses 
of 150 R (at  depth)  lvere qi\ell \\1t11 .i 250 E;\ i r l l l t .  Ho~ l lo t~a l i \ p l ; i~~ t ; i t i o~ - i  \ \ . I \  clone Decelnber 4, 
1963. Renal function has been normal. Note anuric interval. (By permission of S z i r g e r y  56:296, 
1964.) 
resumed in  all but one of the patients treated in this way, but five patients 
subsequently died of later complications. Hume has  demonstrated the value of 
his method in experimelltal animals, and it is possible that  it deser\.es routine 
application in  all cases, a s  he  has  recommended. 
GENERAL MEDICAL CARE 
It is inlportant not only to re\-erse the rejection crisis, but to provide sup- 
portive care as n-ell. The h!-pertension which is a common event during the 
rejection crisis c Chap. 13) is treated with antihypertensive drugs, including 
apresoline, reserpine. and Diuril. It has  been suggested by Parsons that failure 
to do so may result in irrex-ersible changes in the kidne>- n-hich are similar to 
those seen in malignant hypertension. I11 addition, it is conceix-able that  the 
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use of these agents ma!- ha\-e a more specific effect in counteracting the phy- 
siologic effects of acute 1-ascular changes which were discussed in the pre- 
ceding chapters as a possible specific initiating or potentiating factor in rejec- 
tion. 
I t  has  also been noted that  salt retention is a prominent feature of this 
period, urinar5- sodium excretion 1-irtually ceasing in seine cases. Conse- 
quently. the dietary control of electroll-te intake is of the utmost importance. 
The patients are usualll- managed on a 200 mgm sodiunl-restricted diet dur- 
ing the peak of' the crisis. Fluid thei.apy is also a siqnificant facet of' general care. 
Many patients are oliguric. and some are anuric, so that failure to restrict fluid 
intake may result-as has  been obserl-ed in some cases-in vascular over- 
loading and  acute heart failure. 
I n  the more violent rejection crises in avhich oliguria or anuria has  de- 
veloped, it has  been our policy to perforin postoperati1.e dialysis promptly 
(Figs. 71-73). By doing this, the dietary intake can be liberalized, thereby pre- 
venting muscle ~vas t ing  during the period of diminished renal function. Of 
the first 64 patients who received renal homografts from li1-ing donors (LD 
series), 1 3  were d i a l y ~ e d  after operation, usually only once, but in one case, 
eight times. Six of these survi\-ed the immediate eff'ects of rejection. and five 
were alive on June  1. 1964. 
As will be described in more detail in Chapter 21. this is the portion of the 
postoperative period in which the patient incurs the greatest risk of sepsis. The 
proper management  of antibiotic therapy during this time is critical. Early in  
our experience it was considered mandatory that  our patients be confined to a 
relati\-elp aseptic room. \17hile this may be desirable in theory. it has  also been 
found that  profound psychic depression has  often f'ollo.i\-ed. leadills to anorexia 
and general physical deterioration. For this reason, the recent patients have 
been allowed to leave the hospital during rejection crises. e \  en though they 
were receiving n~ax i inu in  in~munosuppress i~-e  th rap!-. Such patients were es- 
corted to the door of the hospital with a minimum of contact xvith hospital 
personnel or other patients and xvere alloxved to r e ~ i ~ a i n  away during the day, 
returning only at night. No serious infectioiis ha1.e occurred which were 
thought to have had their inception during such passes. 
ILIuch information is still unax-ailable concerning s)-stemic response during 
treatment of homograft rejection. .4 peculiar n-asting disease is noted on many 
occasions during that part of the postoperati\-e period in which a rejection 
crisis is evol\-ing. Xlnlost all patients lose 11-eight. Profound inuscle atrophy is 
sometimes observed. Some patients appear to be dying of' maln~itr i t ion.  despite 
a dietarl- intake xvhich might other\\-ise be considered adequate. Pre-existing 
neuropathies ins>- be accentuated. Diarrhea ma>- alternate with qastrointes- 
tinal hypornotility in n-hich pancolonic fecal iinpaction ma!- become a n  al- 
most insoluble problem. Derniatitis is obserx-ed in x-arious areas. In three 
patients in our series. peculiar lesions appeared in the antecubital or popliteal 
spaces avhich looked like second degree thermal burns and n-hich n-ere similar 
to those found in pellagra. Cheilosis and multiple oropharl-ngeal ulcerations 
are common. 
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How this wasting disorder is corrected is not k n o ~ r n .  II'lien recox-e1-y has  
ensued, it has  seemed to be unrelated to an!- specific therap>-. Because of the 
similarity of the condition to multiple deficient>- a\-itaminosis. therapy with 
large doses of' the B l.itainins and \-itamin C is carried out. That some patients 
recover fro111 this phase and that  others do not has  not been satisfactorily ex- 
plained. Equalll- confusing are the etiologic factors leadiilg to malnutrition. I t  
is conceil-able that the xrasting is simply a continuation of pre-existing debili- 
tation. accentuated by the addition of large doses of' prednisone. It is equally 
possible that  interf'erence with the nletabolism of' I itamins. or of other nutri- 
tional elements, is a specific consequence of the large doses of azathioprine 
prescribed a t  this time. Solution to these probleins ~v i l l  require intensil-e study 
by experts in nutrition who are concerned not only with the immediate events 
of the rejection crisis, but n-it11 the long-term eff'ects of' immunosuppressive 
drugs upon nutritional processes. 
A specific metabolic derangement lvhicll may require acti1.e therapy is 
diabetes mellitus, caused by the high doses of steroids. \Vide 1-ariatioils have 
been noted in the de\  elopinent of' side effects of prednisone therapy. In a few 
patients, moon facies. abnormal fat  deposition, hypertension, and glycosuria 
develop a t  a n  early time. In these patients insulin therapy has  been necessary 
on a number of' occasions. The primary objective is prevention of ketosis, 
rather than rigid control of' the urinary sugar loss. Doses as  high as 120 units 
per day NPH insulin h a \  e l ~ e e n  required in a f e ~ v  patients. In others. signifi- 
cant glycosuria has  not been a problem e\.en after protracted periods of 
Iligh-dose steroid therapy. It is important not to attempt control of the induced 
diabetes rnellitus by dietary restriction. hlost patients who ha\-e successfully 
passed a rejection crisis are extremely debilitated. It is more il-nportant to 
re-establish good nutrition at this time than to control the diabetic state 
through limitation of' diet. 
In  inost patients who pass the rejection crisis, there is a remarkable second- 
ary reconstitution of body mass. The appetite becomes \.oracious. Soine patients 
have gained as  much as 30 or 40 pouiids in one month, and it has  not been 
u n c o ~ n m o i ~  to note a 40-to-80-pound lveight gain in the ensuing three or four 
months. In  general. this gluttony is s lo~r ly  replaced by a more ternperate dietary 
approach when the optimal ~veight  ~ v h i c h  had prel-ailed before the onset of the 
original illness has  been reached, but in sorne patients obesity may be a serious 
late complication I\ Chap. 20).  
RECURRENCE O F  R E J E C T I O N  CRISIS 
It was pointed out that  earl>- recurrences of the rejection crisis are usually 
due to faulty manipulation of drug therapy, the most cominon emor being too 
rapid a reduction of prednisone dosage. Early recurrence of rejection has  been 
noted in three patients. Recol-er>- fro111 the prel-ious assault is interrupted by all 
the features of primar>- rejection. n-it11 fel-er and acute renal failure. Although 
162 / REVERSAL OF REJECTION 
re\-ersal of recurrent rejection episodes can  be effectively accomplished, this is 
frequently nlore difficult (Fig. 70). and,  in addition. the patient requires large 
doses of prednisone for a inuch longer period, and is subject to all the attend- 
ant  risks. One patient in our series had a \-ery benign and easily controlled 
primary rejection crisis (see Figure 53). \Yith rapid reduction of steroids, a sec- 
ondary crisis de1-eloped requiring large doses of steroids for ~ n a n y  days. After 
a temporary impro\-einent. she began to lose weight. and ultimatell- de\.eloped 
jaundice and a paralytic ileus. A t  autopsy, 83 d a ~ - s  after operation, she had 
diffuse hemorrhagic pancreatitis. probab1~- caused by excessi\-e amounts of 
prednisone, as has  been demonstrated in aniinals gi\.en steroids f'or prolonged 
periods. 
Another patient had three distinct rejection episodes each reversed with 
progressive difficulty with increased steroid dosages (Fig. 70). The patient, 
who avas k n o ~ v n  to ha\,e a duodenal ulcer, ultimately required einergency 
vagotomy and pyloroplasty for hemorrhage, six and a half months after trans- 
plantation. He died 10 days after this operation. Terminally. he became anuric. 
\T'ith recurrence of a rejection crisis. it beconles mandatory that  a n  
adequate dose of' prednisone be established and maintained for a lorlg time 
after discharge. The necessary ~na in tenance  dose ~ v a s  so~ne\vhat  higher i n  
these three cases than in those patients \vho had a single \sell-controlled crisis. 
After the recurrent rejection. the maintenance le\.el of prednisone xvas 45 to 80 
m g m  per day. In contrast, a dose level of 30 mgm per day or less is usually 
reached within t\vo months in \\ell-managed patients. 
Qui te  as ide  froin t h e  d a n g e r s  e \ o k e d  by p ro t rac ted  high-dose  i m -  
munosuppressi\-e therapy, the obvious additional hazard of secondarl- crisis is 
that  further injury to the homograft parenchyma is inel-itable. In  the patient 
who had three rejection crises, the B U N  never cornplete1~- returned to normal 
(Fig. 70). The homograft. recolered a t  autopsy more than six and a half 
months after  operation. had numerous histologic abnornlalities n-hich xvere ex- 
plicable by the repeated immunologic insults (see Chapter 23).  
The problem of late rejection. four months or longer after hornotransplanta- 
tion, is considered in Chapter 20. 
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Chapter Seventeen 
HOST-GRAFT ADAPTATION 
The dangers of the therapy in current use for reversal of rejection have been 
repeatedly stressed. Hope for long survival with the drug combinations and 
dosages used during the rejection crisis would be remote indeed if' such strin- 
gent measures mere required permanently for protection of the homograft. 
Fortunately, it has becolnc incrcasinglJ- c lc i~r  that ;I s t ~ i t t  of host-qraf't nonre- 
activity is a n  integral a c c o l ~ ~ l ~ a n i i n e n t  of' the successf'ull\ treated i,e,jection 
crisis. 
The mechanism hy ~vhich  adaptation is I~rought a11out is not clcl~i1,: never- 
theless, evidence that this occurs is 1 1 0 1 ~  uncqui\~oc~il .  both in c~xj~c~riinental  
animals and in man.  A t  first. : u ~ d  for ;l long t imt ,  thc on]>- f':iint hopc t1i:it adapta- 
tion in adult life inight be possible xvas pro!-ided by the obser\.ations of \TToodruff 
which demonstrated that guillea piqs dcl-elopcd tolcr;lncc, to th>-roid homografts 
implanted in the anterior cha ln l~er  of the eye. ;Id;il~tation tvas so colnplete that  
the transplanted tissue could then 11e remo\ eel froin tliis f'a\ orecl site to a sub- 
cutaneous location, n-it11 subsequent chronic su r \ i \  al. \Yooclruff' pointed out 
that  the necessar!- prerequisite for clinical application ~ v a s  the de\ elopment of 
means  to prevent graft destruction clurinq tlle ;rclapti\-e phiise. 
Decisil-e e\-iclence that adaptation could occur in dogs lvith renal homo: 
grafts xvas later obtained b>- Zukoski and Pitrcc allti ITarco. Their anilnals were 
treated with 6-nlercaptopurine or steroids for proloniied periods postoperatively. 
After eight months or more. it 11 as possible to \tithclr;t\~ antire.jec~tio11 therapy 
in some of the anilnals 11-ithout cessation o f ren ,~ l  function for as lone as one and 
a half years. I11 our laboratories. it has  11een demonstr~rtecl that partial or even 
apparentlJ- complete tolerance can occasionall!- dex-elop as e,irly as four months 
after carline renal homotransplantation. .At this earl>- tiille. l,ejection usually 
occurs after TI-ithdran-a1 of drug therap!-. 11ut often ill all il~dolent a n d  delayed 
fashion. requirinq man>- 11-eeks or e l ~ e n  se\-era1 inonths Figi .  74. 13 : .  In one 
animal,  normal renal function has continued for eight nlolitl~s after cliscontinu- 
ance of' azathioprine therapy Fiq. 76). 
In the experiments just alluded to. conlplete adaptation lvas a sporadic and  
unpredictable accomplishment. the few ultimate successes contrasting with a 
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Figure 74. The development of partial tolerance in a dog after postoperative azathioprine adminis- 
tration for four months. The animal r e c e i ~  ed both a whole organ spleen and a renal homograft a t  
the same time as  bilateral nephrectom~ and s p l e ~ ~ e c t o m J .  S o t e  the gradual develop~nent of azo- 
ternia after discontinuance of immunosuppressi\e therap)-. The animal is still alive alrnost 15 
months after operation. 
larger group of failures. I n  our clinical series, the development of adaptation c a n  
also be demonstrated, but i t  is undoubtedly incomplete, except, perhaps, in those 
cases followed for the longest periods. In  the latter group. the final test of com- 
plete adaptation has  not been attempted, inasnluch as the at tendant risk of 
discontinuing maintenance doses of azathioprirle has  seemed unwarranted. 
In this chapter, the term "adaptation" has  been used in an  anlbiguous 
5ense: there has  been no attempt to determine whether the host. the homograft, 
or both have undergone a change.  It seems most reasonable to believe that  an 
calteration in the recipient's immune mechanism has  occurred. as suggested by 
Billingham. RIedan-ar. and AIcGal-ic and their associates. but IVoodruff has  
pointed out that  a change in the antigenic structure of the transplanted cells 
may also occur. The principal experimental el-idence i11 favor of' the latter 
possibility is that a second transplant fro111 the donor of a n-ell-established 
homograft is often rejected despite continued surl-il-a1 of the first one. 
In  humans.  it is possible to demonstrate partial adaptation a t  a surprisingly 
early time. frequentl? in four to six T\-eeks. This is usuall>- first seen just a t  the 
time when a clear-cut reversal of rejection is obtained. As the rejection crisis 
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F i g u r e  75.  Renal homograft biopsy from animal shown in Figure 74,75 days after discontinuance 
of azathioprine. Note moderate focal cellular infiltrate. H and E (X 80). 
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F i g u r e  76. Demonstration of a high degree of tolerance in a dog treated with azathioprine for 
four months after homotransplantation and bilateral nephrectomy. Good renal function has con- 
tinued for more than a year after stopping immunosuppressive therapy. 
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Figure  77. Courst. uf a patient . LLI 6) \ \ I 1 0  i.ecei\ed a hornograf't from his ! -oun~er  brother. Onset 
nf rejection occurred despite trcatnlent ~ v i t h  a ~ a t h i o p r i n c .  and as rc \  crsed J t v r  the addition of 
prednisone and  act i~lomycin  C' ,  Kote subsequent re turn  to maintenance therapy solel)- tvith azathio- 
prine in  gradually decreasing do5es. (By permission of ,411 1 , .  I t l t .  . l l t ~ t l .  61: September.  1964.) 
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is brought under control, the therapeutic regimen can be relaxed, and improve- 
ment in renal function continues despite a progressive reduction in immunosup- 
pressive therapy (Fig. 77). The amount of azathioprine necessary usually 
decreases to a level which is near or slightly higher than the ultimate mainte- 
nance dose (Fig. 77). Gradual reductiorl in the amount of prednisone and discon- 
tinuance of actinoinycin C therapy become possible. The pattern of recovery, 
in which management becomes progressil-ely easier, and the delnorlstration 
that an  initiall!. ineffecti1-e regimen is ultimately adequate pro\-ide the stroxgest 
testimony that adaptation has occurred and that it has occunej. at an early time. 
In the f e n  patients in rvhom an unequi\-ocal rejection crisis did not occur, 
there also n-as el-idence of adaptation. For those patients in n-horn azathioprine 
11 as the onl>- treatment  pro^-ided. the dosage has been periodically adjusted 
~Jo~vnward  because of the increasing ease kvith which xvhite blood count depres- 
sion could be produced. In addition. the two patients of this type who had 
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Figure 78.  Possible mechanism of simultaneous loss of host reactivity to specific strains of endog- 
enous bacteria, as  well as  to the alien renal tissue (see text). (By permission of Slcrgery 56:296, 
1964.) 
transient eosinophilia (see Figures 66 and 67 in  Chapter 15) seemed to have 
passed through a phase of temporarily heightened immunologic activity, al- 
though renal function continued unimpaired. 
Temporally, the first evidence of adaptation is coincident with reversal of 
the rejection crisis. It has been pointed out that both events can occur in most 
cases without the necessity for even temporary suppression of the total white 
blood count below normal levels (Fig. 77). Here. the peripheral white cells as 
well a s  the hurnoral antibodies with which the graft is in constant contact 
appear to have ultimately lost at least part of their capacity to injure the foreign 
tissue. The same adaptil-e phase occurred in those patients in whom temporary 
suppression of the white blood count lvas accidentally or deliberately produced. 
In  both cases. the ultinlate leukocyte population seemed to be inactil-e. at  least 
in  a relative sense. against the renal antigen. It is tempting to believe that  
immunosuppressi~-e therapy caused a progressive attrition of those cells which 
were immunological1~- cclnpetent against the homograft antigen and that the 
replace~nent  cells had an  absent or reduced memory of the alien tissue. 
Because adaptation is inconlplete in the early postoperatil-e period. early 
reduction in i l~ll l~ullosuppressi~-e treatment, particularly of prednisone. may 
lead to recurrent rejection. \I-hen this has  occurred. the second episode may be 
much more violent than the first. In each case in which more than one rejection 
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was observed, the recurrent crises were more violent than the original ones (see 
Figures 5 3  and 70). It appeared that  interruption of the adaptir-e process caused 
activation of the remaining competent cell population in the manner  of recall 
or booster immunization. 
The dernonstrations that  adaptation occurs and that  honlograft protection 
becomes progressively more attainable later in the postoperative period are 
.unong the most important recent der-elopments in homotransplantation. These 
findings indicate that  the central problems of adaptation are those xvhich occur 
early after operation, rather than at a later date. Prevention of rejection is not 
entirely dependent upon immunosuppressir~e agents;  a ke>- factor ill\-olves a 
dynamic biologic process in xvhich the immunologic relationship between the 
host and graft changes rapidly. Undoubtedly, better drugs for antirejection 
treatment will become available, but these will be needed a t  maximum dosage 
only a t  the beginning of convalescence. In addition, through pharmacologic 
or other means  it may become possible to augment the biologic changes sub- 
berling adaptation. An example of this last possibility is the current research 
in many laboratories ~ v h i c h  is directed toward a c h i e ~ i n g  enhancement by 
inoculating the recipient with spleen, liver, or peripheral white cells from 
one or inore donors. 
It is probal~le that  the state of "tolerance" which is so necessary for long- 
tern1 survival of' the homograft may pro\-e to be a mixed blessing. It would be 
surprising if memory for other antigens \!-ere not eliminated during reversal of 
the rejection crisis. Thus,  pockets of' pathogenic bacteria could be established 
r 11  a privileged and unrestrained position, unchecked b) body defenses which 
no longer recognize them as  inimical (Fig. 78) - a  concept that  has  already re- 
ceived experimental support from the work of Forsen and Condie. Such specific 
clonal defects may constitute a n  immediate or delayed threat to life. As will be 
discussed in Chapter 19, the fatal  course of some o f t h e  unsuccessfully treated 
c,ases 111ay be explained by such a chain of events. 
In  addition. it must be enlphasized that an  early state of apparent relative 
tolerance is no assurance against dela>-ed rejection. Ser.eral cases har-e been 
c,bser\-ed in rvhich serious indolent rejection has  appeared six to 12 months 
.lfter operation (see Chapter 20). 
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Chapter Eighteen 
PRETREATMENT WITH PREDNISONE 
I n  Chapter 14, the experimental evidence was  considered favoring the em- 
ployment of azathioprine in  a pretreatment regimen. I n  almost all the first 45 
cases in the living donor (LD) series we attempted to use onlv this pharmaco- 
logic agent in the early postoperative period as  well, reserving administration 
of prednisone, actinomycin C,  and local irradiation for the specific indication 
of' rejection. There xvere ser-era1 reasons for this practice. First, it was desirable 
to obtain inforrnation concerning the efficacy of azathioprine without the 
superinlposition of other pharmacologic factors. Second, the benefit of the sec- 
ondarl- drugs could be :lssessc:d onl>- in a situ:ltion in 11-hich prinlary therapy 
with azathioprine had already pro\-ed inadequate. Third, only by the graded 
use of drugs rvas it possil~le to demonstrate clearly the presence and timing, 
first of rejection and then of host-graft adaptation. Fourth, it n-as not a t  first 
evident if adaptation ~voulcl occur if completely successf'ul efforts n-ere made 
to prex-ent thc rejection crisis. Finally. the use of potentially dallgerous doses 
of steroids for periods during the early conr alescent phase ~ v h e n  the!- did not 
dppear to be needed did not seem warranted. The last argument seemed es- 
pecially pertinent inaslnuch as the time of onset of' the rejection crisis was SO 
1 ariable, and because an occasional patient ner-er required any treatment with 
prednisone. 
hlan>- of the nlost forceful of the foregoing reasons for n-ithholding steroid 
rherapy until graft repudiation had clearl>- started n-ere for the purpose of 
delineating the feature5 of' rejection and adaptation, and defining the in- 
iluence of drug therap!- upon these processes. From a clinical point of view, 
this illforlnation is no\\- near1~- complete. as has been described in the pre- 
ceding four chapters. 
Attention is nox7- directed to the proph>-lactic use of steroids in a pretreat- 
ment regimen comparal~le to that alread! described for arathioprine. \I-ith this 
nlodification of manaqement predliisolle is started one to three days before 
operat ion in  l a rqe  doses a n d  con t inued  t h e r e a f t e r  i n  slon-I>- decreas ing  
imounts.  The colnments concerning this use of steroids are based upon a 
clinical study of 19 cases a t  the Uni\-ersity of Colorado which began after De- 
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Table 15. Genetic Relationship of Donors in Steroid-Pretreated Series':' 
Living 6-1 -64 Died 
Mother 2 1 
Father 2 0 
Sibling 6 0 
Aunt  1 0 
Uncle 1 0 
Cousin 1 0 
Nonrelated 2 
"Operations were performed from December 10, 1963, to March 30, 1964. 
In  two patients, f irst homografts fa i led wi th in  one week for technical 
reasons, one because of a problem which was due to anomalous venous 
drainage and the other because of secondary wound hemorrhage. In 
the above tabu lation, the second or def in i t ive donor i s  listed. See 
oppendix for details. 
cember  10,  1963. Since tha t  t ime other aspects  of therapy,  including 
pretreatment with azathioprine, ha1.e remained the same as before. Further- 
more, the genetic relationships of the donors were quite comparable (Table 15) 
to those of the prior series. Preliminary results have sholvn a slight im- 
provement of sun-il-a1 within the al-ailable period of follow-up, due to reduc- 
tion in that early mortality which has plagued efforts at renal homotransplanta- 
tion. Fifteen of these 19 patients are still ah\-e on June 1. 1964. froin 61 to 148 
days after operation. Four (LD 46, 37. 59. and 61) died after 43, 76. 43, and 36 
days, respectivell- (see appendix. Chapter 28). 
Pretreatment with azathioprine was started first. Tlventy-four to 72 hours 
preoperatil-ely, a course of 3 to 3 mgm kgm per day prednisone (or intra- 
muscular prednisolone) xvas instituted (Figs. 79 to 82). divided in six-hourly 
fractional amounts. Care was taken to a\-oid the inad\-ertent on~ission of doses 
on the day of operation. Fifteen to 30 minutes before revascularization of the 
homograft, an additional intravenous infusion of 50 mgm prednisolone was 
given. 
After operation, steroids were continued and reduced in amount every five 
or 10 days so that a dose lei-el of 45 to 60 lngm per day had been reached in 
most adults after 30 to 40 days (Figs. 79 to 82). After this time, the dose schedule 
was carefulls- reduced to maintenance levels in the same general way as in the 
earlier series 'see Chapter 16). 
Local irradiation of the homograft and intra\-enous actinomycin C were 
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F i g u r e  79. Use of' 5rr.roid pretle,itnleilt ill 11,irleilt 1.1) 37 \ \  ho ret r i i-ed a homoeraf't f rom his  
brother.  Both tvere I\- I h r e r  tl.i\ i ai  tei o ~ ~ e i ~ l t i o ~ i .  acute  \i o u ~ i d  tellderrieii. heni,~rurii i .  kind anu r i a  
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of functiorl xv,is i o  ~ . ~ i l ~ i d  r21,it c rea t in i~i i .  t lc,lr,llic es  li'ised on 21 -ho~n .  ~11.ine collec ti011 h a d  only 
slight depression. ,ilthouqh .izotemi,i is r i  ident Setorid relection xi-as a t  11 d,i!-s ivith recurrence  
of renal  failure.  x ~ e i g h t  ~ ~ l i i i .  . ~ n d  temporclr! depresiiori of xxhite courlt. The  steroltl do\e  was not  
i r~creased to t h t  p r e i - i o ~ ~ i  l i i rh  l e ~  el , de ip i te  i x  hich r e \  ersal  folio\\ed ixith a hr l ik  secondar? diuresis. 
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added to the azathioprine-steroid base therapy when rejection was suspected. 
It was usually unnecessary to secondarily increase the steroids at this time, 
even though the dose had frequently been reduced considerably from the high 
levels employed before and immediately after operation (Fig. 79). 
An increased incidence of complications did not seem to follo\v this use of 
prednisone. There n-ere no illfections in the operati\-e n-ounds. although one 
patient (LD 37) sustained a third degree burn to the entire l o ~ v e ~  half of her 
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abdomen froni a hot 11-ater bottle. Infection of this area was probably the 
initiating factor in her death (Chap. 19). Three others (LD 46, 59. and 61) had 
nonsurgical infectious coniplicatiorls which either caused or contributed to 
their deaths. Another tLD 31) de\.eloped moderately se\.ere gastrointestinal 
hemorrhage which did not require operation. The incidence of cosmetic 
deformity and steroid diabetes was coinparable to that encountered with the 
delayed use of prednisone. The total quantity of prednisone administered was 
approximately the same as in the earlier cases. 
EFFECT UPON THE REJECTION CRISIS 
An unequivocal rejection episode occurred in nine patients who received 
steroid pretreatment. In one patient, this occurred after her discharge from the 
hospital, and resulted in the rapid development of anuria (Fig. 80). The patient 
died from the syndrome of acute secondary renal failure, drug toxicity, and 
sepsis which is described in the follo\ving chapter. Another, a six-pear-old girl 
who received a maternal homograft (LD 61), had rejections after three, 14, 
and 25 days with terminal anuria and leukopenia. The se\-erity of rejection 
varied in others (LD 47. 50, 56, 57, 59, 62, and 64), and was an important 
factor in the death of only one (LD 59) who succumbed with pneumonia and a 
lung abscess which developed before the onset of a rejection episode at 37 
days. Fever was completely masked in all the patients except three who died 
with septicemia or pneumonia (LD 57. 59. and 61). 
Rejection crises were indefinite in five of the remaining 10 patients. In 
these fi1.e cases. the e\.idence on which the diagnosis kvas made was flimsy, 
being based on very minor depressions in creatinirle clearance. the temporary 
appearance of oliguria, small rises in BUN.  slight tenderness in the transplant 
wound, or a persistent accentuated hypertension. If any of these findings were 
present in conjunction with a tendency to fluid retention or with a fall in uri- 
nary sodiuin concentration, a course of local transplant irradiation or intrave- 
nous actinoinycin C 1.r as immediately admiriistered. The high index of suspi- 
clon undoubtedl~ lesulted in 01 ertreatment ln some Instances. inasmuch as 
secondarh therap\ \ \ as  gir en to some patients in the absence of an\ meas- 
urable change in creatinine clealance oi B U N  An example is shonn in Figure 
81. Transplant tenderness. relati1 e oliguria. and lo~v  urinarj sodium excretion 
were present. The tenderness was immediately relieved, and the other findings 
were reversed. 
In addition to clouding other features of rejection, the steroid pretreatment 
detracted somen-hat from the diagnostic 1-alue of daily B U N  determinations. 
Heightened catabolisni usually resulted in incomplete resolution of the 
preoperatil-e azoten~ia.  Postoperatil-e B U S  le\.els tended to be stabilized at 25 
to 50 rngni per cent despite high creatinine clearances (Figs. 19. 81. 82) and in 
the presence of dail\- urea excretion of as high as 60 gm. Later. as the steroid 
doses nere  reduced. B U S  dropped to nithin normal ranges. 
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F i g u r e  80. Abrupt rejection after 31 days in patient ~ v h o  had received steroid pretreatment. She 
died of sepsis after 10 days of anuria. She n-as riel-er febrile. The recipient (LD 36) received the 
homograft from her husband. Both were 0 blood h p e .  
In five other cases, no evidence whatever of rejection has ever appeared 
(LD 49, 52. 58. 60. and 63) during the follolv-up (to June 1. 1964) of 61 to 104 
days. The withdrawal of steroids has proceeded at the same rate (Fig. 82) as in 
those cases ~ s i t h  modified or 01 ert rejection described earlier. 
INCIDENCE OF AZATHIOPRINE TOXICITY 
It is pointed out elsewhere (see Chapters 14 and 19) that poor renal 
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Figure 81. Use of secorid:iry therapy in steroid pretreatment group, despite unequivocal evidence 
of rejection. The principal indication for. actinonl!ti~i C' ;\c.ti C I , ~ n d  local irradiation was tender- 
ness in the transplant site n-hich de\eloped :it the time ;1s relati\e oliguria. So te  that these 
findings u-ere unaccompamird by changes  in B L ' S  and C'cr. The patient's LD 53) discomfort was 
immediately relieved after x-ray therapy. 
function is an  important factor in predisposing patients to toxicity from azathio- 
prine. Similar bone marrow depression and leukopenia were encountered in 
the steroid pretreatment series in the two patients (LD 46 and 61) who had 
the severest rejections. In those patients who did not have overt rejection and 
in those in whom the crises xvere easily manageable, precipitous drops of the 
white blood count xvere not seen. 
MORTALITY 
Four of the 19 patients are dead after follow-up of two to five months 
(Table 15). Three died during the first two postoperative months. In compar- 
ison, 11 of the first 43 patients. managed in all but tlvo instances without 
steroid pretreatment. died 11-ithin the first eight postoperati\-e weeks. The alter- 
ation in use of in~munosuppressive drugs does not appear, therefore, to have 
exerted a profoundl>- beneficial influence during the earl!- phase of greatest 
risk. Despite the absence of conl.incing el-idence, it has seemed to us that the 
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was acconlplished as easily in the latter patients as had been possible in the 
earlier series. so that the total quantity administered during the first few 
months after operation pro\-ed to be no greater (Figs. 79, 81, 82). Furthermore, 
those patients f'ollon-ed for as long as five and a half months have not had an  
increased incidence of late complications. 
Nevertheless, it is important to withhold judgment concerning the effect of 
prophylactic steroids upon host-graft adaptation. More than one rejection was 
recorded in six of the 19 patients in this series, compared to only two (or possibly 
three) in the earlier series of 45 (see appendix, Chapter 28). The explanation 
for this ma>- be related to the ambiguity with which rejection presents in the 
patient receiving prophylactic steroids. Since many of its features are blurred 
by the therapy being used, there is a heightened sensiti1-ity to srnall changes 
which previously might not have been considered sufficient to make the diag- 
nosis. These ininor alterations in renal function or in the patient's clinical 
state may not actually have been due to rejection, even though they were treated 
as such. 
Chapter Nineteen 
CAUSES FAILURE 
I n  the analysis of failures, the essential information is given in tabular 
form for each patient treated before March 30. 1964 (Table 16): excluding 
those treated with cadaveric kidneys and heterografts. The latter tn-o groups 
are accounted for separately in Chapters 8 and 23. respecti1,ely. A11 patients 
who died before June  1, 1964, are listed. Additional details of the individual 
cases can be obtained from the appendix (Chapter 28) .  In  this chapter a n  at- 
tempt is made to identify in general terms recurrent clinicopatholoqic patterns 
which defeated attempts a t  treatnlent: therefore the principal emphasis in the 
follo~ving relnarks is on those causes of' death which \\-ere inet repeatedly. 
As has  been made clear, the con\-alescence of patients lvho h a \  e received 
a renal hoinotrarlsplalit is not a n  easy one. The el-ents of rejection and the 
heroic program of' therapy necessary to pre\.ent destruction of the homograft 
impose a period of great risk which lasts se\  era1 nlonths after operation. It has  
been pointed out that  J-oung patients (see  Table 2. Chapter 3 )  and those re- 
ceiving kidne?-s froin familial donors (see Tables 4 and 13. Chapters 3 and 18) 
ha\-e a greater chance of sur~- i \ - ing this dangerous inter\ a1 than older people 
and those n-110 have been donated honlografts from genetically unrelated per- 
sons. 
Although there are differences in the risk of certain classes of' recipients, 
the steps to reco\-ery are qualitati\-el?- silnilar in allnost e\  er?- case. there being 
\-ariation5 only in degree. Thus nlaternal-to-off 's~~rillg transplants usually ha\-e 
a illore temperate rejection crisis n-hicli is more easil?- treated but is otherwise 
like that encountered 11-it11 less fa\-orable genetic combinations. In all groups, 
moreo\-er. most of the deaths and conlplications either ha\-e occurred in this 
earl?- postoperati\-e period. or the el-ents leading to later nlortalit!- apparently 
have had their inception at this time. 
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Figure 83. Typical unsuccessfully treated case I L D  3 2 ) .  The donor and recipient were brothers, 
both of A+ blood type. X violent rejection crlsis folloned yood earl\ function, and anuria developed 
which lasted txvo weeks. Although the reJection n-:ti re1 eried a ~ l d  ;i secoridar) diuresis began, the 
patient died from drug toxicity. leukopenia. and septlcenila. Acti C - E a c h  arron is 200 p g  intra-" 
venous actinomycin C .  (By permission of S u r g e r y  56:296, 1964.) 
EARLY MORTALITY FROM DRUG TOXICITY 
The most frequent cause of failure was the induction of drug toxicity 
during the efTort to treat a rejection crisis. Twelve deaths have been observed 
under these c i rcun~stances .  Tlle clinical course of one such patient is shown in 
Figure 83. and \-arious other exainples are depicted in other chapters. In all 
but one of these cases. the homograf'ts pro\-ided excellent immediate function. 
The \-igor of the subsequent rejection process 11-as frequelltl!- greater than 
usual. In some instances, the disquieting picture of decreasing urinars- 1-olume, 
falling creatinine clearance, and mounting azoteinia pro\-oked ill-advised 
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increases in drug dosage to a dangerous lei-el: in others, 11o~r-ex-er. the thera- 
peutic regimen employed was not thought to be predictably excessive, even 
upon retrospectil-e analysis. 
In  such unsuccessful1)- managed cases. the acute renal failure of the 
rejection crisis n-as accolnpailied by rapidly dex-eloping leukopenia (Figs. 80, 
83) and often by thrombocytopenia as if the patient had undergone a sudden 
change in sensitil-it>- to azathioprine. \Tithin a few hours or da!-s. the onset of 
fever almost always signaled the beginning of' inexorable deterioration which 
usually terminated wit11 fatal  pneunlonia or septiceinia or both (Table 16). Four 
patients who were dial>-zed in the presence of n-hite blood counts of 3,000 or 
lower d e ~ e l o p e d  septicenlia almost imnlediately after t r ea t~nen t .  and all died 
shortly thereafter. The infecting organisms in such cases are listed in  Table 
16. 
In  \-ie\x- of the intensity of the imlnunosupl~ressi\ e therapy necessary for 
control and rex-crsal of the rejection crisis. it is not difficult to appreciate the 
inherent danger of' this phase of' reco\ el.)-. That homograft function could be 
retained at all is perh~ips  the strongest indication of' the extent to lvhich total 
body immunologic def'enses ha1.c Ixen xve;rkened. In addition, loss of reactivity 
to 1,arious test antigens ( see  Ch;ipter 22) .  the inconstant de\.elopment of 
hypogammaglobulinenlia (see Chapter 21). and the appearance of' steroid 
diabetes are all indicators of' the host's i~nperiled state. 
The aforementioned general factors ma! be present to some degree in  
ever), case. Ne\ ertheless. it lvas commonly the additional specific conlponents 
of bone 1narroT.l- depression and leukopeni:~ \vhich appeared to precipitate the 
beginning of a fatal  infection. Although all such cases must he classified as  
errors of arathioprine dose control. it should be emphasized again. as was 
described in Chapter 14, that  the effect of'this agent becoines highly unpredict- 
able in the presence of poor renal function ~ v h i c h  accoinparlies a rejection 
crisis. possibl?- because azathioprine has  a partial renal pathway of detoxifica- 
tion. \f7hether this is the entire explanation is not certain. although it seems 
clear that  the leukopenic effect of this drug is intensified a t  the time of acute 
renal failure. Thus,  a patient with an  unusually se\.ere rejection crisis is most 
vulnerable to toxicity, ex-en though this is the kind of case in xvhich exact ther- 
apy with azathioprine is most needed. Consequentll-. the rejection crisis itself 
has  often seemed to be the initiator of fatal drug toxicity. It might be reasoned 
that aggressi\-e dial!-sis therapy under such circumstances xvould be remedial; 
in practice. l~oxvex-er, hernodial!-sis at this time has. on at least four occasions, 
seemed to be the precipitating cause of terminal sepsis. 
Exact classification of' the cause of death in this kind of patient is often 
difficult because of the multiplicit!- of factors n-hich inr-ariabl!- hax-e been pres- 
ent. Thus. death cannot be accuratel!- ascribed to rejection in man!- instances, 
since sel-era1 patients had passed through the worst phase of renal failure and 
had improx-ing homograft function I Fig. 8 3 ) .  Like~vise, sepsis. n-hich ahnost 
always superl~ened late in the course. appeared to be a coinplication of the drug 
toxicity. Finall!-. the del~eloplnent of drug toxicit!. seemed to be initially pre- 
cipitated bl- the rejection. 
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Because immunosuppressir-e therapy was employed differently in  the last 
19 patients, it is important to note that  the uncontrollable chain of events 
described above was also obserr-ed, although not so frequentl!.. Two (LD 46 and 
61) of' the four deaths in the group rvho had pretreatment n-it11 steroids were 
acconlpanied bl- all the features of this syndi,oine (see Figure 80, Chapter 18). 
A third (LD 59) had all the features but leukopenia. 
FAILURE FROM USE OF DAMAGED HOMOGRAFTS 
The influence of adequate renal function upon the effectiveness of cyto- 
toxic drugs was  stressed in the preceding section. \i7ith the use of homografts 
that  do not function well from the onset as a result of' ischemic injury, the 
problems encountered xvith azoteinia and unpredictability of drug action are 
present from the earliest postoperative period. rather than beginning later a t  
the tirne of the rejection crisis. Four patients died after receiving hoinografts 
which functioned poorll- or not at all. I11 three of' these cases, cadar eric kidneys 
had been einplo>-ed. 
The fate of patients receiving cadaveric kidneys is full\- described in 
Chapter 8. All died of a cornbination of unrelie\-ed uremia. drug toxicity, and 
sepsis. the syndroine being similar to but earlier in de\.elopment than that  
described in the preceding section. No urine excretion from the homograft was  
ever obtained i11 t\vo cases, and function was poor in the third. 
In  one patient who receir ed a homograft from a 1ir.ing donor, a 71-minute 
period of ischemia resulted from the necessit\- for treatinq a cardiac arrest 
which occurred during a double arterial anastoirlosis (see Figure 61, Chapter 
14). Poor initial renal function, and later druq toxicity and sepsis. n-ere the 
events leading to death. Another patient receir ed a nonf'unctioninq hoinograft 
which had been subjected to 85 ininutes of' der.ascularizatlon. A second 
well-functioning hoinograft rvas later placed (LD 29), despite which early 
death resulted froin sepsis. I n  the latter case. the cause of death is classified 
according to the course after the second procedure (Table 16). although failure 
of the initial hon~otransplant rvas undoubtedl>- an iinportant contributory 
factor. 
DELAYED MORTALITY FROM 
EARLY COMPLICATIONS 
In a second group of seven patients (LD 4, 7, 9, 16, 21, 38, 57), a rejection 
episode was successfully reversed despite which death occurred 48 to 207 days 
after operation (Table 16). In these cases, the ultimately fatal  coinpllcations 
were thought to har-e originated during; treatnierit of the preceding rejection 
crisis. exaniple is shoi\~n in Figure 84 of a 23-T-ear-old man  n-lio received a 
holnograft from his wife {LD 7,. -4 ureteral fistula del-eloped, and one week 
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Figure  84. Delayed death from a n  early con~plic:ition I L D  7). The ureteral reimplantation, which 
was necessitated by the development of' :t urin;lry fiitula. ieenied to ha\-e been successful until 
just after re\-ersal of' re,jection. :It this tilne. fe\ er ,~ppc,lred due to staph!lococcal infection around 
the homograft. The organisnls tvere iound throl~rhout  the tiisues. but cellular response of host 
cells \sxs l:tching, r e i ~ ~ l t i l i g  in an unrestr,llned cellulitis. 11 hi ih  \\-as u~iinfluenced by sr~rgical drain- 
age or antibiotics. Septicelnia rermin,itpd the c'oul.ie. The iiniu1t:inrous re\ ersnl of' rejection and 
development of uncontrollable sepsis iurqests that loss of reactit-it>- to bacterial and renal tissue 
antigens may have occurred s imultaneousl~.  (By permission of Surge ry  56:296, 1964.) 
a f t e r  operat ion u r e t e r a l  re i inplanta t io l i  w a s  required. ,  After  t h e  second  
operation. the surgical wound apparently healed lvithout infection. However, 
at the peak of the rejection crisis, f e ~  er and toxemia del-eloped as a result of a 
peritransplant infection. The \\ ound ~7 as n idely drained. Striplz~lococcus 
aurezis was found in the tissues. but there Ivas no pus or ether el-idence of ac- 
tive cellular reaction against the patllogerlic organisms. The patient ultimately 
died of septicemia. Another patient , L D  4, died allnost four nlonths after 
transplantation from a subphrenic abscess xvhich had apparentl>- had its in- 
ception at the time of laparotom>- for intestinal obstruction three months 
previously (see Figure 15, Chapter 6).  
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patient becorne f'e111.ile. . i t  .curops>. lull-u.; I I ~ ~ I ~ I I  L ~ l ~ \ c c ~ i i c s  I \ c ' I . ~ '  ~ I I . P \ C ~ I I ~  ~ \ l - i i (  11 ~ ~ r o l ~ ~ i l ~ l \  had  be-
c o m e  es ta l~l i shed ar a much  r,~l.lirl. t i n ~ i ' .  
Of particular interest were two cases (LD 9 and 21) in which death oc- 
curred 76 and 207 days after operation. Recol ery had seemed to be avithout 
serious incident. although both patients dex-eloped headache. b e h a ~ i o r a l  dis- 
turbances, and unexplained neurologic disability just after re\-ersal of a rejec- 
tion episode (Fig. 85). Fungus brain abscesses and a mixed fungal bacterial 
pneumonia were found at autops>-. These complications probably originated a t  
the time of rex-ersal of rejection. although they did not become o\-ert until 
months later. A similar course rvas follo~r-ed by  a patient ( L D  , T i )  rvho sustained 
a n  extensive thermal burn of the lon-er abdomen three and a half weeks post- 
operatively. Although rejection was controlled. the granulating areas became 
infected with Psezldol77ol7ci.s. Cltin~ately.  she died of Ps t~z ido~~zo?zr i s  septicemia 
and pneun~onia .  
A possible explanation for these late septic deaths T\-as suggested in 
Chapter 17 in the discussion of the concept of host-graft adaptation during and 
after the re\-ersal of rejection. It was pointed out that  loss of reactix-it>- to other 
than homograft antigens was a distinct possibility. It is conceir-able that  de- 
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Figure  86. Course of patient !LD 3 8 )  who died of n-astinr: after t~ro-stage renal homotransplanta- 
tion. Splenectomy and bi1:iter:il neph1.e~ tolily were performed tliree \leeks before the honlografting 
procedure. Steroids xvere starred a ien  hour i  :it'te~. hon~otr:irls~1l:i11t;ition because of fever and 
sluggish early diuresis. He lost 17 hgm 37.4 pounds r 111 the 38 d,~! s 01 s u n  i\ 31. A superficial wound 
dehiscence had no tendency to heal. Pneutnonitis \ \ as  the terminal event. 
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layed infections, such as those described. \$-ere rendered uilcontrollable by the 
development of host tolerance to the specific infecting microorganisms. It will 
be of great practical. as well as theoretical, interest to determine in future in- 
\-estigations I\-hether such dela!-ed infectious complications are due sinlply to 
the suppression of greatly ~veakenecl but  balanced host defenses. or if there is 
the establish~nent of 1-elatix-el>- specihc clonal deficiencies ivhich permit 
selectil-e 01-ergon-th of certain organisnls. 
X sixth patient LD 16 i died of acute and chronic pancreatitis 83 days after  
homot ranspIan ta t ion .  a complicat ion n-hich xvas thought  to ha1-e b e e n  
steroid-induced during treatment of rejection (see Chapter 12). 
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A se\.entlr patient. age 21, died of pneumonia 38 days after receipt of a 
homograft from his mother (LD 38). He had been treated in infancy with exci- 
sion of coilgenital urethral valves, and later with bilateral ureterovesical reim- 
plantation. but had been left n-it11 chronic pyelonephritis and hydronephrotic 
kidneys. At a first stage. bilateral nephrectomy, complete ureterectomies, and 
splenectoiny were performed. Honlotransplantation three \\-eeks later was  un-  
complicated. He passed through a relatii ell mild rejection crisis but continued 
to lose weight (Fig.  86). After one month. superficial dehiscence of the 
transplant wound ~V;IS noted. with no subsequent er-idence of' healing. Various 
measures to iinproi-e nutrition were unsuccessful. At  autopsy, there were no 
distincti1.e features except profound wasting. There was slight pullnonary 
edema and nonspecific pneumonitis from which patlrogei~ic orq;inisrns were 
not cultured. Intranuclear inclusion bodies were found in the al\,eolar cells, a s  
commonly noted in the luilgs of' patients ~ v h o  ha\-e died after homotransplan- 
tation (see Chapter 21). 
LATE REJECTION 
One patient (LD 10) died 295 days after  homotransplantation of a late and  
poorly controlled rejection. This problem is considered in  detail in Chapter 20. 
MISCELLANEOUS CAUSES OF DEATH 
A 16-year-old girl died 18 hours after operation from electrolyte imbalance 
during the acute postoperative diuresis. 
Three patients died of unkno~vn  causes. One was a six-year-old boy of O+ 
blood type (LD 20) who had receir-ed a kidney from his A-mother- a violation of 
blood type compatibility which usualll- has  been unacceptable (see Chapter 6). 
After a stormy postoperati1.e course, fair renal function Jvas ultiirlately at- 
tained (see Figure 60. Chapter 14).  Four lnonths postoperatii-ely, the patient 
developed conr-ulsions and coma from n-hich he  nei.er aroused. Death oc- 
curred 202 days after operation, but renal failure isas not a factor. Pern~ission 
for autopsy \\-as denied. 
Another unexplained death ( L D  8 i  occurred in a 29-year-old man  62  days 
after he  had receii-ed a kidney fro111 his 1-ounger brother. He had passed a rejec- 
tion episode ivithout unusual difficulty. He spent the day before death in the 
mounta i i~s  ~ v i t h  his family: after returning, he abruptll- dei-eloped conr-ulsions 
and coma, and died 24 hours later. A t  autopsl-. no cause could be established. 
Numerous diagnostic studies during life and postmortem toxicologic studies 
were nonre1-ealing. 
An additional patient LD 19; died of a piieumonic process which had a 
number  of unique features and ~ v h i c h  is described fully i11 Chapter 21. 
Chapter Twenty 
LATE RESULTS AND 
COMPLICATIONS 
Unti l  very recent ly ,  opportuni t ies  to s tudy  t he  chron ic  f unc t i on  
and fate of renal homografts were rare for the simple reason that  survival of 
more than a few weeks after homotrarlsplailtation was truly exceptional. 
When Goodwin and Martin collected results of the world experience with this 
operation in the spring of 1963. it avas Sound that 90 per cent of all patients 
treated with renal homografts died Lvithin the first tavo months. This unfa- 
vorable statistic had already iinproa,ed \vhen the results were re\-iewed in  
September, 1963, by  Alurray and the other participants at  the National 
Academy of Sciences Transplantation Conference in iyashington. D. C., a t  
which time 30 patients [I ere reported avith surr-ir-a1 exceeding six months. 
Despite the blealiness of the col1ectii.e figures. a remarkable change in  the 
early postoperati1.e outlook has taken place at se\.eral institutions during the 
last tavo years. By personal corrnnunication in AIay, 1964. it \a-as learned that  
Murray, Hamburger. Hume. and Kolff each were fo1loa.r-ing a half dozen or 
more patients avho ivere lir.ing six or more months after transplantation. Of 
the first 64 p ~ t i e n t s  at  the Unil-ersity of Colorado hledical Center. treated from 
November. 1962. to JIarch 30. 1964. n-it11 homoqrafts obtained froill living 
a-olunteer donors tLD series') 47, or 74.4 per cent, surr-ir-ed more than two 
months: and of this group. 40. or 62.3 per cent. \yere still ali\ e on June 1, 1964 
(see appendix. Chapter 28) .  .As of June 1. 1964. 30 of these patients have 
sura-il-ed transplantation Inore than f'our montlls -2.5 more than six nlonths and 
five for a year or more. Thus the first hurdle of the transplantation problem 
has been 01 ercome- at  least partially-in that relatir-el>- protracted homograft 
function can be attained in considerably more than half the cases. 
iyith this change has come a shift in responsibilit>- for those institutions 
performing clinical inr-estigation in renal homotransplantation. It has  now 
become essentiai to s>-stenlaticall>- obtain data n-hicli \!-ill help those in- 
stitutions to plan maintenance care and to establish a long-term prognosis for 
chronic sur1-il-ors before a ne\v series of homografting procedures is begun. 
For this reason. a six-month delay on nen- cases n-as decided upon at  the 
University of Colorado, beginning in AIarch. 1964. during avhich time addi- 
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tional information could he obtained about the adequacl- of late honlograft 
function: the f recjuenc~.  se\ erity. diagnosis. and treatment of delayed rejec- 
tion: and the incidence of indolent urologic and other co~nplicatiolis. I11 this 
chapter consideration is gi\-en to the late seciiielae after transplantation. with 
special emphasis on those patients IT ho li\ ed or are still li\ ing as long as four 
months after operation. The tn-o identical t\t.in recipients ~ v h o  ha\-e normal 
renal fulictiorl after 26 and 11 nlonths art. not included. 
MORTALITY AFTER FOUR MONTHS 
Thlrtv-three of the first 51 patients in the LD series survived a t  least four 
months Subsequentla. t h e e  of these died The genetic. relationships of all the 
donors in the group a le  glaen In Chapter 28 The best results were obtained 
when the donols and leclpierlts \I ele  qenetic all\ lel,rted 
In  one case (LD 9), death o c c u l ~ e d  aftel 207 da \ s .  follo~xing a n  emergency 
operation for c o n t ~ o l  of .i bleedlnq duude11,il ulcel It ~ u t o p s \ ,  fungal brain 
abscesses and pneunionla \ \ere found 111 thls p'ltlent. \ \hose donoi was a 
fraternal t n i n  (blood gloups 0 to A ) ,  l t  had 1)een necess'na to use large 
maintenance doses of pledtnsone i $0 to GO mqm pel d,r\)  111 older to ni 'i~ntain 
stable renal  func t~or i  see Elgure 70. Chaptei 1 5 ,  In the 1,ist lei \  d,l\ s of life 
there \x ns detellolatlon oi len,il f unc t ~ o n  n 111c 11 c olnc ~dcad \I ith thr dt \ elop- 
merit of fungal and bactelial septlcenll'i The p,rtllologlc h n d ~ n q s  111 the ho- 
mograft a l e  desclibed 111 Ch'iptei 25  Tlle l\ic111e\. 11 I11ch c,iqhecl 180 g11i grossly 
did not appeal to be b,idl\ d,itn,lgecl \ l i c ~ o s t  oplc ,ill\. C ci r r c l l t l ( i  11 ljplriie and 
Nocul c l l n  \I, ele  piesent The nlost ploin~llent  le , l tu~ t.5 IT c ~ c  d~f fuse  tu11~1lar at- 
rophy and recent neclosis, and diffuse in te l s t~ t i~ l l  h ~losis  C ellul'i~ inhltratlon 
was 1 eia mild. and the \ asculal s\  stet11 I\ ,is clultc 11 ell piesel\ ecl except for 
destruction of a nurnhel of pel i tubula~ c ,ipill,ilies 
The second patlent LD 20). .l h \  e \e;ll old Lo\ of O blood t \pe I\ ho re- 
ceived an  X gloup nlatelrlal holnoq~ 'ift. sui \ I \  ed 202 d , ~ \  s TI\ o ~ n o n t h s  before 
his death he  suddenla de\ eloped coil\ ulsions c ~ l l c l  clee11 c olli,r f ion1 \I h ~ c h  he  
riel er  aroused Thele \\ as no e l  ldence of 1,ite lejec tlon Peinl~ssion foi 'iutopsy 
was denled 
A thlrd patient n h o  died at 295 d a \ s  of uncontiolled late lejectlon is con- 
sldered in detall subsequently. 
LATE REJECTION 
It n-as pointed out earlier (see Chapters 16. 17. and 18) that  the intensity of 
iminunosuppressi\-e treatment can usually be relaxed after the critical post- 
operati\ e period of one to three months. If this were not the case. there xvould 
be no hope for the useful clinical application of homografting procedures, 
since long-term use of' maximum therap)- results in  immunologic crippling and  
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death from complications of the agents elnplo\-ed. a situation xvliich has  been 
consistentl\- obserl~ed after heterotransplantation (see  Chapter 23)  and after 
the majority of unsuccessful l l o m o t r a ~ ~ s p l a ~ m t i o l l s  I see Chapter 19).  
Xlthouqh seine degree of host-graft adaptation seenls to be conllnon to 
almost all renal homotraiisplantations. the extent of this change in clinical 
cases is not kiion-n. It is c,oncei\-able that the apparentl\- n-ell tolerated homo- 
graft is in actuality under constant but iliiperceptible attack and that  it will be 
s lo~v1~-  rejected ox-er a period of months or years. In addition, the chronic les- 
ions described hl- Porter in the ascular system of' the homograft nlay prove to 
be important in lilniting longe\-ity after liomotransplantatio~l (see Chapter 25). 
I11 those reported cases follon-ed for thc longest time, justification can be 
found for either a sense of' futility or of' hope. The first chronically successful 
renal homotrailsplant;ition n-as performed hy Doctor ,Joseph AZurray a t  the 
Peter Bent Brigham Hospital in Boston rnore than five years ago. Total body ir- 
radiation n-as the priinar!. i.nrans of' immunosuppression. Other early meas- 
ures to control rejection \I ere ~eportecl by SIerrill in 1960. The patient, whose 
donor n-as  a f'1,atcrnal tn-in. \ \-as a l i ~ e  in  hIay. 1964 ,  ~ v i t h  n o r m a l  r e n a l  
function. llurrily ill a personal cominunication reported the results of a recent 
complete re-e\.aluation of' the case at that time as follo\vs: 
diz\  gotic t\\ in 01' i .ilid .I 11,111 \ ~ ~ 1 1 . i  1 . c ~  en tl! Ic.l't t l ~ t ,  l i o i l ~ ~ t a l  .~f'ter ;I clict kup irlcludiliq a biopsy. 
He i s  ~ ~ c ~ . l ' e c t l !  ~ i o l , r ~ i ~ ~ l  in e\ r r \  11 , I \  ; I \  I ' ;LI.  , IS ~.cli,tl f 'unc tioli i i  conc.rrnrd.  There  a r r  some  micro- 
scopic c h a ~ l g c i  \ \ liicli \ \  c t ,xti't 1.e,111\ i r~ tc~.pre t .  not A~io\ \ i l ic  \ \ - l ~ e r l ~ r r  thev ;*re s c , n r i n ~ :  ;IS a result  of 
his allorti\ e r~cject~ori  cri5Ii of' 5 \r.;1ri ; ~ q o  r. l iethcr it is i o m e  nc.\v 1 e1.v slo\\ tlrilin on the  kidney. 
Ho\ve~\er .  it' \ \ c  liadri't donc rhr  I~iol,s\ \ \ e  \ \ o ~ i i d  co~iiicter Ilim prr.f'rctl! n o r m ; ~ l  in rvc,r! o ther  way. 
Although it ins!- be true. as has been suggested by Goodwin and ,Martin, 
that  some degree of natural cllinierisnj ~nigli t  ha\ .e existed in this case 
because of cross-placental circulation, there seems to be little reason to doubt 
that  the homograft passed through a \-er! mild iinnlunologic insult. Histologic 
evidence of' cellular 1,qjectioii '11 as present in a ljiops!. specimen obtained nine 
months after the original operation. 
The onl!. other liomograf'ts \.r-hich had inaintained life for more than two 
years at the tiine of the \17ashinqton Transplantation Conference in September, 
1963. were reported by Xntoine and Hamburger and hl- Shackinan and Demp- 
ster and their associates. As n-it11 AIurray's case. primary inln~unosuppressive 
therapy \\-as rT.it11 total 11od?- irradiation. I11 Hamburger's patient. \vho was 
operated upon a fexv months after IIurra\- 's. the kidne>- xvas also donated by a 
fraternal tr~.in.  E!- personal communication from Hamburger it n-as learned 
that the patient 11 as still in qood health in Ira!-. 1964. 
The patient treated by Shackman and Dernpster. ah\-e two and a half 
years postoperatil-ely in the fall of 1963, is of the utmost interest. since he  h a s  
surl-i1-ed lonqest after liomotransplantatioii from a nontn-in donor. The 
patient. who rvas r e c e i ~ ~ i n g  1-il.tuall\- no inlmunosuppressi\.e therap\-. had had 
only fair function . Ccr 25 1111 nlin . but there had been no recent tendency to 
deterioration. In a follon--up communication on 3Iay 8. 1964. Dempster has  
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informed us that the patient is still in good condition, now three years and two 
months after operation. 
These three patients 11-it11 exceptionally prolonged survival have not been 
subjected to late rejection. or. if' this has  occurred. it has  been mild and rela- 
tively easily controlled. These facts ma!- gix-e a misleading irnpression o f the  late 
expectation of other patients who ha1-e been treated with honlotransplanta- 
tion. The donor-recipient relatioliship in this sinall qroup of cases n-as highly 
favorable. The homografts \yere p r o ~ i d e d  b>- fraternal t\\-ins in two instances 
and by a nont\.r-in siblirlq in the third-groupings which greatly enhance the 
chances of matching the antigenic constitution of the donor and prospective 
host. Furthertnol,e, these patients represent the further refined product of a 
sensiti\.e biologic test system which eliminated all but those who received the 
most gel~etically suitable homograf'ts. The absence or nlildness of late rejec- 
tion in these x.aluable early cases is encouraging but it does not necessarily 
mean  that  delayed re,jection will be a comparably tr i l ial  problem \\-hen the 
larger n u n ~ b e r s  of patients no\v receix.ing better earl>- iminunosuppressive 
treatment are brought to a sinlilar chronic stage. 
Indeed. there is sound reason to a\-oid overoptimisn~ a t  this time. Delayed 
rejection has  been reported long after operation, usually manifesting itself 
with gradual decline in renal function o\.er man>- weeks or months. \T'oodruff 
and  Robson. in a personal communication. ha\.e described two of the most 
disturbing examples. in which fa ta l  rejections occurred 15 and 16 months 
after two parent-to-off'spring holnotransplantations. In  the most completely 
documented example of late rejection in the literature, K11:js (1962) described 
the same e\-ents in a patient xvho died 17  months after transplantation with 
progressi1-e renal failure ivhich xvas first recogni7ed nine months postopera- 
tively. In this case it is of' interest that a needle biopsy 59 days after ho- 
motrarlsplantation already showed interstitial edema and proliferati1-e vas- 
cular changes. 
In  spite of the dearth of irlforlnation concerning late rejection, it is known 
that  this problem has been encountered in other centers. Hamburger (1964) 
has  allowed us to read a nlanuscript T\-hich \$-ill appear in the -4-11 -11als qf the New 
Yorlz Acctdc.-1tzg o j  Scic~-11c~ in 1964. in which he  describes se\-era1 x.al,iants of 
delayed homograft disease. These include txvo exanlples of acute rejection 
crises similar to those described in Chapter 13, one at six and the other a t  10 
months. Biopsy in both rex.ealed interstitial edema and cellular infiltration, but 
interstitial fibrosis n-as not mentioned. The process n-as re\  ersed in both cases. 
In  another of Hamburger's patients. ivho died of slon- rejection after 22 
months,  severe interstitial fibrosis  as present. 
Hainburger (1963 1 has  also d r a ~ v n  attention to the late de1-elopment of 
chronic glomerulonephritis in the homograft, a conlplication that led to the 
death of one of his patients after 23 months. Although AIurra!- and h'lerrill 
(1958) had obserl-ed this in a patient n-ith an  identical twin isograft. it had not 
previousl?- been seen after true holnografting procedures except in the cases 
reviewed by Porter in Chapter 23. It is of great interest that glonlerulonephritis 
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was also seen by Hamburger after transplantation to a patient whose original 
disease was congenital interstitial nephropathy, a surprising sequence also 
reported by Krieg to have developed within a few days in  a patient who had ori- 
ginally had p>-elonephritis. \Yhether this "glomerulonephritis" observed in ho- 
mografts has  the same pathogellesis as that  co~nnlo i~ ly  seen in clinical practice, 
or is some \-ariant of rejection. remains to be clarified. 
I11 the Colorado series. el-idence of late rejection n-as observed in  six 
patients four months or longer after operation. In  one I LD 10). the process was  
not coi-~trolled. The patient. a 46-year old man of 0- blood type. receil-ed a ho- 
mograft from a volunteer conr-ict donor n-hose blood t>-pe n-as 0-. Steroids 
were withdrawn unusually rapidly because of a series of early coinplications 
including myocardial infarction. gastrointestinal hemorrhage. and \.ertebral 
osteoporosis with fracture. Prednisone n-as discontinued 126 dal-s after  
operation (Fig. 87). One hundred three da>-s later, the BLTY began to rise (Fig. 
87). The homograft Ivas locall>- irradiated ~ v i t h  t11-o doses of 150 R a t  depth, 254. 
and 236 days postoperatil-ely rvith a subsequent brisk diuresis and rapid fall i n  
the BUN.  The improl-ement was short-lil-ed. Within a few days progressive 
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Table 17. Timing of Late Rejections 
LD No.  Days Postop. *Days after Steroid Change 
30 112 30 
* In a l l  but LD 30, steroid treatment had been stopped. For LD 30, the 
al terat ion consisted of. reduction of prednisone from 45 to 30 mgm per day. 
azotemia reappeared (Fig. 87). Prednisone therapy was  restarted, first in  doses 
of 20 m g m  per day and later in doses of 200 m g m  per day to which intravenous 
actinomycin C was added. Renal failure was  not halted, and the patient died 
295 days after  ho~notransplantation. The last B U N  Lvas 165 mgln per cent. 
Terminally, multiple puln~onary e~nbolization occurred. The patient became 
hypertensi1.e for the last 40 days of' life, \vith blood pressure readings in the 
range of 170 90 rnm Hg. 
Except for swelling and a fexv petechial hemorrhages. the homograft ap- 
peared grossly normal. although large ( see  Fiqure 150. Chapter 25'1. Histo- 
logically, there Lvas a I-er>- light cellular infiltration. The nlost p~.olninent 
features were interstitial edema and fibrosis. El-idence of old and recent tu- 
bular damage and acute and chronic I-ascular Icsions II-LIS prtsent.  The fea- 
tures of this kidney are considered in detail in Chapter 23.  
Fir-e other patients ( L D  12. 13. 22. 23, and 30)  had more or less clearly doc- 
umented late rejection occurring 112 to 300 days af'ter operation (Table 17). 
The homografts n-ere obtained from nonrelated donors in t1t.0 cases I Figs. 88, 
89), a siblillg in one (Fig .  90) .  and from mothers in t \ ~ . o  : Fiq. 91 !. The events 
preceding rejection \\-ere similar to those in the case described earlier. Good 
renal function had been maintained despite progressi~-e decrease or complete 
discontinuance of steroid therapy. Sixteen to 154 da>-s after steroid treatment 
was stopped r Figs. 87. 88.  90. 91 1 or reduced to belon- 45 mgm per da>- Fig. 89) 
declines in creatinine clearance Ivere noted. usually before an!- change had 
occurred in the B U S .  In  one as)-mptomatic patient a drop in routinely de- 
termined creatinine clearances ~ 1 - a ~  the onl>- findinq Fiq. 91 #. Orthostatic 
ankle edema I\-as noticed b!- the others late in the day. Rapid loss of' hair. low- 
grade fever. malaise. joint pains. and loss of appetite IT-ere all obser\ ed in more 
than one case but not in all. .A sense of fullness ~ i n d  slight tenderness in the 
transplant site enabled two patients to suspect the diagnosis. 
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therapy. Cre>lt~llilli. cle,ir;ilic i B  I I ( , C . I I I  to t.i\r, ; ? f ' ~ r r  i n \ ~ i t ~ ~ t i o n  01 c.niergenc) thc>1.:111~. l t h o u g h  the  
a z o t e ~ n i ~ i  l )ec , i~~i i .  ic~n111ol.,cril\ \ \ O I \ ( > .  I ul.tI1i.l. irnl)l.o\ c>lnc,nt In rc.n,?l f'unctioll co l l t~nu i~ t l  a f ter  prep- 
aratioli of thi5 gr, i l~h.  <lnd tlul.ini: thr. I , r \ t  ti\-o \veek\ of' 21,1\. ICi(i4. c r r ; ? t i i~ ine  clenr,r~lccs averaged 
85 ml per nli~iuti .  a n d  I!L'\'\ ,i\c'l.,ici.d .32. Iiv pel.mi\\ion of \ I ? I I  111t. .\lcjt/. 61: September ,  1964.) 
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DIFFERENTIAL DIAGNOSIS OF LATE 
REJECTION 
The diagnosis of late rejection niust usually be made by exclusion of other 
causes for late renal failure including chronic pyelonephritis, occlusion of the 
arterial anastomosis, and ureteral obstruction. Examination of the tissues 
after needle biopsy has  not been done because of the potential risks. Conse- 
quently, the principal eiilphasis was on detection of mechanical or infectious 
complications \vliich n-ere correctible. \ i l len these \\.ere not f'ound. \.igorous 
antirejection iiieasures n.ere instituted. 
The ph~-s ica l  fiiidillgs of' late rejection are so~~ie t i lnes  almost pathog- 
nomonic, especially if careful examinatiori \vas c ~ n d u c t e d  ;ind recorded by the 
same physician during preceding follon--up \ isits. The 1lonlol:raf't ~ v h i c h  may 
have been nontender and ;illllost in1palp;iblc may beconle painful and very 
prominent. Slight 1oc;il edctna of the tr;unsplant \vouncI has  11een seen, in addi- 
tion to the collectioll of' fluid in the Ion-el. cxtre~nit ies ,just alluded to. Usually 
these changes e\,ol\.e (11 el. a 11c3riocl of' se\ era1 ~veeks  or e\ ,en months. Rises in  
blood pressure abol e thost' prc\-iously recorded are a l~nos t  a11.r-ays present. 
The renal failure of' delayed re,jec,tiol~ is insidious in comparison to that  
which occurs in the i ~ n m e d i ~ i t e  postoperati\ e period - a f'act 1vhic.11 nlay add to 
the difficulty of establishing certain di:igllosis, b ~ ~ t  lvhich also 111akes prac- 
tical the systeniatic t .~nployn~ent of' cert;ii~l pt.ocetlures bei'ore the patient is 
subjected to a n  intensified course of' i m m u n o s u p p l  e therap!. IIultiple 
urine cultures are immetfiatc.l!- obtained. Urine electrol!-tc concentrations are 
detern~ined.  X falling uriniirl- sodium collct:ntr:~tion such as  that  described in 
Chapter 15 has  tile sanle sigtiificallce as in ;it: ;Lcute rejt~ctioil episode, al- 
though the diagnostic value is not so <reat since st.l,ial dete~,lni~lations u ually 
ha\-e not been done ~1.11ile the patient !\-as tre~ttecl as ;cn outpatient. The dem- 
onstration of increased proteinuli~i supports the cliccqnosis of re,jection. 
If rejection is suspected Ijecause of' declines in renal f'unction or because 
of the other symptoms or findinqs described. the first special examination is 
often a radioisotope renoqram usin< Hippurali \Vinter's techiiiclue, a s  
applied to the care of' transplantation patients h!- Collins mid his associates, is 
employed. Inferential infornlatiwl concerninq the renal circulation can usually 
be obtained quickly in this n-a!~. If' a sharp 1-ascular phase is demoilstrated, the 
likelihood of an arterial anustornotic failure is greatl! decreased. I t  has  not 
been found necessar!. to perform d?e arterio.:rapl~>- in any case. and no oc- 
clusi\-e lesions ha\-e been found subsequently. The radioisotope renogram is of 
limited \ - d u e .  h o ~ r - e ~  er,  in differentiatinq rejections f'rom ureteral obstruction, 
since similar cur l~es  ha\-e been obtained in both situations. 
Because the loss of' renal function is gradual, p! eloqrapliic isualization of 
the extrarenal collecting ST\-stem is usual1~- possible if .i reinforcing dose of con- 
trast material is administered. .\ test dose of in t ra~-enous  odium diatrizoate',' 
"Hypaque, LTinthrop Laboratories, New York 18, New York. 
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is gi\ en ,  follon ed b\ 30 1111 of tlie contrast material. An additional 90 ml  is then 
g i ~  en b\ continuous infiislon o\ el a 30-minute period during which time x-ray 
exposures are made,  de\ eloped, and re1 iewed. 
LATE UROLOGIC COMPLICATIONS 
Few exan~ples  of late urologic complications after  transplantation have 
been reported. although it is kno\vn that  one of Murray's identical twin re- 
cipients de\ eloped renal stones and one of the patients in the St. Mary's 
Hospital series de\.eloped urinary extravasation inore than 100 days after  
transplantatioll (see Chapter 25). 
I11 the Colorado series, late ureteric obstruction Fvas seen in four patients. 
In  three of these (LD 39. 44. 50) the stenosis Lvas asyniptomatic, being de- 
tected by routine in t ra \~e~ious  pyelography: the narrowed area Tvas a t  the site 
of implantation into the bladder (Fig. 92).  The obstructi1.e uropathy was 
relie\-ed in each case h!- reoperation and anastonlosis of' the pel\.is or urete- 
rope1i.i~ jullctioii to tlle patient's own uni1;lteral or contralateral ureter. The 
utility of this type of' secondary procedure in treating co~nplications a t  the 
bladder irnpla~ltation site emphasizes the ad\-isability of not performing ure- 
terectorny except for specific indications a t  the time the patient's olvn diseased 
kidneys are excised (see Chapter 11 ). 
I11 the fourth patient (LD 27) the cause of the obstructive uropathv could 
not be readily classified: this case is described separately because of' the pos- 
sibility t h a t  i t  r epresen ted  a l a te  complicat ion of prel-ious re, jection.  A 
21-year-olci l \~olnan recei~.ed a homograft from a convict volunteer donor on 
September 3. 1963. There ivas onl>- ecluix-ocal evidence of early rejection, fol- 
lowing n-hich she had stable renal function until AIarch 18. 1964, by which 
time her prednisorie dose had been reduced to 10 lngnl per da>-. After a severe 
bout of' diarrhea induced b y  castor oil, anuria de\.eloped n-hich lasted fi\-e days 
(Fig. 93) .  
Emergent>- antirejection measures xvere taken xvith the administration of 
high doses of steroids, actinom!-cin C ,  and two courses (total 900 R) of local ir- 
radiation. During the next se\ era1 lveeks. arluria or oliguria alternated with 
diuresis (Fig. 93). ,411 intra\.enous p!-elogram obtained during a diuretic phase 
showed obstruction higli in the ureter [Fig .  94). On April 18. 1964, the 
proxinlal homografted ureter n-as anastornosed to the distal portion of' her own 
ipsilateral ureter. Reco\ er>- rvas uncomplicated. and good urinary drainage h a s  
since been den~onstra ted c Fig. 94 ,. 
That portion of the ureteric homograft n-hich lvas renio\-ed a t  the time of 
reoperation had a hi~11-grade internal stricture, extending 01-er at least 1 inch. 
,1Iicroscopicall>-. there lvas fibrous thickening of the resected segment with 
extensil-e muscle necrosis. The arteries J\-ere sel-erely damaged ~ v i t h  fibrous 
intirnal thickening of the majorit>- of tlie 1-essels arid ri-it11 rupture of the in- 
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Figure 92. Intravenous pyelogram, four months after homotransplantation, in Patient LD 39. A 
contrast intensification technique was used. Note the partial obstruction at the ureteroneocystos- 
tomy. At a subsequent secondary operation, the proximal ureter of the homograft was anastomosed 
to the patient's own right ureter which had not been removed at the time of the original right ne- 
phrectomy. (By permission of Ann. Int. Med.  61 : September, 1964.) 
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Figure  93. Course oi a 21-)-ear-old \voni;ill. 1-L) 27;. \I lio recci\ ed 'I liol~io?,r,~f t f'rom a n  unrelated 
ma le  donor. Both \yere of 'h  l~lood tvpe. b"11.1y l ~ o i t o l ~ c r , ~ t i \  c re,jcc tion 1% a\ el.\ ~nilt l .  S t t e r  190 days, 
s h e  suddenly bec ,~n ie  ; \ n~ i r i c .  i~~l)s t~cluc~ntI !  ,~ltc>lli , l t inq \ \ i t 1 1  I)out\ of I)r,i\h diol.c. i~i.  . \ l though s h e  
tvas thought to 1 1 ~ \  c h ,~d  .lri i ~ c u t c  rc.jc.ct~ot~. 1t \ L C ( \  i u l ~ s c ~ q u r ~ ~ i t l ~  t f r ~ r n o i i \ ~ ~ , ~ t e d  tl1;it  +he  liad severe 
lnidureteric s t r i c t ~ ~ r e  \\Ilicli \ \  '15 tliouglit to l ~ e  'i co~l iec lue~lce  ol late l~e , l l i~ lg  that iollo\\ed a previ- 
ous rejection. . l i te r  c .o l~~.ect~on of' the  mecl~al l ica l  difficulty. she  h a s  been well. (B>- permission of 
A I I I L .  111t. .\letl. 61: S c p t e ~ n l ~ e r .  1964.) 
ternal elastic lamina. A heavy cellular infiltrate was present, and virus in- 
clusion bodies were noted. The last finding is of special interest, since this 
patient had prel-iously passed through a serious bout of "transplantation 
pneumonia" (see Chapter 21).  The el-idence is strong that the complication 
resulted fro111 heali~lg of an earlier ureteric rejection. 
TREATMENT OF DELAYED REJECTION 
The principles of therap!- are essentially the same as those described for 
reversal of rejection in Chapter 16. The relati\.ely slow dgvelopment of delayed 
rejection in the cases obsen ed in the Colorado series has made it possible in 
some instances to e1-aluate the eff'ect of indil idual agents. Thus. local trans- 
plant irradiation alone Figs. 87. 89 and therap!- solel!. n-it11 increased dosages 
of steroids F i g .  91 ha\ e both been i1lo~r.n to be of therapeutic 1-alue in one or 
more isolated cases. .lctinoin>-cin C has also been used. 
Hon-el-er. in one patient LD 10 in xvho~n these agents n-ere used serially, 
remittent deterioration continued until the secondary renal failure became ir- 
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Figure 94. Intravenous pyelograms of same case (LD 27) as shown in Figure 93. Top-Intra- 
venous pyelogram showing high-grade obstruction of the homograft midureter. Bottom-Appear- 
ance after resection of the stenosed ureter and re-anastomosis to the patient's own ipsilateral ureter. 
The anastomotic site is shown by an arrow. The somewhat dilated distal portion is the patient's 
own ureter, which had previously been demonstrated to have reflux. (By permission of Ann. Int. 
Med. 61: September, 1964.) 
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reversible despite the fact  that  urine excretion was never less than 1,000 ml  
per day. Although the homograft had serious histologic abnormalities (see 
Chapter 23) .  some of the findiilgs probably avould ha\-e been re\-ersible, in- 
cluding the interstitial edema. had more aggressil-e immunosuppressive 
measures been taken irninediatel>-. Consequently, therapy with more than one 
agent is usualll- instituted. 
An idea of the relati\-e role of the various in~munosuppressive agents in  
the treatment of late rejection can be obtained from a review of those events 
which ha\-e in\-ariably preceded the onset of this serious complication. Since 
the ~naxinlunl  safe dose of azathioprine had been used in all these cases with 
onl\- minor I ariations in daily qualltity, inefficient administration of this drug 
was ea-idently not a factor in the initiation of delayed rejection. Furthermore, 
the prelious e m p l o y ~ ~ l e n t  of this agent to limits compatible with safety of the 
host inade further increases in dosages for emergency therapy impractical. I n  
actuality it ma!- be necessar? to temporarily loaver the dose of azathioprine 
because of the increased drug sensiti1-ity which con~monly accompanies renal  
failure (see Chapter 14). 
In  contrast, it appeared as  if' stal~ilit?- of' homograft function avas disrupted 
in e\.ery one of' these cases either by discontinuance of prednisone therapy or 
by reduction in dosage of' this drug to a loaver le\.el than had previously been 
used for some time. Thus,  steroid administration had been stopped f'or patients 
LD 10, 12, 13, 22. and 23: re,jection r\.as recognized 103. 154. 20. 60, and 16 
days later, respectively. Patient LD 30 began to reject 30 days after reduction 
of the prednisone dose frorn 3 5  to 30 nlgnl per day. 
Because of the den~onstration of dependence upon continued steroids for 
stable homograft function in such cases, the inost important immediate altera- 
tion is prompt resumption of prednisone adlninstration in patients n-ho have 
been taken off steroid therapy. or illcrease of' dose in those patients avho have 
had a recent reduction. Tlle deqree to n-hich steroids must  be implelnerlted for 
treatlnerlt of' late rejection is not definitely knolvn. In  \.ieav of the fatal  out- 
c o n ~ e  of one case in rvllich small doses avere first tried (Fiq.  87), it may be adais- 
able to be<iil avith a drastic increase (Figs.  88. 91) and to continue this until 
unequil.oca1 er.idence of' iinpror einent in f'unctior~ has  been sustained for 
sel-era1 xveeks. The   no st important objectil-e measurement of excretory ca- 
pacity to be followed is creatinine clearance. since n~isleading elel-ations in 
BUN can persist because of increased catabolisin despite improi-ement in 
other rlleasures of function :see Chapter 16). The greatest increased dose 
which xvas used. escludinq that for patient LD 10 n-ho ultinlate1~- died. was to 
80 ingin per d a ~ -  Fiq. 88 1 .  
Later. steroid doses are slo~r-l>- reduced in the same n-ay as after early re- 
jection (Figs.  88. 91 !. The success 17-ith rvhich return to slnall dail>- doses can 
be achiex-ed has  >-et to be determined. although it seeins likely that continua- 
tion of prednisone in doses of 20 to 40 lngm per day ~vi l l  be required f'or many 
months and possibl>- ex-en for the remainder of the patient's life. 
Additional prompt immu~~osuppress ive  therapy is usually advisable a t  this 
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time of late rejection. particularly if the diagnosis as not iilade eat.]!- and if 
there is more than slight ililpairrlient of renal function. ;Ictiiiom>cin C and 
repeated local irradiation of' the homograft :Figs.  87 to 91 r :ire used in the 
same \say as for the treatment of a n  earl!- postoperati\ e rejection crisis (see 
Chapters 14 and 16). x-ray therapy being of the greatest immediate value. 
After the first application of 150 R,  the sense of' fullness or pain over the trans- 
plant site is allnost imniediatel>. relie\ ed. Redtiction in the sire of the homo- 
graft nlay be noted by palpation. 
Although the \ d u e  of these adjuvant procedures, especially local ir- 
radiation, is undoubted, they should not be used ;IS the sole adjustment of 
treatment for several reasons. Although tcml)orar!- i~npro\-ement  in renal func- 
tion can be expected, it occurs against ;I backgrounti of that therapy which 
has  already been pro\-ed to be insufficient. Furthermore, the chronic use of the 
added agents. which n-ould presun~:ibl>- be necessar!- if' steroid treatment were 
not intensified, has serious disad\ ;~nt:iges since actinonlycin C. which is prob- 
ably only moderately efTecti\-e, is toxic and therefore undesirable for protracted 
use (see Chapter 14). Altertillti\-ely, repeated courses of local x-ray would 
invol\se the risk of producing irradiation injury to the 1loniogr;if't. The use of 
local transplant irradiation and actinomycin C should, therefore. be \.ieived as  
emergency therapy and should coincide kvitli a definitix.e alteration in steroid 
management.  
It is evident from these remarks that the ease lzith ~ \ l ~ i c h  delayed rejec- 
tion can be treated is directly related to the promptness ~ v i t h  I\ hich the diag- 
nosis is made. For this reason, all patients :LIY follon-ed ill two special trans- 
plantation clinics after their discharge from the hospital. These clinics. tvhich 
are staff'ed by internists. pediatricians, immunologists. and surgeons. have a 
relati\-ely stable personnel so that  patients can be repeatedl>- examined by the 
sanie physicians. A special effort is made to obtain accurate blood pressure 
measurements and weight, and to tllorougl11~- ex.aluate an)- local f'eatures of 
the transplantation site. Hematologic studies aild creatinil~e clearallce deter- 
minations are perf'ormed by research laboratories, thus assuriiiq accuracy in 
deternliiiiiig changes in the regimen. 
Ordinarily, follon--up \.isits are scheduled once a week for the first iilonth 
or tn-o after the patient's discharge froin the hospital. Subsecluent1~- he may be 
seen onl>- once ex-ery tn-o to eight TI-eeks. .At this phase of con\-alescence he  
may be allon-ed to return to his home, ex-en if it is in a distant city. under the 
care of ph!-sicians ~ v h o  hax-e a special interest in renal disease. Each patient is 
impressed with the 11ecessit~- of immediatel>- seeking medical care if'ffuid reten- 
tion. oliguria, or transplant n-ound tenderness is noted. Bet~x-een clinic visits, 
no restrictions are placed on acti\~it>- except for ax-oidance of contact sports, 
such as football. The patients go to mo~- ies  and other public gatherings. Virtu- 
ally all recipients \vho are noxr lix-in? four nionths or more after operation have 
returned to some kind of' n-ork or to school. 
At each clinic. blood urea nitrogen B U S  !. creatinine clearance :Ccr), 
hematocrit value. white blood count and differential. urinal>-sis. and urine 
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cul tu les  ale o~cle led  kiecjucntl\ i n t l a \  enous  pvelograms are  obtained earlv i n  
the  postopelatll  e i o ~ ~ l s e  ,ind these a l e  a l n  a\ s pelfolmed aftel  three months .  
T h e  lmport , inte  of thls test e \ l den t  n hen one c o n s l d e ~ s  tha t  three as l inp-  
t o n l a t ~ c  patients h a \  e alreadl  been  pro\ ed  to ha1  e significant ureteral  obstruc- 
tion 
SYSTEMIC CHANGES 
Perhaps  it is na tu ra l  i n  a text s u c h  a s  this to focus undue  at tent ion on  the  
function and \yell-l~eing of the  homograft ,  sometimes almost  to the  exclusion 
of the  beneficiar? of' this unna tu ra l  gift. I n  order to retain viability of t he  
t ransplant .  a l t e r a t i o ~ ~ s  it1 tlie host :ire ine l - i ta l~ le .  Some of these are  obvious, oth- 
e rs  a r e  s u l ~ t l e  11ut nleasure:il~le ( C h a p .  2 2 ) -  but most of' the  changes  are  proba- 
bly not ?.et kno\vn. The  u l t i ~ n a t e  toxicity of' aza t l~ iopr ine .  for  example ,  i n  te rms 
of a possi l~le increased incideilce of' 11lood c1yscrasi;is. ivill take years to deter- 
mine .  T h e  infiuence of this drug  on reprocIucti\-e p11~-siologl- requires addi- 
tional stud?-. One of the  tnalc t.cc,il)ients I LD (5) ill the Colorado set.ies recently 
became  the  f 'a thet  of' a 11or1ii:il child i \ h o  11 :is c o ~ ~ c , e i \  d clu~,ing the  period of 
postoperati\-e az~ithiopi.inc, and  steroid therapy. LTnpul~lishecl experimental  
s tudies by Doctor ,John .A. Githclns indic.atc, th:it spermatogcncsis  is not 
seriously disturbed I,!- ~ i r a t h i o p r i n t  1,ut that  its chronic adt i l i~l is trat ion to 
females  induces a high illcicience of anomalies  in the ofTsprili2. 
Precise mc~asurement  of immunoloqic capabilities is already possible o n  a 
limited scale:  the  results of'iuc11 studies a re  reported in  Chapter  22. in  which  i t  
i s  s h o ~ v n  tha t  a significant loss occurs of' responsi\ eness to \ arious ant igens.  
Despite this.  tile patients f'ollo~vrd f'ol 111ot~  that1 Sour 111o1iths lla\.e h a d  a 
surpris inq lack of susceptil~ility to serious infection c,I-en thougll there h a s  
been  no  a t tempt  ;it en\- i ronmental  control. Xll~lost all h a l e  Iiad t~ i inor  infec- 
tions f rom which rc3c,o\-el.!- ~ v a s  pl,ompt, In onc patielit I LD 1 ) herpes zoster 
first appeared 1 T months  pos tope l~a t i~  el!- 8, Cli:~p. 21 !. In only one pat ient  (LD 9) 
w a s  a fa ta l  infection c.ncou11tcred nf'tei. four  ~ n o n t h s .  alld in  this ca se  the  
con~pl ica t ion  prol~abl! had  its cencsis  at  a m u c h  earlier tinle ! Chap. 19). 
Two of' the patiellti  LL) 1.5 ancl 36 I de\-elol~ecl symptoms and l~iocheniical  
evidence of hepatitis six and  three  n ~ o n t h s  a f te r  operation. I11 both cases ,  bili- 
rubinemia  I 2 to 6: mgtn per cent  and  ele\  ations in  SGOT. SGPT, ancl alkaline 
phosphatase ha\-e been persistent.  IThether the  hepatic  dysfunction is d u e  to 
virus infection is not k n o ~ t n  since a h i 4 1  incidence of hepatotosicit?- h a s  been  
reported by 3 1 ~ 1 1 ~  anie and  JIcCarth?-, and  b?- Einhorn and Da1-idsohn af te r  
chronic administrat ion of 6-mercaptopurine to patients with leukelnia. 
There  a re  thus  111a11y yaps in our knoi\-leclqe of the 1011.:-term systemic ef- 
fec ts  of i t i~nlunosuppression.  particularl!. those of ~3zathioprine. A m u c h  
clearer  1-ie~i-  can  :llreacl!- be expressed concernil:g the proqnostic implications 
for  those cases  in  TI-hich relati\-el?- hiqh prednisone doses a re  needed for  con- 
t inued protection of the homoqraft .  Those noninfectious complications ~ v h i c h  
ha \ -e  at tended chronic steroid ,idlninistr~ition for the t rea tment  of \-,lrious dis- 
ease  s ta tes  h a l ~ e  also 11een ohse r~~ec i  ;~fter  rena l  llonlotransplantation. T h e  
"Professor of Pediatrics. Uni! ersitv of Colorado School of lIedicine 
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Figure 95. Appearance of aseptic necrosis of the femoral head in two young women after trans- 
plantation. Both were on prednisone therapy at the time of this delayed complication. Top-Patient 
LD 22. Bottom-Patient LD 50. (By permission of Ann. Int. Med. 61: September, 1964.) 
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Figure 96. Moon facies in Patient LD 37, seven months after homotransplantation. Prednisone 
dose was 25 mgm per day. Rapid weight gain had been a severe problem. 
high incidence of acute gastrointestinal hemorrhage during the first four post- 
operative months has already been described (see Chapter 12). After four 
months there have been two additional examples (LD 9 and 30) and in one of 
these bleeding was an important contributory cause of death. 
Radiographic evidence of severe osteoporosis has been noted in many 
patients, but in only one (see Figure 54, Chapter 12) was there a fracture during 
early convalescence. Later, however, two young adolescent females (LD 22 
and 50) developed aseptic necrosis of the femoral head (Fig. 95) five a n d ~ a  
half and five months, respectively, after operation. The prednisone doses at the 
time of these complications were 10 and 30 mgm per day, respectively. 
Earlier, the remarkable increases in body weight were described which are 
often observed in the first few months after transplantation (see Chapter 16). 
In some of the patients in whom it has been impossible to reduce prednisone 
administration below 20 to 30 mgm per day, appetites have continued to be in- 
satiable, and obesity has followed almost to the degree seen in the pickwickian 
syndrome. Both girls with aseptic necrosis of the femoral head developed this 
complication only after a gain of 10.6 and 11.5 kgm over their preoperative 
weights. In Figure 96, another patient (LD 37) is shown seven months after 
transplantation. He had gained 25 kgm during the first 90 postoperative days, 
with stabilization only after prednisone administration was reduced to less 
than 25 mgm per day. Moon facies is still evident. 
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Figure 97. Patients LD 34 and 41, more than six months after homotransplantation. The maternal 
donors for these children are accompanying the respective recipients who are three years and eight 
years of age. Prednisone dose has been reduced to 5 mgm per day, but there is still evidence of hyper- 
corticism. The technique of transplanting adult kidneys to children is described in Chapter 11. 
In young children, the continuous use of large doses of steroids may have 
an especially ominous significance. The alarming weight gains already 
described can be life-threatening because of mechanical respiratory embarrass- 
ment. Bone growth may be limited or arrested if it is impossible to make sub- 
stantial early reductions in dosage. Fortunately, the three youngest patients 
who are still alive have either had prednisone therapy discontinued (LD 1) or 
reduced to 5 mgm per day. Nevertheless, the last two patients have residual 
evidence of hypercorticism (Fig. 97). 
A special note should be made of one consequence of steroid withdrawal 
that has been seen frequently. In Chapter 15, the hyperpyrexia that accom- 
panies a frank rejection crisis was described in those patients whose initial 
therapy was solely with azathioprine. This fever is promptly controlled with 
the administration of prednisone. 
In the absence of sepsis, hyperpyrexia does not subsequently return until 
the quantity of steroid is reduced to 20 to 60 mgm per day, from four to 20 
weeks later. In more than one third of the patients, return of continuous high 
fever (103 to 105°F) is observed at this time, frequently starting just after 
reduction of prednisone dosage from 45 to 30 mgm or 30 to 20 mgm per day. In 
many cases, there is a protracted concomitant shower of peripheral normo- 
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blasts and other iiillnature forms as depicted in  Figure 60, Chapter 14. An ex- 
haustive search for microbial co~nplications is always conducted. but a n  ex- 
planation for the febrile illness is not usually found. D7ith maintenance of the 
steroid dose a t  the new lel-el, hyperpyrexia has  subsided without treatment in  
the usual case in sex-en days to four weeks. Continued reduction of steroid 
dosage h a s  usually been possible lvithout further difficult!.. In sel-era1 excep- 
tional cases. the fel-er n-as associated T\-ith a peculiar '.transplant pneumonia" 
which is described full! in Chapter 2 1. 
The cause of this late febrile syndrome is not kno~vn.  but it inav be a 
variant of the "late extrarenal s!-ndronle" described bl- Hainljurger. Crosnier, 
and Dormont. Se\.eral of their patients de\.eloped clela?-ed fe\.er, splenonlegaly, 
h e p a t i c  d!sf'unction. a n d  h y p e r g a ~ ~ ~ m a g l o b ~ i l i n e ~ ~ l i : i .  H a i n b ~ ~ r g e r  h a s  
suggested that these findings ma! be due to the establishment of an  imperfect 
chronic equilibrium bct~veen the host and the llor~~otransplantecl kiclnev. 
LATE RENAL FUNCTION 
Adequate, if not normal, renal  function was  obtained from virtually all 
homografts which were still functioning after four months. The last creatinine 
clearances and BUN'S are listed in Chapter 28 for every patient who was still 
alive on June  1. 1964. Among those \\-hose sur\.i\.al n-as four months or longer 
a t  that  time, the lorvest creatinine cleararlce Tvas 27 1111 lnin ILD 41, a three- 
year-old child) and the highest E U K  \;n-as 54 mgln per cent (LD 30). The m e a n  
creatinine clearance for those 30 cases after four iiionths or longer was  88.1 
mllmin, and the mean B U N  n-as 23.7 111gm per cent. 
Althougl~ these figures are inipo~,t:int in makillg clear the fact that gener- 
ally good homograft function can be obtained. it should be emphasized again 
that  trends in function are of greater prognostic significance than any in- 
dividual determination. Thus a patient whose creatinine clearance h a s  
dropped from 100 to 70 1111 nlin ma?- pose a f a r  Inore serious problem of late 
management  than another who has  a stable creatinine clearance of 50 
inllmin. 
I11 those patients followed for the longest tiines in 11-horn delayed rejection 
has  not ad~.ersely affected the late course. the fuilctioil has  tended to improve 
with the passage of time (Fig .  98: see Figure 77. Chapter 171 so that  functional 
hypertrophy in the recipient has  been almost parallel with that  of the donor. 
Thus.  in LD 1.  2. and 3. the creatinine clearances n-ere 83. 91.8. and 129 
ml  mill. Determinations in the three respecti\-e donors \\-ere 112. 89.9. and 129 
ml  min.  Prior to delayed rejection. 146 days after operation. the comparative 
creatinine clearances in LD 12 TI-ere 7 0 3  1111 for the donor and 73.3 1111 min for 
the recipient. The tests ha\-e not been repeated since re\-ersal of the subse- 
quent delal-ed rejection s h o ~ v n  in  Figure 90. 
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Figure 98. Chronic course of Patient LD 2 who received a homotransplantation from his sister 
in January. 1963. The patient 1% as of A- 1)lood ripe. His sister 17 as B - .  S o t e  progrcssi\ e improve- 
ment in crentini~le clearance. startint: after three posto11erati1.e months. Prednisone therapy was 
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discontinued after 230 days. The patient had a preliminar?. thymectomy. ( B y  permission of Ann. 
Int. Med. 61: September, 1964.) 
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I n  Chapters 15 and 16 emphasis was  placed upon the cyclic appearance of 
hypertension which was often a troublesome problem during rejection and 
which tended to disappear after reversal of this process. Since very careful 
attention ~ v a s  exercised to maintain normal or near normal blood pressure 
during early con\-alescence. most patients were placed on one or more anti- 
hypertensive drugs during this period. The ultimate blood pressure in these 
patients and the need for later continuation of such pharnlacologic agents 
assume a n  especial in~portance because of the 1-ascular lesions which Porter 
has  found in inany homografts studied by needle biopsy or a t  autopsy (see 
Chapter 23). 
Except in those cases in xvhich con\-alescence 11-as nlarred by delayed re- 
jection, the tendency to hypertension and the requirements for antihyperten- 
sive drugs \yere less xvith the passage of tiine i see appendix. Chapter 28) and 
seelned to be directl>- related to the ler~el  of ~na in tenance  steroid therapy 
required. The a\-erage sitting blood pressure during lIa>-.  1964. is gi\-en for all 
patients in the Colorado series in Chapter 28. as x~-ell as an account of the anti- 
hypertensil-e drugs being used during this time. It xvill be noted that none of the 
patients folloxved for the lo~lgest  interl-als are receil-in% an!- medication of this 
type. 
-)____.._____..-.--- 
- - - 
210 / LATE RESULTS A N D  COMPLICATIONS 
THE INFLUENCE OF THYMECTOMY 
ON LATE RESULTS 
In  Chapter 13. i t  1vas pointed out that  nine of the first patients received 
preliminary tll>-l;lecto~n! in preparation for transplantation. The rationale and  
experimental basis f'or the trial 11 ere described. This adju\ .ant  procedure, per- 
formed throu%h a sternum splittinq incision in patients ~vi t l i  terminal uremia, 
proved to ha\ -e  a high technical risk. In addition, the earl>- course after homo- 
transplantation did not seein to 1)e different from that  obser\ ed in patients who 
did not ha\-e the added operation. Conseriuentl!-. use of this procedure was  
discontiilued ulltil Ic) t1q-tc~i . t l l  f ' o I l o ~ ~ - - u ~ )  could be ol~tained in those patielits for 
whom it had alread! 1)eeii e~jlplo!-cd. 
The cffic,;~c,y of' th!.rnec.tom\ in p r r \ e ~ ~ t i i l r :  01' te~i~pcr inc:  t ~ ; l ~ . I y  rc,jection 
does not, of' course. i.ule out tlie ~)ossil,ility of I a t c ~  Ijc,nefit. Theoretically, this 
might, in fact .  11e consistent \tit11 \I hat has /lee11 Ie:i~.t~t,d of' th>-mic f'unction by 
Miller and others f't.on1 r~xpc~riments on lo\vei a ~ ~ i ~ i l a l s  ( see C ' h ~ ~ p t e ~  1 3  1. In  his 
s tud ies  \vith adu l t  r abb i t s .  s t ~ \ t ~ ~ . ~ ~  i m m u n o s u ~ ~ p i ~ e s s i o ~ ~  coln1)inecl wi th  
thymectoiny 11-as r,ecluirecl at the time of' host exposure to the f~ot.eign tissue in 
order to obtain pro1ongt.d hotnograft sur1- i~  al. Pi~suniabl! .  th! mectom!. would 
not affect the reacti\.ity of immunologically competent cells already present 
throughout the body. 
Because of' this it might be a~lticipated that  the intensity and imn?ed.iacy of 
early rejection ~voulcl not be altered I]\- this operation. If, hon-e\.er, the thymus 
is in some Iva) necessar! f'or continuetl replication of in~~nunoloqically specific 
strains of' host cells, tliese ct~ll lincs miqht be expected ulti~natt.ly to undergo 
d ras t i c  a t t r i t ion  u n d e r  tlie c ,on~bined  infiuenct.  of' u n ~ . c l e n t i n q  i m -  
munosuppressi\.e therapy and the unremitting antigen o\.erloading provided 
by the homograft. 
Four (LD 1 .  2.  3. and 6) of tliese original nine patients are still ali1-e 14 to 
18 niollths af'ter hon~otransplantation. A11 ha\-e normal reiial function. In  
three. maintenance therapy xvith prednisone n-as discontinued in 270 days or 
less and in one LD 3'1 it \\.as ne\  er required. Botli in those n-110 did ( L I I  1 and 
2) and those who did not LD 3 and 6 )  ha\-e a serious rejection crisis. there has '  
been no e\-iclence n-hatsoe\ er of late deterioration of renal function (Figs. 77, 
98). 
Consideration of' the fate of the other fi1-e patients xvho had removal of 
their th!-nlus nlight be iml~or tant  in assessinq the ~ ~ o s s i l ~ l e  long-term role of 
this procedure. Cnf'ortunately. thii  does not seem to be the case since all the 
patients either died in the \-el.>- earl!- poitoperati1 e pe~,iod LD 5 and 11 : CD 2) 
or at a later tiine froln compliciitions other than renal failure LD 4 and 9). The 
position could be taken that th?-nlectom! did not rec~ix-e  a fair test in any of 
these patients. 
There is at present insufhcieiit e l  iclence to permit el-en tentatix-e opinions 
about the potential dela>-ed I alue of t h y m ~ ~ s  excision after homotransplanta- 
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tion 3lost of the  canine  experimental  \ \oi l \  tieslylieti to t c  st tile illfluellee of 
this operatloll h a s  focused upon eaillci ~ ~ o s t o l ~ r i , t t i ~  c c I c t i t i  p.11 t l ~  out  of 
necess in  s lnce tlie numbe l  of chloiilc sui r i \  olc in tio,c 1. 1 1 1 ~ i c  l i  lort e l  t h a n  
aftei cllnlc .il 1 cn,tl h o ~ n o t l  .inspl,intation 111 oul  o \ \  n I,ll,o~ ,it01 ie5 su l  1 11 a1 for  
a s  long a5 a r ea l  11,is not been ,xcl~le\ ed In .ill\  ~ \ t 1 1 t i i ~ t 1  \ \ 111~11 \ \  'is illltldlly 
t reated n it11 tll\ 111e~ tom\ The  c l o y s  I\ 1th 21 r ,1ti st lolice\ l t \  i l l c  lucllllg those 
which no  longel i e q ~ ~ l i e d  ~ m m u n o s ~ ~ p p i  esslr e the1 a p \ .  did not h,i\ e thymec- 
torn\ iC11,tp 1 7 )  
NeI ertlieless, the questloll of hethe1 01 not to 1 e t ~ l o \  e the  t 1 1 ~  111us gland, 
or to ~ r i  .lti~,ltc ~t ,ts pt .lc t l c  t t i  111 Ii,1111l1111 yc.1 1s 1 ) \  1 1 0  ! l i t  .ills sr t t led Iiideed the  
obse l \  atioiis cited f i o111 e\ l~ei lel lc  e \I ltli the e,tillel huln,rn c ,tst>s c,mph,~size 
the  u iqent  n t e d  foi i ui t l i t31  c l i ~ i ~ c  , t l  t \ ,ll~l,1tio1i oi thls ~ ~ t o c c  t1 11c \\'1t11 the  
sm,1ll group of pLrtlc t i t \  ~ i o \ \  c ~ t l t i c  I s t u d \ .  ~t I\ i l l  1)r in i l~oss~l ) l t  to t ictennine if 
t h ~  meetom] c o l i t t ~ l ~ u t t  ti o t i i t ,  t , I \< 01 I,itt 111~1t1~1ct 1tic>11t 01 t l l t~ \e  p,ttients and 
to the iapldl t \  \ \ i t11 \\lilcli stelold tllc.i,tl)\ io~rl(1 Ijc ,  discontitiucd ,iltogether, 
since In e ,~c l i  ol tlle 1 o u ~  c , I \<  s t l i t  dotlot I c c ~ l ) l c ~ t ~ t  ye ietlc I t l ~ l t ~ o ~ i s l l ~ ~ ~ s  \ \ e r e  
h i g l i l ~  f,i\ol,il)le .tlid tlie o ~ l t c o ~ ~ l r  tii,i\ t t , i \  t3 1jc.c.11 t11t' s,ll)it3 \ \ t t l ~  0 1  i t l thout  
r emol  a1 of the  thymus.  
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Chapter Twenty-one 
INFECTIOUS DISEASES ASSOCIATED 
WITH RENAL TRANSPLANTATION 
b y  Daz-id Rifkitzd, Ph.D,  M.D. 
Infectious disease h a s  contributed to 27 of the 33 deaths which have oc- 
curred to date among the 75 patients treated a t  this center bv renal  homo- or 
heterotransplantation (Tables 18, 19, and 20) In addition, infections of varying 
degrees of sel erlt\ h a \  e con~plicated the postopeiatlr e course of irtuallv all 
the patients In t h ~ s  stud\ gloup, except to1 those t ~ ~ o  n h o  had lden t~ca l  twin 
donors and LT 110 d ~ d  not leclull e llnlnunosuppi esslr e thelap\ 
Sept~cemia.  pneulnonl'l. nouncl ~ n f e c  tlolis. ,lnd p \e lo~ leph~i t i s  Ii,i\e been 
the nlost flequent t \  pes of septlc cotl~phc ,xtlolls. ,~ltliou<h ex.ialnples of inaocar- 
ditis and a11scesst.s of t i l t  l u t ~ c .  l11~i111. m d  i u l ~ l ~ l i ~ e ~ i i c  ~ ~ I C I C V  1lcl\e heen en- 
counteled The in,ijol~t\ of these h'lr t 1 ) t t . l l  due to the p\ ogenlc and enteric 
groups of b,xctel~a hut in aclcl~t~on c l ln~c~i l l r  ~lilpol t,xnt ~ ~ l f e c t ~ o n s  11,lr e been 
associated n ~ t h  \ arious fungl, acid-fast bacil l~.  l i ruses ,  and e \  en  a protozoan 
species 
PREDISPOSING FACTORS 
C o ? t s t i t z ~ t i 0 7 1 ~ ~ 1  .-I l terc~tions i n  t h e  H o s t .  Thirty-two of the 35 postoperative 
infections among the first 30 renal transplantation patients occurred following 
the appearance o f  the homograft rejection crisis i Fig. 99). All these cases were 
treated before Decelnber 10. 1963, initial therap>- l ia\~ing been pro\-ided solely 
lvith azathioprine. .At the time of rejection. prednisone and actinomycin C 
ivere added. and fl.ecluentl>- the doses of azathioprine TT-ere increased. IYhile 
the inter\-a1 betn-een surgery and rejection a\-eraged alnlost 12 days in this 
213 
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T a b l e  18. Terminal Infect ions 111 Recipients Receir i ng  Homografts 
from Li\ i ng  DOIIO~S LD Series)  
LD Case 
Number Type of  In fec t ion  E t io log ic  Agent  
Septicemia, pneumonia, 
subphrenic abscess, 
mediast in i t is  
Staphylococcus aureus 
Pseudomonas aeruginosa 
Septicemio, mediastinit is, 
pyelonephrit is 
Staphylococcus aureus 
Pseudomonas aeruginosa 
Septicemia, ~ e r i n e p h r i c  
obscess 
S i a p ~ y ~ o c o c c u s  auleus 
Pseudomonas -- ael uginosa 
Pseudomonasae~ uginosa 
E d i d a  o lb icans 
Candido k lusei  
Nocard ia  asteroides 
Septicemia, pneumonia, 
bra in abscess, pyeIonephrit is 
Pneumonia 
In o l d  nephrectorny wound 
Klebsie l  lo-Aerobacter  
S t a p h y l o ~ o ~ c u s  aureus 
Pseudomonos aeruginosa 
- 
Proteus species 
Pneumonia 
Pneumonia, b ra in  abscess 
Pneumocystis c a r i n i i  
- - - -  
Eschet i ch ia  c o l i  
Candido stel la to idea 
Septicemia Pseudomonos --- oeruginasa 
Proteus species 
Esc he1 i c  hi0 c& 
--
Mvcoboc te r ium tuberculosis 
Pneumonia, septicemia 
2 9 Septicemia Eschei-ichio c o l i  
Proteus s ~ e c i e s  
~ a r o c o l o h  species 
Pneumonia Pseudomonas aeruainosa 
Condido o lb icans 
Escherichia c o l i  
Septicemia, pyelonephrit is, 
myocardi t is  
Septicemio, pneumonia Pseudomonas ael-uginosa 
Pneumonio, septicemia, 
fungus pyelonephr i t is  
Aspel g i  I lus fumigotus 
Candido *+ 
Streotococcus foeca 1 i s  
Septicemia Stapliy lococcus aureus 
Dip lococcus pneumoniae 
Pneumonia, th i rd degree abdominal Pseudomonas aeruginosa 
burn 
Lung obscess, pneumonia 
Septicemia 
Klebsie l lo-Aerobacter  
Escheric hi0 c o l i  
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Table 19. Terminal Infectlolls In Patlents Kecelr lng Cadar erlc Renal 
Homografts ( CD Series) 
C D  Case 
Number Type of  Infect ion Et iologic Agent 
Septicemia, 
pericarditis, 
empyema 
Septicemia, 
lung abscess 
Staphylococcus aureus 
Pseudomonas aeruginosa 
Staphylococcus aureus 
Pseudomonas - aeruginosa 
Streptococcus faecal i s  
Table 20. Terminal Infections in Recipients Receiving Baboon 
Heterografts (SD Series) 
SD Case 
Number 
Type of lnfect ion Et iologic Agent 
Septicemia, 
**pneumonia, 
empyema 
Pneumonia, 
brain abscess, 
myocardi tis, 
septicemia 
Escherichia col i 
Pseudomonas aeruginosa 
Escherichio c o l i  
Pseudomonas aeruginosa 
Pneumocystis car in i i  
Aspei-gil lus fumigatus 
-
*4 Pneumonia Unknown, no autopsy 
Esophagitis 
Pneumonia, 
pyelonephrit is 
Candida albicans 
Klebsiel la-Aerobacter 
*Subsequent homotransplantation. 
**Pneumonitis was secondary to mu1 t ip le  pulmonary emboli. 
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REJECTION 
TRANSPLANT INFECTION 2 
SEPTICEMIA 
2, a O BACTERURIA 
C 3 PNEUMONIA 
0 '  
* '  
MISCELLANEOUS 
- 
0 
0 WOUNDS 
M EDlASTlNlTlS 
TIME IN WEEKS 
Figure 99 The time of appe,l l , tncr of 1nfectlon5 (open dia~nonds)  folloning renal homotrans- 
plantation (solid circles). The nlalority of' infections occurred follolvirlg the rejection crisis a t  which 
time immunosuppressi~~e therap). i5 i~lcre,iied to rnaximal. ( B y  permission o f J A J l A  189:397, 1964.) 
group, less than 10 per cent of the postoperative infections occurred in  this 
earl>- postoperati\.e period, during avhich onl>- azathioprine was being given, 
suggesting that the intensification of immunosuppressi\.e therapy lvhich is  
necessary for control and re\,ersal of rejection played a significant role in  pre- 
disposing patients to inf'ectious con~plic,ations. Leukopenia. h>-poammaglobuli-  
nemia. and steroid-i~lduced diabetes were each noted to h a \  e resulted from 
such therapy. 
hlarked depression in the total white blood cell count occurred in 12 of the 
first 30  patients. In  these cases. total leukocyte counts of less than 3,000/mm3 
were obserl-ed ~ i n d  I\-ere accompanied by \ arious deqrees of granulocytopenia. 
This complication occurred in 60 per cent of all patients in ~ v h o ~ n  death was  
caused or accompanied by o\ -er~vhelmiig  infectious diseases (see  Chapter 19). 
Total serum gamma globulin levels of less than 0.3 gin per cent (normal, 
0 .7  to 1.6 gn1 per cellt 1 n e r e  detected b>- papel. strip electrophoretic meas- 
urements in six of 22pat ie i i t s .  Tlle tleficienc>- IT-as detected in four of 14 
patients tested 11ho s u l ~ s e c ~ u e i ~ t l ~  died ~f-itll  infections. H!.pogalnn:aqlobuli- 
nemia has  been a ieatu1.e unique to those patients r e c e i ~ i n g  high doses of 
corticosteroids in additio~l to azathioprine. and the deficient!- tended to be 
corrected to nor1n~11 \ ~ - l - ~ e n  the steroid dosaqes n-ere decreased to lo\\- levels or 
were discontinued. 
Steroid-induced diabetes 11 as present in many patients tested n-110 later 
succumbed \\it11 infectioui complications. Blood sugar deternlinations in- 
dicated that  the gl>-cosuria resulted fro111 h>-pergl>-cemi rather than from a 
lon-ered renal glucose threshold in the transplanted kidne>-. I t  should be em- 
phasized that  the d iabe to~en i i  effect of prednisone is onl>- one of the Inany 
"anti-inflammatol.!" effects of sti-roicls 1111ic.11 i:1,1>- predispose subjects to in- 
fections and that it in,l> ha\-e special clinic a1 iinport:a!lce o11l>- bec'iuse it is so 
easy to detect as a n  index to steroid toxicity. 
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The same could be said of both leukopenia and 11!-poqammaglobulinemia. 
The several conseciuences of i ln~nu~losuppressioll  \vhich are noted aboi-e dem- 
onstrate only isolated f'acets of' the depressed resistance in these patients. 
Other aspects of loss of host resistance are not so readily app~lrent  because of a 
lack of simple laboratory tests for their detection and quantitatioil, although 
\-arying degrees of loss of iminunologic c;ip;lbilit!- can be demonstrated with 
special analytic nlethods Chap. 2 2 ) .  
Epidt2uziologic.  Fuc,tors. The presence of' the staphylococcal carrier state 
prior to surgery xvas f'oulld to correlate n i t h  the de\  elopment of' postoperative 
infections caused I)!- this organism. This relationship is apparent alllong the 
first 30 patients xvho n-t1.e tre'lted priol. t o  the illstitution of routine antibiotic 
treatment of staph!-1ococc;il ca r r i e l ,~ .  Sur \  e>- cultul,es of' the nasoph:lrynx or 
skin indicated that  I9 of' this initi:tl qroul) 11 ere ca1.1.ie1.s of' Stiil~lr!iloc,oc,c~ls clu- 
rcJlt,s before operatiotl. Of' these 19 c:it,l,icl,s. I T  dc\-eloped ;i siqtlificant sta- 
phvlococc:il infectiol~ during hospitali7:ition. In contrast. onl!- one of' the 11 
noncarriers de\-eloped such an infection. Bacteriophage typinq of the staphy- 
lococcal strains isolated from bloocl cultures and from the nasopharynx of 
two patients \vith staph!.Iococcal s e ~ ~ t i c e n l i a  sugqestecl that the septic process 
was caused b! the stapl~ylococcal strain carried in the patients' on-n naso- 
pharynges. 
At present.  neth hods compar;ible to t h t  staph>-Iococc;~l ~acteriophage 
s c h e m e  were  not ;i\.:iilable f'or t h e  typing of' othel. iilf 'ectious a g e n t s .  
Nevertheless. tliere is suggestil e e \  idence in these patients that  the infections 
caused by enteric er:lm-negati\ e rods. fungi, and ~ i r u s e s  \\,ere also of' endoge- 
nous origin. The clinical experience, theref'ore. is coml~atible \\it11 the in- 
terpretation that inf'ections a1.e usuall!- produced b! endogenousl! carried or- 
ganisms TI-hich in[-acle and cause disease n-hen the host clc,fense mechanisms 
are sharply depressccl I)!- antirejection drug therap!-. 
DIAGNOSIS 
As both infectious diseases and the rejection crisis may present initially a s  
"fevers of unknown origin." the diff'erentiation between the hyperpyrexias 
resulting from these t ~ v o  phenomena is of immediate importance in the 
management of transplantation patients. \\-llile the diagnosis of infectious 
complications is based primaril>- on the usual ph\-sical and laboratory criteria, 
certain disting~iishing features are of' collfirmator>- 1-alue in these patients. 
The laboratory data of differential 1-alue in distinguishin.: re,jection from 
infection may be compared in the same patient in \ t- l~ich these t\\-o pllenomena 
occurred seciuentiallv Fie. 100 ' .  In  this patient LD 13 1 an earl>- rejection 
crisis was accompanied by fel-er and by nlarked renal failure as e\-idenced by 
oliguria. azotemia. and decreased creatinine clearance. \I-ith illstitutioll of high- 
dose steroid therap!., a prompt defer\-escence and return of adequate renal 
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39 RE JECTION INFECTION 
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300- AZATHIOPRINE mgm/day 
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0- 
DO- 
DAYS POST TRANSPLANT 
Figure  100. LD 15. Fever  due  to a honiocrait  ri'lec tin11 , i t tempt n a s  associated with renal  failure,  
a n d  remitted i t l th  steroid ther ,~py.  In cont~. :~s t .  f e \  c r  ~ e \ u l t ~ t i c  f'ronl a s t a p l i ~ l o t o c t a l   round in-  
fection appeared despite steroid therapy. . ~ n d  ~i ,I\ not , ~ \ i o c  i;itrd xi-ith i~np , i i rmrn t  ill renal function.  
( B y  permission of',l..\.\I \ 189:402. I'l(i4 
function occurred. Two weeks later, fever reappeared which was due to a 
staphylococcal wound infection. The temperature rose to 39' C despite the fact  
that  the patient was receiving 100 mgm of prednisone daily. There was no 
impairment in renal function during the infection. if-it11 institution of drainage 
and antibiotic therapy the temperature returned to llorinal and the wound 
healed. As in this case. the fel-er of rejection is inr-ariably controlled b>- large 
doses of steroids. The fe\.er of serious infection is usuall>- not. 
The white blood cell count has  been found to be of little ~ - a l u e  ill differenti- 
ating between infection alid rejection since the degree of leukoc,! tosis is under 
constant control b>- dail>- adjustments in azathioprine dosage. Consequently, 
the appearance of leukoc>-tosis n-ith either infection or rejection i i  probably 
more a reflection of bone marrolr reser1-e after c>-totosic drug therap>- than a 
response characteristic of either process. The peripheral 11-hite 11lood count is a 
resultant of the rates of productioll and destructioll of ~~-1 l i t e  c lls. aild both 
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these processes at present dei'>- cluantitation. i t  is apparent that .  n-ith x-aryitlg 
degrees of drug-depressed production and \\it11 differing rates of' infection or 
rejection-stimulated utilization. the white count could rise. fall. or remain un-  
changed \\-it11 either rejection or infection. 
The differentiation of septic hyperp>-rexia from that  of rejection may be a 
simple problem as in the case cited ab0r.e. ~ I u c l l  inore commonl>-. however, 
serious localized or blood streain infections hax-e first been diagnosed at the 
same time as rejection. The coexistence of a rejection crisis and sepsis also 
leads to a characteristic cliilical picture 1 Chap. 19) a ~ l d  olle that  often cannot 
be effectir-ely treated since the recjuiren~ents f'or control of' the infection and 
reversal of re,jection are mutually ;intaqo~iistic. Thus,  the clinical syndrome of 
severe rejection. i n l r n u ~ l o s u p p l  e drug toxicity. leukopenia. and sepsis h a s  
accouilted f'or the ~najorit!. of deaths. In ;in effort to prex-ent this f'at'il series of 
events bl- teinperinq the ser-clrit>- of' rejection. steroid therapy has  been given 
prophylactically ill more receilt cases. \\-it11 some iinpror-crnent in results 
(Chap. 18). \f'ith this altered regilnen. \vhich in\-olx-c.s the admi~listrat ion of 
massive doscs before as  xvell as after oper~ition, the appearance of early post- 
operative fex-er is usu:~lly strong exiclence of infection since the fever of rejec- 
tion is allnost alx\ ays masked at this time. 
GENERAL ASPECTS OF MANAGEMENT 
Aseptic Precuut iotzs .  The first cases in  the Colorado series were treated 
under conditioils of strict asepsis. The patients xvere placed in isolation a t  the 
time suppressire drug therap>- xvas begun. Precautions included n-earing of 
caps and masks. sterile gon-ns. and surgical gloves by all x.isitors or examiners. 
Everyone entering the roonl n-ore cloth shoe cor-ers and ~valked or-er mats  
soaked rvith detergent. Ex-en laljoratory data  slips. ne\vspapers. books. and food 
were sterilized before being brought into the isolatioil units. 
These expensi~-e  procedure5 ere subsequentl>- ~nodified in the light of the 
findings described earlier rvhich indicated that infections xvere largely of 
endogenous origin. Currentl>- sex-era1 patients are cared f'or in the same ward. 
Clean go~vns  are n-or11 ~ v h e n  the patient is being examined or dressings are 
changed. If an  or-ert inf'ection occurs. the ~ ~ a t i e n t  is r emo~-ed  to a n  indix-idual 
unit: but if recox-cry is uncomplicated, the patients are sent out 01-1 pass during 
the day. usually beginning a fen- da>-s t'ollon-in% surgery. \Vhen the patient 
enters and lear-es the hospital. he n-ea1.s a mask to protect him against the 
increased hazard of' the nosocomial enr-ironment. 
Both before and after operation. cultures are taken sex-era1 times weekly of 
the nose, throat. skin. stool. and urine of the patients. Current information is 
thus continuall>- ax-ailable reqardinl: the endogenous flora of the patients. In  
those circumstances in TT-11ic.11 an  infection arises. it is frequentl>- possible from 
these data  to predict not only the type but also the antibiotic sensitivity of or- 
ganism inr-olx-ed. 
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A17tiDiotic. Treilt1izt~i2t. The choice of antibiotics depends upon a number  of 
considerations. These include the etiolog>- and site of the inf'ection. the general 
condition of the patient. t l ? ~  adecjuac>- of' renal function. and the se\-erit?- of im- 
munosuppressi\-e drug effect n-hich the patient inanif'ests. 
Staph~.lococc:il inf'ectioiis are usually treated n-it11 either penicillin G or 
one of the penicilliiiase-resistant penicillins, depeiidi~iq ul;.on the sensitivity of 
the particular strains. Oral or parenteral for111s are ei\ en ,  and the dose is ad- 
justed according to the renal function of the patient. 
For  ser ious  q r a ~ n - n e q a t i ~  t3 I~:icill,ll,>- in fec t ions .  ch lo r~ impl ien ico l  i s  
frequently cllosen because it is potent. possesses a broad :inti~?iicrobiiil spec- 
trum. and llas no iilcre;ised toxicity ill the presence of' impaired renal f'unction. 
Tetracycline is less coinmonl! e m p l o ~  ed because of' its anti;~n:il)olic effect 
with resultinq ele\ ation of the blood urea nitrogen. R~tctc.ricid:il agents, such 
as streptomycin. colistin. and kana~nycin .  are also rather frequently used. 
Dosage of these drugs must be carefully regulated in the presence of renal insuf- 
ficiency because of' the danger of'jeop:il.dirinq the function of' the transplanted 
kidney. In  gener~tl .  ii-hen renal f'unction is impaired, one-half' the usual daily 
dose is administered e\.ery third day. \\'he11 nccessar>-, kanamycin inay be 
gi\.en intravenously in closes of' 0.25 to 0.3 0,111 tivice daily \\.lien renal function 
is normal, or 0.25 t o  0.5 qnl e \  er!, tl1i1.d day when renal function is neqligible 
as  would be the ( ,as? dur i l~q  a st.\ ere t.t~jectio11 crisis. 
Pseudoinonas infectioiis are treated ivith c,olistii~ and. ;iqain because of the 
potential nephrotosicity of' this drug. dosage is carefull>- ac1,justed according to 
the renal  function of the patient. Doses of this drug 1-ary from 5 mgm kgm daily 
to 2 lngln kgm el-ery third day. The administration of' this antibiotic by the 
intra\,enous route is currently being in\estigated in cases in rvliich edema, 
hypotension, or bleeding tendencies make intranluscular use undesirable. 
0 t lz t . r  Tlzt.rc~pej~~ t i c  Jlc'cls 11 r . c J , 5 .  Of equal importance with appropriate an- 
tibiotic therap>- is the con t~o l  of' the side eff'ects of imm~tnosuppressi\  e drug 
treatment. ;\qranulocytosis has  coine to 11c recognized as an  estreinely om- 
inous sign as it nlriy perl i~it  sudde l~ ,  f'ult11in;int. a11d o\-ei~\.r-heltiii~lg sepsis. To 
date. neutropenia has  l x e n  managed onl! IJ! \~-itlldra\\.al of' the suppressive 
therapy. Halt e \  er. other forms of' treatment may nlerit consideration. Studies 
by IkIorse and his associates h a \ e  suqqestecl that  ivliite cell transf'usions in 
leukenlic patients are of' 1 alue in counteracting iiif'ections. Blood f'rom donors 
who ha\-e extrelnel>- 11i%11 counts of' 111:1ture neutrophils. such ;is those with 
chronic granuloc>-tic leukemia. \\-as particu1;trl~- useful. 
It has  been sho\ \ -~i  I,>- Kosaff' that experimental animals n-ill sun-i1.e irradi- 
ation longer if the>- are treated ivith oral non;lI~sorbable antibiotics to sterilize 
the intestinal tract. and it be that patients qoinq through an episode of 
agranuloc~~tosis  shoulcl receix-e oral iintibiotics 011 ,I prop21!-1:tctic basis. The use 
of such agents as oral colistin has  been suqqested by 1Iarg;aretten as a possible 
mode of pre\ ention of pieudomonas inf'ections in leukemic patients receiving 
cytotoxic therapy. 
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Hypogainmaglobulii~eillia has  beell a frequent occurrence in patients 
during periods of high-dose corticosteroid therapy. \\-hen the qarnina globulin 
level drops to 300 mgm per cent or less in the presence of a n  infection, gamma 
globulin in a dose of 20 to 40 1111 intrainuscularly is administered. It would 
seem reasonable also to adinirlister gainina globulin on a prophylactic basis in  
the event of the sirllultaneous occurrence of agranuloc5-tosis and hypogamma- 
globulineinia. There are insufficient data  to ex aluate the efticac>- of this type 
of therapy. 
Steroid- induced d iabe tes  h a s  been  a frecluent colnpl icat ion of i m -  
munosuppressix-e therap\-. \Then marked glycosuria dex-elops. patients are 
placed on a diabetic diet and insuliii is administe~,ed. I t  has  been noted that  
after the prednisone dosage is lowered to approximately 20 to 40 rngnl daily or 
less, these control measures are usually no longer necessary. 
SPECIFIC INFECTIONS 
AND TREATMENT 
S t u p h ~ l o c o c c u l  W o u n d  In f ec t ions .  The  importance of the staphylococcal 
carrier state in predisposing patients to infections by this organisin has  been 
emphasized. Because of the frequency of these infections, all patients shown 
to be staph\.lococcus carriers are given antibiotic therapy which is started 
before surgery and is usuall>- continued ti\-e to se\.en days postoperati\.ely. Ordi- 
naril>- one of the penicillills is used. depending on the sensitix-it>- of the staphy- 
lococcus. Since insti tutioi~ of' this policy. some 30 patients ha\-e been treated 
by renal homotransplantation. ~ v i t h  dex.elopment of staphylococcal wound 
infection ill only one. It is apparent, howex-er. that this prex-enti\-e use of anti- 
biotics has  not reduced the general irlcideilce of infectious disease-related 
mortality (Tables 18 to 20).  Deaths are still occurring from sepsis although 
somewhat later in the post-transplant period and fro111 infections caused by 
gram-negative rods and fungi. 
In  the past. staphylococcal inftctions at the site of 1~emoclial~-sis catheters 
ha1.e been frequently noted. In inan::. instances. it is rlecessarl- to dialyze a 
number of' times ox er sel-era1 ~veeks  prior to transplantatioil. I11 five such 
c a s e s .  se r ious  staph!-lococcal infect ions  occurred a t  t h e  s i te  of' d ia lys is  
catheters tl-ith resulting bacterelnia in tlvo patients. \\-hen this complication 
occurs. the dialysis catheters should he remox-ed and antistaph>-lococcal antibi- 
otic therap!- i n s t i t u t e d .  If t h e  pa t i en t  h a s  been s t a r t e d  on  aza th iopr ine  
pretreatment in preparation f'oi transplantation. this drug is te~nporarily dis- 
continued until the infection has  been brouqht ~ i n d e r  control. It has  heen pos- 
sible to perform transplantation in these patients n-ithin t ~ \ - o  n-eeks of the 
onset of their inf'ectio:ls. 11-ithout  unto^^-ard com~~licat ions .  
In a n  additional case SD 3, inultiple septic pu l inon :~r~  einboli occurred 
secondary to a staph>-lococcus-infected arteriox-enous shunt catheter (Fig. 
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Figure 101. Patient SD 3. Tomogram of the chest at 7 cm. Note multiple cavitary staphylococcal 
emboli from an infected arteriovenous shunt catheter. 
101). The catheter was removed and the patient treated for six weeks with 
methicillin and oxacillin. The lung lesions cleared and heterotransplantation 
was performed. 
Clinically important wound infections occurred at the site of thymectomy, 
nephrectomy, splenectomy, renal homotransplantation, or other major wounds 
in six patients (Table 21). In all these cases staphylococci were involved, and 
in two cases were accompanied by gram-negative bacilli. These infections 
were cleared in two instances, and led to death of the patients in the other 
four. 
Urinary Tract Infection. Bacteriuria has been a frequent postoperative 
finding, occurring in 19 of the first 40 patients. In four of these, the infections, 
which originated preoperatively, were cured or suppressed following surgery. 
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intensil-e antibiotic therapy is given before surgery and continued for several 
weeks follo\ving bilateral nephrectonl>-. \vhich may be ad\-isable a t  a separate 
initial stage (see Chapters 3 and 11 ). and renal transplantation. The choice of 
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therapy in these infections depends largel!- upon the results of cultures and,  
antibiotic disk sensiti\it!- studies. Antibiotic therap!- is usually follon-ed by 
therapy for one to t ~ v o  inonths with a n  urinar>- antiseptic agent such as nitro- 
furantoin, nlethenainine inandelate. or nalidixic acid. 
One patient I LD 2-2). a IS-year-old girl \\-it11 pol!-c!-stic kidne?- disease, had 
acute pyelonephritis and multiple fungal abscesses in the cysts. Because of 
continuing temperatures in excess of 40' C. bilateral nephrectomy and 
splenectonl!- n-ere performed. follo\vinq ~~-1 l ich  temperatures fell promptly to 
normal (see Fiqure 3.  Chapter 3 1. .Antibiotics Ivere subsequent1~- discontinued. 
The patielit \vas nlailltaiiled by hernodialysis for three 11-eeks ~ l n t i l  renal ho- 
motransplantation n-as performed. Her postoperati1-e course ]\-as une1-entful 
after each procedure. In cases such as this in n-hich ~lepllrectolnies are per- 
formed a t  a first sta:.e. the bladder has  been kept bacteria-free by t~\-ice-iveekly 
instillations of approximately 10 cc of normal saline containing 0.3 gm of 
neorn>-cin and 30.000 units of bacitracin see Chapter 4:. 
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In 15 additional patients. urinar>- tract infections appeared for the first 
time postoperati\-ely, possibly bei,lg introduced by the ind~t-elling urethral 
catheter n-hich n-as used for the first 24 hours follon-ing transplantation. 
Twelve of these infections n-ere either cured or suppressed. These 19 urinary 
tract infections were caused primarily by the g r a m - n e g a t i ~ e  nteric bacilli and 
pseudomonas species: hon-el-er, in three inst;inces staph!-lococci also occurred. 
The long-term effects of bacteriuria folloning renal homotransplantation 
have yet to be assessed. It XI-ould see111 reasonable to assume, hon-el-er. that  
lower urinar!. tract infection in these patients n-ith a single homograft kidney 
who are receiving cytotoxic drugs and co~,tic,osteroids could readily lead to as- 
cending pyelonephritis and iinpaired renal function. For this reason, it is 
belie\.ed that  the risk attendant upon the cautious :idlninistration of poten- 
tially nephrotoxic antibiotics in a n  attempt to eradicate these infections is 
warranted. 
Pzi1nlottc~t.1~ 111Jt~ct1otzs. Pulmonary infecrions caused by bacteria or fungi 
have occurred in 17 patients follo\~-ing transplantation and have pro\-ed fa ta l  
in all but one. In at least four patients the infection has  follo~ved multiple 
pulmonary emboli. In  one instance (LD 25) a n  E. coli pneumonia Tvas cured 
(Fig. 102). In this case multiple antibiotics were gi\.en. the relative hypogam- 
maglobul inet~~ia  Lvas treated ~ v i t h  40 cc of gamma globulin, and the steroid- 
induced diabetes was  controlled ~11 th  insulin. 
Fungal pneumonia has  occurred in four patients following transplantation. 
The chest x-ray and microscopic section of a Ca~~clidri  cllhic,n,zs pneumonia 
are shoxz-n in Fiqures 103 and 104. T ~ v o  cases of aspergillus pneumonia oc- 
curred (Figs. 105. 106). In three instances these fungal pneumonias Jvere com- 
plicated b ~ ;  a brain abscess. In 110 case n-as amphotericin R administered, 
primarily because of failure to establish the diaqnosis ante inortern. The nephro- 
toxicity of' this drug, ho~t-e\-er .  it-ould tilake its use particularly hazardous 
for such patients. In addition, the antibiotic is only fungistatic and,  therefore, 
eradication of' s>-stemic fungal infections ~vould require the assistance of a n  
adequate host response and resistance. Because of' the inlpairlrlent of these 
host factors by irnm~inosuppression. it seems doubtful that cure could be ef- 
fected n-it11 this antifunqal agent. 
Pulmonary tuberculosis occurred in one case follon-ihg renal transplanta- 
tion (Figs. 107. 108,. In this patient a ca\-itar>- lesion in the right lon~er  lobe 
became apparent f'ol1011-ing sur2ery. and ti\-o sputum cultures n-ere positive for 
A21yco1~cicte,.i~i~,l t i l ~ t ~ ~ ~ c ~ z i l o s i s .  The internlediate strenqth PPD skin test was 
negatil-e before surger>-. a feature n-hich is in keeping 11-it11 the depressed 
delayed hypersensiti\-it>- that  obtains in these uremic patients I Chap. 22). Ac- 
tive pulmonary tuberculosis has  also been obserl-ed in one patient treated a t  
this center !\it11 hepatic transplantation. In addition. this infection has  been 
reported follol\-inq renal transplantation b>- Hopen-ell and after bone lnarrow 
transplantation by AIathe. For these reasons transplantation patieilts are given 
T e x t  follori s o?z pcige 231. 
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TERMINAL PNEUN 
Figure 103. Patient LD 21. Chest x-ray of patient with fatal Candida albicans pneumonia. 
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Figure 104. Microscopic section of lung showing necrosis due to Candida albicans infection. 
PAS (X 540). (Courtesy of Rolla B. Hill, Jr., M.D.) 
Figure 105. Aspergillus pneumonia. (Patient LD 43.) Hyphae elements are present within the 
focal abscess area. PAS (X 540). (Courtesy of Rolla B. Hill, Jr., M.D.) 
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Figure 106. Patient LD 43. Chest x-ray of patient with fatal Aspergillus fumigatus pneumonia. 
Note the nodular lesions in the right lower lung field and the cavitary lesion in the left upper lobe. 
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Figure 107. LD 28. C o u r s e  o f  patient in w h o m  t u b e r c u l o s i s  w a s  r e a c t i v a t e d  by i m m u n o s u p p r e s s i v e  
t h e r a p y .  
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Figure 108. Chest x-ray (LD 28) taken on the day prior to death. Cavitary tuberculous lesion is 
seen in the right lower lobe and coliform pneumonia in the left lower lobe. (By permission of JAMA 
189:402, 1964.) 
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Figure 109. Time of onset of "trans- 
plantation pneumonia" in relation 
to steroid withdrawal in six patients. 
In each case the pneumonia appeared 
at  a time when prednisone dosage 
was decreased below 1 mgm kgm 
per dal-. (By permission of JA,VZA 
189: September 14, 1964.) 
"- 
- - PNEUMONIA f: TRANSPLANT 
- PREDNISONE (mgrn/day) f FEVER 
prophylactic INH, 5 mgm/kgm daily, as soon as immunosuppressive therapy is 
initiated, and it is continued as long as prednisone is being administered. 
" T r a n s p l u r z t u t i o ~  P7zezlnzonia." A unique type of pneumonia occurred in 
eight patients in which none of the usual bacterial or mycotic agents could be 
implicated etiologically. These "transplantation pneumonias" all occurred in 
patients under 21 years of age. They were characterized in general by an ab- 
rupt onset of fe1-er and an insidious onset of pulmonary symptoms. These 
pneumonias occurred at the time of steroid n-ithdrawal n-hen the prednisone 
dosage 1s-as decreased to approximatel>- 1 mgm kgm dail>- 'Fig. 109:. Cough of a 
nonproductil-e nature. fel-er. c>-anosis, and tach>-pnea n-ere the predominating 
features. Ph>-sical examination of the chest was routinel>- unremarkable. The 
chest x-rays sho~ved bilateral diffuse infiltrates n-ithout pleural reaction or 
hilar adenopath>- F i g .  110!. Laborator>- studies Table 22)  sho~ved a white 
blood cell count 11-hich 1-aried from 500 to 16.200 111111~. Six patients had a 
detectable cold agglutinin titer. and in  IT-o it was markedl>- ele1-ated. One 
patient demonstrated an ele\-ated heterophil titer and, in addition. one had a 
positi\-e latex-fixation test for rheunlatoid arthritis. In two patients lupus 
erythematosus preparations re\-ealed tart cells. 
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F 
Figure 11 0. Patient LD 19. Chest x-ray one day prior to death from "transplantation pneumonia." 
Bilateral hazy infiltrates are present involving the entire lung fields. 
Table 22. Laboratory Findings in Patients with "Transplantation Pneumonia" 
Series and WBC Cold Agglutinin Heterophi l 
Number mm3 Titer Titer 
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Table 23.  Pulmonar>- Function Studies in Patients with 
"Transplantation Pneumonia" 
Test Normal Values CASE LD 27 LD 19 LD 20 
Hbg 0 2  saturation, air > 92% 4 3 7 1 46 
Hbg02satura t ion ,02  100% 88 77 
C 0 2  content, air 40-45 vol % 42.2 44.6 39.5 
C 0 2  content, 0 2  40-45 vol % 40.7 44.8 
DCO 15 cc/min/rnrn Hg 2.8 
02 "  25-35 l iters/l iter 46.2 
Seven patients were cyanotic, and required oxygen administration. Blood 
gas studies on three demonstrated a n  alveolar capillary block syndrome (Table 
23). Four patients were treated with antibiotics, although no effect was  ap- 
parent from such therapy. Five patients recovered after rather protracted 
courses ranging from two to four weeks. 
Examination of the lungs in one fatal  case (LD 19) revealed enlarged al- 
veolar cells with intranuclear inclusions characteristic of cytomegalovirus in- 
fection (Fig. 11 1). In  addition, the alveoli were filled with a foamy eosinophilic 
exudate which contained nunlerous P ~ e u  )?1ocystis cnritz i i  (Fig. 112). I n  
another patient (SD 3) P)letl ) lzocystis cnri12ii  was found a t  autopsy in  as- 
sociation with aspergillosis. 
P7zez1 ,7zocystii c i o . i ) ~  i i is belie\-ed to be a protozoan parasite which char- 
acteristically causes pneumonia in premature and debilitated infants-the 
so-called interstitial plasma cell pneunionia. JIore recently this disease has  
been recognized in adults 11-it11 malignant disease of the heniatopoietic system 
who are treated with cytotoxic agents and corticosteroids. According to Gaj- 
dusek, the coexistence of this agent wit11 cy:ornegalo\-irus in pneuinonia is not 
i n f r e q u e n t .  T h e  sn-ollen a l \ - eo la r  cells  con ta in ing  i n t r a n u c l e a r  a n d  oc- 
casionall>- intracytoplasmic inclusions are believed on morpholoqic grounds to 
represent c>-tomegalo\-irus infection. This agent is found in the salil-ary glands 
of approximatel>- 10 per cent of infants at autops>-. and IYeller and Hanshaw 
have demonstrated that  antibodies to this agent are present in the serum of 80 
per cent of normal adults. Intranuclear inclusions ha1-e been noted by Rolla B. 
Hill, J r . .  in the lungs of approximatel>- one-third of patients dying after renal  
transplantation (Figs. 113. 114). In  a number of these cases no e1-idence of pul- 
monary disease ~ v a s  uspected clinically or could be demonstrated radiographi- 
cally. The presence of these inclusions is belie\-ed to represent an  essentially 
asymptomatic spread of latent cytomega101-irus under the influence of immu- 
nosuppressi\-e therap>-. 
The frequent>- and role of P~zezl ) , zocys t i s  cni.i,z i i  and c>-tomegalovirus in 
transplantation pneumonia remains to be demonstrated conclusively. Both 
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Figure 1 1  1. Microscopic section of lung of a fatal case of "transplantation pneumonia." Patient 
LD 19. Enlarged alveolar cells and macrophages (arrow) with intranuclear inclusions are present. 
The alveolar spaces are filled with a foamy eosinophilic exudate containing Pneumocystic carinii. 
H and E (X 460). (Courtesy of Rolla B. Hill, Jr., M.D.) 
Figure 112. Patient LD 19. Dark staining cysts of Pneumocystis carinii are seen within the 
alveolar spaces (arrows). Methenamine silver (X 115). (Courtesy of Rolla B. Hill, Jr., M.D.) 
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Figure 1 1  3. Microscopic section of lung of Patient LD 16. Many enlarged alveolar cells and macro- 
phages are seen containing intranuclear inclusion bodies (arrows). H and E (X 95). (Courtesy of 
Rolla B. Hill, Jr., M.D.) 
Figure 114. Microscopic section of lung of Patient LD 8. Large intranuclear inclusion bodies 
and an occasional intracytoplasmic inclusion are seen. H and E (X 660). (Courtesy of Rolla B. Hill, 
Jr., M.D.) 
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Table 24.  Herpes Zoster following Renal Transplantation 
Series and Onset (Days) lmrnunosuppresrion Preceding X-Ray 
Post- 
Number Azathioprine Prednisone Diagnostic Therapeutic 
Transplant 
*Onset 30 days prior to transplant. 
these agents characteristically produce disease in the debilitated patient and 
usually invade in the presence of depressed host resistance. It may be that  in  
these cases other factors aside from immunosuppressive drug therapy were 
operative in the lungs which predisposed them to in\.asion by these micro- 
organisms. Possibly, in reacting to the graft kidney, a n  immune response 
developed which concomitantly attacked the lung and thereby further de- 
pressed the resistance of this organ to infection. 
H e r p e s  Z0stc.r. Herpes zoster has  appeared in one patient before, and in six 
patients after, institution of drug therapy for renal transplantation (Table 24). 
All these patients had had a pre\-ious history of \-aricella. In four cases, 
therapeutic irradiation to the implant had been gi\.en se\.eral days prior to the 
appearance of the zoster lesions. In tn-o cases extensi\.e diagnostic x-ray 
procedures, in one case an  intra\-enous pyelogram, and in the other studies of 
the hips and pel\.is preceded the de\-elopment of zoster. These lesions have r u n  
a n  essentially norillal and benign course despite the inlnlunosuppressive 
therapy. and in no case has  1-aricella pneumonia or encephalitis de\-eloped. I n  
only one patient mas therapy, in the form of gamma globulin. administered. 
In  contrast. herpes simplex has  been surprisingl?- rare despite the rather 
marked febrile responses TI-hich occurred in many of these patients during the 
rejection crisis and in conjunction n-ith infectious diseases. X se\-ere "cold 
sore" has  been obser\-ed in onl>- one patient. This l~i rus .  like the 1-aricella-zoster 
agent,  is frequently carried in the latent state,  and it could ha\-e been an-  
ticipated that  actil-ation of the \-irus in renal transplantation patients would 
ha\-e been common. 
H e p a t i t i s .  Hepatitis has  occurred in tn-o patients follo~\-ing transplanta- 
tion, in one (LD 36)  three nlonths and in the other (LD 151 six months post- 
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operatively. On the basis of clinical s>-mptoms it would appear that the first 
case may represent homologous serum jaundice, and the second, infectious 
hepatitis. The possibility that  the lii-er disease in either case is related to im- 
munosuppressir-e drug therapy, hon-el-er, cannot be excluded. The course in  
both these patients has  been prolonged, and progression into a subacute or 
chronic form of the disease may occur. Therapy in these cases has  consisted 
primarily of bed rest. diet, and adjustment of steroid dosage. 
The rather severe course of hepatitis in the txvo patients receiving im- 
munosuppressive therapy is of interest in light of the observation by Good that  
patients with agan~n~aglobul ineinia  do poorly follo1.r-ing hepatitis, while they 
handle the usual viral infections in an  apparently norrnal fashion. It would 
appear that a n  intact immune s?-stem may be necessary for recol-ery from hep- 
atitis while in other \.iral diseases ancillary defense mechanisms, such as in- 
terferon, may f'acilitate reco1-ery. I11 addition, it has  been noted that  viral upper 
respiratory disease in transplant patients is no more sei-ere or protracted than 
in other persons. 
I?zfectiotzs a,f'tt.'r H e t e t ~ o t r ~ c ~ t z ~ ~ ~ l ~ ~ ~ z t ~ ~ t i o t ~ .  The probleins of infectious dis- 
ease associated with l~eterotransplantation (Table 20) were s i~n i la r  to those 
encountered in honlotransplant recipients. It is interesting to note that  no 
evidence for the transnlission of' infectious agents from the baboon to the re- 
cipients occurred. In one instance. H e p a t o c ~ j $ t i s  I:ocllii was identified in the 
liver of a donor baboon. ' Only the gametocyte stage of this malaria parasite 
appears in the blood of the Papio doguera and for this reason transmission to 
m a n  by means  of inoculation lvould be \-ery unlikely. In  addition. viral cultures 
of segments of ureters of four baboon donors failed to reveal any latent agents. 
PROSPECTS 
In  general the disease pattern in renal transplant patients is that  of severe 
and fatal  infections caused by a wide variety of agents which are infrequently 
associated \vith disease in the otherlvise normal host. The problems of infec- 
tious disease are similar to those which occur in patients with a variety of 
hematologic. neoplastic. and metabolic disorders who are receiving anti- 
inflammatory and cytotoxic agents. The methods which are el-olving for the 
managenlent of infections in patients treated by transplantation could be ap- 
plicable, in part at least, to a n-ider range of medical problelns and could have 
direct applicability in future clinical trials of transplantation of other organ 
systems. Detailed studies of the cellular and molecular alterations produced by 
immunosuppressi~-e drugs which result in heightened susceptibilit>- to infection 
could yield important information regarding the multiple defense mechanisms 
of the normal host against inr-ading microorganisms. 
"Identified by George L. Graham. Associate Professor of Parasitology. Yni\-ersity of Pennsylvania. 
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Chapter Twenty-two 
IMMUNOLOGIC ASPECTS OF 
RENAL HOMOTRANSPLANTATION 
by W .  E .  C .  Wilson, M.D., and 
Charles H .  Kirkpatrick, M.D. 
The developments in surgery which are decribed in the preceding portion 
of this book have resulted in technically successful transplantation of human 
kidneys prior to the solution of many fundamental problems in transplantation 
immunology. Nevertheless, a remarkable. and to some extent unexpected, 
degree of success has been achieved lvith human kidney homografts. Analysis 
of the reasons for this are important in order to determine if. and to what ex- 
tent, the growing body of knowledge about renal honlotransplantation can be 
applied generally to the transfer of other tissues and organs. 
This chapter summarizes an jnquiry into tlie immunological capability of 
the chronicall>- uremic patient and the changes in i ~ n m u n o l o ~ i c  respon- 
siveness xvl~ich f'ollon- operati1 e correction of the kidne>- failure. In addition, 
current laborator)- approaches to a number of practical problelns in human 
tissue transplantation will be rel-ie~r-ed. including selection of the most ap- 
propriate donor, earl\- detection of rejection, and recognition of' a tolerant state. 
EVALUATION OF IMMUNOLOGIC 
RESPONSE IN UREMIA 
In 19.53. Hume and his associates reported the transplantation of kidneys 
from unrelated donors to nine patients with terminal renal failure. Four of the 
nine kidneys functioned for five to 25 weeks even though immunosuppressive 
therapy 1vas not gil-en. Dammin. Couch, and JIurra>- subsequentl>- observed 
histologic elidelice of skin homograft sur~~ix-a1 in six uremic subjects for as 
long as 115 days. These obserl-ations all indicated that the graft rejection mech- 
anism was impaired in the presence of uremia. .A detailed stud!- of the im- 
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munologic capability of patients with advanced renal disease was therefore 
undertaken. 
Delctyecl Critnlzeorts H y p e ~ s e ? z s i t i s ' i t y .  Of the various expressions of im- 
munologic potential, delayed cutaneous hypersensiti1-ity is believed to be the 
type most similar to homograft rejection. In both instances, the reaction has 
been thought to be mediated by an ,'antibodyH n-hich is intimately associated 
with lymphoid cells rather than by demonstrable humoral antibody. 
A group of 33 ureinic patients who were being evaluated for renal trans- 
plantation were studied with respect to their responses to a panel of seven an- 
tigens which were expected to elicit delayed cutaneous reactions. All patients 
had irreversible renal failure and, in the majority of instances, this was the 
result of chronic gloineruloilephritis. Intracutaneous testing was performed 
prior to the institution of any therapy known to alter cutaneous reactivity. The 
antigens used were commercial preparations and were diluted according to the 
manufacturers' directions. Intermediate strength purified protein derivative, 
histoplasmin, blaston~ycin, coccidioidin, and mumps skin test antigen were 
administered in 0.1 ml intradermal inocula. Purified extracts of Cl tnd ida  al- 
bicalzs and Tr ickopk . z j to~z  i l ~ g u i n ~ ~ l e  (1:100 dilutions) were given intrader- 
mally in 0.03 ml inocula. Reactions Lvere measured at 24 to 48 hours. and in- 
duration of 5 mm diameter or greater Tvas considered to be a positive response. 
For each uremic patient. a normal subject was tested with the same antigens. 
The normal subjects n-ere being e\-aluated as kidney donors, and in 26 of the 
33 a genetic relationship to the uremic patient existed. Three potential donors 
were related only by marr iage ,  and  the remaining four  were unrelated 
volunteers. 
Of 212 tests applied to the donor and to the recipient groups. 89 positive 
responses were seen in the normal subjects. There \\-ere only 28 positive reac- 
tions in the uremic patients. Table 25 re\-iews the reactions observed with 
each antigen and demonstrates that dela~-ed cutaneous responsiveness to all 
the antigens was impaired in the presence of chronic uremia. 
To characterize the nature of this impaired responsiveness. the skin tests 
were repeated in 23 patients n-ho n-ere selected for renal transplantation, and 
who were available for retesting in the immediate postoperati\-e period prior to 
the institution of adrenal steroid therapy. Because the kidney transplantation 
operation inl.011-ed the transfer of leukocytes within the renal 1-asculature 
and the transfer of hilar lynphoid tissue. a potential model for the passive 
transfer of delayed h>-persemiti\-ity existed. The majorit>- of the patients were 
retested during the 48 hours follo~l-ing surgery, and all n-ere studied by the 
twelfth day. Some patients were retested a second time in association with 
the rejection crisis, and the results of this study n-ill be discussed later in this 
chapter. 
In the postoperative period. each patient was found to have reactions in 
addition to those present preoperati1-ely. In each instance of acquired reaction, 
sensitivity to the antigen had been prel-iously demonstrated in the donor. Table 
26 illustrates that 61 specific reacti1-ities n-ere possessed by the donors, but not 
by their recipients. Forty-sel-en ('77 per cent) of these reactil-ities n-ere de- 
monstrable in the kidney recipients after the operation, Immediate function of 
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Table 25. Preoperative Tests for Dela!-ed Cutaneous Hypersensitivity in 
Uremic Patients and Their Donor Candidates 
-- -- -- 
No. of Positive Positive Reactions 
Antigen Donor-Recipient Reactions in  Donor 
Pairs Studied i n  Recipients Candidates 
Intermediate PPD 33 0 5 
Histoplasmin 33 1 9 
Blastomycin 33 0 0 
Cocc id ia id in  33 0 7 
Mumps 33 1 1  26 
Candida 30 1 1  2 9 
Trichophyton 17 
- 
5 
- 
To ta l 2 12 28 
Table 26. Passive Transfer of Delayed Cutaneous Hypersensitivity 
following Kidney Transplantation 
Reactivit ies Possessed by Reactivit ies Demonstrated i n  
Antigen Donors but N o t  Recipients Recipients Postoperatively Preoperotively 
N o .  No. Per Cent 
Intermediate PPD 
Histoplasmin 
Blastomycin 
Coccidioidin 
Mumps 
Candida 
Trichophyton 
To ta l 
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Figure 115. Photomicrograph of a skin biopsy of a passively acquired reaction to Candida albicans 
in a 40-year-old male kidney recipient (LD 30). Note the perivascular aggregation of mononuclear 
cells, which are predominantly lymphocytes. The biopsy was obtained 24 hours after antigen injec- 
tion. 
the kidney did not occur in all patients, indicating that correction of the 
uremia was not a prerequisite for the postoperative change in skin reactivity. 
The results indicate that passive transfer of immunologic competence ac- 
companied the kidney transplantation. 
Furthermore, it is apparent from this investigation that the basis for the 
impaired cutaneous reactivity in uremia is not an inability of the skin to re- 
spond, and the defect must therefore lie in the preparative phase of reaction. 
Similar observations have been made by Sones and Israel in patients with sar- 
coidosis. The decreased incidence of delayed cutaneous reactivity dem- 
onstrated by Kelly in Hodgkin's disease appears to have a different patho- 
genesis, since passive transfer studies in patients with this disease were unsuc- 
cessful. 
The histologic features of the delayed cutaneous hypersensitivity, pas- 
sively acquired by the kidney recipients, were studied by Rowlands with serial 
skin biopsies. The microscopic reaction appeared to reach its peak at 24 to 27 
hours, and by 36 hours the infiltrate had decreased. Figure 115, a photomicro- 
graph of a biopsy taken 24 hours after antigen injection, demonstrates the 
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perivascular accu~nulat ion of lymphocytes which is a characteristic of the 
delayed cutaneous response. 
A number of features ~ r h i c h  characterize delayed cutaneous h?-persensi- 
tivity ha\-e been observed in homograft rejection. Because of these similari- 
ties, many inr-estigators consider these tivo inlnlunologic reactions to have a 
common pathogenesis. I t  lvas therefore of' interest to stud!- the relationship of 
the suppressed delayed cutaneous reacti1-ity de~nonstrated in these uremic 
patients to their ability to respond to the transplanted kidnel-s. 
Assessment of delayed cutaneous reacti1-ity n-as carried out in 25 patients 
who later recei\.ed renal homografts and ~ v h o  sur\-ii-ed the i~nmedia te  post- 
operative period. These patients ivere di\ ided into t ~ v o  groups 011 the basis of 
their reactions to the panel of' antigens. I.'ourteen patients had no reactions to 
the antigens. and the 11 melnbers of' the other group reacted to at least one 
antigen. These groups rvere co~npared  with respect to the time of' onset of the 
rejection reaction. Criteria f'or the diagnosis of' rejection ha1.e been discussed 
in  Chapter 15. and include B L-S e1e1-atioli, decrease in urinary \.olume, fall in  
creatinine clearance, a ~ i d  fever. A favorable response to adrenal steroid 
therapy supported the diagnosis. 
One patient \~-l-io sholr ed no response to the antigens has  not manifested a 
rejection crisis (LD 1 4 )  and ~vi l l  not be considered further. The mean  time of 
onset of the rejection reaction in the remaining 1 3  unresponsil-e patients was  
14.8 days. By contrast. the onset of the reaction occurred on a n  a\-erage of 4.3 
days after transplantation in the group of 11 patients in n-holn delayed cu- 
taneous reactivity had been demonstrable. 
The two groups compared were similar with respect to age and to the du- 
ration of 0peratil.e renal ischemia. \T'lien these 24 patients ~ v h o  experienced a 
rejection crisis were dil ided on the basis of donor relationship, no difference in 
the time of onset of rejection ~ y a s  noted betxveen those ~ v h o  were related to 
their donors and those ir~lio were not. 
These obserl-ations support the concept that  impaired immunologic re- 
sponsiveness in uremia is an  important factor in successful h u m a n  kidney 
transplantation. Furthermore. the difference in rejection tiines between the 
responsil-e and unresponsi~-e groups suggests that the reactive group might 
benefit from additional iininunosuppressi\-e therapy prior to the rejection 
crisis (see Chapter 181 .  
1777 nzecliclte C L ~  tiiueorls Hzjper,e ,zi  i t i i  ity. To f u r t h e r  e ~ - a l u a t e  i m -  
m~iiivlogic responsi\-eness in uremia, a group of patients were studied lvith re- 
spect to their abilit!- to inanifest cutaneous n-heal and erythema. Such a re- 
sponse. follon-ing 15 minutes after intl.acutaneous injection of antigen, in- 
dicates the presence of a specific circulating antibod!-. 11-hich has  skin-fixing 
properties. In this chapter, antibodies possessing this characteristic are re- 
ferred to as reagins. 
The reactions obtained in 30 uremic patients were compared to the reac- 
tions of their donors to a panel of antigens expected to elicit the 11-heal and ery- 
thema response. Twenty-three donor-recipient pairs were genetically related. 
244 / IMMUNOLOGIC ASPECTS OF RENAL HOMOTRANSPLANTATION 
Table 27. Preoperative Tests for Iinnlediate Cutaneous Reactivity in Uremic 
Patients and Their Donor Candidates 
No. of Donor- Positive Reactions Positive Reactions Antigen Recipient Pairs in Recipients in Donor Candidates 
Molds 30 
Trees 30 
C henopods 30 
Ragweeds 30 
Grasses 30 
Candida .30 
Trichophyton 17 
Total 197 
The antigens were commercial preparations of mixed molds, mixed tree pollens, 
mixed chenopod pollens, mixed pollens of ragweed and sage, mixed grass pol- 
lens, Canclicla. and Trickopkyton.  All were used in 0.03 ml intracutaneous 
inocula. Table 27 summarizes the results of this comparison in which 74 
positive reactions (greater than 1 cm wheal or erythema) were observed in the 
normal group, compared to only 26 in the uremic patients. LYhen co~nparison 
was made betaveen only the genetically related pairs. 18 positive responses 
were seen in the uremic group and 61 in their normal relatives. 
To define the pathogenesis of this impaired response. the skin reactivity to 
a standard intrader~nal injection of 0.03 ml of histamine (1:100,000) was 
measured in 14 uremic patients. The mean n-heal and erythema response was 
2.5 cm with a range from 1.4 cm to 4.0 cm. These reactions were not signifi- 
cantly different from those seen in the normal subjects. Passive sensitization 
to rag\veed was successfully demonstrated after intracutaneous injection of 
0.1 rnl of serum. containing reaginic antibody to ragaveed. in all 13 patients 
studied in this manner. In sea-en of these patients, the response to passively 
administered reagin was determined quantitatil-ely using tenfold dilutions of 
the antibod>--containing serum. -411 sea-en shoax-ed reactil-it>- following injection 
of the 1:  10 dilution. and three had reactil-ity n-ith the 1 :  100 dilution. Injection 
of a 1:1.000 dilution did not produce passil-e sensitization. These responses 
were similar to those of the donor population. 
These results indicate that the decreased response in uremia is the result 
of an  absence of a sufficient quantity of a specific reagin since the cutaneous 
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Table 28. Humoral Antibod>- Response to T>phoid I'accine in 10 Uremic 
Patients and 22 Tormal Subjects 
*Prestimu lat ion Antigen * Poststimu Iat ion Titers Group Titer 1 wk 2 wk 3 wk 
0 Normal 20 50 80 50 
0 Uremic * * l o  10 30 20 
Norma I 
H Uremic 10 10 40 20 
*Titers expressed as the mean of the reciprocals o f  the t i ter observed 
in  each member o f  the group. 
**Patients and normal subjects w i th  an observed t i ter o f  less than 1/20 
were arb i t rar i ly  assigned a reciprocal value o f  10 for determination 
of the mean titer of each group. 
receptor sites for reagin, the histamine content of cutaneous mast cells, and 
the vascular response to histamine are normal. Recent studies by Heremans 
and Vaerman indicate that reagin is a constituent of the gamma,% globulin 
fraction of serum proteins. The presence of grossly normal gamma, ,  globulin 
bands following immunoelectrophoresis of the sera of 18 patients in this group 
does not suggest a gross disturbance of gamma , protein metabolism. Quan- 
titative determinations of serum gamma , globulin levels showed values in 
the normal range. 
Inclzictio,~ oj' Hli nzorcil Atztibotly P1.0dli~tio1z. Because the previously 
outlined results were indicati1-e of suppression of pre-existing inlnlunologic 
capability in individuals whose effector pathways appeared to be intact, a 
study was undertaken to measure the abilit>- of the uremic patient to produce 
humoral antibod>- in response to a standard antigenic stimulus. Typhoid vac- 
cine was selected as the test antigen because the normal response has been 
sho~vn b:; LoSpalluto to inr-olx-e both gamma and g a m m a  globulin produc- 
tion. Typhoid vaccine in a dosage of 0.3 1111 was administered subcutaneously 
to 10 uremic subjects.   no st of 11-horn had b>- history been prer-iously immunized. 
The responses seen at inter\.als after the booster injection are summarized 
in Table 28. The patients' responses n-ere significantl?- suppressed when com- 
pared to those of a normal population. 
Co,zclzl s io~z. The impaired abilit>- of the chronicall?- uremic patient to 
reject homografted tissue appears to be onl?- a part of a more generalized sup- 
pression of immunologic capabilit>- xvhich includes the delayed cutaneous 
hypersensitix-ity reaction and the production of all three classes of hu~noral  
antibody (i.e.. gamma, ,  , gamma ,,, and gamma, globulin). 
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DONOR SELECTION 
The problem of selecting the optimal tissue donor remains a major ob- 
stacle in successful organ transplantation. Since most uremic patients do not 
have a n  identical twin, a donor must be selected who is of necessity genetically 
dissi~nilar  to the recipient. It has  already been pointed out (see Chapters 5 and  
18) that  use of the patient's mother or a sibling greatl>- increases the likelihood 
of success of a renal homograft. presumably because of reduction in the 
number of differences in histocon~patibility antigens. 
JI( i tchi l lg  o f '  Tisslic~ : l t z t i q r ~ ~ . $ .  Although little is kno1r.n about tissue an- 
tigens in man .  the existing data  suggest that  a great many are present and  
that  a few are organ specific. Until more refined methods of tissue typing 
become a~.a i lable .  the immunoloqist must de\-ise experimental models which 
will permit soine degree of' comparison of tissue antigens betn-een donor and 
recipient. In this section we propose to i,e\.ien. some immunologic studies 
which have been ~inder taken in a n  attempt to identify antigenic. relationships 
between the recipient and a prospecti\.? donor. Xlthouqh se\.eral tests have 
been proposed \-arious groups, 110 one method has  recei\.ed sufficient 
clinical trial to \\.arrant its general applic:~tion. The problein is further com- 
plicated by the f'ac.t that the long-term success of a transplanted organ will re- 
quire months or !-ears to determine. 
Because transplantation of any test tissue from a donor to the recipient 
may result in sufficient sensitization to jeopardize the success of the final 
graft, iVilson. Heni.1.. and AIerrill ha\-e described a method for detection of com- 
mon antigens ~ v h i c h  is based upon the obserl-ed beha\-ior of skin grafts trans- 
planted from both the prospecti\-e donor and recipient to a third person. The 
first graft is transplanted f'rom the recipient to the third person, and 15 days 
later skin fro111 the donor is similarly placed. The rate of' rejection of this sec- 
ond graft gi\.es an  indication of' the degree of' antigen-sharing between the 
two grafts. X second graft which is re,jected rapidll- (accelerated rejection) or 
without becominq 1-ascularized (white graft rejectior)  implies a high degree of 
antigenic siinilarit!- between the donor and recipient. Con\.ersel~-. a second 
graft ~ v h i c h  is slolr-ly re,jected indicates that f'en- antigens are shared. Xlthougfi 
this system does perinit assessment of' antigens .is-hich are common to skin 
from different subjects. the direct application of the method to organ trans- 
plantation is linlited because it does not prol~ide for assessnlent of antigenic dif- 
ferences. Experimental 1-erification of' the importance of this limitation h a s  
been reported bl- Rapaport and his associates. 1~110 obserl-ed a poor correlation 
betn-een the indirect demonstration of shared antigens with this method and  
the surl-ival of test skin homografts. 
A different approach to donor selection has  been proposed b!- Brent and  
Meda~var .  I11 their experiments, I!-mpl~oc>-tes from a potential recipient guinea 
pig were injected intradermall!- into ser-era1 other guinea pigs I[-hich were 
later used as skin graft donors. The intensit!- of the cutaneous reaction was  
found to correlate directly with the order of breakdon-11 of skin grafts after  
IMMUNOLOGIC ASPECTS OF RENAL HOMOTRANSPLANTATION / 247 
subsequent transplantation. The animal that sho~ved the weakest cutaneous 
reaction was the donor of choice. This inflan~matory response lvas believed to 
be a localized "graft versus host" phenomenon in n-hich the injected leu- 
kocytes reacted against antigens in the donor skin. This scheme permitted 
some classification of donors based on the sel-erity of the reaction of the im- 
mune mechanism of the recipient. It also has  the ad\-antage of not sensitizing 
the recipient. 
When the method was investigated in guinea pigs, in which it could be 
evaluated by test skin grafts from all members of the panel, it was successful in  
predicting relative rejection times. X similar direct e\-aluation of its appli- 
cability in human  kidney transplantation is impossible. A partial appraisal of 
the rnethod may be deri\.ed from the stud!. of' a large group of patients who are 
to receive kidneys from genetically related donors. These patients are known to 
have a more fa\-orable prognosis than those recei\.ing kidneys froin unrelated 
volunteers. Indirect support f'or the utility of the inethod would be obtained by 
the demonstration that lymphocytes from the patients of' this preferred group 
cause a less intense reaction in the skin of their related donors than they cause 
in the skin of nonrelated indi\ iduals. 
M'e have applied this approach in tn-o patients who n-ere being evaluated 
for renal transplantation. In the first case (LD 23) ,  the panel of donors included 
the patient's brother and tlvo unrelated volunteers. A11 members of the group 
were gi\-en 3.52 x 10"ymphocytes f'rom the recipient. and the cutaneous 
induration was measured a t  24 and 48 hours. These data are summarized 
in Table 29. The patient's brother Tvas selected to be the donor because of 
his genetic relationship. Unfortunately the kidne) failed immediately. probably 
as the consequence of a blood group incompatibility (see Chapter 6) that  will 
be discussed in more detail. X second transplantation was subsequently done 
using a n  unrelated donor. This organ ~ v a s  till functioning nine months later. 
Another patient (LD 28) ivas also studied in a similar manner .  His lympho- 
cytes were injected into his sister and a n  unrelated 1-olunteer prior to trans- 
plantation (Table 29). LIinimal reactions occurred in both. possibly because 
the cellular inocululn 11-as small. The kidne>- transplanted froin his sister 
functioned well for sel-era1 weeks and then deteriorated. The patient died as  
the result of drug toxicity. rejection. sepsis. pulmonary embolization, and 
intestinal infarction (Chap. 19).  
\5'hile our experience ~ v i t h  this method of donor selectioil is limited. and 
definitive conclusions are not possible, in the tn-o patients studied the system 
did not re\-eal differences betn-eel1 related and unrelated potential donors. \Ve 
have also attempted to apply the principle of this method to the earl!- detection 
of graft rejection. These experiments ~vil l  be described filrther on. 
The relationship of leukocyte antigens to s u r \ ~ i ~ - a l  of renal holnografts in 
six cases has  been reported by Hamburger and his associates. Leukoc>-tes from 
both donor and recipient n-ere "t!-ped" according to their reaction in leukoag- 
glutinating sera obtained from a large number of h!-perimmune subjects. A11 
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Table 29.  Donor Selection Using Intradermal Injection of 
Lymphocytes fro111 Recipients 
Group lnoculum Induration Re lation Total Lymphocytes (cm) 
Recipient (LD 23) 3.52 X 106 0.6 
First donor Brother 3.52 X 106 0.5 
Second donor Unrelated 3.52 X 106 0.5 
Control Unrelated 3.52 X 106 0.7 
Recipient (LD 28) 0.89 X 106 0 
Donor Sister 0.89 X 106 0.1 
Control Unrelated 0.89 X 106 0 
these patients were related to the donors, and  in  three of the six the mothers 
donated kidneys to their children. I n  the three cases in which the donors pos- 
sessed leukocyte antigens different from those of the recipient, function of the 
transplanted kidney ceased within hours after surgery, and all three recipients 
were dead by the t1,ventieth post0peratix.e dal-. However. in three cases all 
donor antigens were possessed by the recipients, and graft survival was  pro- 
longed. Two patients were ah\-e, one and tlvo and a half years after transplan- 
tation, a t  the time of reporting. \\'bile the number of patients i11 this series was  
small. the results suggest that leukocyte typing may have more general appli- 
cation in donor selection. The number of antigens which are common to leu- 
kocytes and kidne>- tissue is not knon-n. 
A n  additional approach to the study of antigenic relationships. which is, 
now being el-aluated in se\-era1 centers, is in\-estigation of the behax-ior of the 
recipient's l?-mphocytes in the presence of' histocompatibility antigens from the 
proposed donor. Bain. I7as ,  and Lon-enstein obserl-ed that ,  n-hen peripheral 
blood lymphocytes from t ~ o  indii-iduals are mixed in tissue culture for five 
days, the 1~-mphoc>-tes nlarge and synthesize DS-A. It n-as suggested that  his- 
toconipatibilit>- differences betn-een the txl-o lyl~iphoc!-te populations may have 
been the stinlulus for the changes n-hich occurred. That cells from a single 
indil-idual or mixtures of cells fro111 identical t ~ r i n s  did not undergo this transi- 
tion supported this postulate. 
The application of the technique to the selection of donors for organ trans- 
plantation n-as coinplicated by inability to quantitatil-el!- separate the responses 
of each population in the l>-mphoc>-te mixture. Bach and Hirschhorn circum- 
vented this difficulty by demonstrating. that transformation 1-2quired x-iability 
of onlp one population of lymphocytes. since the antigenic stimulus could 
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Figure 116. Left-The microscopic appearance of peripheral blood lymphocytes which were 
cultured for 10 days in the presence of frozen-thawed leukocytes from an unrelated individual. 
Right-The response of the same lymphocytes to frozen-thawed autologous leukocytes. 
be provided in the form of frozen-thawed cells of the donor candidate. Figure 
116 (left) illustrates the changes which are induced in peripheral blood lympho- 
cytes following culture for 10 days in the presence of frozen-thawed leukocytes 
from an unrelated individual. The companion photomicrograph (Fig. 116, 
right) shows the lymphocytes of the same test subject which were exposed to 
his own frozen-tha~ved leukocytes in the control experiment. 
Preliminary studies of the applicability of this concept to donor selection in 
human transplantation ha\-e been reported by Rubin and his associates. They 
studied the reactil-ity of the lymphocytes of two individuals to the antigens of 
their donors prior to transplantation and obserl-ed a correlation between the 
cellular response and the rapidity of onset of graft rejection. Because studies 
of this type are performed in 1-itro, they do not involve the possibility of sensiti- 
zation of the recipient during repeated testing. Substantiation of the validity of 
this technique for selection of donors in human organ transplantation must 
await denlonstration of a correlation betn-een the In T-itro lymphocyte response 
and the subsequent fate of the homograft in a large number of patients. 
Donor-Recip ien t  Blood Grozip  J l a t c l i i y g ,  lIatching of erythrocyte anti- 
gens of the donor and recipient does not ensure success after a homografting 
procedure because man!- tissue antigens are not represented in the red cell. 
Nevertheless. . lBO blood group antigens can pose fornlidable barriers to 
transplantation. In Chapter 6, the practical guidelines for donor selection are 
outlined in detail. as they ha\-e del-eloped fro111 our experience ~vi th  the use of 
donors n-hose blood groups differed from those of their recipients. In five 
. cases, lnisnlatches were used which 11-ould no longer be considered acceptable. 
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Table 30. Isoagglutinin Titers in Patients follon-ing Transplantation of a 
Kidney from a Donor ~ v i t h  an  Inconlpatible XBO Blood Group 
Case Blood Group Postoperative Recipient Antibody Titer Day 
LD 2 Sister Donor B 56 
Recipient A 85 
1 95 
LD 19 Mother Donor A - 1 
Recipient 0 3 
7 
11 
32 
LD 20 Mother Donor A -1 
Recipient 0 1 
12 
24 
LD 23 Brother Donor B -1 Anti-B 1 :64 
Recipient 0 3 Anti-B 1 :64 
5 Anti-B 1 :64 
13 Anti-B 1:128 
68 Anti-B 1 :64 
I n  one instance (LD 2), a patient of blood type A received a kidney from his 
sister who was type B. The kidney functioned well postoperatively. A severe 
rejection crisis which began on the twenty-fifth day was reversed. and the  
patient remains well 16 months after operation (see Figure 98. Chapter 20). 
Another patient of blood type 0 receil-ed his kidney from a type X cadal-er (CD 
1). The kidney never functioned well. but the contribution of the blood group 
incompatibility to the unsuccessful outcome is difficult to assess because of a 
long period of ischemia. In a third case, a type 0 recipient (LD 20) received a 
homograft from his mother 8, type -4). There n-ere signs of' rejection within 24 
hours which were re\-ersed (see Figure 60. Chapter 14). Adequate renal func- 
tion was maintained during the ensuing 202 days until death froin a '.stroke" 
(Chap. 19). The fourth patient (LD 23).  also type 0. receil-ed one of his broth- 
er's kidneys Itvpe B ,  ~ v h i c h  n-as the target of a n  acute inlnlunologic reaction 
upon co~npletion of the \-ascular anastomosis. The organ was i~ninediately 
remo1-ed (see Figures 18 and 19. Chapter 61. &A similar series of el-ents was  
obserl-ed follon-ing transplantation of a kidne!- from a t!-pe .A mother to her son 
(LD 19). whose blood t q e  \\-as 0. This kidne>- xvas also remol-ed a t  the time of 
the original operation ; see Figures 17. 18. and 19. Chapter 6'). 
The isohemagglutinin responses of four of these fil-e patients are sum- 
marized in Table 30. Studies on patient LD 2 Tvere not begun until 36 days 
after the transplantation. and consistently lon- titers were obserl-ed. In  patient 
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LD 20, a n  abrupt fall in anti-.A agglutinin f o l l o ~ ~  ed insertion of the kidney, 
suggesting adsorption of the anti bod!^. I11 one of the remaining patients whose 
mismatclied kidne)-s n-ere immediatel!- remoi ed a siqnificant rise in isoag- 
glutinin titer occurred. In  this case i LD 19) donor er>-throcytes svhich mere not 
ren101-ed by perfusion prior to the transplantatiol~ probably p r o ~ i d e d  the 
stimulus for the rapid rise in isoagglutinin titer, a finding .rvhich was not pres- 
ent  in the other comparable patient I LD 23 1. 
From these obserr.ations. it appcars certain that blood group mismatched 
kidneys bind specific pref'ormed host isohemagglutinins pionlptly after recon- 
stitution of blood flow. I n  two cases (LD 19 and 23), this apparently occurred 
with such rapidit). that there tvas in~inedia te  holnograi~t failure. 11: tn-o others 
(LD 2 and 20). in which renal function was obtained, the 10\v autibody titers 
postoperative1)- indicated that binding persisted for iong periods. Similar 
findings in other misnlatches ha \  e been reported L) Porter isee Chapter 25), 
Shackman, and Hume. This is not surprising in \ ieit of the pre\-ious demonstra- 
tion by Glynn and Ho1bl .o~  and b) Szulnlrln that 11 and B antigens are present 
in renal parench? ma1 and \.ascular cells. 
The precise n~echanis ln  by which specific isoagglutinins inflict injury on 
the homograft is not kno\vn. Expor.,ure of the antigens in the renal blood 
vessels to circulating isoantibody is one explanation for the immediate immu- 
nologic reaction obserr.ed in t\vo patients (LD 19 and 23). There is little direct 
evidence to support this concept. / j i l t  the observations made at the time of the 
operation and shortl>- tht.1,eaf'ter clearly indicated a ina,jor disturbance of renal 
parenchymal blood fion isee Chapter 6). It is also possible that the intravas- 
cular erythrocyte clulnping illustrated in Chapters 6 (Fig.  19) and 23 (Fig. 148) 
may have contributed an  obstructil e coi-nponent blood flow reduction in these 
cases, but the el-idence of isohemagglutinin binding f'or prolonged periods in 
the patients with good renal f'unction ( L D  2 and 20) cannot be explained on 
this basis. and it is unlikel!- that such a simple mechanical etiologl- is the sole 
explanation in the tn-o examples of' instant organ failure. The role of ag- 
glutinating humoral antibodies in the etiology of rejection is considered 
further in Chapter 24. based upon obser\.ations on six patients who received 
heterografts from baboons. .All were found to ha\ -e  circulating heteroaggluti- 
nins to the donor erythroc!-tes prior to transplantation, Kone of these patients 
had immediate organ failure. The titers of these heterospecific antibodies fell 
folloaving transplantation. again suggesting absorption of the humoral antibody 
on the foreign tissue. although the declines occurred more slon-l>- than with 
the anti-X titer in LD 20. One interpretation of this diff'erence is that the con- 
centration of antigenic determinants with .\ specificit). ~vi th in  the h u m a n  
kidnel- n-as higher than the concentration of heterospecific determinants 
within the baboon kidne)-s. 
To our knon-ledge. kidne)-s from Rh positil-e donors ha\-e not been trans- 
planted into recipients presensitized to the Rh antigens. S o  difficulty has  been 
obser\.ed ~ v i t h  sel-era1 transplants from Rh positil-e donors into Rh negative 
patients ~ v h o  Irere not sensitized. In a study b)- La~z-ler and Shat~z-ell, the Rh 
antigens could not be demonstrated 011 platelets. 1eukoc)-tes, epithelial cells, 
and secretions of R h  positi\-e subjects. 
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Table 31. The Evaluation of Passi\-el>- Transferred Delayed Hypersensitivity 
before and during .Attempted Kidney Rejection 
*Positive Tests Positive Tests Steroid 
Patient Immediately after during Rejection Therapy Transplantation 
LD 22 1 /3 3/3 Yes 
LD 25 2/3 3/3 Yes 
Yes 
LD 37 2/2 1 /2 Yes 
Yes 
*The fract ion designates the number of successful passive transfers to the 
recipient over the number of possible transfers. 
DETECTION OF REJECTION 
In  discussing the use of immunosuppressive measures (see Chapters 14, 
15, and  18) it is disturbingly clear that  the methods used to diagnose the onset 
of rejection are crude, that  they become diagnostic only after the immunologic 
response is well ad\-anced, and that  it is accordingly necessary to employ a n  in- 
herently dangerous forin of therapy without precise criteria. consequently, a 
number  of in\-estigations ha\-e been undertaken in a n  attempt to characterize 
immunological l>-  t h e  degree  to which  c u r r e n t  cl-totoxic the rapy  i s  i m -  
munosuppressi\-e and to specifically identify the rejection crisis at its onset. 
The first approach to the problem of identification of' the rejection crisis 
again invol\-ed the dela>-ed cutaneous 11ypersensiti1-ity reaction. As outlined ear- 
lier in this chapter, skin reactil-ities of donor specificity jrere passively ac- 
quired postoperati\-el>- by the kidne>- recipients. .Issuming that sonle degree of 
antigenic identity existed between the transplanted renal tissue and the accom- 
panying leukoc>-tes, the rejection process XT-ould be expected to be directed 
against both t>-pes of cells. Rejection ~vould,  therefore, be manifested by a 
reduction or loss of passii-el>- transferred delayed h>-persensiti\-ity as n-ell as by 
deterioration of kidne>- function. This hypothesis iras studied in six patients 
who had passi\-ely acquired reactions. They were tested immediatel>- following 
transplantation and again during the  ejection crisis. The results of these 
studies are summarized in Table 31. It is apparent that no regular qualitative 
loss of transferred reactil-it>- occurred in association ~ v i t h  rejection. although 
in  se1-era1 instances in IT-hich adrenal steroids Ivere being gi\-en the intensity 
of the reaction was reduced. 
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Table 32. Serum Complement Actia-ity folloaving Renal Transplantation 
Postoperative Peak 
Preoperative Prerejection A c t i v i t y  during Postoperative 
Patient A c t i v i t y  Ac t i v i t y  Rejection A c t i v i t y  
I t  is thus apparent that  this method will not be successful for identifica- 
tion of the rejection crisis. One possible explanation for this is that  rejection of 
the kidney and destruction of the immunologically competent cells occur a t  
the same rate. and the cutaneous test may be insufficiently sensitive to dis- 
criminate a fractional decrease in the number  of cells. In  addition. the per- 
sistence of the acquired skin reactil-ities may be related to the "transfer factor" 
reported bl- La~vrence.  This is a constituent of h u m a n  peripheral blood leu- 
kocytes m-hich will passil-ely transfer delayed cutaneous hypersensitivity. 
A number of diseases which are beliea-ed to ha\-e an  iinlnunologic patho- 
genesis are associated with lolv seruln complement actiaity. In 1933, Hume 
reported that  serum complernelit lea-els did not change significantly in six 
homografted patients avho n-ere not receia-ing inimunosuppressi\-e therapy. 
The results of serial estimates of total colnpleinent actil-ity in nine of the 
patients fro111 the treated Colorado series are recorded in Table 32. The range 
of normal 1-alues for complement actil-it!- in this laborator>- is 35 to 70 (50 per 
cent hemolytic) units. The preoperati1-e lei-els avere in the loav normal range, 
and in general the actir-it?- increased progressi1-el!- during ihe earl!- postopera- 
tive period. In the later postoperati1-e period, complement 1-alues decreased to 
near preoperatil~e le\-els. 113 sel-era1 patients, e1-idence of graft rejection ap- 
peared within a fen- da?-s after transplantation, and in these cases colnplement 
actil-it>- avas not measured until after graft rejection had begun. The com- 
plelnent lel-el of patient LD 23 fell folloaving transplantation of a kidney avhich 
failed immediately because of a B to 0 mismatch.  It is difficult to be certain 
that this transitory fall was significant, but it is of interest that it did occur 
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in association with the kind of antigen-antibody combination which will fix 
complement in I-itro. These results indicate that  changes in total serum com- 
plement ler-els Ivere of no value in either prediction or detection of graft rejec- 
tion. Howel-er, preliminary studies by Guiney. Austen. and Russell shon-ed that  
the activity of a complement fraction (C.2)  n-as depressed during rejection, 
suggesting that  more detailed analysis of the role of the complement system 
will be necessary. 
Hume (1963) reported the temporary appearance of a n  unusual protein 
band on microelectrophoresis of the serum of' one of six patients undergoing 
kidney rejection lvhile on iinmunosuppressii-e therapy. 1f.e ha\-e performed 
serial immunoelectrophoresis on the sera of nine patients. Ko definite changes 
in the patterns xvere obser\-ed at the time of rejection. 
Hume (1963) reported the temporary appearance of a n  unusual protein 
first six patients in his later series. Lymphocytes were noted in the urine of one 
patient after the B U N  had risen significantly. A second patient appeared to 
have a n  increase in the number of' 11-mphocytes in the urine as a prelude to 
three rejection attempts beginning 72. 107. and 137 days after transplantation. 
The third patient had a fall in urine output on the elel-enth postoperative day, 
and,  in association ~ v i t h  this. microscopic helnaturia and a f e ~ v  lymphocytes 
were noted in her urine. Assessment of the \ - d u e  of this technique as a method 
for the early detection of' kidnel- rejection requires further in\.estigation. The 
mechanism by which the cells are excreted has  been illustrated by Porter (see 
Chapter 25). 
The principle of Brent and AIedawar's method for donor selection has  been 
applied to predict graft rejection. The concept tested was that  a t  the time of 
rejection a n  increased number of' iminunologically competent cells, specifi- 
cally sensitized to the kidnel- donor, should appear in the recipient's circu- 
lation. The studies of hlerrill pro\-ided some support for this approach. These 
investigators reported that  normal subjects, at the time of skin graft rejection, 
h a d  a sufficient n u m b e r  of immunological ly  c o m p e t e n t  ce l ls  i n  the i r  
peripheral circulation to produce a delal-ed h>-persensitir-it>- response when a 
suspension of these cells Jvas injected intradermall\- into the donor. 
Lymphocl-tes obtained from the peripheral blood \!-ere injected intrader- 
mall>- into the kidney donor and,  as controls, back into the recipient and into a 
third unrelated x-olunteer. Figure 117 demonstrates the clinical course of one 
patient in 11-horn this study n-as carried out. The arrow indicates the postoper- 
ative day on which the lymphocyte transfer was made.  It can be seen that  a t  
this time she had a n  unexplained fel-er. and a fall in creatinine clearance was  
beginning. The lymphocytes injected into her mother's skin n-ere responsible 
for a reaction with a n  induration of 14 111111 and erythema of 35 lnln compared 
to 11 and 8 nlm in the patient and the nonrelated control. Similar studies were 
carried out on eight patients. and the results are summarized in Table 33. The 
IMMUNOLOGIC ASPECTS OF RENAL HOMOTRANSPLANTATION / 255 
O R E  OP DAYS j) POST OP DAYS TIME IN DAYS 
W 
a 
2 PT. D.S. 
k 1 5 Y O  9 
r 
4 0 -  
2 
f 0 35- 
100- 
8 0 -  
F i g u r e  11 7. Clinical course of patient (LD 17) with unexplained fever following transplantation. 
The arrow indicates time when lymphocytes from the patient \\-ere injected intradermally into the 
patient's donor as described in the text. The onset of'\ iqorous drug therapy corresponds to the time 
of recognition of' rejection from clinical el-idence. 
6 0 -  
Table 33. Detection of Rejection Using Intradermal Injection of 
Lymphocytes from Recipients 
- - . . . . . - - - 
Lymphocyte Donor Relation Lymphocytes Postoperative Induration 
 id^^^ ~ ~ ~ i ~ i ~ ~ ~ )  Transferred Day of Test 
- - - - ~  
(c.) 
LD 40 LD 40 Self 2.1 X 106 6 0.5 
Kidney donor Mother 2.1 x 106 6 0.7 
Control None 2.1 X 106 6 0.4 
LD 39 LD 39 Self 1.5 X 106 9 0.2 
Kidney donor Mother 1.5 X 106 9 0.5 
Control None 1.5 X 106 9 0.4 
LD 17 LD 17 Self 23.2 X 106 38 1.1 
Kidney donor Mother 23.2 X 106 38 1.4 
Control None 23.2 X 106 38 0.8 
LD 28 LD 28 Self 6.7 X 106 6 0.4 
Kidney donor Sister 6.7 X 106 6 0.5 
Control None 6.7 X 106 6 0 
LD 19 LD 19 N o t  done -- -- 
First kidney donor Mother 2.0 X 106 8 0.6 
Second kidney donor None 2.0 x 106 8 0.7 
Control None 2.0 X 106 8 0.4 
LD 27 LD 27 Self 3.5 X 106 9 0.4 
Kidney donor None 3.5 X 106 9 0.4 
Control None 3.5 X 106 9 0 
LD 21 LD 21 Self 3.9 X 106 26 0.3 
Kidney donor None 3.9 X 106 26 0.7 . 
Control None 3.9 X 106 26 0.5 
LD 23 LD 23 Self 8.1 X 106 18 0.4 
Kidney donor None 8.1 X 106 18 0.5 
Control None 8.1 X 106 18 0.4 
LYMPHOCYTE ANTI REJE-_ 
TRANSFER 
I t+ 40- 
8 
z g 20- 
3 o- 
80- 
6 0 -  
40. 
K 
.g 2 0 -  
L \ 
0 0 
v 0 o1 
? 5 10 15 2 0  25 30 35 40 45 50 55 
+ 
z 
J 
m 
Z 
a 
--:-------? 
i /" +Ad 
A, / \, ,.___---..,.-I\., 
/ ', / ,------,.-- '---___________-----, 
'\ _.--- 
---______-. 
---._ 
,,,- 
--.. .*' 
--, 
. 
256 / IMMUNOLOGIC ASPECTS OF RENAL HOMOTRANSPLANTATION 
reactions in the donor skin n-ere more intense than those in the control skin, 
but in general the differences were small. 
A serious drawback to in vil-o inr-estigations of this type is the possibility of 
transmission of the serum hepatitis 1-irus. A11 the kidney recipients receive 
multiple blood transfusions shortly before the transplantations which makes 
them dangerous cell sources for such a stud>-. The in vitro method of Bach and 
Hirschhorn is under study currently in an attempt to obtain quantitative in- 
formation on the number of specifically sensitized cells in the recipient circu- 
lation. 
The addition of phytohemagglutiriin. an extract of Phaseolzls ir t lgaris ,  to 
cultures of peripheral blood lymphocytes stimulates morphologic transforma- 
tion and cell division. An in 1-itro method for detection of kidney rejection em- 
ploying lymphocyte responsi~.eness to this extract has been described by Rubin 
and his associates. They reported that the administration of azathioprine to 
recipients of renal homografts abolished the responsiveness of the patients' 
lymphocytes to phytohemagglutinin. In one patient lymphocyte responsiveness 
reappeared coincident with the onset of kidney rejection. The stimulatory ef- 
fect of phytohemagglutinin on the 11-mphyocytes of three renal homograft re- 
cipients in the Colorado series who had manifested no evidence of rejection for 
several months has been studied. In each instance a typical mitogenic effect 
was observed. Figure 118A demonstrates the response of the lymphocytes of 
a n  18-year-old male four months after kidney transplantation (LD 37). Figure 
118B shows the appearance of his lymphocytes in the absence of phytohemag- 
glutinin in the control experiment. For comparison, the response of lympho- 
cytes from a normal subject is shown in Figures 118C and 118D. These ob- 
servations indicate that azathioprine does not produce permanent suppression 
of the response to phytohemagglutinin, In I-ie\v of these results, the re- 
lationship of the onset of the rejection reaction in the early postoperative 
period to the suppression of the mitogenic effect of the extract requires further 
evaluation. 
One of the most promising recently reported tests to diagnose rejection in 
its premonitory phase is that of Kountz. Laub, and Cohn. Rather than using 
immunologic methods, the exanlination is based upon serial measurements of 
renal blood flon- using a single injection radioactil-e iodohippurate technique. 
They have demonstrated that a sharp fall in flow occurs before 01-ert clinical 
or biochemical el-idence of homograft rejection, a disclosure which is in ac- 
cordance n-ith the growing body of e\-idence that tissue ischemia is an important 
component of rejection (see Chapters 13 and 23) .  By deli\-ering maximum im- 
munosuppressi~-e treatment before rather than after physiologic evidence of 
tissue injury, they have greatl>- impro1-ed their results after canine renal homo- 
transplantation. 
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Figure 118. The effect of therapy with a purine analogue on the behavior of lymphocytes in tis- 
sue culture. The response of the cells from a patient (LD 37) who had received azathioprine and 
prednisone for six months to phytohemagglutinin is shown in (A). The same cells in the absence of 
phytohemagglutinin are shown in (B). These responses are comparable to parallel experiments 
using lymphocytes from an untreated patient as shown in (C) and (D) with and without phyto- 
hemagglutinin, respectively. 
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Table 34. Humoral Antibody Response to Typhoid I'accine by 11 Kidney 
Recipients and 22 Normal Subjects 
Antigen *Prestimulation *Poststirnu lat ion Titers Group 
Titer 1 wk 2 wk 3 wk 
0 Normal 20 
0 Recipients * * l o  
H Normal 30 70 80 60 
H Recipients 20 20 70 20 
*Titers expressed as the mean o f  the reciprocals of the t i ter observed i n  
each member o f  the group. 
**Patients and normal subjects w i th  an observed t i ter of less than 1/20 
were arb i t rar i ly  assigned a reciprocal value of 10 for determination 
o f  the mean t i ter of each group. 
IDENTIFICATION OF A TOLERANT STATE 
The early success in maintaining function of renal homografts has created 
another problem in human transplantation immunology which deserves con- 
sideration. Patients from several institutions are now apparently healthy over 
a year after the operation. Almost all these patients are receiving maintenance 
therapy with azathioprine, but the correct course for long-term management is 
not clear. The potential risks inherent in continuous cytotoxic therapy for 
periods of years are not known. X-ray is the only other cytotoxic agent with 
which similar experience is a\-ailable. and the deleterious effects of chronic ir- 
radiation are well recognized. In addition, the degree to ~vhich azathioprine 
therapy impairs the iminunologic response to microbial antigens and in this 
manner comproinises the patient in his environment is not knon-n. To inves- 
tigate this problem. 11 patients. all doing well three to 14 months after trans- 
plantation. Lvere injected with typhoid \-accine and their antibody titers 
measured (Table 34). Although their responses appear to be less than those of 
the normal subjects, a larger series n-ill ha1.e to be studied n-ith additional an- 
tigens before a firm conclusion can be dra11-11. 
Patients who attempt rejection unsuccessful1~- and then do \\-ell for long 
periods may achiel-e a stage of tolerance ~vhich does not require cytotoxic 
therapy for perpetuation. In dogs, se1-era1 isolated examples of this have been 
obserl-ed. Hon-e\-er, other dogs zvhich were tolerant while receil-ing therapy 
rejected the graft n-hen the drugs were n-ithheld, as \\-as discussed in Chapter 
17. These experiences indicate that before drug therapy can be stopped with 
safety, methods for the detection of tolerance are required. 
IMMUNOLOGIC ASPECTS OF RENAL HOMOTRANSPLANTATION 1 259 
Figure 119. The response of the lymphocytes from a kidney homograft recipient (LD 36) to frozen- 
thawed leukocytes from his wife donor (left), himself (middle), and an unrelated subject (right), 
after 10 days of culture. This study was done six months following the transplantation, while 
the recipient was receiving azathioprine and prednisone; he showed no clinical or laboratory evi- 
dence of active graft rejection. Note that the response to tissue from the donor is similar to that 
with the unrelated person. 
One possible approach to this problem is the model proposed by Brent and 
Medawar for detection of specific immunologically competent cells in the pe- 
ripheral blood. A test of this nature was carried out by Gray and Russell using 
lymphocytes from a patient who had received a kidney from her brother four 
months before. The inoculum caused a smaller reaction in the skin of her 
brother than it did in the skin of an unrelated volunteer. Whether the obtunded 
response was the result of the close genetic relationship or some degree of 
tolerance is uncertain, but it is evident that the recipient did have cells capable 
of recognition of the donor's skin antigens. Because of the risk of serum 
hepatitis, an in vitro method would be preferable. 
Employing the lymphocyte culture technique, the responsiveness of three 
homograft recipients to their donors' antigens has been evaluated. These 
patients manifested no evidence of rejection at the time the studies were per- 
formed, six to nine months postoperatively. Figure 119 illustrates the response 
of a recipient's lymphocytes to the antigens of his donor, himself, and a third 
person after 10 days in culture. Reactivity against his donor was present and 
was indistinguishable from his response to the third person. Similar results 
were obtained in each instance. The observation that cells capable of recogni- 
tion of the donor's antigen can be identified several months after kidney 
transplantation in the apparent absence of rejection raises the distinct pos- 
sibility that renal damage may be taking place continuously at a subclinical 
level. 
PROSPECTS 
The purpose of this chapter has been to review those areas of current re- 
search in which answers are being sought to certain problems in human trans- 
plantation immunology. Chronically uremic patients have been demonstrated 
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to have many specific i~n~nunologic deficiencies, indicating that chronic uremia 
may be an important factor in the success of hunlan kidney transplantation. 
It is clear. hon-el-er, that definitil-e answers to most of the problems discussed 
concerning immunologic tests for donor selection, for diagnosing rejection. and 
for identification of tolerance are not 3-et available, and must await wider 
experimental application of the many approaches which have been reviewed. 
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Chapter Twenty-three 
RENAL HETEROTRANSPLANTATION 
Despite the advances that  have taken place in the field of renal  ho- 
motransplantation, unique social and moral issues exist which have no coun- 
terpart in other forms of medical endeavor. Much of the clinical progress of 
the last 10 years has  resulted from the performance of procedures invol\.ing 
the use of healthy l i l ing donors, a practice which inlposes upon these well- 
motivated volunteers an  inlillediate operative risk as well as a negligible but 
unknown long-term liability. \Vith the use of li\-ing donors. it has  been possible 
to obtain a n  increased insight into many aspects of' the problem. The impor- 
tance of technical f'actors in determining the outcome has  become appre- 
ciated. paramount being the degree of anoxic in,jury during transfer of tissue. 
Although there are recorded examples of' urinary excretion af'ter \-ery long 
periods of ischemia, inconstant f'unction results n-hen the inter\-a1 of homo- 
graft de\.ascularization exceeds 40 minutes. as described in Chapter 7. When 
cada1-eric sources are employed. the inequity is to the recipient patient instead 
(Chapter 8 ) .  since hoinograft in juq-  during the agonal and postmortem period 
of the prospectix-e donor may be so great that  all hope of sun-i\-a1 is unknowingly 
lost from the beginning. 
Because these problems of tissue procurement ~vi l l  in the long run greatly 
limit the ~videspread application of therapeutic clinical hoinotransplantation, 
the introduction of heterotransplantation by Reemtslna in the autumn of 1963 
was a n  el-ent of great significance. \Yith his first chimpanzee-to-man renal 
heterograft. Reemtsma dispelled many preconcei1-ed notions regarding the un- 
feasibility of this approach to therap>-. His subsequent chimpanzee cases as 
well as our OT\-II later experiences with baboon-to-man heterografts have 
s h o ~ v n  that  surl-i1-a1 for more than t ~ v o  months can only rarely be obtained 
with the immunosuppressi~-e techniques al-ailable at the present time. Yet 
the>- hal-e also demonstrated that the behal-ior of the heterografts is in many 
i~npor tan t  respects similar to that of homograf'ts. and the>- point to the impor- 
tant  future possibilit>- of emplo?-ing li\-ing animal tissues for replacement - a 
concept no more repugnant than the use of bovine illsuliil or other biologic 
derir-atil-es. 
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Although modern interest in heterotransplantation must be dated from the 
time of Reemtsma's clinical investigation, the first attempt to transplant an 
animal kidne>- to m a n  n-as made by Jaboulay allnost 60 years ago (Table 35). 
In  1906. he revascularized heterografts froin a pig and a goat to the antecu- 
bital space in tn-o patients in terminal uremia, using nonsuture anastomotic 
techniques for the r-essels. In  both cases the vascular connections thrombosed 
within three days. Later Unger 11906). Schtinstadt (19131. and Neuhof (1923) 
each performed a transplant to the feinoral area of a uremic patient. using a 
Macacus monkey. an  "ape." and a lamb, respecti\-ely (Table 33). The first and 
third of these patients 1i1-ed for 32 hours and nine days. The fate of the second 
is unknon-11. In  each instance. pro\-ision for urinary drainage n-as with a skin 
ureterostomy. 
Although measurable renal function was not obtained in any of' these early 
cases. the experience lvas 1.aluable as  a background for later work. The ap- 
plicability of vascular suture techniques was established. It was shown that  
toxemia, anaphylaxis, or sudden death did not folio\\- re\-ascularization of the 
foreign tissue. and that thrombosis of the graft's vascular system could be 
avoided. The principle of' incontinuity removal and re\-ascularization of both 
kidneys, aorta, and \.ens ca1.a was clearly described. as was the technique for 
transplantation of a single organ. Perfusion of the heterograft to remove donor 
red blood cells Ivas alluded to. In addition, future developments were predicted 
with prophetic insight. including (1) the ad\-antages of the pelvic implantation 
site. (2) the desirability of ureteral anastomoses to the patient's own lower 
u r i n a r y  t r a c t .  ( 3 )  t h e  l e sse r  degree  of pathologic  d a m a g e  a f t e r  
heterotransplantation between primates than that observed n-ith more distant 
genetic relationship, and (4)  the potential reversibility of the histologic 
changes in the heterografts. Finally, the problem n-as discussed of providing 
total renal mass equivalent to that of a single human  kidney. 
After  Neuhof ' s  c a s e ,  no  h u m a n  r e n a l  h e t e r o t r a n s p l a i ~ t a t i o i ~ s  were  
recorded in t h e  e n s u i n g  40  years .  On February  16.  1963 .  t h e  first 
heterotransplantation of modern times was carried out by Hitchcock and his 
associates at the ~I inneapo l i s  General Hospital. under immunosuppressive 
coverage with azathioprine and a leucine analogue IDON). X baboon kidney 
(Papio doguera) n-as placed in the femoral triangle of a 63-year-old Indian 
woman, using Seuhof ' s  technique, rl brisk diuresis began proinptl>- and con- 
tinued for fir-e da!-s. Urine production then abruptly ceased. At the time of 
removal of the heterograft, the renal artery Ivas found to be thrombosed. An 
account of the case Tvas not prepared for publication until more than a year 
later, and its existence 1x-a~ not knon-11 n-hen Reelntsma performed the first of 
his simian transplants in S e ~ i -  Orleans. 
Reemtsma's experience is outlined in Tables 33 and 36. In the first of his 
cases, a pair of rhesus monkey kidneys n-ere anastolnosed rvith an  aortic and 
vena car-a1 pedicle Figs. 120. 121)  to the iliac 1-essels of a 32-year-old uremic 
female. and the ureters TI-ere implanted into the bladder. There x a s  unequiv- 
ocal proof of renal function, but this was of relatively- poor quality. The hetero- 
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Table 35. World Experience with Heterotransplantation 
Exclusive of Colorado Baboon Cases': :+: 
Author Year Donor Anastomosis P r " q a -  iupp~esr ion 
Jaboulay 1906 Pig Poyr N o  
prosthesis 
Jaboulay 1906 Goa t  Payr N o  
prosthesis 
Unger 1910 hnacocus Suture N o  
nemestrinus 
(swine ape) 
Schonstadt 1913 "Ape" Suture N o  
Neuhof  1923 Lamb Suture N o  
Hi tchcock 1963 Baboon (papio Suture Azathioprine 
doguera) " D O N "  
Reemtsma 1963 Macoca Suture Azathioprine 
mulotta Act inomycin C 
Azaserine 
Reemtsma 1963 Chimpanzee Suture Azathioprine 
Act inomycin C 
Locol i r radiat ion 
Prednisone 
Reemtsma 1963 Chimpanzee Suture Azothioprine 
Act inomycin C 
Locol i r radiat ion 
Prednisone 
Reemtsma 1964 Chimpanzee Suture Azathioprine 
Act inomycin C 
Locol i r rodiat ion 
Prednisone 
Reemtsma 1964 Chimpanzee Suture Azothioprine 
Act inomycin C 
Loca l irradiation 
Prednisone 
First graf t  - A 
Second graf t  - 0 
Reemtsma 1964 Chimpanzee Suture Azathioprine 
Act inomycin C 
Local i r radiat ion 
Prednisone 
Reemtsma 1964 Chimpanzee Suture Azothioprine 
Act inomycin C 
Local i r rcd iat ion 
Prednisone 
Sigr i f ican+ Survivol Pathological Func'ion Findings 
N 0 
N 0 
N o  
N o  
N o  
Yes 
Yes 
Yes 
Yes 
Yes 
N o  
Yes 
Yes 
Yes 
3 doys 
3 days 
32 hours 
"Several 
hours" 
9 days 
4 days 
12 days 
(removed) 
9 weeks 
7 weeks 
L iv ing and 
we l l  o t  18 
weeks w i th  
normal renal 
funct ion 
2 weeks 
18 days 
Transplant 
removed 
19 doys 
after ~mp lav  
Thrombosis, renol 
vessels 
Thrombosis, renal 
vessels 
Tubular necrosis; 
round ce l l  in f i l t ra te 
N o t  known 
Morked degeneration 
wi thout  round c e l l  
i n f i  rrote 
M in ima l  round c e l l  
in f i l t ra te 
Marked round ce l l  
inf i l trate; f ibr inoid 
necrosis, arterioles 
Acute tubular 
necrosis; no cel lular 
in f i l t ra t ion 
Acute tubulor 
necrosis; no cel lu lar  
in f i l t ra t ion 
N o  biopsy 
Tubu lor degeneration; 
interstit ial edemo; 
moderate cel lu lar  
in i i l t ro te;  tubular . 
degeneration 
Tubu lor degeneration, 
edemo; perivascu lor 
in f i l t ra t ion w i th  
lymphocytes 
Tubuor necrosis; 
inters-it iol edema; 
r i c  ce l lu lar  
i n f i -ea t ion  
*More complete notes on the chimpanzee heterografts ore in  Table 36. 
**Histor ica l  doto prepared by Dr. George N. Peters. 
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Table 36. Features of First Six Chimpanzee to Human Heterotransplants 
Performed by Reemtsma:. 
Donor- Average of  
Donor Recipient Average of A l l  Postop Average 
N o .  A Dai ly  Rejection Crises Postop Primary Cause Weight  of  Death Anur ia 
Blood Postop BUNS Groups (ml/min) 
1 41 kgm A - A  34.8 mgm% 60.6 4 days: ? 32 days 6,705 Sepsis N o  
2 29.5 kgrn 0 -0 32 rngrn% 41 .I 10 days: 30 days: 40 days** 9,035 Sepsis; re ject ion Yes 
3 30 kgm 9 - 0  18.6 mgm% 49 24 days 4,208 Liv ing I8 weeks N o  
6-1 -64 
4 29.5 kgm A - 3  Acute fa i lure - Yes 
38.6 kgm 0-0 97.8 mgm% Poor funct ion d i f f i cu l t  to 3,430 Sepsis; unrelieved N o  
determine uremia 
5 43 kgm A -A  48.4 mgmOh 23.7 12 days 5,040 Sepsis N o  
6 33 kgm A - A  63.5 rngrn% 24.3 8 days** 10,370 Rejection Yes 
*Analyses are from raw data provided us by Dr. Ke i th  Reemtsma, New Orleans, and from the published accounts of  his 
f irst cases. 
**Irreversible. 
grafts were removed on the twelfth postoperative day, and the patient died 24 
hours later. Histologically, there was evidence of very aggressive rejection 
with moderate mononuclear cell infiltration and diffuse vascular injury (Table 
35). 
Using an identical surgical technique and imnlunosuppression with 
azathioprine. prednisone, actinomycin C, and local transplant irradiation, 
Reemtsma then performed six chimpanzee-to-human heterotransplantations 
(Tables 33 and 36). Five of the patients died after 14 to 63 days. The sixth was 
living and well as of June 5, 1964, with normal renal function 18 weeks post- 
operati1 ely. 
Encouraged by Reemtsma's early results and ha1 ing obtained accurate in- 
formation about the RIinneapolis case, the group at the U n i ~  ersity of Colorado 
AIedical Center attempted a clinical trial of renal transplantation in December, 
1963. and January. 1964. using baboons as donors. The in\-estigation was done 
in collaboration ~vi th  Dr. Claude Hitchcock, and ad!-ice was sought from most 
of the American authorities in the field of clinical renal homotransplantation 
in order to obtain the nlaxilnuln in useful information from these cases. This' 
clinical experiment was decided upon for sel-era1 reasons. Comparison of the 
relatil-e merits of the baboon and chimpanzee was not otherwise possible. In 
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Figure 120. Preparation of heterografts. A-Complete midline incision. B-Method used to cold 
perfuse the heterograft complex. See text. C - In situ perfusion. D -The heterograft after removal. 
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Figure  121. Insertion of heterografts after technique of Reemtsma. E-Anastomosis of distal 
aorta and vena cava to external iliac vessels. F-Parallel ureteroneoc~stostomies. G-Folding 
back of kidneys in  order to occupy less space. (By permission of Transplantat ion 2: November, 
1964.) 
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addition, the baboon is the cheapest and most readily available of the large 
subhuman primates. in contrast to the chimpanzee, avhich is a rapidly disap- 
pearing species. Finally, it had been prel-iously established by Wiener and 
hloor-Jankon-ski that the chimpanzee has only two ABO blood types. the 0 and 
A,  making it impossible to obtain donor-recipient blood group identit! for all 
clinical heterotransplantations. The baboon. which has A. B, and AB blood 
groups, could fill this gap if it pro~.ed to be a suitable donor in other respects. 
The six patients treated u i th  baboon heterografts all had immediate fair 
renal function, and survival before death or removal of the heterografts was 
obtained for 19 to 60 dais. Ultimately, the biologic penalty with the use of ba- 
boon heterografts was mobilization of a much stronger immunologic host re- 
sponse than that described for homografts elsewhere in this book. EL entually, 
this proved uncontrollable in t n o  months or less in each case. 
Despite fai lure  of all of the baboon and  most of the ch impanzee  
heterotransplantations, the temporarily fa\  orable earl! course of a number of 
patients. \\ith maintenance of life-sustaining renal function for man! weeks, 
provides hope that animal donors nil1 be useful when better immunosuppres- 
sive measures become a \  ailable. The experiences to date should serve as the 
base upon avhich future progress can be built. For this reason, it is as worth- 
while to completely record all data accruing from this work as it is to thoroughly 
document progress in homotransplantation. 
METHODS IN HETEROTRANSPLANTATION 
Donor Operat ions .  Because of the expendability of the donors, it is pos- 
sible to remove the kidneys under even more favorable circumstances than 
with human volunteers. Special methods are necessary for control and manip- 
ulation of the animals during the performance of preoperative studies and in 
order to make them susceptible to standard anesthesia techniques. A tranquil- 
izer, Sternyl.;' is useful for this purpose. This agent, in an intramuscular dose of 
1 mgm kgm, paralyzes voluntary movement in fi\-e to 10 minutes. For donor 
nephrecton~y, the animals are then anesthetized with sodium pentobarbital, 
intubated endotracheally and cooled in an ice n-ater bath to 28 to 32" C. 
The heterografts are removed transabdominalll- through a complete mid- 
line incision (Fig. 120). reflecting the ascending and descending colon off the 
respecti\-e kidneys. The organs can be remol-ed indil-idually, using the prin- 
ciples of block excision described in Chapter 10 for human hornograft removal. 
When this is done. it is advisable to remol-e a small ellipse of aortic wall in 
order to facilitate the arterial anasto~nosis in the recipient's operating room 
(Fig. 122). 
Perhaps the simplest technique ~ v h e n  both kidne!-s are to be transplanted 
is that described by Reemtsma: the skeletonized aorta and vena cava are 
"Parke, Dal-is Bi Co., Detroit, Michigan. 
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Figure 122. Double heterotransplantation of individual kidneys used for SD 1 of baboon series. 
Note inclusion of aortic and vena caval cuffs with renal vessels in order to provide larger vascular 
anastomoses. 
removed in continuity with the renal vessels, the kidneys, and ureters (Fig. 
120), avoiding dissection in the central hilar areas. Just before removal, a 
cannula can be inserted proximally into the aorta through the common iliac 
artery (Fig. 120) and perfusion commenced with a pressure of 70 to 120 m m  
Hg. using a cold electrolyte or low molecular weight dextran infusate. The 
heterograft complex can be cooled in this way \vithin seconds after inter- 
ruption of its circulation. 
R e c i p z e n t  O p e r a t i o n .  In all of Reemtsma's cases and in five of the six 
University of Colorado heterotransplants, the heterograft complex avas placed 
in the right retroperitoneal space and re\-ascularized to the distal donor aorta 
and inferior vena cava (Fig. 121). By folding the posterior surfaces of the or- 
gans together, less space is occupied (Fig. 121). The ureters are implanted with 
the ureteroneocystostomJ- described in Chapter 11, the ureteral implants being 
placed approximately 1 cm apart. In one of the baboon heterotransplants, the 
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Table 37. Changes in Urine Yolume. B U N ,  and Renal Clearances for the 
First Three Postoperati\-e Days after Baboon Heterotransplantation:' 
Urine Volume 
(mi) Hrs post-transplant Hrs post-transplant Hrs post-transplant 
z:: First 24 hr Second 24 hr Third 24 hr Pretransplant 6 18 42 64 6 18 42 64 6 18 
Mean  16,500 4,330 2,810 95 82 60 51 52 37.9 46.3 51 37 123 255 
. - . . .- . . . . - . - -- -
'Analyses performed and table prepared by Dr. David A. Ogden. 
**BUN-blood urea nitrogen; CCr-endogenous creatinine clearance; CpAH-para-aminohippurate clearance. 
individual kidneys were placed in the contralateral retroperitoneal spaces of 
the recipient, using end-to-side vascular anastomoses to the external iliac ar- 
tery and vein (Fig. 122). 
Postoperntice Care.  Most of the chimpanzee and baboon heterografts 
have had an acute postoperative diuretic phase of' at least as great a magni- 
tude as that described in Chapter 12 for homograf'ts. Urine volumes during the 
first 24 hours follo~ving placement of the baboon heterografts are shown in 
Table 37, the first-day diuresis being as much as 25 liters in two cases. The 
principles of care are similar to those for patients after homotransplantation 
(see Chapter 12), although the large 1-olume losses necessitate even closer 
management of fluid and electrolyte replacement. 
I r n r n z ~ ~ ~ o ~ z i p p r e s s i z ~ e  T/7er~il1,zj. All of Reemtsma's chimpanzee hetero- 
transplants as well as those of the baboon series were given a pretreatmerlt 
regimen of both prednisone and azathioprine, similar to that described in 
Chapter 18. In the Colorado cases, azathioprine was gix-en seven to 10 days 
preoperatil-ely, and prednisone. 100 to 200 mgnl per day. was gi~.en one to two 
days before operation. Postoperati\-el!, these drugs were continued. In addition, 
intravenous actinolnycin C. 200 to 400 pg per day. and local irradiation to the 
transplant site were gi~.en either prophylacticall>- or for the treatment of rejec- 
tion. \Vhen used. irradiation was gi\-en ever>- other day for three or four times 
with the techniques described in Chapter 16. Indil-idual doses of irradiation 
were 150 to 200 R at depth, delivered n-ith a 250-K.\7. machine. Details of 
therap>- for the indi1-idual baboon transplants are described in Figures 123 
to 128. Later in the postoperati\-e course. an effort n-as inade to reduce the 
quantity of steroids as quickly as possible in both the Sen- Orleans and Colorado 
series, but in both groups, this was not done as easily as with patients who 
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Figure  123. Course of SD 1. The baboon and recipient were both A blood type. Bilateral nephrec- 
tomy and splenectomy were performed concomitantly with heterotransplantation. Pretreatment 
was given with azathioprine and prednisone. Secondan- therapy ~ v i t h  actinom>-cin C and local 
irradiation is indicated. The case differed from the other five in that a definite rejection episode 
was not diagnosed. The patient died of pulmonap- sepsis after multiple pulmonan- embolization. 
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had received homografts. As will be mentioned subsequently, dependence on 
massive steroid dosages for maintenance of renal function was much less with 
the chimpanzee heterotransplants than with those of the baboons. 
INFLUENCE OF HUMAN BLOOD TYPES 
UPON HETEROTRANSPLANTS 
Only 0 and A blood groups have been found in chimpanzees. Animals of 
this species with A blood type have this antigen in their erythrocytes, making 
blood grouping analysis possible by direct hemagglutination techniques, and 
leading to the prediction that the directions of tissue transfer in relation to 
ABO groups should follow the rules outlined in Chapter 6. This expectation 
was confirmed by Reemtsma, who transplanted a chimpanzee heterograft of 
type A to a patient of type 0. There was immediate failure of the transplant 
(Table 36), similar to that described in Chapter 6 for two comparable human 
cases. The heterografts were removed a few days later and a new chimpanzee 
donor of 0 blood type was used. Prompt function was obtained after the second 
operation. 
With baboons, a different situation exists. Baboon red cell antigens do not 
react with specific human isoagglutinins, the blood groups being identifiable 
only by reverse hemagglutination techniques or by salivary testing. Because of 
the absence of erythrocyte antigens. and because of the possibility that renal 
tissue was also free of these substances, the possibility existed that baboon- 
to-man heterografts would not be adversely affected by blood group mis- 
matches. The converse would not be true. Because baboon serum does contain 
preformed hemagglutinins to human A and B erythrocyte antigen, mis- 
matches in human-to-animal transplants would be predicted to be dangerous. 
In order to test the postulate that baboon-to-human transplants lvould not 
be adversely affected by blood group incompatibilities, three patients with 0 
blood type were treated with kidneys of baboons of B or AB blood type. These 
patients fared slightly less well than three others who received matched kidneys 
(Table 38). Renal function was obtained for an  average of 28 days. Two of these 
three patients developed anuria after 25 and 10 days, respectively, although one 
excreted substantial quantities of urine until the day of death. (Table 38). The 
three patients who received heterografts from baboons with compatible blood 
types had an average duration of urinary excretion of 44 days. Anuria was not 
observed in the latter three cases. 
Although the survis-a1 figures in  the two subdis-isions of baboon 
heterotransplants cannot be said to have statistical significance. the serial 
changes in anti-X and anti-B titers to be described in the next chapter indicate 
that there lvere important specific immunologic changes consequent to trans- 
planting mismatched kidneys to these patients. This evidence, added to the 
fact that misnlatched conlbinations did not do as n-ell clinically. makes it inad- 
visable to accept such donor-recipient incompatibilities in future cases. 
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Table 38. Function and Survival of Heterografts. and Relation to Blood 
Group Matching (Baboon Series) 
Case Ischemia Donor Blood Type Recipient Blood Type First Ur ine Duration Urine Excretion 
Survival w i t h  
Heterograft I n  
1 Rt-29 min A A+ 4.5 min 23 days 23 days 
Lt-37 rnin 
2 44 min B 0- 10 min 25 days 35 days 
3 34.5 min B AB+ 8 min 6 0  days *60 days 
4 2 9 m i n  B B+ 90 min 4 9  days *49 days 
5 27.5 min A B 0- 8 min 10 days 19 days 
6 37 min A B O t  90 min 4 9  days 4 9  days 
*Heterografts removed. Homografts placed. 
COURSE AFTER HETEROTRANSPLANTATION 
The course of patients receiving chimpanzee heterografts is summarized 
in  Table 36. All except one died after 14 to 63  days. The notable exception was 
still alive and reported to have normal renal function on June  1, 1964, more 
than 18  weeks postoperatively. 
The patients treated with baboon heterografts lived for 19  to 98 days after 
operation (Figs. 123-128). Four died with the baboon kidneys still in place after 
19, 23, 35, and 49 days (Table 38). In two of the cases, the heterografts were 
removed after 60 and 49 days, respectively, and homografts from volunteer 
convict donors were placed on the opposite side (Figs. 125, 126). Survival after 
the second operation was 38 days in one of these patients, and 44 days in the 
Table 39. Baboon Heterotransplants 
Case 
Became 
Anuric Direct Cause of Death 
Ult imate 
Heterograft 
Function 
1 N o  Pulmonary emboli w i th  Fai l ing 
abscess formation 
2 Yes Rejection Failed 
3 N o  "Regrafted Fai l ing 
4 N o  * Regrafted Fai l ing 
5 Yes Rejection Failed 
6 N o  Pneumonia: poor renal Fai l ing 
function 
*Died o f  sepsis 38 ond 44 doys, respectively, after the secondarily' 
performed homo transplanto tion (see text) . 
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PT H.K. 
46 Y.O. f 
64.7-, 55.5 kgm 
X - R A Y  150 R 80  
AZATHIOPRINE 200 
PREDNISONE 
-10 -5 0 5 10 15 20 25 30 35 
>RE ^P 2 C S 7  O P  
TIME IN DAYS * 
Figure  124. SD 2. Recipient was 0-. The baboon was B blood type. The pulmonary resection was 
necessitated by a perforated lung abscess ~vhich  resulted from pulmonary embolization. The pa- 
tient had been anuric for two months before transplantation. S o t e  repetitive rejections after four, 
nine, and 15 days. The last of these was irrex-ersible and proceeded to anuria 10 days before death. 
other. In each of the secondarily operated patients, the primary cause of death 
was sepsis. 
It will be noted (Table 39) that complete cessation of urine excretion oc- 
curred in only two of the baboon cases (Figs. 124, 128). although renal 
function was failing in the remainder prior to death or before removal of the 
homograft (Figs. 123. 123. 127). 
All patients in both the Yen- Orleans and Colorado series were critically ill 
at the time of heterotransplantation. A11 exhibited early clinical improvement 
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Figure  125. SD 3. Recipient was AB+ blood group, and donor was B. The patient was anuric pre- 
operatively. The difference in quality of function of the heterografts. compared to the secondarily 
placed homograft. is e\.ident. Heterotransplant rejection crises occurred after five and 50 days. 
Urine function continued until heterografts Tvere removed. (By permission of Trcozspla~ztation 
2: November. 1964.) 
at the time of initial diuresis and for varying periods thereafter. However, recov- 
ery was interrupted in each instance (Table 40, baboons: Table 36, chim- 
panzees) by early rejection crises which lr.ere characterized by transplant site 
tenderness, and by the other stigmata of rejection (see Chapter 15). The in- 
fluence of these episodes upon renal function of the baboon heterografts is 
graphically portra>ed in Figures 123 to 128. 
The management of rejection in both the chinlpanzee and baboon cases 
was more difficult than after holnotransplantation. The rejection crises tended 
to be repetitive and closely spaced, a feature more prominent in the baboon 
than in the chimpanzee series. The indil-idual crises in both types of case 
could be at least partiall>- controlled in lnost instances ~vi th  local transplant ir- 
radiation. actinom>-cin C.  or increases in steroid dosage. \I-ith the baboons, the 
adverse consequences of rejection could not be completel!- re1-ersed before the 
onset of the next assault (Figs. 124-1528), and the cumulative effect was 
276 / RENAL HETEROTRANSPLANTATION 
100 
URINE No 75 
(rnEq / L )  
50- 
URINE 750 
UREA 
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TIME IN DAYS 
Figure  126. SD 4. Course after heterotransplantation (left) and subsequent homotransplantation 
(right). The patient was B- blood type, and received donations from a B baboon and a n  0 human 
volunteer. The cause of death tvas pneumonia. S o t e  sharp falls in urine sodium concentration with 
heterograft rejection episodes. ( B y  permission of T r i i i ~ s p l c c ~ ~ t i i t i o ~ z  2:  No\-ember. 1964.) 
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Figure 127. SD 5 .  Fulminant rejection with development of anuria in 10 days. Patient was 0- 
blood type. Baboon was AB. 
PREDNISONE ,,,_ 
(mgrnlday) 
200 
progressive deterioration interrupted by incomplete remissions. In the two 
longest surviving patients of the baboon series, removal of the heterografts 
was necessitated by the sudden formation of masses in the transplant areas. of 
such size in one as to produce massive edema of the right leg which was ap- 
parently due to local colnpression of the 1-enous and 1.i-mphatic systems. At the 
time of reoperation. the sn-ollen and boggy heterografts were surrounded ~v i th  
300 to 1.000 1111 of serosanguineous fluid under considerable pressure. 
Because of the intensity of rejection, it TI-as difficult to successful1~- relax 
the stringent!- of immunosuppressi~-e lneasures in the chimpanzee heterotrans- 
plants, and it was impossible in the baboon series. In the latter group, every 
- 
1 
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F i g u r e  128. SD 6. Patient (0+) received AB baboon heterografts. Rejections occurred a t  four, 
18. and 48 da>-s. Direct cause o f  death was pneumonia.. Note gradual falls of' creatinine clearance 
- 
L PT. G.S. 
1,000- o 3 5 Y O  3 W 58 2 -, 71 5 k g m  
800- URINE 
UREA 
CONCENTRA- 600- 
TlON 
400- (m gm 'lo) 
200-  
and slow progression of azotemia between partiall!. re\-ersible rejection crises. (By  permission of 
T r a ~ z s p l a i z t n t i o ~ z  2: November. 1964.) 
0 
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3,000- 
URINE 
VOLUME 21000- 
(cclday) 
attempt to reduce the dosage of prednisone was followed by serious rejection. 
The prolonged use of dosages in excess of 100 mgm per day resulted in profound 
hypercorticism. The extraordinary degree of im~nunosuppression required to 
maintain e ~ - e n  mediocre function after baboon heterotransplantation (Figs. 
123-128) undoubtedly contributed to the septic complications which played a 
role in the unfal-orable outcome of the majority of cases (see Table 20. Chapter 
21). Similar difficulties were encountered by Reemtsma in maintaining chim- 
panzee heterografts, although his longest li\-ing patient had had steroids 
reduced to 40 mgm per da!- after 18 weeks with continuation of essentially 
normal renal function. 
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BABOON HETEROGRAFT FUNCTION 
E a r l y  Fzinctio?z. The most detailed functional studies of the baboon heter- 
ografts were obtained for the first few days after operation. Table 37 indicates 
24-hour urine volume, changes in BUN. and clearance of PAH and endoge- 
nous creatinine for the first three postoperative days.'.' 
A large diuresis was observed in each case. Urine volume for the first 24 
hours ranged from 8.710 ml to 24.510 ml with a mean of 16,500 ml. Volume 
fell sharply in the second 24 hours to an average of 4,330 ml with a range of 
2,555 ml to 6,000 ml. 
Blood urea nitrogen fell progressively for the first three days in the 
majority of baboon heterotransplants. but reached normal only in Patient 2 
(Table 37). Creatinine clearances six hours post-transplant averaged 37.9 ml 
per minute with a range of 15 to 59. Tavelve hours later, Ccr had increased to 
34 to 61.1 ml per minute lvith a mean of 46.3. Simultaneous PAH clearance 
ranged from 74 to 216 with a mean of 123 ml per minute at six hours and 130 
to 316 with an average of 253 ml per minute 18 hours post-transplant (Table 
37). 
Later Heterocjraft Fzi t ~ c t i o ? ~ .  Figures 123 to 128 portray 24-hour urinary 
output, B U N ,  Ccr, and urinary sodium (in two cases) before operation and for 
the duration of the patient's sur\.ival. In t~vo  of the cases, comparison with the 
subsequent beha\-ior of secondarily placed homografts was possible (Figs. 125, 
126). It should be emphasized that the recipients' diseased kidneys were re- 
moved in each case so that the function studied was entirely that of the trans- 
planted tissue. 
The early renal function described above was not normal, but it was suf- 
ficient to produce immediate clinical benefit, and if sustained, it seemed to be 
compatible with long surl-ival. Unfortunately. acute deterioration was noted in 
all but the first baboon heterotransplant within eight days. with the onset of 
the first of multiple rejection crises (Figs. 124-128). Even with partial reversal 
of these crises, there was a progressi\-e deterioration of function. and renal 
failure contributed to or was the direct cause of death in each instance (Table 
39). 
COMPARISON OF HETEROGRAFT REJECTION 
TO THAT OF HOMOGRAFTS 
The characteristics of heterograft rejection have been found in both the 
Neav Orleans chilnpanzee series and in the baboons to have many features in 
common n i th  those of homografts. After allnost all the recently performed 
heterotransplants. function n-as prompt in the earl! postoperative period, and 
in  s e ~ e r a l  it kvas on11 slightly less adequate In many respects than that 
"Examinations were performed by Doctor David A. Ogden. 
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described by Homer Smith for the normal animal. In the majority of both 
chimpanzee and baboon heterograft transplants, the urine composition during 
diuresis was similar to that described in Chapter 12. Nor were the subsequent 
events qualitative1~- unique in cornparison to the behavior of homografts. Re- 
jection crises occurred which were partially reversj.ble, which had the same 
general characteristics seen after homotransplantation, and which responded 
to the same therapeutic measures. The differences were quantitative in that 
rejection of the alien tissue was more vigorous and insistent and that evidence 
of host-graft adaptation was not seen in any but Reemtsma's longest surviving 
patient. 
The alterations in renal function seen during heterograft rejection are 
shown in Figures 124 to 128. There were diminutions of urine volume, sudden 
rises in BUN and serum creatinine, and declines in creatinine clearance. The 
changing patterns of urine composition described in Chapter 15 were also ob- 
served in both the baboon (Figs. 125, 126) and chimpanzee transplants. This 
sequence consisted of a sharp diminution of urine sodium concentration at the 
time of oliguria, usually with an  increase in urea and creatinine concentration. 
Despite the similarities to homografts and the ease with which partial re- 
jection reversal could be achieved with actinomycin C,  local x-ray therapy, or 
adjustment of steroid and azathioprine dosage, the improvement in most cases 
was transient (Tables 36, 40). Especially with the baboon heterografts, restora- 
Table 40. Features of Rejection and Its Reversibility after 
Baboon Heterotransplantation 
Onset Durat ion before Agent Used for Case *Degree o f  (days) Reversal Reversal Therapy Reversal 
1 None de f in i te  --- --- --- 
2 5 2 days Ac t inomyc in  C Excel lent  
9 3 days Act inomycin C: local  x-ray --- 
15 Irreversible Act inomycin C: local  x-ray None  , 
3 5 4 days Loca I x-ray 
5 0  --- N o t  attempted 
Good 
--- 
4 8 21 days Ac t inomyc in  C: local  x-ray Fair 
37  6 days Ac t inomyc in  C: local  x-ray Fair 
5 4 2 days Local x-ray Fair 
7 Irreversible Act inomycin C: local  x-ray; None 
increased steroid 
6 4 3 days Local x-ray Good 
18 5 days Ac t inomyc in  C: local  x-ray Fair 
48 --- N o t  attempted --- 
*Complete reversal was no t  achieved i n  any instance since improvement ceased before pre-existing 
renal funct ion hod been reached. The consequence was a progressive deter iorat ion o f  function, 
interrupted by I remissions. 
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tion of renal function was either short-lived or incomplete. Ff'ith the baboon 
donor, the shortest interval between the first and subsequent rejection crises 
was three days. and the longest was 45 days. Between these dramatic occur- 
rences, there was frequently a subtle diminution in function (Figs. 124-128). 
COMPARISON OF BABOON AND 
CHIMPANZEE HETEROGRAFTS 
In the pathological section (Chap. 25), it will be pointed out that the degree 
of s t ruc tura l  damage  was greater  i n  the baboon heterograf ts  t han  i n  
Reemtsma's chimpanzee transplants. In Tables 36, 38, 40, and 41, other 
measures can be compared following the use of the two types of donors. On 
superficial examination, it appears that the survival of patients receiving ba- 
boon donations was at least as good as in those receiving chimpanzee kidneys 
if one excludes from consideration Reemtsma's longest living patient (Table 
36). Nevertheless, there seemed to be a definite functional superiority in the 
latter type of heterograft. The average of daily creatinine clearances during 
the entire postoperative period was much higher in three of these patients 
than that attained in any of the baboon series (Table 36). Relief of azotemia 
was also more complete (Table 36). Although the weights of the chimpanzee 
Table 41. Recipient Patients'% 
Wt, Sex of  Reno l Contraindicat ion for Case Wt .  Age Donor Disease Volunteer Homograft 
1 61.6 kgm 40 20.9 kgm male * * C G N  None available; age; 
neuropathy 
2 62 kgm 46 17.3 kgm male C G N  Age: advanced 
neuropo thy 
3 47.2kgm 17 16 .4kgmmale  C G N  Mu1 t iple recent 
pulmonary emboli and 
abscesses; 
? tuberculosis 
4 53.6 kgm 18 24.8 kgm male C G N  None avai lable; 
neuropathy 
5 46.3 kgm 35 15.7 kgm female Pyeloneph. None available; 
pyelonephrit is 
6 69.8 kgm 35 16.4 kgm female C G N  None available; 
neuropathy 
* A l l  were male. 
**Chronic glomerulonephritis. 
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donors (Table 36) were approximately twice those of the baboons (Table 41), 
the functional disparities between the two groups exceeded those of the weight 
disproportions. 
Furthermore. the rejections in the chimpanzee heterotransplantations of 
the New Orleans series did not occur at such brief intervals (Table 36),  and 
were more completely reIersible. Finally, the results in Reemtsma's chim- 
panzee cases were obtained with far less dependence upon steroid therapy, the 
maximum doses of prednisone ranging from 40 to 100 mgm per day. Thus, 
better control seemed to have been possible without such a high degree of im- 
munoparalysis. despite which septic conlplications still contributed heavily to 
his mortality figures. On the basis of these findings. it may be tentatively 
suggested that the chimpanzee is a biologically more satisfactory source of 
donated kidney tissue for human use than the baboon. 
T H E  PRESENT UTILITY O F  HETEROGRAFTS 
Results of recent clinical heterotransplantations provide little hope that 
heterografting procedures will be of immediate consistent value for the 
treatment of human renal disease. .4lthough there appears to be a slight ad- 
vantage in the use of the chimpanzee, only one survival of significantly more 
than two months was obtained with either species of donor. Nevertheless, the 
amount of potentially useful information that can be obtained from a limited 
number of well monitored clinical heterotransplantations is great from the 
physiologic. immunologic (Chap. 24), and pathologic (Chap. 25) points of view. 
As will be discussed in the ensuing chapters. many new observations have 
been made after those procedures which may contribute to a more fun- 
damenta l  understanding of the rejection process,  and  may lead to the 
development of better immunosuppressive techniques. 
These benefits of heterotransplant research have been of little comfort 
to the unsuccessfull~ treated patient or his bereaved family. Consequently, a 
misleading prognosis must not be given before such an undertaking. The use of 
any form of heterotransplantation must be considered as the purest form of 
investigative effort, and it is necessary to make this clear to all in\-ol\-ed. There 
is, at present. no place for unplanned or casual procedures of this type. What 
must emerge from a minimun number of cases is a clean body of unassailable 
factual data upon which to build future progress. There is no other justification 
for such a surgical experiment. 
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Chapter Twenty-four 
IMMUNOLOGIC STUDIES OF 
BABOON-TO-MAN RENAL 
HETEROTRANSPLANTATION 
b y  Charles H .  Kirkpatrick, M.D., 
and W .  E .  C .  Wilson, M.D. 
The homograft rejection phenomenon is an  immunologic process which is 
determined by genetic factors. The survival time of skin transplanted between 
mice of different inbred strains varies directly with the antigenic similarity 
between the donor and recipient strains. Although transplantation between 
members of different species has been the subject of relatively little sys- 
tematic study. the fate of heterospecific organ transplants appears to be an  
extension of this concept. 
It was documented in the early transplantation literature that kidneys, 
grafted between members of widely disparate species. failed rapidly following 
revascularization. However, the more recent demonstration by Makinodan that 
mice may be protected from otherwise lethal irradiation by infusions of rat  
bone marrow suggested that immediate destruction of the heterografted tissue 
might be pre\-ented if there was intensive suppression of the immune response. 
The temporary function of kidneys transplanted from baboon donors to 
human recipients (Chap. 23) supports this postulate, but the ~.igor of the im- 
munologic response n-hich \\-as e\-oked emphasizes the importance of the ge- 
netic disparit>- that existed. Inasmuch as each of the six patients n-as dem- 
onstrated preoperatii-el?- to possess a circulating antibod>- lvhich agglutinated 
the erythrocl-tes of his donor baboon, a unique opportunity existed to study 
the relationship of a hurnoral antibody to the rejection reactions. 
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Table 42. Clinical Data from Recipients of Baboon Kidneys 
before Transplantation 
* * *BUN 
(mgm %) 
1 4 0 C G N  2.6 
2 46 C G N  0 
3 17 C G N  0 
4 18 CGN 1.6 
5 35 CPN 0 
6 35 C G N  1.8 
*CGN-chronic glornerulonephritis. 
CPN-chronic pyelonephritis. 
**Creatinine clearance. 
***Blood urea nitrogen. A l l  patients had received mul t ip le  hemodialyses, 
so the figures noted do not ref lect the severity of the uremic process. 
Table 43. Comparison of ABO Types of Recipients and Baboon Donors 
Recipient Baboon 
Patient Blood Blood 
Group Group 
BLOOD GROUPING 
The six patients who received baboon heterografts had irreversible renal 
failure with severe uremia. In five cases the underlying disease was chronic 
glomerulonephritis, and in one. chronic pyelonephritis. All the patients were 
males, and their ages ranged from 17  to 46 years. The clinical features of these 
six patients are summarized in Table 42. Typing of the human erythrocytes 
was done according to standard procedures using comn~erciallp prepared anti- 
sera. The results of the blood grouping are shon-n in Table 43. Patients 1. 3 ,  
and 4 lvere group A. XB, and B, respectively, and the remaining patients were 
group 0. 
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The XB groups of the baboons (Table 43) xvere determined by Doctor J. 
Moor-Jankowski. One baboon was type A. three were type B, and two were AB. 
Human erythrocl-tes are classified as &A. B. XB, or 0 according to their reac- 
tions with type-specific antisera. Determinants cross-reacting with h u m a n  
anti-A and anti-B typing sera ha\-e been found on the red cells of chimpanzees, 
orangutans,  and gibbons, but not on the red cells of Old [Yorld monkeys (Cer- 
copithecidae) such as baboons and rhesus monkeys. Therefore. the "blood 
group substances" of the donor baboons were determined by two indirect meth- 
ods. The sali1-a and other secretions of these animals contain the blood group 
substances A. B. or AB which react with tl-pe-specific h u m a n  antisera and spe- 
cifically inhibit the agglutination of the h u m a n  erythrocytes. For example, the 
saliva of a type A baboon will abolish the agglutinating property of anti-A 
serum for group X h u m a n  erythrocytes. In  addition, the serum of the baboon 
contains agglutinins for h u m a n  red cells of the reciprocal type with the result 
that  the serum of a type A or B baboon will specifically agglutinate h u m a n  type 
B or A erythrocytes respectively. Using these methods, Wiener and Moor- 
Jankowski have found baboons with A, B, and AB types, but none with 0. 
SEROLOGICAL STUDIES 
Blood samples were collected from the six recipients preoperatively and  
serially after transplantation of the baboon kidneys. The serum was removed 
after centrifugation. divided into aliquots, and stored a t  -20°C. Thus eryth- 
rocyte agglutinin activity in a series of samples from a n  individual patient 
could be assessed using a single preparation of test red cells. if7hen all the sam- 
ples from one recipient were not e\-aluated together, sera from the first group 
were restudied lvith the second to pro\-ide control for nonspecific variation. To 
quantitate the agglutinin activity. serial doubling dilutions of each serum sam- 
ple were prepared with saline. An aliquot of a 2 per cent saline suspension of 
washed test red cells xvas added to each dilution. The titers were read after in- 
cubation at 25°C for one hour. 
A n t i - A  rtlzcl A ~ z t i - B  r l g g l l ~ t i ) z i ? z s .  Four patients (Cases 2. 4. 3. and 6) had 
agglutinins for type A h u m a n  erl-throcytes preoperati\-ely. Patient 4. type B ,  re- 
cei\-ed the kidneys of a type B baboon, and a \-ery gradual decrease in anti-A 
activity was noted during the postoperative period (Fig. 129). Patients 3 and 6 
were group 0 and receil-ed kidneys from type XB baboons. and in both patients 
a rapid fall in titer occurred (Figs. 130. 131). Patient 6 subsequently showed a 
brief rise in titer and then a s lo~v  fall similar to that  seen with patient 4. Patient 
5 became anuric on the ninth postoperati\-e dal-. and his anti-X activity in- 
creased rapidly (Fig. 130). Patient 2 was also group 0 and receil-ed a kidney 
from a type B baboon. The le\-el of anti-X actil-it!- in this patient also decreas- 
ed: hon-el-er. the fall was somewhat slower than that  noted with patients 5 and 
6 (Fig. 132). 
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F i g l i ~ e  129. The anti-,\ hemagglutinin and heteroagglutinin activities in Patient SD 4, type B, 
following transplantation of kidneys from a type B baboon. The rejection episodes occurred from 
day 8 to day 29 and from day 37 to day 43. The heterografts were removed and replaced by a homo- 
graft on day 49 (arrow). ( B y  permission of T~nizsplrtntation 2: November. 1964.) 
PT. 5 
2 4 6 8 10 12 14 16 18 
POST OPERATIVE DAYS 
Figure 130. Serial nleasurements of the acri\-ities of anti-.A and anti-B hemagglutinins and 
heteroagglurinins of Patient SD 5. t!-pe 0, follo~r-iilg tra~lsplantation of the kidneys from a type AB 
baboon. So te  that the antlbody titers rose after the patient became anuric during the second rejec- 
tion episode. B>- permission of T r i c ~ ~ s p l i i ~ ~ t ~ t i o l z  2 :  Nor-elnber. 1964.) 
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PT. 6 
REJECTION EPISODES 
0 3 ,-----, ANTI -B  
o c  ANTI - A  
. . HETEROAGGLUTININS 
1 
5 lb 1'5 2b 35- 30  35 410 
POST OPERATIVE DAYS 
Figure  131. The activities of the anti-A and anti-B agglutinins and heteroagglutinins of Patient 
SD 6, type 0, following the transplantation of kidneys from a type A B  baboon. (By permission of 
Transplantiltion 2 :  Nor-ember. 1964.) 
Figure 132.  The postoperatir-e changes in titers of anti-A and anti-B hemagglutinins and heteroag- 
glutinins of Patient SD 2,  group 0, follo~ring transplantation of the kidne!-s of a type B baboon. The 
clinically apparent rejection episodes are also shol\-n. B!- permission of Trrcltsplic,ltatzo,z 2: Novem- 
ber, 1964.) 
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I PT. I 
I ,----, ANTI-B  HETEROAGGLUTlNiNS 8 ----------------- 6 
- 
POST OPERATIVE DAYS 
Figzcre 133. Serial measurements of the anti-B hemagglutinin and heteroagglutinin activities in 
Patient SD 1, blood group A, follo~ving transplantation of kidneys from a type A baboon. (By permis- 
sion of Trn?2splautrction 2: November. 1964.) 
Patients 1, 2, 5, and 6 had anti-B agglutinins before the transplantation 
operation. In Case 1,  both the donor and recipient were group A, and no change 
in anti-B occurred (Fig. 132). The remaining three patients were group 0 and 
received kidneys from type B or AB baboons. In all three patients a rapid de- 
crease in activity occurred following the transplantation (Figs. 130.132). How- 
ever, late increases in titer were seen in each case. Two patients, Cases 2 and 5 ,  
became anuric (Chap. 23) and in one (Case 5) a marked increase in agglutinin 
activity was seen. The relationships of the antibody titers and the active rejec- 
tion reactions for each patient are shown in Figures 129 to 133. 
In summary, postoperative decreases in the activities of preformed anti- 
bodies to human A and B erythrocytes were observed in all three patients 
who recei1-ed kidneys from baboons mismatched with respect to the A B  sys- 
tem. These three patients n-ere group 0. One received the kidneys of a type B 
baboon. and two receil-ed the kidneys from type XB baboons. The fall in anti-A 
and anti-B titers in Patients 3 and 6 and anti-X titer in Patient 2 was presum- 
ably the result of absorption of the antibodies on the antigenic sites within the 
transplanted organs. The -4 and B agglutinogens ha\-e been demonstrated on 
the capillary endotheliuln of hunlan kidneys b>- Szulman. and also in aqueous 
extracts of organs iillcluding kidne>-s) fronl rhesus monkeys by IViener. Can- 
dela, and Gross. Although the rate of disappearance of anti-B appears to exceed 
that of anti-A, the differences are not significant when the data are considered 
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PT. 3 
. HETEROAGGLUTININS 
10 2 0  3 0  40 5 0  6 0  7 0  8 0  90 
POST OPERATIVE DAYS 
Figure  134. The changes in heteroagglutinin actil-it?- and the rejection crises in  Patient SD 3, 
group AB, following transplantation of the kidneys from a type B baboon. The heterografts were 
replaced by a homograft on day 60. (By permission of T~ci , zsp lr in ta t ion  2: November, 1964.) 
in terms of absolute amounts of antibody removed. That the isoagglutinin titers 
never fell to zero suggests that saturation of the combining sites within the 
kidney occurred. 
The decrease in anti-A as well as anti-B activity observed in Patient 2 may 
be a result of a cross-reacting antibody present in group 0 serum. Wiener, 
Samwich. hlorrison, and Cohen identified this antibody by the obserl-ation that 
absorption of human group 0 serum with A cells also reduced the titer of anti- 
B agglutinin and. conversely, that absorption \z.ith B cells reduced the titer of 
anti-A. Although the mechanism of this cross-reactivity is not clear. an anti- 
genic determinant. C, has been proposed. The C substance is present on both 
group A and B cells: therefore, the antibody occurs only in group 0 serum. Ab- 
sorption with X presumably remoI.es both anti-X and anti-C and consequently 
reduces the actil-it!- for B cells. 
The fluctuation in hemagglutinin titers in the three patients n-ho recei\-ed 
AB mismatched heterografts did not have a clearly defined correlation with 
the rejection episodes. Nel-ertheless, specific exceptions to this general state- 
ment are of interest. Patient 2 shon-ed an elel-ation of anti-B titer during the 
course of each of three rejection crises. The highest titers were seen shortly 
after he became anuric on the twenty-fifth postoperati\-e da\- (Fig. 132). Patient 
5 underwent a mild and re!-ersible rejection reaction on the fourth postopera- 
tive day, but an intractable rejection crisis occurred on day 7. The patient was 
anuric from day 9 until his demise on the nineteenth day after transplantation 
(Fig. 130). During this anuric phase his anti-A and anti-B activity rose markedly, 
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and hemolytic antibod>- actil-ity ~ v a s  demonstrable. Patient 6 also showed a 
rise in anti-X and anti-B actil-ity during his second rejection episode. Serum 
samples Lvere not available during the final rejection reaction n-hich began 
48 days after transplantation. 
Although a precise explanation for these changes in antibody activity is 
not apparent. it is of interest that each patient showed an increase in antibody 
activity during his second. and in one case, first and third rejection reactions. 
These changes are consistent with the hypothesis that one component of the 
tissue rejection is reduction in blood flow (see Chapters 13 and 25), a change 
which would result in functional exclusion of the circulating antibody from 
the combining sites within the kidney. The increases in agglutinin activities 
also suggest that ne\v antibodies were being synthesized while the patients 
were under intensive irnrnunosuppressive therapy. 
Heteroclgglzlti1zi,2s. Although baboon erythrocytes do not possess A or B 
antigenic determinants, they frequently agglutinate in human sera. The re- 
sponsible human heteroagglutinin is usually present in low titer, and its activity 
may be abolished by slight dilution. Preoperative serum samples were analyzed 
for heteroagglutinin activity in all six recipients. il'ith the exception of Patient 
5, each recipient was tested for this antibody employing the red cells of his 
donor baboon. The pre0peratil.e sera of all six patients contained heteroagglu- 
tinins for baboon erythrocytes (Figs. 129.134). 
The baboons lvere exsanguinated follow~ing nephrectomy, and the donor 
erythrocytes were stored in ACD solution in small aliquots at 4°C. Under these 
conditions the cells retained their immunologic properties for approximately 
two months. In five of the six cases the early postoperative serum samples 
were tested using the red cells of the donor baboon. Sera obtained more than 
two months after the transplantations and all sera from Patient 5 were studied 
using erythrocytes that were freshly obtained from another baboon of the 
same blood type as the actual donor. 
Folloxving transplantation the heteroagglutinin actil-ity disappeared in all 
six instances. In four patients (Cases 2. 4. 5, and 6) the antibody Lvas not detect- 
able by the fourth postoperatil-e day (Figs. 129.132). In the remaining two 
patients activity n-as demonstrated on the fourteenth postoperatil-e day but 
had disappeared by the sel-enteenth (Figs. 133. 134). The decrease in titer of 
this antibody follolving transplantation suggests that the antigen \\-as repre- 
sented on the baboon kidneys as n-ell as on the er?-throcytes. It is unlikely that 
the number of donor erythroc>-tes remaining in the kidne)- following perfusion 
was sufficient to cause the fall in antibod>- titer. The slow- reino\.al of the anti- 
body from the circulation implies that the colnbining sites in the kidney were 
relatil-el>- inaccessible, or that the a\-idity of the antibody for the combining 
sites n-as lon-. Finall!-. the colnplete disappearance of the heteroagglutinin in- 
dicates that initiall?. there was insufficient antibody to saturate all the a~.ail-  
able antigenic determinants, .A rapid fall in heteroagglutinin actil-it>- has not 
been obser1-ed following transplantation of chi~npanzee kidneys into man by 
the Sen -  Orleans group. DeI17itt has obserl-ed that chilnpanzee spleen and kid- 
ney tissues will not absorb the heteroagglutinin from human serum. 
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The changes in antibody actix-it)- which were observed in the later post- 
operative period are of interest when considered relative to the patient's clinical 
course. In all recipients. except Case 1. antibody acti1-ity reappeared at some 
time during the postoperative period. \5'hile in Patient 4 the reappearance 
of heteroagglutinin was associated with his first rejection reaction, there 
was no apparent relationship betlveen heteroagglutinin activity and the initial 
rejection episodes in the other patients. However, the titers \\-ere observed to 
rise in association with the subsequent crises in the five patients in whom re- 
jection crises were identified (Cases 2-6). A rapid rise in titer was seen in the 
two patients who became anuric during a rejection reaction (Figs. 130, 132). 
The reappearance of heteroagglutinin in five of the six recipients indicates 
that the kidney transplantation stimulated synthesis of the antibody. It is also 
apparent that the amount of antibody produced was sufficient to saturate all 
the available combining sites within the transplanted kidneys. 
IMMUNOLOGICAL CON'SIDERATIONS 
REGARDING GRAFT REJECTION 
The  Role of Hzlmornl a n d  Cell-Bound Antibodies. The pathogenesis of 
destruction of organ grafts has not been completely characterized, but there 
exists strong evidence that more than one immunologic pathway may be in- 
volved, at least under certain experimental conditions. 
Human kidneys, transplanted from donors mismatched with respect to the 
ABO antigen system, mav be rejected immediately upon revascularization (see 
Chapters 6, 22, 25). The rapidity of onset of the graft failure suggests that pre- 
formed humoral antibody was involved in the process, a postulate supported by 
the observation of an abrupt fall in the isohemagglutinin titer. A second model 
which implicates humoral antibody in graft rejection has been termed the 
white graft reaction. One example of this, reported by McKhann and Berrian, is 
the fate of a second skin homograft transplanted to a mouse that is rejecting a 
first graft from the same donor. The second graft does not become vascular- 
ized and consequently is rejected even more quickly than a typical second- 
set skin graft. Since erythrocyte agglutinins and cytotoxic antibodies are pro- 
duced in association with graft rejection. it has been postulated that these 
humoral antibodies mediate rejection of second grafts placed at this critical 
time. Employing canine kidney transplantation as the model system. Calne has 
reported a similar phenomenon. He observed that a renal homograft sensitized 
the recipient dog to a second kidney graft from the same donor with the result 
that the second transplant was rejected immediatel5-. Because of the rapidity 
of rejection of the second graft and the absence of cellular infiltration, he con- 
cluded that humoral antibod!.. produced in response to the first graft. mediated 
the rejection of the second. 
Preformed antibody has also been strongly incriminated in the rejection of 
heterospecific organ transplants. The rapid failure of organs grafted between 
members of widely disparate species was documented in the early transplanta- 
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tion literature by Neuhof and summarized recentls- by Calne. He observed that 
a goat kidney, transplanted into a dog, failed within minutes. follon-ing release 
of the vascular clamps. The dog's preoperative serum contained an agglutinin 
directed against the goat's erythrocytes. 
Although these obsen-ations clearly implicate humoral antibody in graft 
repudiation under certain circumstances. equally impressive el-idence in- 
dicates that graft rejection nlay proceed in the absence of hurnoral antibody 
production. Kelvborn infants (Fowler) and aganiinaglobuliilemic children 
(Good) may reject homografts despite the absence of hurnoral antibody-forming 
capability. A second obserl-ation is that by Algire that tissue grafts placed 
within millipore chambers, impermeable to lymphocytes. remain viable for 
protracted periods. It has been demonstrated by Billingham that allogeneic 
skin grafts on highly tolerant niice can be rejected only by lymphocytes from 
nontolerant mice of the same strain. Finally. Brent and Rledawar have ob- 
served that serum from sensitized mice was without effect on skin grafts in 
tolerant mice. 
Although graft rejection in different experimental models can frequently 
be ascribed primarily to huinoral antibody or alternatively to "cell-bound" anti- 
body, there is little understanding of either mechanism at a molecular level. 
Most of the fragments of evidence implicating humoral antibody imply that 
acute vascular injury is a major factor, and Stetson has postulated that an  
Arthus-like reaction is the lesion involved. As noted earlier, the experience with 
transplantation across species barriers suggests that huinoral antibody was 
important in the rejection of heterospecific grafts. 
I l e r ~ l u g g l ~ i t i ~ l ~ i t i r ~ g  A ~ t i l ~ o d l ~  crrld t h e  Rcjcc t ior~  of W c i h o o ~ ~  Kit lr~e!/  1rc1ns~)lants.  
The six patients n-ho received baboon heterografts all had early renal func- 
tion in spite of the presence of heteroagglutinins against baboon erythrocytes 
in the serum of each recipient. 1~1 S , ~ Z ~ O  acti\-it!- of the l~eteroagglutinin was 
demonstrated by the rate of clearance of Cr5' donor erythrocytes from the 
recipients' circulations. In Cases 1 and 3 the survil-a1 of donor baboon eryth- 
rocytes was measured within a few hours follon-ing the kidnel- transplanta- 
tion. Baboon red blood cells were incubated lvith 130 nlicrocuries of Cr51 for 
30 minutes at 23'C. and the reaction \\-as stopped b>- the addition of ascorbic 
acid. A small \-olume of the tagged cells lvas injected into the patient. Blood 
samples were collected at frequent inter\-als, and the radioactil-it? was deter- 
mined with a well-type scintillation counter. The heterologous erl-throcytes 
were remo\-ed from the circulation with a 30 per cent clearance time of 12 
minutes (Fig. 133). a rate comparable to that obser1-ed by Cutbush and AIolli- 
son when labeled human erl-throcytes. ~nisniatched n-ith respect to the ABO 
antigens. are infused. 
The reasons for the failure of the huinoral antibody to e\-oke an inlmediate 
immunologic reaction are not clear. One possibility is that the er!-throcpte- 
agglutinating antibody did not ha\-e affinit>- for the kidney. but this seeins 
unlikely in 1-ie~v of the consistent fall in heteroagglutinin titers follo~ving 
transplantation. X second possibhty is that the steric configuration of the 
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Figure 135. The disappearance of 
radioactivity from the circulation fol- 
lowing injection of' C1"'-labeled baboon 
erythrocytes into patients SD 1 and 
SD 3. The TI,, in each instance is 12 
minutes. 
antigen-antibody complex was not correct for initiation of a n  immediate vas- 
cular response such as that  observed by Calne. The association constant of 
the antibody for its combining site is probably not very high. Since the aggluti- 
nin apparently cross-reacts with the erythrocytes from a number of distinct 
species of infrahuman primates. it is unlikely that  the reaction with the cells of 
any particular animal is highly specific. The possibility of a lolv association 
constant is strengthened by the observation of the comparatively slow decline 
in  heteroagglutinin titer follo\ving baboon kidne>- transplantation in contrast to 
the rapid fall in specific isohelnagglutinin lel-el following transplantation of a 
h u m a n  ABO mismatched kidney (Chap. 22). Finally, the general reduction in  
immunologic capacity which is present in uremic patients (Chap. -22) probably 
contributed to a n  attenuation of the host response. This could be a n  important 
factor since the intensit?- of the Arthus reaction is a function of the amount of 
precipitating antibody in the circulation. 
In  three patients there Tvas a n  er-en greater possibility of immediate rejec- 
tion of the heterografts because of the additional presence of another group of 
preformed humoral antibodies. the anti-X or anti-B hemagglutinins, or both. 
The evidence for cross-reaction between these hemagglutinins and the hetero- 
specific transplants was just as clear as with the heteroagglutinins. It is of 
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interest, in contrast. that abrupt rejection of a chimpanzee kidney by a human 
recipient has been described using a similar ABO mismatch (Chap. 23). In the 
latter case. there was an abrupt fall in the host isohemagglutinin titer. The 
difference in results ~vi th  the chimpanzee as opposed to the baboon donor 
is presumably the result of dissimilarities in the number of combining sites in 
the kidneys of these two species and in the comparative avidity of the isohemag- 
glutinins for the combining sites. The slow decline in isohemagglutinin titer 
after baboon heterotransplantation is in accord with this concept. 
The response of the patients to the baboon kidney transplantation was gen- 
erally similar. Following an initial period of renal function, abrupt deteriora- 
tion occurred. This was reversed temporarily to a greater or lesser extent by 
additional immunosuppresive therapy. Nevertheless. rejection was not success- 
fully controlled in any case. since severe pathologic alterations were present 
(Chap. 25) in all the heterografts. and sustained adequate renal function could 
not be maintained in any case (Chap. 23). 
The findings in these patients suggest that both humoral and cell-bound 
antibodies may have been operative in the pathogenesis of the rejection reac- 
tions. Two observations may indicate a role of the heteroagglutinins. In Case 1, 
no acute rejection episode was observed, and heteroagglutinins did not reap- 
pear during the postoperative course. In the other patients, there was a temporal 
relationship between some rejection crises and the reappearance of circulating 
antibody. Whatever the role of the humoral antibodies, the heterografts also 
evoked a vigorous cellular response. The rejected organs all had an extensive 
mononuclear cell infiltration (see Chapter 25). 
Possible Puthologic E f f ec t s  of  Hemcigglziti?zati?zg Ant ibody .  While the 
heteroagglutinins and isohemagglutinins may not have mediated the rejection 
in a classic sense. these alltibodies were bound to antigenic determinants within 
the kidney and undoubtedly contributed to tissue injury. The distribution 
of these combining sites within the kidney is not known. Using another heter- 
ologous antibody system. Feldman has demonstrated that antibody. produced in 
rabbits folloaving immunization with rat kidney, avas directed against the base- 
ment membranes of rat kidneys. \t-ithin 30 minutes following rejection of this 
antiserum into a norlnal rat, structural abnormalities were found in the base- 
ment membrane, and proteinuria developed. Proteinaceous deposits appeared 
in the basement membrane, followed later by similar accumulations in the 
subendothelial region of the glomerular capillaries. The material in the base- 
ment membrane n-as composed of the rabbit antibody, basenlent membrane, 
and complement. Later. larger deposits composed of host antibody, rabbit anti- 
body, and colnplement were found. Enlargement of the fenestrations and pro- 
liferation of the endothelial cells were noted, and the foot processes of the 
epithelial cells n-ere broadened. 
Proteinuria n-as obserl-ed during the early postoperatix-e period in all six 
recipients of baboon heterografts. This proteinuria, coupled with the absorption 
of the humoral antibody, prompted a study of the ultrastructure of the glom- 
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Figure 136. Electronmicrograph of a glomemlar capillary of the heterograft removed from Patient 
SD 4. The basement membranes (b) show areas of focal subendothelial thickening (arrows) and the 
foot processes (0 of the epithelial cells are smeared. Endothelial cells (e) show some hyperplasia. 
1 -Capillary lumen. (Approx. X 5,500.) 
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Figure 137. A small part of a glomerulus of the heterograft removed from Patient SD 4. The 
arrows indicate areas of subendothelial thickening of the basement membrane (b). 1-Capillary 
lumen; e-Endothelial cells; f-Foot process of epithelial cell. (Approx. X 21,000.) 
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eruli of the heterografts n-hich \\.ere remol-ed from Patient 4. Inllnediately fol- 
lowing extirpation, sections of the kidneys were fixed in osmic acid for examina- 
tion in the electron microscope. The glomeruli of the rejected kidneys were 
abnormal. There n-as hyperplasia of the endothelial cells n-ith considerable 
thickening of the cytoplasmic lining of the capillaries. The endothelial cells 
were swollen and vacuolated. There was smearing of the foot processes of the 
epithelial cells. However, these changes are not specific. as they may occur 
with a variety of renal injuries that result in proteinuria. \Yhile the basement 
membranes showed some fusifornl thickenings without consistent subendo- 
thelial deposits. occasional subendothelial thickenings were observed (Figs. 
136, 137). The relationship of these abnormalities to the heteroagglutinin 
absorption cannot be proved although the capillaries might be expected to be a 
site of the heterospecific antigenic determinants. 
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Chapter Twenty-five 
PATHOLOGICAL CHANGES IN 
TRANSPLANTED KIDNEYS 
by K .  A. Porter, M.D., D.Sc. 
Although this chapter will deal primarily with the histopathological changes 
encountered in the human renal transplants performed at the University of 
Colorado Medical Center. an attempt will be made to relate these findings to 
those of other investigators doing similar work elsewhere and to those ob- 
tained from animal experiments. 
Of the 64 patients treated in the living donor (LD) series at the University 
of Colorado betlveen Nolember, 1962, and  march 31. 1964. 24 died by June 1, 
1964. During the same period. three cadaveric homotransplantations (CD 
series) were performed. all unsuccessfully. Six baboon heterotransplantations 
were also attempted. n i th  death of the patients from 19 to 98 days later. An 
autopsy was granted for 30 of the 33 patients who died. In addition, seven homo- 
or heterografts became available for study after their surgical rein01 al. Finally, 
one ureter n a s  resected eight months after the initial homotransplantation 
because of a stricture In considering the findings in the 37 retrieled kidneys 
and in the slngle ureter, the homotransplants nil1 be separated from the hetero- 
transplants. 
RENAL HOMOTRANSPLANTS 
Before discussing these cases, all of which were treated with azathioprine, 
prednisone, and, in most instances, actinom?-cin C ,  it is necessary to consider 
at some length the changes that occur in untreated renal homotransplants. In 
this way a background will be pro!-ided against which nlodifications in the 
rejection pattern brought about b\- treatment can be assessed. 3Iuch of this 
information nlust inel-itably be dran-n from the results of renal homotrans- 
plantation in dogs, because not onl\- has allnost all the fundamental work been 
done in these experimental animals. but also because on no occasion has a 
kidne>- been homotransplanted into a healthy nonuremic human. 
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At this point. a distinction has to be made bemeen first and subsequent 
renal homotransplants. I11 their classic descriptions, both Dempster and Simon- 
sen drew attention to the fact that a second transplant from the same donor 
not only functioned for a shorter time than the original transplant. but showed 
different and rather characteristic histological changes. However, a second 
transplant from a donor other than the original one looked and behaved like a 
primary transplant. Except ~vhere  specifically stated, the following account 
refers only to primary homotransplants. 
UNTREATED CANINE RENAL HOMOTRANSPLANTS 
Homotransplants in dogs rapidly become swollen so that they are two or 
three times as hea1.y by fi\-e days as they had been originally, and the capsule 
and perirenal tissues become thickened. \Yhen the kidney is examined on the 
day urine flo~v has ceased, the cut surface can show se\.eral patterns. The cortex 
is usually wider than normal, pale. and swollen. There may be hemorrhagic 
foci scattered throughout the kidney: sometimes the hemorrhage is predomi- 
nantly medullary in distribution. 
Microscopically there is an infiltration with lymphocytes and a 1-ariety of 
cells with pyronine-positive cytoplasm (Fig. 138). This invasion starts in the 
cortex, can easily be seen in conventional sections at about the third day. and 
progresses until the kidney becomes anuric. At first, the cellular infiltration is 
focal (Fig. 139, top), but later the cells are diffusely distributed in the inter- 
stitium (Fig. 139. bottom). Electronmicroscopic studies have shown that at 24 
hours small lymphocytes can be found adhering to the endothelial cells lining 
the peritubular capillaries and I-enules in the cortex (Fig. 140, top). From 
48 hours onward two groups of larger cells appear. 
Many of these cells resemble either large l!-mphocytes or monocytes (his- 
tiocytes). Two such cells are seen in Figure 140, bottom. The nucleus is often 
indented. and there is usually a large nucleolus. The cytoplasm is abundant 
and contains many ribosomes. a f'exv granules. and some 1-acuoles. Small pro- 
jections froin these cells indicate micropinocytosis. Endoplasnlic reticulum is 
frequently present but rarely abundant. YIitochondria are large and numerous. 
Some of the infiltrating cells, hon-e~-er,  seem to be of the plasma cell series 
(Fig. 141). They ha1-e a central or slightly eccentric large nucleus in which the 
chromatin is loosel>- arranged and nucleoli are sometimes seen. The cytoplasm 
is usually abundant n-ith a pronlinent ~vell-del-eloped elldoplaslnic reticulum 
with many ribosomes attached to the surface of the membranes. In some the 
reticulum is lamellar, but in a f e ~ v  the cal-ities are dilated and contain ainor- 
phous material (Fig. 1-12). -1 Golgi zone is often apparent close to the nucleus. 
RiIitochondria are fairl>- numerous and prominent. 
The heterogeneity of the cell population entering homotransplanted kidneys 
contrast with the homogeneity of the infiltrate in skin hoinografts in which 
Wiener. Spiro, and Russell 11a.1-e demonstrated that all cells are of the "lpmph- 
ocytic" type until the final stages of rejection. 
T e x t  c o n t i n u e s  o n  page 306. 
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Figure 138. Dog kidney five days after homotransplantation into an  untreated recipient. High 
power view showing heterogeneity of cellular infiltration. Many of the cells have basophilic cyto- 
plasm. A few are obvious plasma cells (p); some are small lymphocytes (s); a few are large "lymph- 
oid" cells (L); many are intermediate in their size and cytoplasmic characteristics between these 
main groups. H and E (X 870). 
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Figure 139. Top-Dog kidney five days after homotransplantation into an untreated recipient. 
There is a heavy, but focal, cellular infiltration. Some of the proximal convoluted tubules are under- 
going necrosis, and epithelial debris is seen in the lurnina. 
Bottom- Untreated canine renal homotransplant at eight days. The heavy cellular infiltration is 
diffuse, and includes some neutrophils. There is much tubular necrosis, and a glomerulus is under- 
going destruction. H and E (X 250). 
Figure 140. Top-Electronmicrograph of a dog kidney 24 hours after homotransplantation into 
an untreated recipient. A lymphocyte (L) is seen lying in close contact with the endothelium of a 
peritubular capillary (C) near the corticomedullary junction. On either side of the capillary are the 
basement membranes of adjacent tubules (T). The lymphocyte has several large mitochondria at 
its upper pole and a few scanty ergastoplasmic profiles (X 10,000). 
Bottom-Electronmicrograph of a dog kidney 72 hours after homotransplantation into an un- 
. 
treated recipient. Two infiltrating host cells, one resembling a lymphocyte (L) and the other a 
monocyte or histiocyte (M) are seen lying in the edematous interstitium. Both cells contain some 
profiles of endoplasmic reticulum and mitochondria. There are also granules in the larger cell and 
- many projections from the cell periphery. An erythrocyte (E) is present in the upper part of the . 
photograph (X 8300). (By permission of Lab. Invest. 13: September, 1964.) 
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Figure 142. Top-Electronmicrograph of a dog kidney 72 hours after homotransplantation into 
an untreated recipient. A plasma cell is lying in the interstitium. It shows plentiful endoplasmic 
reticulum (er) in the form of cisternae, numerous mitochondria (m), and a Golgi zone (g). (X 10,000.) 
Bottom-Higher power view of part of the plasma cell shown above illustrating the arrangement 
of ribosomes (r) on the membranes of the endoplasmic reticulum. The Golgi zone is at g (X 58,000). 
(By permission of Lab. Invest. 13: September, 1964.) 
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The c!-toplasm in both groups of large cells contains much ribonucleic acid 
(RNX) and is consequently pyronine positi1-e. In  thin paraffin-embedded sec- 
tions these pyroninophilic cells can be seen marginating in the peritubular 
capillaries and 1-enules (Fig .  143. top). Intinlate association of these infiltrating 
cells with the endothelium is fo l lo~~ .ed  by disruption of the capillary ivalls 
(Fig. 143. bottom). Under the electronmicroscope apparent telnporary estab- 
lishment of c>-toplasmic continuit)- between the infiltrating cells and the en- 
dothelial cells has  been described by Kountz and Deinpster and their associates 
(Fig. 144, top). Af'ter this, there is escape of fluid and cells into the interstitium 
of the transplant (Fig. 144. bottom). \\'ithill the graft some of'the cells undergo 
division. the total cell cycle being about 12 hours. As time passes, more of the 
cells entering the kidney 11al.e the appearance of n ~ a t u r e  plasma cells. 
There is swelling of' the endothelial cells lining the arterioles and small  
arteries (Fig. 145, top). The glomeruli undergo fen. changes. but the tubules 
become necrotic. One of the earliest tubular changes is a shedding of the 
superficial part of the proximal tubular epithelium into the l u n ~ i n a .  This dam- 
age affects most commonly the outer cortical tubules and particularly the very 
first part of these, according to Darnlady. Dempster. and Str:~nack. In  the 
terminal stage there is \videspread interstitial hemorrhage and edema. Poly- 
morphonuclear leukocytes and macrophages are prominent in the cellular 
infiltrate. Sometimes the small arteries and arterioles sholv fibrinoid necrosis 
of their walls n-ith plugging of' their lumina lvith fibrin, platelets. and cells. 
Such primary renal homotransplants in dogs usual!). cease to function 
after four to eight days. although Zukoski and Jeejeebhoy l l a ~ . e  obser\.ed func- 
tion for 60 and 30 days. respecti\-ely. In the latter experiment. a biopsy at 18 
days shoxved rnassi1-e cellular infiltration, destruction of peritubular capil- 
laries. se\.ere tubular degeneration. and obstruction of' damaged interlobular 
arteries by cells. fibrin. and platelets (Fig.  145, bottoin: Fig. 146. top). \\'hen the 
dog died at 30 days, there was widespread tubular atroph>-. interstitial fibrosis, 
f a r  less cellular infiltration. and fibrous obliteration of man>- peritubular capil- 
laries, arterioles. and snlall arteries (Fig .  146. bottom). There was commencing 
fibrous intimal thickening of some larger arteries. 
These occasional prolonged sur1-i\-als are probabl>- due to chance genetic 
compatibility of the host and donor, the transplant not possessing any strong 
histocoinpatibilit>- genes ~ v h i c h  are lacking in the host. 
UNTREATED HUMAN RENAL HOMOTRANSPLANTS 
When homotransplants have been performed for acute renal failure in 
humans,  the pattern of rejection has  been sinlilar to that  seen in dogs, although 
rather more protracted. anuria occurring at about 22 days. One of the best 
documented cases is that reported by 1Iichon and his associates in which a 
boy of 16 years tragicall?. had his only kidney remo\-ed because of hemorrhage 
Text  c o n t i r ~ u e s  on page 31 1 .  
PATHOLOGICAL CHANGES IN TRANSPLANTED KIDNEYS 1 307 
Figure 143. Top-Dog kidney 48 hours after homotransplantation into an untreated recipient. 
Host cells with basophilic cytoplasm (arrows) can be seen marginating in three peritubular capil- 
laries. 
Bottom-Dog kidney 72 hours after homotransplantation into an untreated recipient. A peritubu- 
lar capillary (arrow) has partially disintegrated, releasing erythrocytes and host cells with basophilic 
cytoplasm into the interstitium. H and E (X 550). 
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Figure 145. Top- 
from Jeejeebhoy's 
obtained, probably 
-Biopsy of untreated canine renal homotransplant at 72 hours. The tissue is 
experiment (see text) in which unusually prolonged homograft function was 
due to chance genetic similarity of the donor and recipient. There is swelling of 
the endothelial cells lining the arterioles and small arteries (arrows). 
Bottom-Biopsy of same homograft after 18 days. There is marked cellular infiltration, edema, 
and tubular damage. H and E (X 210). 
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Figure 146. Top-Same 18-day biopsy of canine renal homograft as was shown in Figure 145. 
There is obstruction of a damaged interlobular artery by cells, fibrin, and platelets. Fat spaces 
(arrow) are present just inside the internal elastic lamina due to breakdown of platelets. 
Bottom-Autopsy appearance at 30 days of the same renal homotransplant. There is widespread 
tubular atrophy, interstitial fibrosis, only a moderate cellular infiltration, and fibrous obliteration of 
a small artery (arrows). The tissue was kindly provided by Mr. H. F. Jeejeebhoy. H and E (X 210). 
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following trauma. Seven days later a kidney n-as transplanted from his mother 
who was of the same blood group. The transplant excreted 3 liters of urine in  
the first 24 hours and then 1.3 liters per d a ~ -  until the tn-ent>--second day when 
it suddenly stopped f'unctioning. \\'hen explored. the transplant n-as sn-ollen, 
purple. and speckled n-ith petechial hemorrhages, but the main 1-essels and 
ureter were patent. A biopsl- showed accumulations of lymphocytes and plasma 
cells. necrosis of tubules, and intimal thickening with thrombosis in some 
small arteries. The patient became uremic and died 10 days later. At autopsy 
many cf the intrarenal 1-essels were thrornbosed. and there n-ere many small 
areas of infarction. During the time the transplant was  in the recipient, the 
serum gamma globulin le\.el slo~vly rose. 
\fThen kidneys ha1.e been holnotransplanted into recipients with chronic 
uremia, marked prolongation of' survival has  been recorded, and the histological 
features ha\-e been modified in some instances. Nine such cases were pub- 
lished by Hume in 1935. Four of the transplants functioned adequately and 
continued to excrete urine for 37. 47. 99. and 176 days. The kidneys were is- 
chemic for 55 to 200 minutes before transplantation and because of acute 
tubular necrosis went through a n  initial period of anuria. After 8.3 to 19 days, 
repair of' the damage had progressed f'ar enough for urine excretion to begin. 
Microscopically, the kidney ~vhich  functioned longest showed striking vascular 
changes in addition to tubular atrophy, interstitial fibrosis. and foci of infiltrat- 
ing plasma cells. In many of' the arteries there was a se\-ere degree of intimal 
fibrous thickening. In many n-ays this kidney histologically resembles Jee- 
jeebhoy's 30-day canine renal homotransplant n-hich was  mentioned earlier. 
Since publication of Hurne's stud>-. it has  been proven by Mannick that  
uremia does influence the survil-al of honlotransplanted kidneys. Uremic dogs 
will retain a renal hoinotransplant for 15 to 23 days. The pathological changes 
in the uremic transplants are the same as those observed in kidneys homo- 
transplanted to nornlal dogs. but the cellular infiltration commences later. 
The mode of action of' uremia in prolonging homograft survi1-a1 is considered 
in detail in Chapter 22. 
MECHANISM OF REJECTION OF 
UNTREATED RENAL HOMOTRANSPLANTS 
Although the principal n~orphological changes in kidney homotransplants 
have been recognized for man>- years, most fundamental  aspects of the rejec- 
tion process are still far  from clear. 
H o s t  Recogizltzoiz of t h e  Ti.ni1splilizt. It is known, for example, that  the 
host's I>-mphoid tissues are made an-are of the transplant. This is based upon 
three pieces of el idence. F ~ r s t .  a second kidney holnotransplanted from the 
same donor is rejected mole quickl\- than the primary graft. Second, sensitiza- 
tion with a skin graft fro111 the donor or cross-circulation n-ith the donor prior 
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to renal transplantation TI-ill also produce rapid rejection of the kidney. Third, 
renal homotransplantatio~l causes large and medium-sized cells with pyronine- 
positive cytoplasin to accumulate in the host around the postcapillary venules 
of the lymph nodes and along the arterioles of the spleen. These cells are similar 
to those demonstrated by Scothorne in the lymph nodes draininq a skin graft. 
Hon- this information about the foreign antigen reaches the host's spleen 
and lymph nodes is not kno~vn .  
One possibility is that antigen enters the plasma that  circulates through 
the vessels of the transplant and is con\-eyed to the lymphoid tissues. perhaps by 
passage across the endothelial cells of the arterioles and postcapillary venules. 
Another possibilit>- is that circulating host l>-mphocytes interact with the 
transplant endothelium and become altered in some \\-a>-. It has  already been 
shown that  some 1yinphocl;tes are seen in thc first 23 hours clinging to the lining 
of the peritubular capillaries (Fiq.  140). These cells could then transi'orm within 
the transplant into pyroninophilic cells, some lvith endoplasmic reticulum and 
some without. and enter a proliferati\-e phase. Such transfornlation of sensi- 
tized lymphocytes is kno\vn to occur in \-i\-o and in \ itro ( see  Con-ling. Gowans, 
and Porter). Later s o n ~ e  of the progeny of' these cells could enter the blood 
stream, traT el to the 1\ inphoid tissues of the host. dnd thcre form further clones 
of pvroninophilic cells. 
A third explanation is that  the lymphocytes, after contact with the kidney 
antigen, lea1.e by n-a>- of the blood stream, enter the host's lyinphoid tissues, 
and there transform into large proliferating cells. Some of the cells produced 
then return to the kidne\ la the l \ inph and blood streain, at tach t h e i n s e l ~ e s  to 
the pentubular caplllarT endothell,\l cells. and there cause local damage. The 
last explanation fits the knonn  facts best F,upeliinents in our laboratory in 
whlch l \mphoc\ tes  n e l e  labeled l t i th tlltlated th~rn id ine  and adenosine 
showed, first. that cells plesent In the tholacic duct 1\ mph of the host four da? s 
after  renal transplantation enter the transplant, and,  second, that some of 
the cells lnfiltratlng the graft had been manufactured In the spleen after renal  
transplantation 
Prodzlct/o12 of Cell-Bo111zd A ~ ~ t z l ~ o d ~ j  I lhlle damage to the ~xa l l s  of the 
peritubular capillaries following contact n-it11 the p!-roninophilic cells is presurn- 
ably caused by a cell-bound antibody, there is no proof of this. The paucity of 
rough endoplasnlic reticulum and profusion of free ribosomes ~vi thin  many of 
the cells that  infiltrate the graft in the hrst fen- da>-s may be related to the fact  
that  these cells are producing antibodies which are not released, but adhere to 
the cell surface. 
Localization of the infiltrating cells in the peritubular T-essels may be 
determined simpl>- b>- the slon-ness of the blood flo~l- in this capillar>- meshn-ork 
leading to margination of l>-mphocytes, just as m a r ~ i n a t i o n  of pol>-morphs in  
the T-enules in acute inflammation follo~r-s loTvin2 of the blood ~ ~ O T T - .  his proc- 
ess might be encouraged b>- unusual stickiness of the endotllelium resulting 
froin the slight ischemic damage which is ine~- i table  in all renal transplan- 
tations. 
Destruction of the peritubular capillaries will inevitably lead to interstitial 
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edema, some hemorrhage. ischenlic necrosis of the proximal tubules. and func- 
tional arrest of the transplant. This sequence of e\-ents prob,~bly accounts for 
the abrupt termination of function of nlost unmodified kidney homotransplants, 
as suggested by Kountz and his colleagues. 
Prodllctioiz of Ci i.cziloti)z(j Ailti1)odlj. In the terminal phases of renal  
homograft rejection in both humans and dogs, areas of' fibrinoid necrosis may 
occur in the n-alls of' arterioles and arteries. Recently Horowitz and his as- 
sociates demonstrated b>- a fluorescent-antibod>- technique that  gamma globulin 
appears in the n-alls of' the arteries and arterioles of the transplant during 
rejection. They found that this gamma globulin 11-as soluble in acid buffer and  
that  it bound complement. features which suggest that it is probably part of a 
recent l~ .  formed antigen-antibody complex. Reaction of antibody with antigen 
in vessel walls causes damage, and could account for the endothelial swelling 
and marked fibrinoid necrosis noted in some transplants. 
Although this antibody might come from host cells infiltrating the vessel 
walls, there is some e \  idence that circulating antibod>- is in\.ol\.ed. Folloaving 
kidney ho~notral-isplantation. the tnorphological changes that  occur in the 
lymphoid tissues of' the host resemble those seen when antibodies are being 
produced against known antiqen. This naturally leads to speculation that  
antibody against the transplant antigens is nlade by cells in the host's lymphoid 
tissues and. af'ter a delay of' solne days, is released into the circulation. Such a 
thesis could explain the localization of' fibrinoid necrotic lesions to the arteries, 
arterioles, and glomerular capillaries because circulating antibodl- would tend 
to be deposited most heavily in that  part of the foreign vasculature first en- 
countered. 
The difficulty in demonstrating circulating antibody against a primary renal  
homotransplant which has been experienced by man)- investigators in the 
past may simply be due to sampling before there has  been time for the anti- 
body titer to reach detectable le1-el5 and to the use of relati1-el>- crude analytic 
techniques. X rise in the serum gamma qlobulin of four of fi1-e recipient dogs 
10 to 12 days after relno\.al of' a renal homotransplant x.r-hich n-as mentioned 
briefly b>- iT-est. the rise in gamma globulin in the human  renal homotrans- 
plant recipient reported I>!- 1Iichon. and the recent demonstration b!- Simonsen 
and Altman of c>-totoxic antibodies appearing bet~veen se1-en and 14 days after 
transplantation TI-ould all tend to support this \ - ie~v.  
TREATED HUMAN RENAL HOMOTRANSPLANTS FROM THE 
UNIVERSITY OF COLORADO MEDICAL CENTER 
For convenience the findings in these homotransplanted h u m a n  kidneys 
will be described under sel-en headings: 
1. Three transplants n-hich did not function a t  all because of prolonged 
ischemia. 
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2. Two transplants which failed immediately, probably because the major 
blood groups of donor and recipient n-ere not compatible. 
3. One transplant n-hich bled, necessitating its renlol-a1 after four days. 
4. A transplant which n-as examined 12 hours after operation because of 
the death of the patient from electrolyte imbalance. 
5. Fourteen transplants n-hich tvere examined during or just after a rejec- 
tion episode. 
6. Eight transplants from patients n-ho died some time after at least one 
rejection episode had been recognized and apparently treated successfully. 
7. Three transplants from patients who died without having had at any 
time a clearly recognizable clinical episode of rejection. 
TRANSPLANTS WHICH DID NOT FUNCTION 
BECAUSE OF ISCHEMIA 
The three patients who received these kidneys have been referred to briefly 
in Chapters 8 and 19. In one case (LD 29) the renal homotransplant, which 
came from a living donor, had been ischemic for 85 minutes, never functioned, 
and was removed at 48 hours. In a second case (CD 3 ) ,  both kidneys from a 
man who had died from a inyocardial infarct were transplanted into a woman. 
The left kidney was ischemic for 137 minutes and the right for 215 minutes. 
Both failed to excrete urine and the patient died at four days. The third patient 
(CD 2) recei1-ed a cadaveric homograft n-hich xvas revascularized in the re- 
cipient 124 minutes after death of the donor. After 12 days of anuria. the kid- 
ney. which ruptured after minor trauma. was removed. 
Grossly. the kidneys in these cases n-ere found to be slightly swollen, soft, 
pale, and a little hea1-ier than before transplantation. The cortex was widened 
and the corticomedullary junction blurred. The I-essels were patent and the 
ureter was unobstructed. 
AIicroscopically, there was massive recent tubular necrosis, affecting par- 
ticularly the proximal part of the nephron (Fig, 147). The lulnina of the tubules 
were filled with casts of protein and cell debris. There was e\-idence of active 
repair in the form of mitoses among surl-ir-ing proximal tubular cells and the 
lining of some tubules by new flattened epithelium. The interstitium n-as edem- 
atous and contained scattered foci of small lymphocytes. plasma cells, and 
occasicnal pol?-rnorphs. chiefly in relation to se1-erel>- damaged tubules. Cel- 
lular infiltrate n-as most prominent in CD 2 ~ v h o  was actil-el>- rejecting ' see Fig- 
ure 157). The glomeruli were normal in the transplant that had come from 
the lil-ing donor. but in one of the other cases there ivas periglomerular fibrosis 
and a few fibrotic glomeruli. The cacial-eric kidneys also s h o ~ ~ - e d  sonle fibrous 
intimal thickening of the interlobular and arcuate arteries. 
Figure 147. Top-Cadaveric human renal homotransplant from Patient CD 3 examined at four 
days. The transplant was ischemic for 137 minutes. There is severe tubular necrosis involving 
particularly the proximal parts of the nephrons which are filled with casts of cell debris. The inter- 
stitium is edematous. H and E (X 125). 
Bottom-Higher power view of transplant from Patient CD 3. Some of the proximal tubules are 
lined by flat regenerating epithelium. The glomerulus shows slight periglomerular fibrosis, but is 
otherwise normal. H and E (X 300). 
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Such tubular changes are characteristic oi temporary complete ischemia 
of a kidne>- and are often seen in transplants. Sephron dissection in one such 
h u m a n  renal homotransplant described by Joekes in 1937 shon-ed that  in addi- 
tion to se\-ere necrosis of the proximal con\-oluted tubules lvith rupture of the 
basement membranes,  there n-ere occasional focal areas of necrosis in the 
loops and distal convoluted tubules. X inild degree of this change occurs e1-en 
in  most renal autotransplants and accounts f'or the brief' period of disturbed 
tubular function and transient proteinuria that is often noted. That the damage 
is due to the period of ischemia to which the kidney has been subjected was dem- 
onstrated clearly in 1947 by Hamburger who sho\ved that clampilig the renal 
artery of a dog for as short a period as 13 minutes resulted in proteinuria and 
defective urea concentration. In  o\ er  half ' the nnilnals in this experiment renal  
function did not return to norlnal f'or o\ er se\.en days. Later Illitchell and \Vood- 
ruff showed that the damage Ivas lessened if' the kidney ivas cooled during 
the time its blood supply was occluded. an adjunct routinely employed in one 
form or another for all the Colorado homotransplants. 
I los t  cads\-eric human holnotransplants that ha1.e been described have 
shown proximal tubular necrosis. but this damage need not be se\.ere if the 
donor has  not been hypotensi1.e before death and if' the kidney is cooled while 
awaiting transplantation. At St. hIary's Hospital. London. sel-en of the last 
eight consecuti\-e cads\-eric renal hoinotransp1:lnts ha \  e functioned well from 
the time of operation ~ v i t h  a daily urine excretion of' at least 1.3 liters. In  these 
seven cases the Inean ischemic pei.iod ivas 1.1.1 minutes, with a range of 
69 to 187 minutes. In  the one kidne>- that lvas oliguric f'or four days after trans- 
plantation the ischemic period was 210 minutes. Kone of' these kidneys had 
double renal arteries, although the\- Ivere present in Case LD 29. 
Although proximal tubular necrosis is rapidly healed by reqeneration of tu- 
bular epi thel iun~,  and there is el-er>- reason to belie\.e that ex-en a sel-erely dam- 
aged kidney n-ill begin to excrete urine after a period ranging f'roin five to 20 
days, the difficulties of diagnosing and treating a rejection episode under these 
circumstances are 1-ery great. The i1npor:ance of avoiding ischemic tubular 
damage to holnotransplants for this and other reasons has been e n ~ p h a s i z e d j n  
Chapter 7. 
The glolnerular and arterial changes in tht> cadal-eric transplants (CD 2 
and CD 3 )  \yere almost certainly present at the time of transplantation. and 
merely reflect the diseased state of the donor. This illustrates another of the 
difficulties in using cada1-eric kidneys. There is rarely time to ill\-estigate the 
donor adequatel!.. and occasionall>- sel-erely diseased kidne>-s are inadx-ertently 
used. I11 the St. J lary 's  series a case occurred in n-hich it was discox.ered, some 
days after a successful renal transplantation, that  the donor had suffered from 
malignant phase h>-pertension. X biops>- showed fibrinoid necrotic changes in  
the 1-asculature of the transplanted kidney. 
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TRANSPLANTS WHICH FAILED BECAUSE 
OF BLOOD GROUP INCOMPATlBlllTY 
Two kidneys, which were incompatible on the basis of ABO blood groups, 
when transplanted into group 0 rhesus positive recipients became cyanotic 
within a few minutes and failed to excrete urine. The course of these trans- 
plants and the pathologic findings have been described fully in Chapter 6 (see 
Figures 17. 19). The first kidney (LD 19) came from a group A +  donor and the 
second (LD 23) n-as from a group BT donor. Both transplants ryere removed 
within three hours of their insertion. 
A similar example of immediate anuria following transplantation of a n  
A l  kidney into an 0- recipient has  been recorded by Shackman. In his case, 
a s  in LD 19. there was a sharp rise in the anti-A heinagglutinins ~vi thin  a few 
days after operation. Six transplants from A- donors to 0+ recipients and one 
from a B+ donor to an  0- recipient h a \  e been perf'ortned a t  St. hIary's Hospi- 
tal. Three of these ne\ .er  f'unctioned, and one became anuric a t  t ~ v o  days. The 
other three failed at \.arious times up to 39 days. The transplants which devel- 
oped immediate anuria sho\ved sludginq of' red cells in the gloinerular capil- 
laries (Fig. 148, top) similar to that described in Chapter 6 (see Figure 19), and  
the transplant \vhich ceased f'u~ictioni~i:: at 48 hours also contained er>-throcyte 
clumps in the tuft loops (Fig. 148. bottoln). It seems clear that \.iolations of 
the rules propounded in Chapter 6 must be avoided if donors and recipients 
of different blood types are to be paired. 
Cases of anuria in which there has  been MN incompatibility between donor 
and recipient ha1.e also been reported by Hamburger in 1962 and by Shack- 
m a n ,  but in  these cases there was no concoinitant rise in  anti-N antibodies. 
REPORTED HOMOTRANSPLANT FAILURE 
BECAUSE OF OTHER FACTORS 
Examples of immediate postoperative anuria or oliguria which did not 
seem to be due either to ischemia or to blood group incompatibility have been 
reported from time to time. Three of these cases proved a t  autopsy to have 
developed acute glomerular lesions in the transplant. Two of the patients were 
suffering from either the microscopic form of polyarteritis nodosa or from 
Ellis's rapidl>- proqressi1-e Type I glomerulonephritis. The Boston case,  reported 
by Hume in 1953. xvas described as "pol!-arteritis nodosa." This n a s  also the 
clinical diagnosis in a case studied at St. liar?-'s Hospital. but it 11-as decided 
after autopsJ- that this xvas in realit! an  example of glo~nerulonepl~ritis. The 
homotransplants 11-ere untreated and 11-ere oliguric from the time of operation. 
The first patient died after 38 da!-s: the second at six da!s. In  Hume's case, 
there was  marked crescent formation in Bowman's capsule and obliteration of 
Figure 148. Top-Cadaveric human renal homotransplant from St. Mary's series, from a donor 
who was of blood group B+, two hours after transplantation into an 0+ recipient. The kidney became 
cyanotic within a few minutes, and failed to excrete urine. The glomerular tuft capillaries are 
distended with sludged erythrocytes, and there is protein-containing fluid in Bowman's space. 
There is some hemorrhage into the interstitium, and the proximal tubules show early signs of 
ischemic necrosis. H and E (X 340). 
Bottom-Biopsy at 48 hours of an untreated cadaveric human renal homotransplant (St. Mary's 
series) which became anuric at that time. Some of the glomerular tuft capillaries contain collections 
of sludged red cells presumably resulting from the major blood group incompatibility between the 
donor who was group A+and the recipient who was O+. There is tubular damage due to 105 minutes 
of ischemia imposed on the cooled kidney during transplantation. H and E (X 300). 
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Figure 149. Left-Biopsy at 24 hours of an untreated cadaveric human renal homotransplant in 
St. Mary's series. The donor was a man of 36 years who died as the result of a head injury. The 
kidney, although cooled, was ischemic for 106 minutes. There is interstitial edema, tubular damage, 
and hyaline thickening of the wall of an arteriole (arrow). 
Middle-The same kidney at autopsy six days after transplantation. The homograft had remained 
oliguric during that period. There is patchy fibrinoid necrosis of the glomerular tuft capillaries and 
early crescent formation in Bowman's capsule. The tubules are severely damaged, and the distal 
parts contain red cells. 
Right-One of the patient's own kidneys from the same case. The glomerular tuft shows some 
fibrinoid necrosis and a large, partly fibrosed, crescent. These changes were part of a rapidly progres- 
sive Ellis Type I glomerulonephritis. H and E (X 175). 
glomerular capillaries. The St. Mary's homograft showed fibrinoid necrosis of 
many tuft capillaries and some early crescents (Fig. 149). In these two cases it 
seems probable that the factors responsible for the original disease also pro- 
duced the lesions in the transplants. It will be recalled that neither recipient 
received immunosuppressive treatment. 
The third case, described by Krieg, was rather different in that the recip- 
ient, an 11-year old boy, was suffering not from glomerulonephritis but from 
chronic pyelonephritis. The cadaveric transplant he received was ischemic 
for almost three hours and never really functioned. The patient died after 
10 days. At autopsy the glomeruli within the transplant were enlarged, and 
the capillary basement membranes were thickened. However, there was also 
focal fibrinoid necrosis of many of the arterioles, and infiltration of the inter- 
stitium with plasma cells, lymphocytes, and edema fluid. Although there were 
no changes in the patient's gamma globulin, in this case it is possible that 
glomerular, vascular, and interstitial changes were all part of an acute homo- 
graft rejection. 
In other homotransplants sudden cessation of function after a period of 
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satisfactory diuresis has been reported. Some of these kidneys, all from patients 
who had received between 250 R and 450 R n-hole bod!- irradiation. showed a 
predominantly hemorrhagic histological picture, A typical case was described 
by Murray in 1962. The patient was exposed to 210 R and 190 K of total body 
x-irradiation on successive days. and then recei\-ed a kidne>- ho~llotransplant 
from his brother. Function of the transplanted l<idne~- was immediate, rapidly 
reducing the BUN from 223 lngln per cent to norrnal le~.els. At the fifth day a 
few red cells appeared in the urine. A biopsy of the transplant at the sixth day 
showed patchy interstitial hemorrhage, thrombosis of occasional afferent ar- 
terioles, but no infiltrating mononuclear cells. This progressed steadily to ex- 
tensive tubular destruction and massive interstitial hemorrhage, and the pa- 
tient died at the thirteenth day. No information was gi\,en about the presence or 
absence of plasma cells and other pyroninophilic cells in the ly~nphoid tissue 
at autopsy. These cases have been regarded as examples of "humoral" rejec- 
tion by Murray. Hamburger has also postulated that pre-existing antibodies are 
the cause of failure in this type of case. There is no direct e\-idence for this, how- 
ever, and this clinical and histological picture does not seem to have been seen 
except in association with treatment by large doses of ionizing radiation to the 
whole body. Before one hastens to incriminate inllnunological factors, the pos- 
sibility of other causes should be \-ery carefully considered i n  all such cases. 
TRANSPLANT REMOVED 
BECAUSE OF HEMORRHAGE 
When the kidney, which was donated by the recipient's sister (LD 49), was 
transplanted there were technical difficulties resulting in an  ischemic period 
of 58 minutes. Flow of urine from the homotransplant did not begin for two 
hours, but after this there was a daily excretion of 2 to 3 liters. However. the 
urine was heavily contaminated ~v i th  blood. Hematuria persisted, and even 
after three explorations no cause could be found. After four days the kidney 
had to be removed. 
Examination of the gross specimen showed blood in the pel\-is, but no 
bleeding point could be identified. iJIicroscopically. there was some proximal tu- 
bular damage and many crystals of calcium oxalate in the lumina. but no 
evidence of blood or pigment in an!- of the nephrons. There n-as no interstitial 
edema, only minimal cellular infiltration. and no el-idence of inflammatory 
changes in the pel\% of the transplant. In the peripel\.ic fat there n-as a band 
of hemorrhage xvith necrosis of se\-era1 snlall arteries. -At many tiny points the 
pelvic transitional epithelium n-as destroyed. and hemorrhagic oozing into the 
pelvis has occurred o\-er a n-ide area. The cause of the disastrous bleedillg in 
this case remains a mystery. X second transplant \\-as not similarly afflicted. 
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TRANSPLANT EXAMINED AT HEIGHT 
OF POSTOPERATIVE DlURESlS 
One patie~lt  ( L D  26) died 12 hours after operation from hyponatremia and 
hyperkalemia during a massi1-e postoperative diuresis in which urine output 
from the transplant a\-eraged 1.320 ml per hour. The immediate caxse of 
death was cardiac arrest (see Chapter 12). The kidney was a little swollen and 
pale. but showed a normal pattern on the cut surface. 
I2licroscopicall>-. the tubules and interstitium appeared to be normal, but 
some of the glomeruli were fibrosed and a few showed fibrous thickening of 
the capillary basement nlernbranes associated with periglomerular fibrosis. 
There was hyalinization of the walls of occasional afferent arterioles. The 
glomerular changes in this kidney must ha1.e been present before transplanta- 
tion. The alterations in the afferent arteriolar walls presumably were also pres- 
ent when the kidney n-as transplanted. It is interesting that no significant 
morphological changes lvere detected in the tubules. 
Copious excretion of urine in the first 24 hours has been seen in many 
renal transplants, and at least two other patients have died because of electro- 
lyte imbalance at this time. One lvas a chimpanzee heterotransplant in Hume's 
experience and the other a homotransplant in Murray's series. 
TRANSPLANTS EXAMINED DURING OR 
JUST AFTER A REJECTION EPISODE 
Fourteen of' the Colorado homografts came from patients who were either 
at  the peak of a rejection episode or were just beginning to recover from such 
an event. 
Most of the homotransplanted kidneys were enlarged. The mean weight 
was 225 gm. wit11 a range of 130 to 350 gm. Similar enlargement was encoun- 
tered in a series of 22 kidney hon~otransplallts examined at St. Mary's Hos- 
pital. London. where the mean was 242 gin. lvith a range of 180 to 350 gm. 
In all the cases this enlargement was almost entirely due to interstitial edema 
following damage to the peritubular capillaries in the acute rejection process. 
In one of the transplants (LD 10)  that had functioned for 293 days in a bilater- 
ally nephrectomized recipient, compensatory hypertrophy was responsible for 
part of the increase in ~veight (Fig. 150). The capsule n-as considerably thick- 
ened, but stripped easil!- leal-ing a smooth cortical surface (Fig. 150, top). In 
onl>- one transplant t LD 24) was the capsule fairly adherent. In others the 
subcapsular surface 11-as speckled n-ith petechiae :Fig. 150, top), and similar 
hemorrhages were sometimes present in the sn-ollen cortex. 
In the St. 3Iar~- 's  experience more striking gross pathologic changes have 
been seen, including profound congestion of the ~nedulla F i g .  131). Another 
pattern, common1~- seen in the St. liar>-'s patients 11-110 died during rejection 
but less frequently seen in the Denr-er series. Tvas a band of hemorrhage and 
. congestio~l at the corticomedullary junction of the swollen kidne>-. Some homo- 
grafts in both groups showed tiny areas of infarction. 
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Figure 150. Homograft 295 days after operation in LD 10. The patient died of late rejection, after 
months of stable renal function. 
Top-Partially stripped capsule. A few subcapsular petechiae are seen. 
Bottom- Bisected kidney. The homograft weighed 260 gm, and is slightly swollen. (By permission 
of Ann. Int. Med. 61: September, 1964.) 
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Figure 151. Cadaveric renal homograft (St. Mary's series) from a patient receiving 6-mercapto- 
purine, steroids, and actinomycin C. Two rejection episodes at the fifteenth and thirty-eighth post- 
operative days were successfully reversed, but the third, starting at  the forty-fifth day, had not been 
reversed when the patient died at 62 days. The kidney was swollen, weighed 300 gm, and showed a 
characteristic speckling of the cortex with hemorrhages and congestion of the medulla. 
Generally, these gross changes are the same as those commonly seen in 
both canine and human untreated renal homotransplants that are undergoing 
rejection. 
In all the Colorado cases the main renal vessels were patent, and in all but 
two the ureters were unobstructed. The exceptions were the kidneys from LD 
35 and LD 61. In LD 35 blockage of the ureter by debris during a rejection epi- 
sode led to rupture of a necrotic area in the pelvis of the transplant, necessitat- 
ing removal of the kidney at 20 days (see Chapter 12). The other patient (LD 
61) was found after a very severe rejection episode to have a necrotic but not 
perforated area on the anterior surface of the pelvis and evidence of obstruc- 
tion at the ureterovesical junction. The pelvic wall was reinforced with a piece 
of ascending colon and the ureter implanted into the bladder at a different site. 
When the patient died at 36 days (six days after ureteral reimplantation), there 
was no longer any obstruction, but the ureter and pelvis were dilated with thin 
walls. A similar, but more chronic, example of urine extravasation following 
rupture at the pelviureteric junction has been met in the St. Mary's series. In 
this patient a sac filled with urine was formed around the kidney by 116 days. 
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;LIicroscopically. fibrinoid necrosis was seen in the walls of some of the ar- 
terioles and interlobular arteries in 12 of the 14 homotransplants. The change 
was most widespread and severe in CD 1, in whom a cadaveric kidney was 
transplanted from an A- donor to an 0- recipient. This case has been referred 
to previously in Chapter 8. In the affected transplants the necrotic process was 
found in the afferent arterioles but not in the efferent ones, and usually in- 
volved the whole thickness of the vessel wall (Fig. 132, top). Fibrinoid necrosis 
of some of the glomerular tuft capillaries accompanied the arteriolar changes 
in the four most severe cases: CD 1. LD 10. LD 32. and LD 46 (Fig. 132, bot- 
tom; Fig. 153> top). Fibrinoid necrosis was not found in the s-essels of the sec- 
ond transplant of LD 29, the homograft having been in the recipient for only 
eight days, nor in LD 28. in whom the exact period of rejection was ill-defined. 
Swelling of the endothelial cells lining the arterioles was present in six 
cases, including case LD 28. Fibrin and platelet deposits on the intilna of the 
interlobular arteries were seen in seven of the kidneys (Fig. 153, bottom) and 
fibrous intimal thickening of these vessels in seven (Fig. 154). This latter 
change was most severe in LD 46 in whom many of the arcuate and interlobular 
arteries within the graft showed obliteratjve changes (Fig. 155, top). In most of 
the vessels there was general thickening of the intima by loose. \.cry cellular 
fibroblastic tissue (Fig. 155. bottom). In some, the intinlal thickening n-as con- 
fined to only part of the circunlference of the artery: in others it had caused 
complete obliteration of the lumen. Deposits of fat of 1.ariable size ivere pres- 
ent in the deeper layers of the thickened intilna immediately adjacent to the 
media. Reduplication of the internal elastic lamina was present in four cases, 
and rupture of the same layer in t~z-o. The \-ascular lesions were more frequent 
and severe where arteries divided and gave rise to small side branches. Dar- 
mady recently obtained confirmation ofthis distribution of the lesions in human 
renal homotransplants by microdissection of the vessels. Thrombosis of occa- 
sional small veins was found in six of the transplants. with associated patchy 
infarction of the superficial cortex in three of these cases. 
Cellular infiltration was present in all the cases except LD 28 and LD 61. 
It was never so se1-ere as in the untreated dog kidneys. was usually very light 
and focal. and consisted of small 15-mphocytes. plasma cells, and larger cells 
with pyroninophilic cytoplasm as in canine renal homotransplants ' Fig. 156). 
Often the cells were found only ~vithin peritubular capillaries; ~liitoses n-ere 
not seen. The hea\-iest concentrations of infiltrating cells were found in Cases 
LD 35 (first transplant). LD 43. and CD 2. 
Tt'idespread recent tubular necrosis with acti1.e repair and casts of protein 
and cell debris was seen in four of the transplants {LD 29. LD 43. LD 32. and 
CD 1). Patchy tubular damage was present in most. L>-mpliocytes were found 
in the lulnina of some tubules, but 01115- in those cases n-it11 tubular damage 
and interstitial infiltration ,Fig. 137).  Presumably these are the cells that ap- 
pear in the urine at the height of rejection 'Fig. 138, and ~vhich 1ve.e discussed 
in Chapter 13. -4 fexs- oxalate cr>-stals TI-ere present in six of these kidne5-s :Fig. 
159). Text co?zti?zzies o n  page  331. 
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Figure 152. Top-Treated human renal homotransplant from Patient LD 43 who died at 38 days 
while in a rejection phase. There is severe fibrinoid necrosis of the wall of an interlobular artery 
(two arrows) and obstruction by fibrous intimal thickening of another interlobular artery (single 
arrow). There is also tubular atrophy, interstitial edema, and foci of cellular infiltration. H and E 
(X 125). 
Bottom-Treated human cadaveric renal homotransplant from Patient CD 1 who died at 25 days 
while in a rejection phase. There is severe fibrinoid necrosis of the wall of an afferent arteriole 
(arrow) with extension of the same process into the tuft. H and E (X 340). 
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Figure 153. Top-Treated human renal homotransplant from Patient LD 10 who died at 295 days 
of late rejection. There is fibrinoid necrosis of part of the wall of an afferent arteriole. There is 
much tubular atrophy, interstitial fibrosis, and edema. H and E (X 300). 
Bottom-Treated human renal homotransplant from Patient LD 11 who died at 25 days from 
sepsis while recovering from a prolonged rejection episode, during which anuria was present for 
10 days (see Figure 5, Chapter 3). In the center of the photomicrograph there is an arcuate artery 
with platelets and fibrin deposited on the intima lining a damaged part of the vessel wall (two 
arrows). An arteriole with fibrinoid necrosis of its wall is indicated by one arrow. H and E (X 170). 
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Figure 154. Treated human renal homotransplant from Patient LD 10 who died at 295 days of 
late rejection. There is marked fibrous intimal thickening in an arcuate artery. Elastic counter- 
stained with hematoxylin and van Gieson (X 170). (By permission of Ann.  Int. Med.  61: September, 
1964.) 
Figure 155. Top-Treated human renal homotransplant from Patient LD 46 who died at 43 days 
during a rejection crisis with anuria (see Figure 80, Chapter 18). Two interlobular arteries (arrows) 
are greatly narrowed by marked thickening of the intima by fibrous tissue. The interstitium shows 
edema, some fibrosis, and a scanty cellular infiltration. There is some tubular atrophy. H and E 
(X 125). 
Bottom-Greatly narrowed arcuate artery in renal transplant from Patient LD 46. The intimal 
thickening is largely composed of fibroblasts with some infiltrating plasma cells. Adjacent to the 
internal elastic lamina (el) there are spaces (arrows) in which fat has been dissolved in the prepara- 
tion of the section. These fat deposits are derived from the breakdown of platelets. H and E (X 300). 
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Figure 156. Top-Treated human renal homotransplant from Patient LD 35. The kidney was 
removed at 20 days because of rupture of the pelvis of the kidney following obstruction of the 
ureter by debris during a rejection phase. There is a heavy but focal infiltration of cells around an 
interlobular artery. H and E (X 125). 
Bottom-A higher power view of the infiltrating cells (LD 35) in which many appear to be of the 
plasma cell series. H and E (X 800). 
--4 . + 6.S 
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F i g u r e  157. Treated human cadaveric renal homotransplant from Patient CD 2 showing alympho- 
cyte (arrow) in the lumen of a tubule. The interstitium is edematous and infiltrated with cells. At 
the upper right of the photomicrograph there are also some red cells. The tubular epithelium is 
damaged, and two tubules at the lower left contain protein casts. This kidney was actively being 
rejected. H and E (X 340). 
F i g u r e  158. Cells seen in the fresh deposit from the urine of a patient in the St. Mary's series at 
the onset of a rejection episode. Almost every cell is a lymphocyte. Most were alive as shown by 
their ability to take up tritiated adenosine, and some exhibited characteristic lymphocytic move- 
ment. Phase contrast (X 450). 
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Figure 159. Birefringent oxylate crystals in the tubules of a human renal homotransplant. This 
patient (CD 1) was the most severely affected in the Denver series. Polaroid (X 350). 
In addition to edema which was present in eight of the kidneys, there was 
some interstitial fibrosis in four of the five transplants which survived 36 days 
or longer. Small hemorrhages and collections of fibrin in the interstitium also 
accompanied arteriolar fibrinoid necrosis in these five cases. 
Glomerular changes were not significant in these cases, but Merrill has 
noticed endothelial cell hyperplasia and proliferation in the tuft capillaries of 
one case during a rejection phase. 
Monilial lesions were seen in two of the kidneys. In Patient LD 32, who 
had systemic fungus infection (see Chapters 19 and 21), the lesions consisted of 
necrotic areas filled with budding forms centrally and hyphae peripherally with 
no cellular response. In Case LD 43 fragments of hyphae were surrounded and 
partly engulfed by giant cells (Fig. 160). 
Ureteric changes are common during a rejection episode. In the St. Mary's 
series edema and cellular infiltration of the wall were common, with endo- 
thelial swelling and fibrinoid necrosis of the small arteries and arterioles. Rup- 
ture of the internal elastic lamina in the affected vessels was frequent. Later in 
the process areas of focal infarction and hemorrhages into the ureteric inter- 
stitial tissues and the peripelvic fat were seen. Loss of the transitional-cell 
epithelium lining the damaged ureteric segments was usual. Fibrin and platelet 
deposition on the intima of affected vessels and organization of this material to 
fibrous tissue also occurred. These changes were present in LD 61. Similar find- 
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Figure 160. Treated human renal homotransplant from Patient LD 43 who died at 38 days. Two 
candida hyphae (arrows) are seen surrounded by foreign body giant cells. Periodic acid-Schiff 
(X 300). 
ings were clearly illustrated by Kiiss in the renal homotransplant from their 
patient, who died at 490 days. 
Early swelling of the afferent arteriolar endothelial cells and fibrinoid ne- 
crosis of the walls of both these vessels and the interlobular arteries are now 
recognized as important features of the acute rejection process in renal homo- 
transplants modified by treatment. The longer the rejection episode lasts with- 
out being reversed by therapy, the more common it becomes to find fibrin and 
platelet deposits on the damaged endothelial lining of these vessels, and, later, 
fibroblastic intimal thickening with progressive narrowing of their lumina. 
Vascular changes in a homotransplanted kidney were first described by 
Hume in 1955, and have since been mentioned in 18 other human renal homo- 
transplants (Table 44). Similar lesions are seen in dogs. Analysis of the patho- 
logical changes in 200 canine renal homotransplants recently performed in 
collaboration with Calne and Zukoski showed that when the life of a kidney 
homotransplant was prolonged by immunosuppressive drug treatment, arterial 
and arteriolar lesions, which are relatively minor and late features of the un- 
modified graft, often came to dominate the histology. In the transplants which 
ceased to function before 28 days, disintegration of the peritubular capillaries, 
swelling of arteriolar endothelial cells, and fibrinoid necrosis of arterial and ar- 
teriolar walls were common. Fibrinoid necrosis was seen in the vessels of as 
many as 35 per cent of the renal transplants which functioned for 15 to 21 days 
Text  continues on page 336. 
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(Fig. 161. top). From the tn-entl--eighth day arteriolar narrowing and arterial 
intimal thickening became increasingl>- frequent. Deposits of fibrin and plate- 
lets on the endothelium of the interlobular and larger arteries were often seen 
in the transplants surviving up  to 70 da?-s: after this fibrous intimal thickening 
was commoner, affecting 64 per cent of the transplants surviving beyond 70 
days (Fig. 161, middle). There lvas apparent transitions between the fibrinous 
and fibrous lesions, and rupture of the internal elastic lamina was also common 
(Fig. 161. bottom). 
I n  seeking a n  explanation for these arterial changes a number of possibili- 
ties can be excluded. Neither x-irradiation, corticosteroids. nor purine analogues 
can be responsible. because the\ hni  e not alxz ax s been used in the treatment of 
patients n ho h a \  e s h o n n  such lesions Indeed, no olze drug or agent is common 
to all the cases that  h a \ e  been reported 
Total renal I ascular occlusion for periods exceeding t n o  hours can cause 
severe daiiiage to arteries and arterioles. and in the repair process iritimal hyper- 
plasia is prominent. Although some of the hornotransplants that  showed \.ascu- 
lar  lesions were ischemic for long periods. this lvas not a factor in all cases. For 
example. in the Den\-er series, the kidney transplanted into patient LD 46 was 
ischemic for only 31 minutes, and yet during an  uncontrolled rejection episode 
de\-eloped the most se\ ere arterial lesions seen in this group of patients (Fig. 
155). 
Hypertension seemed the most likely explanation to Hume.  Admittedly 
man? of' the recipients of' renal transplants h a ~ e  been h?-per tensi~e.  and the 
view has  to be considered that  all these changes occur because the vessels of 
the transplant. accustoined to a normal blood pressure. ha1-e suddenly been 
exposed to a considerably higher pressure. Hon-e\.er. 1-ascular lesions have 
occurred on inan? occasions ~ v h e n  the recipient's blood pressure has  been care- 
fully controlled lvith hypotensive drugs and in se\-era1 cases when the recipient 
was  not hypertensi\.e a t  all at the time of' transplantation. \T'hile it thus seems 
clear that  \-ascular lesions are not initiated bl- a raised blood pressure. any 
existing hypertension ~vi l l  probably f'urther damage the weakened vascular 
walls. Il'hen hypertension emerges late in the course of a renal homotransplant, 
this often appears to h a \ e  been due to ischemia caused by the obstructive 
arterial lesions. 
If the arterial changes are not initiated bl hypertension, an  iiniiiunological 
cause becomes a strong possibility. Certainly 1-ascular damage of this type has  
not been reported in kidneys transplanted between identical t~v ins .  It could be 
that  in patients receil-ing renal homotransplants chronic uremia and treatment 
depress but do not halt the imm~l i i e  reaction 11> the host against the transplant. 
If this is so one could expect to find histological changes similar to those seen in 
acute canine renal rejection. but modified and spread ox-er a longer period, the 
duration and sel-erit>- being dependent upon the efficac>- of the treatment and 
the genetic relationship between donor and recipient. I11 general this prediction 
appears to be correct. Practicall>- all h u m a n  renal homotransplants surl-i\-ing 
more than a few days ha1-e sho.ivn some degree of infiltration by cells resembling 
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Figure 161. Top-\-ascular chanxes  in canirle renal homografts.  Renal  homotransplant a t  19 days  
f rom a dog treated with azathioprine and acrinorn!cin C .  There is fibrinoid necrosis of the  whole 
wall  of a n  interlobular artel?,  and the surrounding tissues are hea1-il!- infiltrated b>- cells. H and  E 
(X 180). 
hliddle-Renal homotransplant a t  739 da!-s f rom a dog treated ir-ith 6-methyl mercaptopurine.  
An interlobular arter! shoivs dlffuse i r i t i~nal  thickening b>- fibrous tissue. Thls m a t e r ~ a l  n-as  kindly 
p r o ~ i d e d  by Doctor C Zukoslii Elastic counterstairled ir-ith helnatos!-lin and \-an Gieson :X 
Bottoni-Renal homorransplarlr a t  330 da>-s from a dog treated it-ith azathioprine and  actinom)-cin 
C. .An interlobular arter! sho~r - s  marked fibrous intlrnal thlchenirlg i ~ h i c h  has  almost obliterated 
the  lurnen of the 1-essel. The internal e l a s t ~ c  laniina has  been ruptured. Elastic counterstained 
with hemarox)-lin and ~ a r l  Gieson ,S 160,. 
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those seen in the earl>- stages of dog homografts. The infiltration has  been maxi- 
mal  in those cases in n-hich chronic uremia and treatment were lacking or 
genetic disparitl- n-as combined with ineffecti\-e treatment: and nlinimal in  
those cases in which close genetic similarity was combined with \-igorous treat- 
ment.  
It will be remembered that in the later stages of renal homograft rejection 
in  a normal untreated dog the capillaries, arterioles, and arteries may show 
fibrinoid necrosis of the lvhole or part of the circumf'erence of' their \valls and 
that  some e\.idence n-as produced to support the thesis that these lesions may be 
due to circulating antibody. 
An exterlsion of this hypothesis would be that ivith continued persistence of 
the graft in the host the humoral aspect of'the host's response assunles greater 
importance in that during a re,jection episode circulating antibod>. is rapidly 
produced. The resulting antibody-antigen 1.eaction occurring in or oli the arte- 
riolar walls n-ould damage the intiina and cause sT\.elling of the endothelial 
cells, and might induce spasm of' the s~nooth  muscle in the \essel \ \al l .  Such 
lesions. widespread in the transplant. could explain the alterations in water, 
electrolyte. and creatinine excretion that occur at this time. The similarity 
between some of the functional changes obser\.ed during acute rejection of a 
renal  homograft and those which can be induced by a constricting clip on the 
renal artery has  been corninented upon in Chapter 15. That it is possible to 
abolish the arteriolar endothelial s~vell ing and to reduce \-ascul~ir  spasm in  
canine renal transplants by gi\-in< cortisone. as Demptster has  sho\vn. might 
explain lvhy prompt treatment with prednisone has  been so successf'ul in induc- 
ing a diuresis from h u m a n  renal transplants that  have shortly before suddenly 
ceased to function. 
Halting the rejection process at the stage of' endothelial s.ivellinr: and prob- 
ably even at that  of' fibrinoid necrosis of' arterioles should lead to complete res- 
toration to n o r n ~ a l .  Once the damage has in\  011-ed the interlobular arteries and 
intimal change has  induced deposition of platelets and fibrin. ending the rejec- 
tion episode ~vi l l  not pre\.ent healing xvith replacement of' the intiinal deposits 
by fibroblasts. This progression has  been clearl!- demonstrated in the St. 4lary's 
experience b>- successi\-e biopsies taken from a human renal ho~notransplant 
during and after treatment of' a se\-ere rejection episode. The deposition of 
platelets on the damaged arterial segments is probably due to release from the 
vessel ~ v a l l  of substances ~ v i t h  properties similar to adenosine di- and triphos- 
phate which. in high concentrations. h a ~ ~ e  be n s h o ~ v n  b>- Honour and 1Iitchell 
to induce clumping of the platelets and their adherence to the intima. 
\Then the 1-essel 11-all has  been appreciably IT-eakened I)!- the necrotic proc- 
ess. compensator!. intima1 thickening T~-ill contribute substantiall>- to narro~ving 
of the lumen. This aspect of' the process is comparable to the rapid l a ~ ~ i n g  down 
of fibroblastic tissue on the intima ! endarteritis fibrosa' in inaliqnant phase 
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hypertension. If the necrosis is initial1~- widespread in the larger arteries, this 
healing process can produce crippling obliteratia-e fibrous lesions like those that  
have been seen in both hulnans and dogs. The breakdon-11 of the man>- platelets 
in  the earl!- intinlal deposit accounts for the fat  spaces later found in the deeper 
parts of the thickened fibrous layer. because 1 per cent of the dry weight of 
platelets consists of' lipid. 
When there is extensil-e fibrinoid necrosis involving the media, rupture of 
the internal elastic lamina is likely to occur. During healing. this elastic damage 
is not repaired and,  just as in healed polyarteritis nodosa. the fragmented elastic 
persists indefinitely as ea.idence of the earlier destructi1.e phase. 
The vessels of'the transplanted ureter are not immune froin these processes. 
Fibrinoid necrosis of the small arteries and arterioles is followed by focal infarc- 
tion of the ureteric wall. If' at the same time the ureter distally becomes blocked 
by debris due to tubular destruction resulting from the intrarenal vascular 
changes, then rupture of the necrotic ureteric or pelvic wall may occur. This 
was the mechanism in LD 35. 
TRANSPLANTS EXAMINED LONG AFTER REVERSAL 
OF A REJECTION EPISODE 
Eight of the Colorado renal homotransplants were from patients whose last 
clearly recognizable rejection episode had occurred 14 to 117 days previously. 
Two of these patients had survi1-ed two rejection episodes, and in one case 
(LD 9) three such crises had been encountered. A ureter was also available for 
examination from Patient LD 27. 
All the kidneys were enlarged. the mean n-eight being 202 gm,  avith a range 
of 180 to 230 gin. Unlike !$-hat occurred in those patients avho died during or 
immediatell- after a rejection episode. edema was not a n  important factor in  
this increase in weight. A11 these kidneys had been for long periods (48 to 207 
days) in bilaterally nephrectomized recipients. and in se1-era1 compensatory 
hypertrophy was the main cause of the enlargement: this finding is not surpris- 
ing since Couch has  delnonstrated that dogs n-ith a solitary autotransplanted 
kidne>-. in which there is 110 question of a n  in l~nui le  mechanism, develop in- 
creases of' up to 55 per cent in the weight of the transplant in one year. In  all 
the clinical cases the capsule Tvas thickened and fibrous. 1Iost of the transplants 
had a sn~ooth  subcapsular surface, the cortex n-as pale, and the ~nedul la  avas 
reddish-bron-11, The only exception Jvas Case LD 19 in ~ v h o m  there was an 
iatrogenic superior polar infarct see Figure 47. Chapter 11). In Patient LD 4, 
in whom a-ena cal-a1 plication had been performed following pulmonary embo- 
lectomy (see Chapter 1 2 .  the renal and right iliac 1-eins and the loxver inferior 
vena ca1-a n-ere completel!- thrombosed. but in the other sel-en cases the renal  
vessels and their anastomoses n-ere free from an>- obstruction. Similar rela- 
tivell- normal gross findings hal-e been reported from other centers and do not 
differ greatly from those s h o ~ v n  in Figure 130. 
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Figztre 162. Treated human renal homotransplant fro111 Patient LD 21 ~ v h o  died at 76 days from 
a fungal pneumonia and brain abscesses. .I fairly severe re,jection episode had lasted from the 
fifth to the thirty-fifth days. There is minirnal cellular infiltration: one small group of cells is indi- 
cated by a n  arrow. The interstitiurn is a little Inore prolnillerit than rlornlal because of some focal 
tubular atrophy. H and E (X 125). 
Microscopically, seven of the eight cases showed cellular infiltration. This 
was usually very mild and focal. Often the cells were confined to the peritubular 
capillaries. A typical case is illustrated in Figure 162. Most of the cells were 
lymphocytes and mature plasma cells, but there were a few other more prirni- 
tive cells with pyroninophilic cytoplasm and nucleoli. hlitoses were never seen. 
Similar but usually much hea\-ier cellular infiltrates have been described i n  
biopsies taken from long-survix-ing renal homotransplants in other series. 
Galle and ICIontera made a detailed electronmicroscopic study of the cells pres- 
ent in one such kidney 70 days after transplantation at a time when the pa- 
tient's blood urea was 23 rng 100 ml and there was only 0.1 gm of proteinuria 
per 24 hours. They found that about 40 per cent of the cells were not easily 
classified: ultrastructurally the majorit?. of these n-ere related to 1)-mphocytes, 
while some resembled histiocytes (monocytesj. These cells had in common 
similar size and scanty cytoplasm with sparse ergastoplasm and many free 
ribosomes. These are the same two categories of cells that are found infiltrating 
canine renal homotransplants at 48 hours !see Figures 140 and 144). X further 
4 per cent were plasma cells in 1-ar?-ing stages of maturity: 13 per cent were 
typical lymphocytes: 8 per cent were histiocytes: 26 per cent n-ere fibroblasts 
associated with collagen fibers: 4 per cent were fixed reticular cells: and 3 per 
cent were eosinophils. It seems probable that if a similar analysis had been 
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Figure  163. Treated human renal homotransplant from Patient LD 16 ~ v h o  died at 83 days from 
pancreatitis. The patient had experienced t ~ v o  rejection episodes, the first at the fifth day and the 
second a t  the t~venty-fifth day ,  both apparently successf'ully re\-ersed. A partly obliterated inter- 
lobular artery can be seen as well as a focus of cellular infiltration. H and E ( X  300). 
done on some of the Colorado cases more plasma cells would have been re- 
corded, and far fewer of the unclassifiable "lymphoid and histiocytic" cell 
types. 
Fibrinoid necrosis was present in the arteriolar walls of two of the eight 
transplants. Only in case LD 38 were an appreciable number affected, and it is 
perhaps significant that this patient had recovered from a rejection phase only 
14 days before the transplant was examined. The characteristics and distribu- 
tion of the vascular necrotic lesions were the same as in the kidneys which were 
examined duricg a rejection phase. 
Four of the kidneys. however. showed intimal thickening of some of the 
interlobular arteries. In one the new intimal layer consisted only of fibrin, 
platelets, and a few lymphocytes: in the other three both this type of thickening 
and fibrous thickening were present (Fig. 163). Reduplication or rupture of the 
internal elastic lamina accompanied these changes. 
Tubular damage was present in six of these kidneys. In some it was recent 
necrosis affecting predominantly the proximal convoluted tubules and probably 
related to ischemia from terminal hypotension in patients dying from such 
causes as pneumonia and septicemia. In others there were atrophic changes, 
the tubules being lined by flattened epithelium. Protein casts and crystals of 
calcium oxalate were present in three of these transplants. Where there was 
some patchy tubular atrophy the interstitium was prominent and fibrous. All 
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the tubular and interstitial changes were most pronounced in the transplant 
which functioned for 207 days I LD 9). TII-o of the cases showed some hyaline 
thickening of the basement membranes of the capillaries forming the glomeru- 
lar  tufts. 
The very slight cellular infiltration and the paucity of severe obliterative 
vascular lesions in these eight patients, all of n-horn had suffered at least one 
clinically obi-ious rejection episode. is most encouraging. In effect, it means  
that  if rejection is recognized promptly and treated, e1-en by the imperfect 
drugs which are at present a t  our disposal, at least 50 per cent of the patients 
will suffer no permanent arterial or arteriolar damage. 
The presence of some atrophic tubules in most of'these transplants suggests 
either that  tubular damage is occurring from the use of' high dosages of drugs 
such as  actinomycin C ,  which is suspected of' nephrotoxicity. or more probably 
that  peritubular capillaries continue to be damaged on a small scale by host 
cells, resulting in focal loss of tubules. Some of the tubular damage is probably 
corrected by regeneration, and most of these kidneys do in fact shoxv evidence 
of continuing tubular repair. 
Only t ~ v o  f the Denr.er transplants shoiz-ed some thickening of'the glomer- 
ular tuft capillarl- basement membranes.  AIuch more se\-ere lesions have been 
encountered b>- Hamburger (1963) in txvo human renal homotransplants seven 
and 15 months after operation. Similar changes de\-eloped in some of the trans- 
plants in the long-sur\-i\.ing doqs treated ivith immunosuppressi\-e drugs (Fig. 
164). The canine lesjons .r~-ere thought to ha1.e resulted f'roln a combination of 
ischemia and deposition  of^ antigen-antibody complex, gi\.ing a histological 
picture reminiscent of late Ellis T!-pe I1 i m e ~ n b l ~ a n o u s )  glolnerulonephritis. The 
renal lesions in Hamburger's cases n-ere associated iz-ith splenomeqaly and 
hypergammaglobulinemia-further circumstantial e\.idence of a continuing 
host-against-graft im~nunological  reaction with production of' circulating 
antibody. 
These lesioils must be clearl!- distinguished from the glomerular changes 
encountered by Pf'eiffer and JIerrill in some of the kidlie>-s transplanted between 
identical tn-ins. Of the 23 or more renal transplants that hal-e been performed 
betn-een identical twins. at least fi1.e of those lvho originally suffered from 
glomerulonephritis are said to 11al.e del-eloped this disease in the transplants. 
In  these cases. as in the t ~ v o  instances mentioned earlier, in \I-hich glomerulo- 
nephritic changes del-eloped in anuric hoii~otransplants. there ma>- have been 
transmission of host disease to the transplant. 
The ureters of homotransplanted kidneli-s \vhich ha\-e successfully survived 
a rejection episode often s h o ~ v  thin fibrotic ~va l l s  no longer lined by transitional 
epithelium. There ma>- be se\-ere intimal fibrous thickening of the arteries and 
rupture of the internal elastic lamina.  These changes n-ere \-el.!- prominent in 
the ureter remo\-ed from LD 27. a patient n-hose onl\- rejection episode had been 
clinicall?- rei-ersed man\- months pre1-iousl>-. Follon-ing se\-ere diarrhea she had 
become anuric,  and exploration re\-ealed a thickened, SIT-ollen ureter with 
petechial hemorrhages and a great1~- narroived luinen 2 c m  from the uretero- 
pell-ic junction. 3Iicroscopicall~-. in addition to the 1-ascular changes. there was 
much  muscle necrosis, a hea1-!- cellular infiltration, and 1-irus inclusion bodies. 
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F i g u r e  164. Top-Renal homotransplant a t  739 da!-s fro111 a dog treated x\-it11 6-methyl mercapto- 
purine. Four glomeruli shoxs thickening of their tuft capillary basement ~nembrane  by deeply PAS- 
positil-e material. There is some tubular atroph!-. interstitial fibrosis. and foci of cellular infiltration. 
This animal also had ser ere obliterarix-e I ascular lesions see Figure 161. middle . Periodic acid- 
Schiff X 125 
Bottom-Higher porver Ilexl. Tlle ~llarked rhlckeniny of the basement ~nel l lbra~les  of the capil- 
laries in the glolnerular tuft 1s n-ell sho~i.11. This ~narer ial  ma>- be antigen-antibody complex. Peri- 
odic acid-Schiff 'X 200;. 'By permission of Lob. In ies t .  13:809. 1964.) 
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TRANSPLANTS FROM PATIENTS WHO HAD NOT DEVELOPED 
CLINICAL EVIDENCE OF A REJECTION EPISODE 
There were three homotransplants from patients who, up to the time of 
their death, had shown no clinical signs and symptoms to indicate that they 
were rejecting their transplants. 
The first patient. a man of 50, received a homograft with two renal arteries 
from an unrelated donor. During the operation cardiac arrest developed just 
before the arterial anastomoses were completed. Resuscitation was successful, 
but the transplant was ischemic for 71 minutes, and urine excretion was de- 
layed for 12 hours. After this, the kidney excreted 2 to 4 liters per day, but the 
patient died from mediastinitis and generalized sepsis on the tenth postopera- 
tive day (see Figure 61, Chapter 14). The transplant weighed 210 gm. and was 
pale and swollen. Microscopically, there was widespread tubular necrosis which 
was healing. Many of the tubules were lined by flattened epithelium. Mitoses in  
epithelial cells were frequent, and some of the tubules contained protein, pig- 
ment, and blood casts. Within the peritubular capillaries cells with pyronino- 
philic cytoplasm were marginating, and probably represented the beginning of 
a homograft reaction. The interstitium was edematous, and contained a few 
hemorrhages. 
The second transplant came from a patient (LD 35)  whose primary renal 
homotransplant had been removed at 20 days because of rupture of the pelvis 
following obstruction to the ureter during a rejection phase (see Chapter 12). 
Another transplant from the patient's sister was placed in his left iliac fossa 
and was still functioning perfectly when the recipient died from septicemia at 
nine days. Grossly this second kidney appeared normal, but microscopically 
there was some interstitial edema and a few pyroninophilic cells within occa- 
sional peritubular capillaries. 
In the last case (SD 3), a pair of baboon renal heterotransplants had been 
removed, and at the same operation they had been replaced by a homotransplant 
from a living unrelated donor. The homotransplanted kidney functioned well 
with a diuresis of 8 liters in the first 24 hours. The B U N  rapidly fell and never 
again exceeded 52 mgm per cent: the creatinine clearance rose. and at no tim'e 
did it fall below 65 ml per minute. There was no evidence of rejection, but at  
the thirty-eighth day. when the transplant was still functioning perfectly, the 
patient died of pneumonia (see Chapter 23). The kidney was not s~vollen, and 
microscopically some of the interlobular arteries were greatly narrowed or even 
completely blocked by intimal fibrosis while others showed fibrin or platelet 
deposits on the intima: there was also fibrous obliteration of a number of the 
afferent arterioles. The areas of damage tended to be wedge-shaped as in 
chronic pyelonephritis. but there was no cellular infiltration in these areas 
nor periglomerular fibrosis, and the tubules were not dilated and did not contain 
protein casts. It seemed most probable that these scarred areas were due to 
healing of damage done during a clinically unrecognized rejection phase, 
rather than to infection. 
An additional patient (LD 4). who had ven- equivocal el-idence of rejection, 
was considered to be in the preceding category of patients long past rejection. 
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RENAL HETEROTRANSPLANTS 
In the years before 1923 a number of renal heterotransplants were per- 
formed between various species, but little useful information was recorded 
about the histology (see Chapter 23). The two heterografts of feline kidneys to 
dogs, which according to Avramovici sur\.ived for 49 and 58 days, were not 
examined microscopically. Since that time the only heterotransplants recorded 
have undergone progressil-e vasoconstriction within a few minutes after corn- 
pletion of the anastomosis. and when removed after a few hours have shown 
very much the same histological changes as were seen in the two human renal 
homotransplants ( L D  19 and LD 23). which failed because of blood group incom- 
patibility. 
During recent months six baboon to man renal heterotransplants (see 
Chapter 23) have become a\-ailable for examination. and the pathological 
changes found in a pair of rhesus monkey kidneys and in two chimpanzee 
'kidneys after transplantation into huma.ns have been reported bv Reemtsma 
and his colleagues (See chapter 23) ,  who kindly allowed us to examine the 
transplanted tissues. 
CHIMPANZEE-TO-MAN RENAL HETEROTRANSPLANT 
A compound chimpanzee heterograft was examined. The recipient, a 43- 
year-old man suffering from chronic glomerulonephritis, was treated for one 
week prior to the transplant and for the remainder of his life with azathioprine, 
actinomycin C ,  and steroids. The donor, a 41 kgm male chimpanzee, was blood 
group A1,zcD M; the patient was group AlccDee M. Following transplantation, 
by Reemtsma and his colleagues in New Orleans. there was an initial diuresis, 
but on the fourth day a rejection episode occurred which was treated with 
increased doses of irnrnunosuppressive drugs and three doses of 200 R irradi- 
ation to the kidney at three-day intervals. Improvement was rapid, and function 
was soon restored to normal. X second rejection crisis occurred during the 
fourth postoperative week following a period during which azathioprine therapy 
had been discontinued. Restoration of drugs and further irradiation of the trans- 
plant apparently completely reversed the rejection process. Later the patient 
developed progressive pulmonary infection and hypokalemia. His death a t  
63 days was preceded b>- 36 hours of shock. necessitating the use of s-asopres- 
sors. 
At autopsy the transplanted kidneys showed tubular necrosis with repair. 
Many of the tubules n-ere lined by flattened epithelium. and some contained 
casts of blood and protein Fig. 165). There was interstitial edema and fibrosis, 
but no cellular infiltration and no glornerular or blood 1-essel changes. 
The lack of any histological stigmata of rejection in these chimpanzee 
kidneys is most striking when it is remembered that in eight comparable human 
homotransplants, i.e.. those in \vhich the last rejection episode had been 14 to 
117 days previously, se\-en showed cellular infiltration, and in four there was 
intimal thickening of interlobular arteries. 
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F i g u r e  165. Heterotransplanted ch impanzee  kidnc?- i'roni a p,~tir>nt \I I10 died i rom plleumonia a t  
54 days.  There  is extc,nsi\c. t ~ i l ~ u l a r  necrosls t ~ i t l i  c , ~ s t \  ,itld e \  idvnie of repair.. The  in ters t i t ium i s  
edema tous  and f ihroui .  Tlic rlumeruli  and  blood I e\\tll\ .Ire tlol.ni,il. I'11c.1.e is lie cellularinfi l trat ion; 
t he  f e w  black dots thLtt c a n  be seer1 a re  e r > t h ~ o c ) r e s  l)111g 111 the perirubular capillaries. (This 
mater ia l  w a s  kindly provided by Doctor Keith Reerntsma.) H a n d  E (X 125). 
BABOON-TO-MAN RENAL HETEROTRANSPIANTS 
One pair of baboon heterotransplants (SD 1) showed no evidence of clinical 
rejection before the patient died. Three other pairs of transplants (SD 3, SD 4, 
and SD 5) successfull\- survil-ed an  early rejection phase, but were in recurrent 
episodes avhen the!- n-ere studied. The remaining two pairs of kidneys (SD 2 and 
SD 6) were in rejection for the third time avhen examined. 
All the kidneys were s~vollen,  each TI-ith a thickened capsule which stripped 
easily. leaving a smooth surface. In  four of the pairs of transplants this surface 
was  mottled n-it11 irregular hemorrhages and yellow- areas each of which was 
surrounded by a bright red zone. The cut surface bulged, and the same hemor- 
rhages and paler areas were seen in the cortex and extending into the deep red 
medulla (Fig.  1661. The kidneys from SD 3 ar-ere a uniform reddish purple, and 
i t  was not possible on the cut  surface to differentiate betiveen cortex and me- 
dulla. In  the sixth case SD 1 . in !I-hich there had been no clinical episodes of 
rejection, the kidneys were a-ery different. The\- n-ere firm, pale brown. and 
speckled TI-ith petechial hemorrhages. Blotch!- hemorrhages and yellow areas 
were conspicuously absent. The a-ascular anastolnoses 11-ere open in each case, 
but major branches of the renal artery and vein were thrombosed in SD 5 .  The 
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F i g u r e  166. Gross findings 'SD 6) typical of four of six baboon heterografts. 
Top-Uncut paired kidne!-s sholr-ing mottled and greatly enlarged gross appearance. The kidneys 
weighed 80 gm each. 
Bottom-Bisected heterografts. The dark color is due to diffuse intraparench!-ma1 hemorrhage. 
Despite the adl-anced dalllage t o  the transplant, large quarltities of urine Irere excreted to the time 
of death. 'By permission of Trniz i p l n , ~  t ( i t /0 ,7  2 .  No1 einber. 1964.: 
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right kidney of SD 1 was surrounded by a large hematoma which might have 
partially compressed the renal artery on that side. There were many obvious 
large hemorrhagic infarcts in the kidneys of Patient SD 2. The ureters in SD 2 
and SD 5 contained blood clots. All the other ureters had swollen walls, but were 
patent. 
In contrast to the chimpanzee heterotransplants. the baboon kidneys 
showed a very heavy cellular infiltration. It was more marked than in the group 
of human homotransplanted kidneys which were examined while undergoing 
rejection, and sometimes it approached in density that seen in canine homo- 
transplants. One of the more severe infiltrations was in SD 1, a case in which 
there was no blood group incompatibility and the heterotrallsplants were func- 
tioning reasonably well up to the time the patient died of complications of a pul- 
monary embolus (see Figure 123, Chapter 23).  The last creatinine clearance in 
this case was 60 ml per minute and the B U N  was 63 mgm per cent. There had 
been no clinical evidence of a rejection episode. 
The cells were distributed in a patchy fashion in four of the cases, just as  
in canine renal homotransplants which are undergoing rejection, but in cases 
SD 1 (Fig. 167) and SD 4 the cells were scattered in a diffuse manner throughout 
theinterstitium, hlany of the infiltrating cells had pyroninophilic cytoplasm, and 
some of them were obviously mature plasma cells. In the kidneys from Patient 
SD 3 there were also eosinophils (Fig. 168). Alitoses were seen only in SD 1. 
Phagocytic cells containing large masses of deoxyribonucleic acid (DNA), and 
looking just like lupus erythematosus (LE)  cells. were found in small numbers 
in the interstitium of two of these pairs of' kidneys (Fig. 169). Such cells have 
not been recorded previously in any canine or human renal homotransplant. 
All the kidneys were edematous. and contained many scattered hemor- 
rhages (Fig. 170, top) and hemorrhagic infarcts (Fig. 170, bottom). These were 
very marked and confluent in the two pairs of heterotransplants which re- 
mained in the host for nine and 12 days after becoming anuric. Focal infarcts 
were least apparent in the three patients SD 1. SD 3 ,  and SD 4 in whom function 
was reasonable to good and and whose last creatinine clearances ranged from 
19.1 to 60 ml per minute. Vascular lesions seemed to account for these changes. 
In all six pairs of heterotransplants there was narrowing of a variable number 
of interlobular arteries by fibrin and platelet deposits on the intima. In four 
this was associated with fibrinoid necrosis of the walls of these vessels (Fig. 
171) and of the afferent arterioles: in three with swelling of the endothelial 
cells lining the arterioles: and in three lvith fibrous intimal thickening of inter- 
lobular arteries. Rupture of the internal elastic lamina of affected vessels was 
common, and thrombosis of occasional small arteries with damaged walls was 
not unusual. Destruction of peritubular capillaries was widespread in all six 
cases. Obi-ious secondary thrombosis of large arteries and veins was present in 
the two pairs of heterotransplants that ceased functioning several days before 
death of the patient. 
Text  continues on page 355. 
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F i g u r e  167. Top-Hererotransplanted baboon kldne!- fro111 a patient SD 1 it-ho died from pneu- 
monia and a p u l m o n a n  embolus at 23  da>-s There had been no clinical el-idence of a rejection 
episode. There is a heal->- and diffuse infiltration. xvith cells permeating the irhole interstitiurn. 
H a n d E X  125 
Bottom--4 higher pon-er I-ieir-. There 1s inrerstlt~al edema and a heal-? diffuse cellular infiltration. 
The tubules show recent necrosis. H and E (X 300). 
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F t g r c ~ e 1 6 8  Top 
rejection episode 
H a n d  E X 300 
-Baboon renal  l~eterot ransplar l t  II hich lvas rellio\ ed iron1 Patient SD 3 dur ing a 
at  60 da!-s. -1 n:ore patchy, hut still 1-er! hear->- cellular ~nfil tratioli .  is present.  
Bottorn-.A higher  polver ~ i e ~ i - .  lIa11!- of the  infiltrating cell- ha \ -e  basophllic cytoplasm. Several  
a r e  plasrna cells p : one is a n  eosinophile e : so111e are  smal l  lymphoc!-tes s : and  soirle a r e  la rge  
lymphoid cells (L). H a n d  E (X 800). 
PATHOLOGICAL CHANGES IN TRANSPLANTED KIDNEYS / 351 
Figure  169. Baboon renal heterotransplant from Patient SD 3. A phagocytic cell (probably a 
neutrophil), containing a large mass of basophilic material (DNA), is seen lying in a peritubular 
capillary. This cell looks like a lupus erythematosus (LE) cell. H and E (X 1,000). 
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Figure 170. Top-Baboon renal heterotransplant from Patient SD 3. This photomicrograph shows 
an area of interstitial hemonhage.  A11 the dark cells are el?-throe)-tes. H and E 9 300). 
Bottom-Baboon renal heterotransplant from Patient SD 6 who was in rejection when he died at 
49 days. An area of hemorrhagic infarction H ,  1s shoxr-n. The glor~~erulus indicated I\-ith an arrow 
is necrotic. H and E (X 123). (By permission of Transplantation 2 :  h-ovember, 1964.) 
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Figure 171. Baboon renal heterotransplant from Patient SD 4 who was in  rejection when he died 
at  49 days. An interlobular artery shows not only fibrinoid necrosis of its wall, but also cellular 
infiltration of the damaged area indicated by arrows. This is a true arteritis. H and E (X 200). 
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F i g z t r e  172 .  Top-Baboon renal heterotransplant from Patient SD 3. >Ian>- tubules ha\-e been 
destroyed. Those sur1-ix-ing are dilated and  lined b>- flattened epithelium. The inrers t i t iu~n is  edem- 
atous and h e a d > -  infiltrated 11-ith cells H and E S 125 . B>- permission of T r a l ~ j p l a ~ z t c ~ t i o ~ z  2 :  
No\-ember.  1961. 
Bottorn-Higher pov-er l i e n  of bahoon hererotransplant from Patlent SD 3.  Damaged tubules 
a re  lined b!- flattened e p i t l ~ e l i u ~ n .  The illtersrltium is edematous and infiltrated with cells. Many 
pentubular  capillaries ha\-e been desrro:-ed H and E X 300: 
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Figure  173. High polver 1-ielr- of' baboon renal heterotransplant from SD 4. a patient who was 
hypertensive. The heterografts were removed surgically after 49 da!-s. The photomicrograph shows 
part of a glomerular tuft IT) ,  a n  enlarged juxtaglomerular body ( JG) .  and the rnacula densa (md). 
The juxtaglomerular cells contain many cytoplasmic granules. Periodic acid-Schiff ( X  670). 
Tubular damage with evidence of regeneration was present in all the 
cases. This was most severe in SD 3 and SD 6, in both of whom there was ample 
clinical evidence of these changes (Fig. 172). Casts of protein and cell debris 
were frequent. 
Glomerular changes were not striking. There was some hypertrophy of 
the tufts in the case that functioned for 60 days [SD 31, the longest period 
for a baboon heterotransplant. Hyperplasia of the juxtaglomerular apparatus 
was present in the single hypertensil e patient (SD 4) (Fig. 173). 
It is apparent that there is simple eFidence of a rejection process in the 
baboon heterotransplants and that the cellular component of this is much more 
pronounced than in comparable human homotransplants. 
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RHESUS MONKEY-TO-MAN RENAL HETEROTRANSPLANT 
Both kidneys, the aorta, and the vena cava from a group A+ rhesus monkey 
were transplanted by Reemtsma and his colleagues into the right iliac fossa 
of a 32-year-old woman. The recipient was in terminal uremia from chronic 
pyelonephritis. Her blood group was A+. She was treated with azathioprine, 
steroids, actinomycin C ,  and azaserine. Urinary output was 3.5 liters on the first 
day, and the creatinine clearance rose to 24 ml per minute. At five days a 
rejection episode started. By seven days there was oliguria, and at 10 days the 
transplant was removed. 
There were several punctate hemorrhagic areas on the surface of the 
kidneys. Microscopically, there was marked cellular infiltration. This tended 
to be focal, and consisted of lymphocytes, pyroninophilic cells, some mature 
plasma cells, and a few neutrophils. Interstitial edema was present. Many of 
the arterioles and occasional interlobular arteries showed severe fibrinoid 
necrosis of their walls (Fig. 174), and there was extension of the process into 
some glomerular tufts. In places the necrotic wall was surrounded by neutro- 
phils. Hemorrhages and small pools of fibrin were seen in the interstitium ad- 
jacent to necrotic arteries. There was some tubular damage and a few red cell 
casts. 
Figure  174. Heterotransplanted rhesus monke)- kidne!- rr-hich ~ r a s  remor-ed from a patient a t  10 
days after it had ceased to function. There is gross fibrinoid necrosis of the rrall of an afferent 
arteriole !arrows:, with spread of the necrotic process into the tuft. The inrerstitium is edematous 
and heavily infiltrated rr-ith cells. There is tubular damage and loss. (This material was kindly 
provided by Doctor Keith Reemtsma.) H and E X 300). 
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These severe changes are I er> like those seen in some canine renal homo- 
transplants treated with imrnunosuppressi~ e drugs. in ~vhich the \ ascular 
component of the rejection process is .i ery prominent. 
CONCLUSIONS 
From the material discussed in this chapter it will have been seen that 
there are two important events which can bring about failure of renal homo- 
and heterotransplants: first, disruption of peritubular capillaries and venules 
caused by infiltrating host cells; and second, endothelial swelling and vaso- 
constriction of arterioles followed by fibrinoid necrosis of the walls of these and 
larger arteries. 
When a kidney is homotransplanted into a normal, healthy, nonuremic, 
untreated recipient, damage to the small peritubular vessels occurs early. 
This causes ischemic tubular necrosis, and is the main reason why the trans- 
plant ceases to excrete urine. Although fibrinoid necrosis of vessels is some- 
times seen in these cases, this only appears as a terminal event and apparently 
plays little part in bringing about failure of the transplant. 
When rejection occurs in a renal homotransplant the life of which has 
been prolonged by treatment for uremia, the fibrinoid necrotic lesions assume 
great importance. Once they have involved the interlobular or larger arteries, 
halting the rejection process will result only in healing and compensatory 
intimal thickening with fibrous narrowing of part of the intravenal arterial 
tree. Successive waves of damage and repair resulting from poorly controlled 
rejection episodes can lead to severe impairment of renal function and death. 
However, it is evident from the Denver series that with prompt and \ '1 'g orous 
treatment the earlier stage of arteriolar endothelial swelling and fibrinoid 
necrosis of arteriolar, as distinct from arterial walls, can be successfully re- 
paired, leaving no appreciable residual damage. 
On the basis of present information, which is admittedly rather scant, 
it would appear that a treated chimpanzee renal heterotransplant fares no 
worse in the early stages than a treated human renal homotransplant from an  
unrelated donor. It is clear, however, that baboon heterotransplants, and par- 
ticularly rhesus monkey transplants, invoke a fierce response on the part of 
the host despite any treatment that is available at present. In the resulting 
rejection process. cellular infiltration and peritubular capillary destruction 
are prominent earl!, features, but by nine days the vasculonecrotic element 
is marked. 
There is some circumstantial evidence to suggest that whereas the peri- 
tubular capillary damage is mediated by cell-bound antibody, the fibrinoid 
necrotic vascular lesions are caused by circulating antibody. 
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Chapter Twenty-six 
PRECEPTS OF RENAL 
HOMOTRANSPLANTATION APPLIED 
TO HOMOGRAFTING OF 
OTHER ORGANS 
In this book, the problems of tissue transplantation have been surveyed as 
they apply specifically to the kidney and its function. As an experimental 
model, this organ has unique advantages for the acquisition of knowledge 
which may have more general application. With renal homografts, the func- 
tional status of the kidney can be followed with precision using the specific 
measurements of urine volume, blood urea nitrogen, creatinine clearance, 
urine protein and urea, and blood pressure. The onset of rejection can be 
defined with accuracy. Inferential information concerning the mechanisms of 
tissue deterioration is available for analysis. as has been described. The effect 
of agents used for the prevention or reversal of rejection can be determined 
unequivocally since the transplanted kidney is essential for life. It is probable 
that at least some of these data will be useful in problems in~olv ing  other 
organs. 
Finally. the technical requirements which must be met have much in 
common with those to be anticipated in the employment of other tissues in 
clinical transplantation. inasmuch as the problems of ischemic injury. preser- 
vation, reconstitution of blood supply. and reconstruction of nonvascular vis- 
ceral passages are all essential details common to most organs. 
The first requirement before consideration of clinical transplantation of 
any organ is knowledge of the natural history of the untreated homograft. Only 
when this has been established will it be possible to intelligently diagnose and 
treat rejection. In working with 1i1-er homografts, for example, the pattern of 
rejection is considerably different from that n-hich had been expected. In dogs, a 
clinical picture of earl1 rejection is encountered which is indistinguishable 
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from that of obstructive jaundice, rather than that of diffuse parenchymal 
disease which might have been predicted. In pulmonary homografts, a well- 
integrated and distinctive pattern of rejection which could be used in day-to- 
day management has not yet emerged. M7ith the use of spleen, cardiac, and 
endocrine homografts, specific measurements are also required to guide appro- 
priate antirejection therapy. 
In addition to cataloging those factors which permit the diagnosis and 
treatment of rejection. it will be necessary in the case of each organ to 
establish means to differentiate the early functional impairment which occurs 
as a result of ischemic or traumatic injury from that consequent upon im- 
munologic attack by the host. As with cadaveric renal homografts, other 
organs obtained after death will be more difficult to use than those procured 
from living volunteers. The only available sources of most of the tissues in 
which there will be a future interest will be cadavers or lower animals (hetero- 
grafts) making the problems both more challenging and more difficult. 
The need for tissue of good quality for transplantation has been repeatedly 
stressed throughout this text. Successful management of the admittedly diffi- 
cult problem of renal homograft rejection has undoubtedly been rendered 
impossible in the past by the provision of irreparably damaged kidneys. It 
would seem unnecessary to travel this road of tragic experience for each new 
organ used in clinical treatment. Instead, vigorous efforts from the beginning 
should be directed toward shortening the period of ischemia, toward finding 
methods of effectlve storage, and toward exploring the possibilities of hetero- 
transplantation. 
The knowledge that most attempts at rejection can be rebersed provides 
the essential starting point in transplantation of any organ. The difficulty with 
which this is accomplished is subject to wide \ariation, necessitating such 
vigorous treatment in the more difficult cases as to endanger the life of the 
host. Nevertheless, that the usual rejection episode is both controllable and 
reversible makes it almost certain that homotransplantation of other organs 
will become a regular clinical service at some time in the future. It is possible 
that the intensit!, of the rejection process will vary with different tissues and 
organs. There is already evidence that pulmonary and cardiac homografts may 
be of low antigenicity. and that splenic and hepatic homografts may be the 
opposite. \Irhatever such differences might prove to be. the laws governing 
the onset, treatability, and rexersal of rejection should apply, at least in a 
general sense. 
The principle of host-graft adaptation will also haxe to be demonstrated 
for tissues other than the kidney. That adaptation appears to occur promptly 
and in a great many cases is perhaps the most fundamental and encouraging 
fact that has emerged from all previous experience with whole organ renal 
grafts. 
Although the kidney is one of the xital organs. cessation or serious deterio- 
ration of its function can be tolerated for protracted perlods because of the 
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availability of facilities for renal dialysis. In applying what was learned in 
renal homografting to the grafting of other organs, the prospect of acute 
temporary failure may be unacceptable. This is particularly true if one is 
considering the use of cardiac, pulmonary, or hepatic homografts in which 
complete loss of function even for short inter\-als would be fatal. In transplant- 
ing these organs. the prophylactic use of steroids as defined in Chapter 18 
may be useful. As has been described, the full vigor of a rejection attempt can 
often be tempered or prevented with this approach. Even with the most 
intense immunosuppressive therapy. however. temporary organ failure may 
ensue. This fact should promote efforts to develop better mechanical devices 
which could be used for interim treatment. In the eventuality of temporary 
homograft failure. the use of artificial livers or of prolonged cardiopulmonary 
by-pass during the treatment of a rejection crisis may be the only suitable type 
of treatment. 
Further demonstration will be required of the value of current immuno- 
suppressive regimens in preventing rejection of other organs. Imperfect as 
it is, the therapy described elsewhere in this text (see Chapters 14 to 18) is of 
proven worth for long-term renal homograft survival. but its value has not 
been nearly so well documented with hepatic, cardiac, pulmonary, or splenic 
homografts. It is conceivable that azathioprine has a relatively specific protec- 
tive effect for kidneys, a possibility that cannot be precluded until more is 
known of its mode of action and the degree of protection afforded to other 
alien tissues. In clinical practice, the addition of steroids to azathioprine 
greatly increases the likelihood of controlling renal hoinograft rejection, but 
these adjuvants have not extended survival in dogs after hepatic or pulmonary 
homotransplantation beyond that achieved with azathioprine alone. A con- 
tinuing search will therefore be necessary, not only for agents which will 
improve resul ts  with rena l  homotransplantat ion.  but for different im- 
munosuppressive methods which may be more decisively directed to the protec- 
tion of other kinds of homografts. 
Chapter Twenty-seven 
TECHNICAL TRIUMPH AND 
MORAL MUDDLE* 
b y  Chauncey D.  Leake, Ph.D., Sc.D., L.H.D. 
The major problems in organ transplantation are almost certain to have 
eventual and satisfadtory solutions. The technical surgical skill is already 
available. The immunological problem relating to the rejection of a trans- 
planted organ is more difficult, but the way to a satisfactory solution promises 
to be at hand. 
Experimental studies on the control of rejection factors are being success- 
fully applied to clinical practice in organ transplantation. 9Iercaptopurine 
compounds, such as azathioprine. combined with certain steroids such as 
prednisone, seen1 to block antibody formation sufficiently in many cases to allow 
a transplanted organ to surl-ive, even if obtained from an immunologically 
unrelated source. The problem is one of clinical judgment in achieving enough 
immunological block to permit the transplanted organ to sun-ive. without 
interfering \vith the long-range immune protection of the patient against infec- 
tion. 
Difficult moral questions are certain to accompany further progress in this 
field. These ethical problems in1 olve not on11 the physicians, patients. donors, 
and families, but also the social climate of opinion and understanding in the 
community. 
Let it be clear that the ethical problems of organ transplantation and dial- 
ysis are those of fundamental morality, and not thcse aspects of '#medical 
ethics" which are merely matters of professional etiquette. The situation can 
be serious. since after centuries of debate, the basic approaches to a satisfy- 
ing morality are not yet generally agreed upon. 
'This discussion is modlfied f1.0111 that offered at a Synposium on Organ Transplants and 
Dial>-sis held at Rochester. lIinnesota. l Iay 18. 1964, under the auspices of the Minnesota lledical 
Association. 
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EXCURSUS ETHICUS 
If we wish to make a reasonable approach to the ethical problems arising 
in connection with organ transplantation, it is wise to take a little excursion in 
order to become better acquainted with some of the complexities in the picture. 
It is unfortunate that philosophy is not ordinarily a part of the humanistic 
effort in our chaotic medical school curricula. Philosophy, however, is not popu- 
lar in any of our modish educational endeavors. This may simply be a result of 
the declining ability of philosophers to talk the common language, or it may 
come from a lack of enough leisure to permit the public to reflect upon philo- 
sophical issues. The resulting moral confusion may become overwhelming as  
population pressures continue to increase. 
There are several ethics. These are answers which have been proposed 
since antiquity to the basic question, "LT7hat is Good?" They are tentative and 
relative like the various answers to the other questions, "What is True?" and 
"What is Beautiful?" 
Various logics have been suggested in the effort to find the truth about 
ourselves and our environment. Aristotelian logic, based on the validity of 
certain assumptions and on principles of deduction, became so powerful in 
medieval Europe that the only answer permitted was "The Logic." Currently, 
scientific logic, dependent on precision of measurement, seems to be amazingly 
successful in telling us what is "true," or verifiable, about ourselves and our 
environment. 
Various esthetics try to obtain general acceptance about matters of taste 
and judgment. Similarly, various ethics try to win general public approval about 
motivations, interpersonal relations, individual and social goals and purposes, 
and about different sorts of moods and behavior. 
Part of our difficulty o ~ ~ e r  ethics results from the conditions of organization 
of living material: we tend to confuse, because we do not understand, the fac- 
tors operating at an i n d i t i d u u l  level of biological organization with those 
operating at a social  level. Individual "good" may not always coincide with 
social "good." Much of the histor) of the development of ethical theory is con* 
cerned with attempts to harmonize these often diverging conditions of indi- 
vidual and social welfare. 
It is not easy to trl to analyze our ethical predicament in a few paragraphs. 
The various ethics suggest I arious pzirposes as being worthy of our conscious 
life-long endeavor. \Te ma)- begin by considering biologically purposeful oper- 
ants. 
Biologically, as Paul AlcLean indicates, our purposes in lil ing are dependent 
on built-in drives which direct us toward satzsfnctzo~zs in a continually recur- 
ring search for food (necessary for self-preservation). and in the postpubertal 
desire for sexual experience (necessary for species preservation). The biological 
answer to that ancient question. "What do we li\ e for?" seems to be to obtain 
recurring satisfactions in our recurring driles for food and for sex. These 
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requirements are subject to conditioning, not only reflexly, but also at various 
levels of consciousness. 
In a more formally conventional manner, the earliest theory of ethical 
behavior suggested by the ancient Greeks was that which is called h e d o n i s m ,  
the proposition that our primary purpose is to obtain personal pleasure, and 
that our beha\-ior is based on maximizing our individual personal happiness. 
This is not as simple a matter as it may sound. Practical circumstances 
intervene, adjustments to others become necessary, and an  enlightened in- 
dividualism may emerge, as Warner Fite suggested. 
Hedonism, one may note. has overtones which are both epicurean and 
stoical. A more sophisticated ethic was proposed by Plato. This was the sugges- 
tion that the "true" good is social rather than individual, and that individual 
happiness is dependent on social welfare. Under P l a t o n i c  i d e a l i s m ,  which 
became the accepted Judeo-Christian ethic, an individual is expected uolz tntar-  
i ly to suffer sacrifice for the benefit of the social group. This ancient tribal 
ethic continues to trouble us, as when conventional Christianity, which also 
emphasizes individual worth, confronts authoritarianism, either within itself 
or in the surrounding environment. 
Attempts have been made to compromise hedonism and Platonic idealism. 
One such effort is utilitarianism, the principle of getting the "greatest good for 
the greatest number,' ' as proposed by John Stuart Mill in the nineteenth cen- 
tury. This turns out to be a calculated hedonism, however, as Fite has explained. 
Recently certain scientists, such as Julian Huxley and C. H. Waddington, 
have become interested in a scientific basis for an ethic. Clearly this is most 
readily done on the basis of evolutionary and survival factors. This trend, 
which started with E. G. Conklin, has been accelerated by the moral problems 
raised by applications of nuclear energy. Some philosophers, such as Max Otto, 
are particularly articulate about it. 
A quarter of a century ago a deliberate attempt was made to find a 
naturally operating ethic, which might function on survival values. This was 
developed by E. G. Conklin and myself, and was critically examined by Patrick 
Romanell. After considering the plethora of common experience in the every- 
day interplay of differing personalities, we induced a principle which seems 
to be naturally operative in governing interpersonal relations and the motives, 
purposes, and behaviors associated with them. The naturally operating ethical 
principle may be stated as follows: 
T h e  probab i l i t y  of t h e  s u r z i z n l  of a  r e l a t i o n s h i p  b e t z c e e n  i n d i z ' i d u a l s ,  o r  
g r o u p s  of  indiz~iclzlnls.  i n c r e a s e s  w i t h  t h e  d e g r e e  t o  z ~ ~ l z i c h  t h a t  r e l a t i o n s h i p  
i s  m u t u a l l y  s a t i s f y i n g .  
Clearly, if this principle is 1-alid, there are many significant consequences. 
If either party wishes a relationship to continue, it is necessary to do whatever 
can be done to make the relationship satisfying to the other party. This has 
overtones of what is called The Golden Rule. The principle also takes into 
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account the basic biological factor of satisfaction, an  emotional feeling as- 
sociated with the fulfillment of the dri1.e for food or sex. 
What does all this mean in regard to organ transplantation? At once, these 
ethical theories raise the iinmediate questions of motivation, of desires and 
goals. and of behavior. These questions will become of even greater impor- 
tance when organ transplantation becomes an increasingly successful thera- 
peutic method. 
MORAL PROBLEMS IN ORGAN 
TRANSPLANTATION 
Some of the problems raised in the field of organ transplantation have 
been surveyed by Joshua Lederberg, the distinguished Nobelate geneticist; by 
J .  Russell Elkinton, editor of the A72nuLs of In tern (11  M e d i c i n e :  and by Belding 
H. Scribner, who has defined five specific and practical moral questions 
confronting physicians and surgeons who are interested in renal transplanta- 
tion and dialysis. In addition, the ethical issues have been discussed in the lay 
press, some of the best analyses being those of Victor Cohn and those printed 
in L i f e  and Nez~lszueelz.  The relation of these questions to "medical ethics" is 
not so much concerned with medical etiquette between members of the medic- 
al profession as it is with the more basic morality explored by Fletcher which 
lies at  the heart of the patient-doctor relationship. 
It is interesting that the current situation is historically analogous to that 
present in the Seventeenth Century, when blood transfusion was first under- 
taken. At that time, blood transfusions failed tragically, because of scientific 
ignorance. Under these circumstances. the moral situation became clear: one 
could not undertake blood transfusion without the risk of death, and the whole 
matter was banned by social fiat. 
Two centuries lvere required to clarify the requirements for successful 
blood transfusion. It was only after Karl Landsteiner (1868-1943) classified 
blood-group incompatibilities that blood transfusion gradually became a suc- 
cessful and socially approved procedure. The resultant community blood banks' 
paved the way for the development of corneal. cartilage. skin, bone, and 
endocrine depots. These banks are stocked from cadar-eric sources and gener- 
ally require relati\-ely prompt utilization of the tissues. 
b'ith whole organ transplantation, it seems likely that technical skill and 
understanding will triumph much more rapidly than was the case n-ith blood 
transfusion. On the other hand, it seems that the moral problems which are 
invo1.i-ed may multiply. 
Joshua Lederberg has pointed out that the transplantation of hearts, livers, 
and even complete limbs mas- be relati\-ely easy within the next 20 years. 
Vigorous exploration of the necessary techniques is under way, not only in this 
country but also in Russia. The humanistic problems raised by the potential 
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success of these efforts are quite as serious in other parts of the world as they 
may be with us. 
Lederberg asks: \T7ho will choose which dying cardiac patients should get 
new hearts and who will control the decisions concerning storage or transplan- 
tation of the homografts? He concludes that the future of organ transplanta- 
tion, which may e\-en include efforts at eugenics, may result in serious contro- 
versy. All parents would be likely to insist that their children be given the 
intelligence of genius, if this were possible. \Tho will decide how to use our 
genetic pool. with possible transplantation of the organs of regeneration? 
These problems are too important to be entrusted to biomedical scientists or to 
members of the health professions. They require careful and detailed public 
study, with solutions dependent upon moral, social. and economic factors, and 
most important upon enlightened public opinion. 
Elkinton has criticall>- reviewed another aspect of the problem. Is the 
unknown life extension of the recipient patient worth the potential, though 
presumably slight. reduction in the life span of the donor? Many factors must 
be considered in decisions regarding organ transplantation, such as relative 
ages of the patients. their relative productiveness, their potential social contri- 
butions and value to the community, and the motivations of the individuals 
involved. As Victor Cohn has indicated, it is to the lasting credit of the 
health-team personnel concerned in these matters that these considerations 
are carefully weighed and that all aspects of the case are fully explored before 
the team decides to let nature take its course. or. on the contrary. to inter\-ene. 
Scribner. who is President of the American Society for Artificial Internal 
Organs, outlines five specific practical problems facing surgeons who are 
proposing kidney transplantation: ( I )  Out of the 10,000 or so who may die 
yearly from acute kidney disorder. ~ v h o  among the 50 or 100 that can be 
handled by presently a\-ailable kidnel- transplantation teams or by dialysis 
programs will be chosen? 12) Should homografts be obtained from the family 
or a friend. from anonymous volunteer donors. from cadavers. or from publicly 
maintained organ banks? ( 3 )  What should be done with the patient who may 
interfere with any therapy by means of a suicidal attempt? (4) Is there a 
violation of the patient's right to die when he is treated after the disease has 
run its natural course? and (5) In the case of dialysis, who should decide when 
it may have to be stopped, as in a patient who has suffered a stroke or a heart 
attack? 
Let us consider the situation from the standpoint of recipient and donor. 
Here is a patient for whom a transplant may be considered: anxious. trying to 
repress the unpleasing contelnplation of death, and perhaps appalled at the 
responsibility which is suddenly apparent of accepting something truly ~valu- 
able beyond price from sonleone else, Yet, in the case of e\-er>- ordinar>- patient, 
even if well self-disciplined, there is the n-ill to lil-e at an!- cost, to self or to 
anyone else. The moral position of the recipient is essentially the hedonistic 
one. 
Then there are the physicians - on the surface cool. collected, self-reliant in  
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technical skill, troubled only by the possibility of failure through lack of 
knowledge and experience in controlling the immune processes, and also 
worried a bit over the delicacies of obtaining a suitable and willing donor. The 
surgeon's ethical position is essentially that of the pragmatic utilitarian. 
Finally, there is the donor, often overeager to sacrifice because of some 
subconscious guilt complex. or simply happy to give something of great impor- 
tance for a loved one. Here is the personification of Platonic idealism on which 
our acceptable Judeo-Christian ethic is based. 
One might think that this categorization covers the interpersonal re- 
lationships involved in organ transplantation. Ho~ve\-er, the situation is much 
more complex. as a little reflection will reveal. Consider, for example, the 
somewhat related matter of blood transfusion, now a socially acceptable proce- 
dure. Despite this, there is continual difficulty in obtaining enough blood 
donors in spite of every inducement. Or consider the more emotionally charged 
problems of artificial insemination, which are still under vigorous social debate. 
In these examples, the scientific aspects have largely been solved, and risks 
to the donors are minimum. Nevertheless, difficulties remain, indicating how 
serious the moral problems associated with organ transplantation may prove 
to be. 
One of the most perplexing aspects of organ homotransplantation is that 
there is still a good possibility that the homograft will be rejected in spite of 
every effort at  immunosuppression. Should this happen, the recipient is clearly 
as poorly off as ever, and a volunteer donor is potentially worse. The recipient 
may- have gained a few more weeks of life. but what about the potential re- 
duction in the fullness of living for the donor, even if such subsequent limita- 
tions are purely psychological? The physicians involved can only have a sicken- 
ing feeling at having operated upon a healthy, well-motivated donor, without 
providing any real benefit to the recipient. 
Between recipient and donor. a two-way responsibility exists. If I am the 
sick person with a diseased organ that may be successfully removed and 
replaced by a transplant. am I justified in calling on el-en a close relative to 
yield a healthy organ merely to keep me alive for an  as yet undetermined 
period of time? If I am the healthy person and wish to be generous. would I be 
wise to sacrifice one of my healthy organs if I had heavy family responsibili- 
ties? 
The ethical issue for the donor is slight. Sacrifice is commended for 
generosity and for social welfare. yet sacrifice is not always justified even on 
the basis of social expediency, let alone enlightened self-interest. From the 
standpoint of the recipient. it does not seem that anyone has the right to expect 
that someone else .rvould rvillingly gi\-e up a healthy part of his or her body for 
the recipient's benefit. For the recipient the problem is complicated by our 
sentimentalized fear of death. Fesz of us ha\-e disciplined oursell-es to be 
willing to die with dignity and decency n-hen that time comes. 
The establishment of sociall>- acceptable organ banks might reduce some 
of the moral difficulties inherent in organ transplantation, but these are not 
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yet feasible. Even donations of organs at death to an organ bank might not be 
as simple as would be imagined. In addition, there may be emotional factors 
involved for recipients who receive tissues from unknown donors. 
It is apparent that a complex of psychosocial factors is in operation in the 
organ-transplant drama, not only with respect to the three principals (recipient, 
donor, and physician) but also with respect to the social environment in which 
each, respectively, moves. and in the larger environment of the whole com- 
munity. 
To maintain mutually satisfying interpersonal relationships under these 
conditions is difficult. It is doubtful if harmonious relations between recipient, 
donor, and physician and between these principals and their respective com- 
munities can be consistently maintained in the eventuality of failure. Al- 
though these interpersonal relations seem to be pleasant and promising in 
anticipation, maintenance of harmony is often very delicately balanced and 
partially dependent upon carrying the transplantation to a successful conclu- 
sion. The naturally operating ethical principle? of which I have spoken, con- 
tinues to exert its force, whether we are aware of it or not, and whether we like 
it or not. 
This ethicogenic principle. however, itself points to a way out. If those who 
are enmeshed in the particular interpersonal relationship under consideration 
and wish it to continue, then it is clearly incumbent upon each to do whatever 
is possible to make the relationship satisfying to the others. This does suggest 
the operation of The Golden Rule. 
If, in the case of organ transplantation, all those who are concerned will 
explore together the factors that are involved and reach some clear advance 
understanding between themselves on the matter, there may be hope for 
continued harmony among them. This requires calm, honest, and open discus- 
sion between the recipient, donor. and their respective families under the 
leadership of the physicians and, wisely, with the guidance of religious ad- 
visers. 
ETHICAL RESPONSIBILITIES OF PHYSICIANS 
From all this discussion. then. one may propose the basic ethical respon- 
sibilities of surgeons in organ transplantation: (1) to undertake nothing, except 
for purely investigational purposes, until the technical procedures are fully 
under control, including the as yet incompletely sols-ed immunological problem 
of transplant rejection: (2) to discuss the whole matter carefully and in detail 
with prospective recipient, proposed donor, their respecti\-e families, and their 
religious ads-isors. ( 3 )  to be well versed in ethical theory and in psychology, so 
that indis-idual motis-ations can be detected, exposed. and discussed: and (4) to 
be prepared to do everything possible to maintain harmonious Interpersonal 
relations betn een recipient, donor. families, and religious ads-isors, no matter 
what the outcome of the endeavor may be. 
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IN PROSPECT 
The moral problems of organ transplantation are not the exclusive respon- 
sibility of physicians, nor of biomedical scientists who may be working on the 
technical details which must be solved for greater clinical success. Nor are 
they the primary responsibility of prospective recipients or donors. They are 
the responsibility of all intelligent people. 
The chief responsibility of scientists and of members of the health profes- 
sions is to place all the verifiable information available before the rest of the 
medical profession. before interested public agencies which must provide 
financial support for these efforts, and before the public. In this way. the re- 
markable ad\-ances that have been witnessed in the past few years can be 
unified, not only in a scientific sense. but for the attainment of maximum social 
welfare. 
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APPENDIX 
Chapter Twenty-eight 
TRANSPLANTS AT THE UNIVERSITY 
OF COLORADO MEDICAL CENTER 
The following pages list in tabular form the details of each patient treated at 
Colorado General Hospital or the Denver Veterans Administration Hospital. 
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EPILOGUE 
September 1,1964 
In preparing this book, all statistics were brought up to date to June 1,1964. 
As of September 1, 1964, there have been no additional deaths in the first 55 
patients. Thus the statistics in Chapters 1 to 17 and Chapter 20 are valid as 
they stand, all 34 surviving patients within this first group of 55 now being six 
months or longer past operation. Within this group there are now 13 patients 
who are alive more than one year after transplantation. 
In the later patients, three additional deaths occurred (LD 56, LD 62, and 
LD 64). These deaths influence the statistics only in Chapter 18, the chapter 
concerned with an evaluation of steroid pretreatment. These additional deaths 
have eliminated the advantage that the steroid pretreated patients seemed to 
have enjoyed during the early postoperative course: the number of deaths was 
just as large, but did tend to occur at a later time. The three additional deaths 
occurred 151 (LD 56), 11 1 (LD 62), and 65 (LD 64) days after operation. 
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